31208-2,Specimen,SPEC,Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified,Specimen source,,Specimen source identified,,Specimen Nom (Specimen)
8462-4,Intravascular diastolic,BP.ATOM,Art sys; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.ATOM; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random,BP dias,mm Hg,Diastolic blood pressure,mm[Hg],
8480-6,Intravascular systolic,BP.ATOM,Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.ATOM; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP,BP sys,mm Hg,Systolic blood pressure,mm[Hg],
2160-0,Creatinine,CHEM,Chemistry; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Creat SerPl-mCnc,mg/dL,Creatinine [Mass/volume] in Serum or Plasma,mg/dL,Creatinine [Mass/Vol]
2951-2,Sodium,CHEM,Chemistry; Level; Na; Na+; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Sodium SerPl-sCnc,mmol/L,Sodium [Moles/volume] in Serum or Plasma,mmol/L,Sodium [Moles/Vol]
2345-7,Glucose,CHEM,Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Glucose SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma,mg/dL,Glucose [Mass/Vol]
2823-3,Potassium,CHEM,Chemistry; k; K+; Level; Pl; Plasma; Plsm; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Potassium SerPl-sCnc,mmol/L,Potassium [Moles/volume] in Serum or Plasma,mmol/L,Potassium [Moles/Vol]
2075-0,Chloride,CHEM,Chemistry; Cl; Cl-; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Chloride SerPl-sCnc,mmol/L,Chloride [Moles/volume] in Serum or Plasma,mmol/L,Chloride [Moles/Vol]
3094-0,Urea nitrogen,CHEM,Blood urea nitrogen; BUN; Chemistry; Kidney; Level; Mass concentration; N; N2; Nephrology; Nit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN; UniversalLabOrders,BUN SerPl-mCnc,mg/dL,Urea nitrogen [Mass/volume] in Serum or Plasma,mg/dL,Urea nitrogen [Mass/Vol]
17861-6,Calcium,CHEM,Ca; Cal; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Calcium SerPl-mCnc,mg/dL,Calcium [Mass/volume] in Serum or Plasma,mg/dL,Calcium [Mass/Vol]
2028-9,Carbon dioxide,CHEM,Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; tCO2; UniversalLabOrders,CO2 SerPl-sCnc,mmol/L,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",mmol/L,CO2 [Moles/Vol]
9279-1,Breaths,RESP.ATOM,Breathing; Count/time; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; RESP.ATOM; Respiratory rate; RS,Resp rate,{breaths}/min,Respiratory rate,{breaths}/min;{counts}/min,
786-4,Hemoglobin,HEM/BC,Auto; Automated detection; Elec; Elect; Electr; Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles,MCHC RBC Auto-EntMCnc,g/L;g/dL,MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count,g/dL,MCHC Auto (RBC) [Entitic Mass/Vol]
787-2,Observation,HEM/BC,Auto; Automated detection; Elec; Elect; Electr; Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles,MCV RBC Auto,fL,MCV [Entitic mean volume] in Red Blood Cells by Automated count,fL,MCV Auto (RBC) [Entitic mean vol]
785-6,Hemoglobin,HEM/BC,Auto; Automated detection; Elec; Elect; Electr; Entitic mass; Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles,MCH RBC Qn Auto,pg,MCH [Entitic mass] by Automated count,pg,MCH Auto (RBC) [Entitic mass]
789-8,Erythrocytes,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UniversalLabOrders; WB; Whole blood,RBC # Bld Auto,10*12/L,Erythrocytes [#/volume] in Blood by Automated count,10*6/uL,RBC Auto (Bld) [#/Vol]
718-7,Hemoglobin,HEM/BC,Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Hgb Bld-mCnc,g/dL,Hemoglobin [Mass/volume] in Blood,g/dL,Hemoglobin (Bld) [Mass/Vol]
8867-4,Heart rate,HRTRATE.ATOM,Count/time; Heart beat; HEART RATE.ATOM; Misc; Miscellaneous; nRate; Number rate; Number Rate = Count/Time; Other; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified,Heart rate,{beats}/min,Heart rate,{beats}/min;{counts}/min,
788-0,Erythrocyte,HEM/BC,Auto; Automated detection; Blood; Discocyte; Elec; Elect; Electr; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,Erythrocyte DistWidth Bld Auto,%,Erythrocyte [DistWidth] in Blood by Automated count,%,Erythrocyte Auto (Bld) [DistWidth]
777-3,Platelets,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes; UniversalLabOrders; WB; Whole blood,Platelet # Bld Auto,10*9/L,Platelets [#/volume] in Blood by Automated count,10*3/uL,Platelets Auto (Bld) [#/Vol]
6690-2,Leukocytes,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,WBC # Bld Auto,10*9/L,Leukocytes [#/volume] in Blood by Automated count,10*3/uL,WBC Auto (Bld) [#/Vol]
1975-2,Bilirubin,CHEM,Bili; Bilirubins; Billirubin; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL; UniversalLabOrders,Bilirub SerPl-mCnc,mg/dL,Bilirubin.total [Mass/volume] in Serum or Plasma,mg/dL,Bilirubin [Mass/Vol]
2885-2,Protein,CHEM,Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Prot SerPl-mCnc,g/L;g/dL,Protein [Mass/volume] in Serum or Plasma,g/dL,Protein [Mass/Vol]
1742-6,Alanine aminotransferase,CHEM,Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; Hepatology; L-alanine; Liver; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGPT; SR; UniversalLabOrders,ALT SerPl-cCnc,arb U/L,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,U/L,ALT [Catalytic activity/Vol]
32623-1,Platelet,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; WB; Whole blood,PMV Bld Auto,fL,Platelet [Entitic mean volume] in Blood by Automated count,fL,Platelet Auto (Bld) [Entitic mean vol]
6768-6,Alkaline phosphatase,CHEM,Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; AP; Catalytic Concentration; Chemistry; Hepatology; Liver; MSK; Musculoskeletal; Ortho; Orthopedics; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,ALP SerPl-cCnc,arb U/L,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,U/L,ALP [Catalytic activity/Vol]
1920-8,Aspartate aminotransferase,CHEM,Asp; Aspartate amino transferase; Aspartate transaminase; Aspartic acid; AST; Catalytic Concentration; Chemistry; Glutamic oxaloacetic transaminase; Hepatology; Liver; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGOT; SR; UniversalLabOrders,AST SerPl-cCnc,arb U/L,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,U/L,AST [Catalytic activity/Vol]
4544-3,Erythrocyte/Blood,HEM/BC,Auto; Automated detection; Blood; Discocyte; Elec; Elect; Electr; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Volfr; Volume fraction; WB; Whole blood,Hct VFr Bld Auto,L/L;%,Hematocrit [Volume Fraction] of Blood by Automated count,%,Hematocrit Auto (Bld) [Volume fraction]
10466-1,Anion gap,CHEM,Ag; AnGAP; Calc; Calculation; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,Anion Gap SerPl Calculated.3Ions-sCnc,mmol/L,Anion gap in Serum or Plasma by Calculated.3Ions,mmol/L,Anion gap Calculated.3Ions [Moles/Vol]
751-8,Neutrophils,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Neut; Neutr; Neutrophil; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Neutrophils # Bld Auto,10*9/L,Neutrophils [#/volume] in Blood by Automated count,10*3/uL,Neutrophils Auto (Bld) [#/Vol]
704-7,Basophils,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Baso; Basophil; Basos; Blood; Bph; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Basophils # Bld Auto,10*9/L,Basophils [#/volume] in Blood by Automated count,10*3/uL,Basophils Auto (Bld) [#/Vol]
742-7,Monocytes,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Mono; Monocyte; Monos; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Monocytes # Bld Auto,10*9/L,Monocytes [#/volume] in Blood by Automated count,10*3/uL,Monocytes Auto (Bld) [#/Vol]
731-0,Lymphocytes,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Lymphocytes # Bld Auto,10*9/L,Lymphocytes [#/volume] in Blood by Automated count,10*3/uL,Lymphocytes Auto (Bld) [#/Vol]
711-2,Eosinophils,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Eosinophil # Bld Auto,10*9/L,Eosinophils [#/volume] in Blood by Automated count,10*3/uL,Eosinophils Auto (Bld) [#/Vol]
770-8,Neutrophils/Leukocytes,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neutrophils NFr Bld Auto,%,Neutrophils/Leukocytes in Blood by Automated count,%,Neutrophils/Leukocytes Auto (Bld)
5905-5,Monocytes/Leukocytes,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Monocytes NFr Bld Auto,%,Monocytes/Leukocytes in Blood by Automated count,%,Monocytes/Leukocytes Auto (Bld)
736-9,Lymphocytes/Leukocytes,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Lymphocytes NFr Bld Auto,%,Lymphocytes/Leukocytes in Blood by Automated count,%,Lymphocytes/Leukocytes Auto (Bld)
33914-3,Glomerular filtration rate,CHEM,Chemistry; GFR; Glom; Modification of Diet in Renal Disease; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Square Meter; SR; Volume rate/area; Volume Rate/Ratio,GFR SerPl Creatinine-bsd frml MDRD,mL/min; ml/min/1.73m2,Glomerular filtration rate [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD)/1.73 sq M,mL/min/{1.73_m2},GFR Creatinine-based formula (MDRD)/1.73 sq M [Vol rate/Area]
1751-7,Albumin,CHEM,Alb; Chemistry; Hepatology; Kidney; Level; Liver; Mass Concentration; Nephrology; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Albumin SerPl-mCnc,g/L;g/dL; mg/dL,Albumin [Mass/volume] in Serum or Plasma,g/dL,Albumin [Mass/Vol]
20570-8,Erythrocyte/Blood,HEM/BC,Blood; Calc; Calculation; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UniversalLabOrders; Volfr; Volume fraction; WB; Whole blood,Hct VFr Bld Calc,%,Hematocrit [Volume Fraction] of Blood by calculation,%,Hematocrit Calc (Bld) [Volume fraction]
713-8,Eosinophils/Leukocytes,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Eosinophil NFr Bld Auto,%,Eosinophils/Leukocytes in Blood by Automated count,%,Eosinophils/Leukocytes Auto (Bld)
706-2,Basophils/Leukocytes,HEM/BC,Auto; Automated detection; Baso; Basophil; Basos; Blood; Bph; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Basophils NFr Bld Auto,%,Basophils/Leukocytes in Blood by Automated count,%,Basophils/Leukocytes Auto (Bld)
8661-1,Chief complaint,H&P.HX,Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random,Chief complaint Reported,,Chief complaint - Reported,,
29463-7,Body weight,BDYWGT.ATOM,AOEObservation; Bdy weight; bod; Bodies; BODY WEIGHT.ATOM; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt,Weight,pounds;kilograms,Body weight,[lb_av];kg,
11556-8,Oxygen,CHEM,Blood; Chemistry; Lung; O2; O2 partial pressure; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; WB; Whole blood,pO2 Bld,mm Hg,Oxygen [Partial pressure] in Blood,mm[Hg],Oxygen (Bld) [Partial pressure]
8302-2,Body height,BDYHGT.ATOM,AOEObservation; Axial length; bod; Bodies; BODY HEIGHT(LENGTH).ATOM; Body length; Length; Point in time; QNT; Quan; Quant; Quantitative; Random,Body height,inches; cm,Body height,[in_us];cm;m,
39156-5,Body mass index,BDYWGT.ATOM,BMI; bod; Bodies; BODY WEIGHT.ATOM; Point in time; QNT; Quan; Quant; Quantitative; Quetelet index; Random; Ratios; Rto,BMI,kg/m2,Body mass index (BMI) [Ratio],kg/m2,
48643-1,Glomerular filtration rate,CHEM,"Blood; Chemistry; GFR; Glom; Kidney; Modification of Diet in Renal Disease; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood",GFR SerPlBld Creatinine-bsd fmla /1.73sq,mL/min; ml/min/1.73m2,"Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M among black population",mL/min/{1.73_m2},GFR Creatinine-based formula (MDRD)/1.73 sq M among black population (S/P/Bld) [Vol rate/Area]
8310-5,Body temperature,BDYTMP.ATOM,Bdy temp; bod; Bodies; BODY TEMPERATURE.ATOM; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature,Body temperature,deg C,Body temperature,Cel,
48642-3,Glomerular filtration rate,CHEM,"Blood; Chemistry; GFR; Glom; Kidney; Modification of Diet in Renal Disease; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood",GFR/BSA pr.non blk SerPlBld MDRD-ArV,mL/min; ml/min/1.73m2,"Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M among non black population",mL/min/{1.73_m2},GFR Creatinine-based formula (MDRD)/1.73 sq M among non black population (S/P/Bld) [Vol rate/Area]
19123-9,Magnesium,CHEM,Chemistry; Level; MAG; Magnes; Mass concentration; Mg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Magnesium SerPl-mCnc,mg/dL,Magnesium [Mass/volume] in Serum or Plasma,mg/dL,Magnesium [Mass/Vol]
2339-0,Glucose,CHEM,Blood; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Glucose Bld-mCnc,mg/dL,Glucose [Mass/volume] in Blood,mg/dL,Glucose (Bld) [Mass/Vol]
38518-7,Granulocytes.immature/Leukocytes,HEM/BC,Blood; Gran; Grans; Granulocyte; Granulocytes; HEMATOLOGY/CELL COUNTS; Imm; Imm Granulocytes; Immat; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Imm Granulocytes NFr Bld,%,Immature granulocytes/Leukocytes in Blood,%,Immature granulocytes/Leukocytes (Bld)
5902-2,Coagulation tissue factor induced,COAG,Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Hematology; Heme; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PT; QNT; Quan; Quant; Quantitative; Random; Tilt tube; UniversalLabOrders,Prothrombin time,s,Prothrombin time (PT),s,PT Coag (PPP) [Time]
2777-1,Phosphate,CHEM,Chemistry; i Phos; Inorganic phosphate; Level; Mass concentration; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; Plsm; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Phosphate SerPl-mCnc,mg/dL,Phosphate [Mass/volume] in Serum or Plasma,mg/dL,Phosphate [Mass/Vol]
41653-7,Glucose,CHEM,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Endocrine; Endocrinology; Finger stick; Glu; Gluc; Glucomtr; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders,Glucose BldC Glucomtr-mCnc,mg/dL,Glucose [Mass/volume] in Capillary blood by Glucometer,mg/dL,Glucose Glucometer (BldC) [Mass/Vol]
30353-7,Hemoglobin,HEM/BC,Bld cord; Cord BldV; Cord venous blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random,Hgb BldCoV-mCnc,g/dL,Hemoglobin [Mass/volume] in Venous cord blood,g/dL,Hemoglobin (BldCoV) [Mass/Vol]
74774-1,Glucose,CHEM,"Blood; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; LimitedUseLabOrders; Mass Concentration; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood",Glucose SerPlBld-mCnc,mg/dl,"Glucose [Mass/volume] in Serum, Plasma or Blood",mg/dL,Glucose (S/P/Bld) [Mass/Vol]
58413-6,Erythrocytes.nucleated/Leukocytes,HEM/BC,Auto; Automated detection; Blood; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Normoblasts; nRBC; nRBCs; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Rto; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,nRBC Bld Auto-Rto,%,Nucleated erythrocytes/Leukocytes [Ratio] in Blood by Automated count,%,Nucleated RBC/Leukocytes Auto (Bld) [Ratio]
71695-1,Granulocytes.immature/Leukocytes,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; Gran; Grans; Granulocyte; Granulocytes; HEMATOLOGY/CELL COUNTS; Imm; Imm Granulocytes; Immat; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Imm Granulocytes NFr Bld Auto,%,Immature granulocytes/Leukocytes in Blood by Automated count,%,Immature granulocytes/Leukocytes Auto (Bld)
2093-3,Cholesterol,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Cholest SerPl-mCnc,mg/dL,Cholesterol [Mass/volume] in Serum or Plasma,mg/dL,Cholesterol [Mass/Vol]
2085-9,Cholesterol.in HDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL; UniversalLabOrders,HDLc SerPl-mCnc,mg/dL,Cholesterol in HDL [Mass/volume] in Serum or Plasma,mg/dL,Cholesterol in HDL [Mass/Vol]
2514-8,Ketones,CHEM,Acetest; Acetoacetate; Acetoacetates; Acetone bodies; Chemistry; Dip stick; Dipstick; Ketone; Ketone bodies; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn,Ketones Ur Ql Strip,,Ketones [Presence] in Urine by Test strip,,Ketones Test strip Ql (U)
94500-6,SARS coronavirus 2 RNA,MICRO,2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus,SARS-CoV-2 RNA Resp Ql NAA+probe,,SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection,,SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Respiratory system specimen)
2571-8,Triglyceride,CHEM,Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; Trig; Trigly; Triglycerides; Triglycrides; UniversalLabOrders,Trigl SerPl-mCnc,mg/dL,Triglyceride [Mass/volume] in Serum or Plasma,mg/dL,Triglyceride [Mass/Vol]
26478-8,Lymphocytes/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Lymphocytes NFr Bld,%,Lymphocytes/Leukocytes in Blood,%,Lymphocytes/Leukocytes (Bld)
26464-8,Leukocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,WBC # Bld,/uL,Leukocytes [#/volume] in Blood,10*3/uL,WBC (Bld) [#/Vol]
5778-6,Observation,SPEC,Nominal; Point in time; Random; SPEC; UA; UR; Urn,Color Ur,,Color of Urine,,Color (U)
26485-3,Monocytes/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Monocytes NFr Bld,%,Monocytes/Leukocytes in Blood,%,Monocytes/Leukocytes (Bld)
26515-7,Platelets,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes; UniversalLabOrders; WB; Whole blood,Platelet # Bld,10*3/mm3,Platelets [#/volume] in Blood,10*3/uL,Platelets (Bld) [#/Vol]
26450-7,Eosinophils/Leukocytes,HEM/BC,Blood; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Eosinophil NFr Bld,%,Eosinophils/Leukocytes in Blood,%,Eosinophils/Leukocytes (Bld)
49024-3,Differential cell count method,HEM/BC,Blood; Diff; Differential method; Differl; Differn; HEMATOLOGY/CELL COUNTS; Meth; Method of; Nominal; Point in time; Random; Typ; WB; Whole blood,Differential method Bld,,Differential cell count method - Blood,,Differential cell count method Nom (Bld)
61151-7,Albumin,CHEM,Alb; Chemistry; Hepatology; Kidney; Level; Liver; Mass Concentration; Nephrology; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Albumin SerPl BCG-mCnc,g/dl,Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method,g/dL,Albumin BCG dye [Mass/Vol]
30180-4,Basophils/Leukocytes,HEM/BC,Baso; Basophil; Basos; Blood; Bph; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Basophils NFr Bld,%,Basophils/Leukocytes in Blood,%,Basophils/Leukocytes (Bld)
13457-7,Cholesterol.in LDL,CHEM,Calc; Calculation; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,LDLc SerPl Calc-mCnc,mg/dL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation,mg/dL,Cholesterol in LDL Calc [Mass/Vol]
51584-1,Granulocytes.immature,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Gran; Grans; Granulocyte; Granulocytes; HEMATOLOGY/CELL COUNTS; Imm; Imm Granulocytes; Immat; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Imm Granulocytes # Bld,10*9/L,Immature granulocytes [#/volume] in Blood,10*3/uL,Immature granulocytes (Bld) [#/Vol]
630-4,Bacteria,MICRO,Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UA; UniversalLabOrders; UR; Urn,Bacteria Ur Cult,,Bacteria identified in Urine by Culture,,Bacteria identified Cx Nom (U)
59408-5,Oxygen saturation,PULM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Lung; Mass Fraction; O2; Percent; Point in time; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2,SaO2 % BldA PulseOx,%,Oxygen saturation in Arterial blood by Pulse oximetry,%,
28542-9,Platelet,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; WB; Whole blood,PMV Bld,fL,Platelet [Entitic mean volume] in Blood,fL,Platelet (Bld) [Entitic mean vol]
5799-2,Leukocyte esterase,UA,Dip stick; Dipstick; Leuc; Leuk; Leukocytes; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells,Leukocyte esterase Ur Ql Strip,,Leukocyte esterase [Presence] in Urine by Test strip,,Leukocyte esterase Test strip Ql (U)
5767-9,Observation,SPEC,Appearance; Nominal; Point in time; Random; SPEC; UA; UR; Urn,Appearance Ur,,Appearance of Urine,,Appearance (U)
2341-6,Glucose,CHEM,Blood; Chemistry; Dip stick; Dipstick; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; Manl; Manual Strip; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Glucose Bld Manual Strip-mCnc,mg/dL,Glucose [Mass/volume] in Blood by Test strip manual,mg/dL,Glucose Test strip manual (Bld) [Mass/Vol]
24321-2,Basic metabolic 2000 panel,PANEL.CHEM,00; Bas Metab 2000 Pnl; BMP; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Bas Metab 2000 Pnl SerPl,,Basic metabolic 2000 panel - Serum or Plasma,,Basic metabolic 2000 panel
5802-4,Nitrite,UA,Dip stick; Dipstick; NO2; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Nitrite Ur Ql Strip,,Nitrite [Presence] in Urine by Test strip,,Nitrite Test strip Ql (U)
9830-1,Cholesterol.total/Cholesterol.in HDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Lipid; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TC; TCHHDL; Tot; Totl,Cholest/HDLc SerPl,ratio,Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,{ratio},Cholesterol.total/Cholesterol in HDL [Mass ratio]
24323-8,Comprehensive metabolic 2000 panel,PANEL.CHEM,00; Chemistry; CMP; Comp Metab 2000 Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Comp Metab 2000 Pnl SerPl,,Comprehensive metabolic 2000 panel - Serum or Plasma,,Comprehensive metabolic 2000 panel
4548-4,Hemoglobin A1c/Hemoglobin.total,CHEM,Blood; Chemistry; Endocrine; Endocrinology; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; Hgb; Hgb A1c; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,HbA1c MFr Bld,%,Hemoglobin A1c/Hemoglobin.total in Blood,%,HbA1c (Bld) [Mass fraction]
5803-2,pH,UA,Dip stick; Dipstick; Kidney; Log molar concentration; Nephrology; Point in time; Random; Renal; SmQn; UA; UniversalLabOrders; UR; URINALYSIS; Urn,pH Ur Strip,pH,pH of Urine by Test strip,[pH],pH Test strip (U)
21612-7,Age,MISC,MISC; Point in time; QNT; Quan; Quant; Quantitative; Random,Age - Reported,years,Age - Reported,a,Age - Reported
5792-7,Glucose,UA,Dip stick; Dipstick; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; Random; SmQn; UA; UniversalLabOrders; UR; URINALYSIS; Urn,Glucose Ur Strip-mCnc,mg/dL,Glucose [Mass/volume] in Urine by Test strip,mg/dL,Glucose Test strip (U) [Mass/Vol]
6301-6,Coagulation tissue factor induced.INR,COAG,Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Hematology; Heme; Internat norm ratio; International normal ratio; International normalization ratio; International normalized ratio; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Prothrombin time INR; Protime; Protime INR; PT; PT INR; QNT; Quan; Quant; Quantitative; Random; RlTm; Tilt tube,INR PPP,INR,INR in Platelet poor plasma by Coagulation assay,{INR},INR Coag (PPP) [Relative time]
14979-9,Coagulation surface induced,COAG,Activated partial thromboplastin time; aPTT; Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube; UniversalLabOrders,aPTT PPP,s,aPTT in Platelet poor plasma by Coagulation assay,s,aPTT Coag (PPP) [Time]
2965-2,Observation,CHEM,Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Sp Gr; UA; UniversalLabOrders; UR; Urn,Sp Gr Ur,,Specific gravity of Urine,,Specific gravity (U)
33037-3,Anion gap,CHEM,Ag; AnGAP; Calc; Calculation; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,Anion Gap SerPl Calc-sCnc,mmol/L,Anion gap in Serum or Plasma by calculation,mmol/L,Anion gap Calc [Moles/Vol]
30385-9,Erythrocyte,HEM/BC,Blood; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,Erythrocyte DistWidth Bld,%,Erythrocyte [DistWidth] in Blood,%,Erythrocyte (Bld) [DistWidth]
30428-7,Observation,HEM/BC,Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles,MCV RBC,fL,MCV [Entitic mean volume] in Red Blood Cells,fL,MCV (RBC) [Entitic mean vol]
5794-3,Hemoglobin,UA,Blood; Dip stick; Dipstick; Haemoglobin; Hb; Hgb; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Hgb Ur Ql Strip,,Hemoglobin [Presence] in Urine by Test strip,,Hemoglobin Test strip Ql (U)
26453-1,Erythrocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,RBC # Bld,10*12/L,Erythrocytes [#/volume] in Blood,10*6/uL,RBC (Bld) [#/Vol]
3016-3,Thyrotropin,CHEM,Arbitrary concentration; Chemistry; Endocrine; Endocrinology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH; UniversalLabOrders,TSH SerPl-aCnc,mIU/L;mcU/mL; mU/L; U IU/mL,Thyrotropin [Units/volume] in Serum or Plasma,m[IU]/L,TSH Qn
1759-0,Albumin/Globulin,CHEM,Alb; Chemistry; GLB; Glob; Glob%; Globul; Globulins; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Albumin/Glob SerPl,ratio,Albumin/Globulin [Mass Ratio] in Serum or Plasma,{ratio},Albumin/Globulin [Mass ratio]
600-7,Bacteria,MICRO,Bact; Blood; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders; WB; Whole blood,Bacteria Bld Cult,,Bacteria identified in Blood by Culture,,Bacteria identified Cx Nom (Bld)
5797-6,Ketones,UA,Acetest; Acetoacetate; Acetoacetates; Acetone bodies; Dip stick; Dipstick; Ketone; Ketone bodies; Level; Mass concentration; Point in time; Random; SmQn; UA; UniversalLabOrders; UR; URINALYSIS; Urn,Ketones Ur Strip-mCnc,mg/dL,Ketones [Mass/volume] in Urine by Test strip,mg/dL,Ketones Test strip (U) [Mass/Vol]
28539-5,Hemoglobin,HEM/BC,Entitic mass; Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles,MCH RBC Qn,pg,MCH [Entitic mass],pg,MCH (RBC) [Entitic mass]
27353-2,Estimated average glucose,CHEM,Blood; Chemistry; eAG; eAVG; Endocrine; Endocrinology; Est; Est. average glucose; estimation; gHb Est; Glu; Gluc; Glucose mean value; Glucoseur; Glycos; Glycosylated; Level; Mass concentration; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Est. average glucose Bld gHb Est-mCnc,mg/dL,Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin,mg/dL,Average glucose Estimated from glycated hemoglobin (Bld) [Mass/Vol]
21020-3,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Anaerobe+Aerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,Bacteria Spec Anaerobe+Aerobe Cult,,Bacteria identified in Specimen by Anaerobe+Aerobe culture,,Bacteria identified Anaer+Aer cx Nom (Specimen)
10839-9,Troponin I.cardiac,CHEM,Cardio; Cardiology; Chemistry; cTnI; Heart Disease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TnI; TrI; Trop I; Troponin; UniversalLabOrders,Troponin I SerPl-mCnc,ug/L;ng/mL,Troponin I.cardiac [Mass/volume] in Serum or Plasma,ng/mL,Troponin I.cardiac [Mass/Vol]
13945-1,Erythrocytes,UA,#/area; Discocytes; Erthrocyte; Erythrocyte; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,RBC #/area UrnS HPF,/HPF,Erythrocytes [#/area] in Urine sediment by Microscopy high power field,/[HPF],RBC LM.HPF (Urine sed) [#/Area]
3097-3,Urea nitrogen/Creatinine,CHEM,Blood urea nitrogen; BUN; Chemistry; CR; Crea; Creat; Kidney; Mass concentration ratio; Mass ratio; MCRto; N; N2; Nephrology; Nit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN; UniversalLabOrders,BUN/Creat SerPl,mg/mg creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,mg/mg{creat},Urea nitrogen/Creatinine [Mass ratio]
26449-9,Eosinophils,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Eosinophil # Bld,/uL,Eosinophils [#/volume] in Blood,10*3/uL,Eosinophils (Bld) [#/Vol]
26484-6,Monocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Mono; Monocyte; Monos; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Monocytes # Bld,10*3/mm3,Monocytes [#/volume] in Blood,10*3/uL,Monocytes (Bld) [#/Vol]
26474-7,Lymphocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Lymphocytes # Bld,/uL,Lymphocytes [#/volume] in Blood,10*3/uL,Lymphocytes (Bld) [#/Vol]
28540-3,Hemoglobin,HEM/BC,Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles,MCHC RBC-EntMCnc,g/dL,MCHC [Entitic Mass/volume] in Red Blood Cells,g/dL,MCHC (RBC) [Entitic Mass/Vol]
24358-4,Hemogram WO platelets panel,PANEL.HEM/BC,Blood; CBC WO Platelets; Complete Blood Count; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Platelet; Platelets Pnl; Platelt; Plt; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood,CBC WO Platelets Bld,,Hemogram without Platelets panel - Blood,,Hemogram without Platelets panel (Bld)
3141-9,Body weight,BDYWGT.ATOM,Bdy weight; bod; Bodies; BODY WEIGHT.ATOM; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt,Weight Measured,gm;kg;lb-oz,Body weight Measured,[lb_av];kg,
43396-1,Cholesterol.non HDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL + IDL + VLDL; Level; Lipid; Mass concentration; NonHDLc; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,NonHDLc SerPl-mCnc,mg/dL,Cholesterol non HDL [Mass/volume] in Serum or Plasma,mg/dL,Cholesterol non HDL [Mass/Vol]
8251-1,Service comment,MISC,cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Spec; To be specified in another part of the message; Unspecified,Service Cmnt-Imp,,Service comment,,Service comment [Interp]
26499-4,Neutrophils,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Neut; Neutr; Neutrophil; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Neutrophils # Bld,10*3/mm3,Neutrophils [#/volume] in Blood,10*3/uL,Neutrophils (Bld) [#/Vol]
63638-1,Smoking status,PHENX,Finding; Findings; Nominal; PhenX; Point in time; Random,Smoking status FTND,,Smoking status [FTND],,
5821-4,Leukocytes,UA,#/area; Kidney; Leuc; Leuk; Leukocyte; Lkcs; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBCs; White blood cell; White blood cells,WBC #/area UrnS HPF,/HPF,Leukocytes [#/area] in Urine sediment by Microscopy high power field,/[HPF],WBC LM.HPF (Urine sed) [#/Area]
13458-5,Cholesterol.in VLDL,CHEM,Calc; Calculation; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Very low density lipoprotein cholesterols; VLDLc,VLDLc SerPl Calc-mCnc,mg/dL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation,mg/dL,Cholesterol in VLDL Calc [Mass/Vol]
3040-3,Triacylglycerol lipase,CHEM,Catalytic Concentration; Chemistry; LIPA; Lipase; LPS; Pancreatic lipase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Steapsin; Tributyrase; Tributyrinase; UniversalLabOrders,Lipase SerPl-cCnc,arb U/L,Lipase [Enzymatic activity/volume] in Serum or Plasma,U/L,Lipase [Catalytic activity/Vol]
41276-7,Anion gap,CHEM,Ag; AnGAP; Blood; Calc; Calculation; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood,Anion Gap Bld Calc-sCnc,mmol/L,Anion gap in Blood by calculation,mmol/L,Anion gap Calc (Bld) [Moles/Vol]
50558-6,Nitrite,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; NO2; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Nitrite Ur Ql Strip.auto,,Nitrite [Presence] in Urine by Automated test strip,,Nitrite Auto test strip Ql (U)
11557-6,Carbon dioxide,CHEM,Blood; Carbonic anhydride; Chemistry; CO2; Lung; Partial pressure; PCO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; WB; Whole blood,pCO2 Bld,mm Hg,Carbon dioxide [Partial pressure] in Blood,mm[Hg],CO2 (Bld) [Partial pressure]
72514-3,Pain severity - 0-10 verbal numeric rating,H&P.HX,H+P; H+P.HX; P prime; Pain severity 0-10; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale,Pain severity 0-10 Score Reported,score,Pain severity - 0-10 verbal numeric rating [Score] - Reported,{score},
35591-7,Creatinine renal clearance.predicted,CHEM,C-G; Chemistry; Cl; Cl predicted; Clear; Clearanc; Clearances; Clr; Cockroft-Gault formula; CR; Crea; Creat; Flow; Kidney; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Volume rate; vRate,Creat Cl predicted SerPl C-G-vRate,mL/min,Creatinine renal clearance predicted by Cockcroft-Gault formula,mL/min,Creatinine renal clearance predicted Cockcroft-Gault formula [Vol/Time]
1988-5,C reactive protein,CHEM,Chemistry; CRP; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Reac; React; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,CRP SerPl-mCnc,mg/L;mcg/mL; mg/dL,C reactive protein [Mass/volume] in Serum or Plasma,mg/L,CRP [Mass/Vol]
66418-5,Patient type,PHENX,Finding; Findings; Nominal; Point in time; Random,Patient type PhenX,,Patient type [PhenX],,
50560-2,pH,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Kidney; Log molar concentration; Nephrology; Point in time; Random; Renal; SmQn; UA; UR; URINALYSIS; Urn,pH Ur Strip.auto,pH,pH of Urine by Automated test strip,[pH],pH Auto test strip (U)
1968-7,Bilirubin.glucuronidated+Bilirubin.albumin bound,CHEM,Alb; Associated; Bc; Bili; Bili.delta; Bili-alb; Bilirub Conj; Bilirub Delta; Bilirub Direct; Bilirubin conjugated; Bilirubin direct; Bilirubin glucuronides; Bilirubins; Billirubin; bnd; Chemistry; DELB; Delta bilirubin; Deltab; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL; TBIL-(Bu+Bc); TBIL-Bu; UniversalLabOrders,Bilirub Direct SerPl-mCnc,mg/dL,Bilirubin.direct [Mass/volume] in Serum or Plasma,mg/dL,Bilirubin.direct [Mass/Vol]
53115-2,Granulocytes.immature,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Gran; Grans; Granulocyte; Granulocytes; HEMATOLOGY/CELL COUNTS; Imm; Imm Granulocytes; Immat; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Imm Granulocytes # Bld Auto,10*9/L,Immature granulocytes [#/volume] in Blood by Automated count,10*3/uL,Immature granulocytes Auto (Bld) [#/Vol]
2887-8,Protein,UA,Kidney; Nephrology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urn,Prot Ur Ql,,Protein [Presence] in Urine,,Protein Ql (U)
3024-7,Thyroxine.free,CHEM,Chemistry; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4; UniversalLabOrders,T4 Free SerPl-mCnc,ng/dL,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,ng/dL,Free T4 [Mass/Vol]
50557-8,Ketones,UA,Acetest; Acetoacetate; Acetoacetates; Acetone bodies; Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Ketone; Ketone bodies; Level; Mass concentration; Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn,Ketones Ur Strip.auto-mCnc,mg/dL,Ketones [Mass/volume] in Urine by Automated test strip,mg/dL,Ketones Auto test strip (U) [Mass/Vol]
17856-6,Hemoglobin A1c/Hemoglobin.total,CHEM,Blood; Chemistry; Endocrine; Endocrinology; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; Hgb; Hgb A1c; High performance liquid chromatography; High pressure liquid chromatography; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; UniversalLabOrders; WB; Whole blood,HbA1c MFr Bld HPLC,%,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,%,HbA1c HPLC (Bld) [Mass fraction]
53328-1,Glucose,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn,Glucose Ur Strip.auto-mCnc,mg/dL,Glucose [Mass/volume] in Urine by Automated test strip,mg/dL,Glucose Auto test strip (U) [Mass/Vol]
50561-0,Protein,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Kidney; Level; Mass concentration; Nephrology; Point in time; PR; Prot; Random; Renal; SmQn; UA; UR; URINALYSIS; Urn,Prot Ur Strip.auto-mCnc,mg/dL,Protein [Mass/volume] in Urine by Automated test strip,mg/dL,Protein Auto test strip (U) [Mass/Vol]
11475-1,Microorganism,MICRO,C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Microorganisms; Misc; Miscellaneous; Nominal; Org; Organism; Organisms; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified,Microorganism Spec Cult,,Microorganism identified in Specimen by Culture,,Microorganism identified Cx Nom (Specimen)
11579-0,Thyrotropin,CHEM,2nd generation TSH; Arbitrary concentration; Chemistry; DL&lt;=0.05 mIU/L; Endocrine; Endocrinology; Left; Levo; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH; UniversalLabOrders,TSH SerPl DL<=0.05 mIU/L-aCnc,mIU/L;mcU/mL,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,m[IU]/L,TSH DL <= 0.05 mIU/L Qn
2340-8,Glucose,CHEM,Auto; Automated detection; Blood; Chemistry; Dip stick; Dipstick; Elec; Elect; Electr; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; Random; SmQn; WB; Whole blood,Glucose Bld Strip.auto-mCnc,mg/dL,Glucose [Mass/volume] in Blood by Automated test strip,mg/dL,Glucose Auto test strip (Bld) [Mass/Vol]
57747-8,Erythrocytes,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Dip stick; Dipstick; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Number concentration; Number Concentration (count/vol); Point in time; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; SmQn; UA; UR; URINALYSIS; Urn,RBC # Ur Strip.auto,/uL,Erythrocytes [#/volume] in Urine by Automated test strip,/uL,RBC Auto test strip (U) [#/Vol]
50563-6,Urobilinogen,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Level; Mass concentration; Point in time; Random; SmQn; UA; UBG; UR; URINALYSIS; Urn; Urobili; Urobilngn,Urobilinogen Ur Strip.auto-mCnc,mg/dL,Urobilinogen [Mass/volume] in Urine by Automated test strip,mg/dL,Urobilinogen Auto test strip (U) [Mass/Vol]
5811-5,Observation,UA,Dip stick; Dipstick; Point in time; Random; SmQn; Sp Gr; UA; UniversalLabOrders; UR; URINALYSIS; Urn,Sp Gr Ur Strip,,Specific gravity of Urine by Test strip,{Spec grav},Specific gravity Test strip (U)
11580-8,Thyrotropin,CHEM,3rd generation TSH; Arbitrary concentration; Chemistry; DL&lt;=0.005 mIU/L; Endocrine; Endocrinology; High sensitivity TSH; Left; Levo; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH; UniversalLabOrders,TSH SerPl DL<=0.005 mIU/L-aCnc,mIU/L;mcU/mL; mU/L,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L,m[IU]/L,TSH DL <= 0.005 mIU/L Qn
77147-7,Glomerular filtration rate,CHEM,"Blood; Chemistry; GFR; Glom; Kidney; LimitedUseLabOrders; Modification of Diet in Renal Disease; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood",GFRSerPlBld MDRD-ArVRat,mL/min/1.73 sq m,"Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M",mL/min/{1.73_m2},GFR Creatinine-based formula (MDRD)/1.73 sq M (S/P/Bld) [Vol rate/Area]
50553-7,Observation,UA,Auto; Automated detection; Elec; Elect; Electr; Nominal; Point in time; Random; UA; UR; URINALYSIS; Urn,Color Ur Auto,,Color of Urine by Auto,,Color Auto (U)
24318-8,Manual Differential panel,PANEL.HEM/BC,Blood; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Manual diff Bld,,Manual Differential panel - Blood,,Manual Differential panel (Bld)
20564-1,Oxygen saturation,HEMODYN.MOLEC,Blood; Hemodynamics; HEMODYNAMICS.MOLEC; Lung; Mass fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2; WB; Whole blood,SaO2 % Bld,%,Oxygen saturation in Blood,%,
2276-4,Ferritin,CHEM,Chemistry; Ferr; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Ferritin SerPl-mCnc,ug/L;ng/mL,Ferritin [Mass/volume] in Serum or Plasma,ng/mL,Ferritin [Mass/Vol]
25145-4,Bacteria,UA,Bact; ID; Infectious Disease; InfectiousDisease; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Bacteria UrnS Ql Micro,,Bacteria [Presence] in Urine sediment by Light microscopy,,Bacteria LM Ql (Urine sed)
1989-3,Calcidiol,CHEM,25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D3; Calciderol; Calcifediol; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vitamin D 25 hydroxy,25(OH)D3 SerPl-mCnc,ng/mL,25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma,ng/mL,25-hydroxyvitamin D3 [Mass/Vol]
2161-8,Creatinine,CHEM,Chemistry; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UCr; UniversalLabOrders; UR; Urn,Creat Ur-mCnc,g/L; mcg/mL; mg/dL; mg/mL,Creatinine [Mass/volume] in Urine,mg/dL,Creatinine (U) [Mass/Vol]
2132-9,Cobalamins,CHEM,C721; Cbl; Chemistry; Cobalamin; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vit B12; Vitamin B12,Vit B12 SerPl-mCnc,pg/mL,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,pg/mL,Cobalamin (Vitamin B12) [Mass/Vol]
11289-6,Body temperature,BDYTMP.ATOM,1st; Bdy temp; bod; Bodies; BODY TEMPERATURE.ATOM; Encounter; QNT; Quan; Quant; Quantitative; Temp; Temperature,Bdy temp 1st enctr,deg F; deg C,Body temperature at First encounter,Cel;[degF],
890-4,Blood group antibody,BLDBK,Ab; Bld gp Ab Scn; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Bld gp Ab Scn SerPl Ql,,Blood group antibody screen [Presence] in Serum or Plasma,,Blood group antibody screen Ql
5770-3,Bilirubin,UA,Bili; Bilirubins; Billirubin; Dip stick; Dipstick; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TBIL; UA; UR; URINALYSIS; Urn,Bilirub Ur Ql Strip,,Bilirubin.total [Presence] in Urine by Test strip,,Bilirubin Test strip Ql (U)
49541-6,Fasting status,MISC,AOEObservation; MISC; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen,Fasting status Patient Ql Reported,,Fasting status - Reported,,Fasting status Reported Ql
10834-0,Globulin,CHEM,Calc; Calculation; Chemistry; GLB; Glob; Glob%; Globul; Globulins; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR,Globulin Ser Calc-mCnc,g/L,Globulin [Mass/volume] in Serum by calculation,g/L,Globulin Calc (S) [Mass/Vol]
8247-9,Mucus,UA,Kidney; LM; Micro; Micros; Microscopic; Mucous; Mucous Threads; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Mucous Threads UrnS Ql Micro,,Mucus [Presence] in Urine sediment by Light microscopy,,Mucus LM Ql (Urine sed)
58410-2,Complete blood count panel,PANEL.HEM/BC,Auto; Automated detection; Blood; CBC Pnl; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Hemogram; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; UniversalLabOrders; WB; Whole blood,CBC Pnl Bld Auto,,CBC panel - Blood by Automated count,,CBC panel Auto (Bld)
9194-2,Class,IO_OUT.MOLEC,Coll; Collect; Collected; IO_OUTPUT; IO_OUTPUT.MOLEC; Nominal; Point in time; Random; Typ; UA; UR; Urn; Urn Collect Method,Urn Collect Method Class,,Type of Urine collection method,,
4537-7,Erythrocyte,HEM/BC,Blood; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Sed Rat; UniversalLabOrders; WB; Westerg; Westrgrn; Whole blood,Erythrocyte Sed Rat Bld Westrgrn,mm/h,Erythrocyte [Sedimentation Rate] in Blood by Westergren method,mm/h,Erythrocyte Westergren method (Bld) [Sedimentation Rate]
8329-5,Body temperature,BDYTMP.MOLEC,Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature,Bdy temp Core,deg F; deg C,Body temperature - Core,Cel;[degF],
66746-9,Observation,SPEC,Nominal; Point in time; Random; Spec; Typ,Specimen type,,Specimen type,,Observation Nom (Spec)
50562-8,Observation,UA,Auto; Automated detection; Elec; Elect; Electr; Point in time; QNT; Quan; Quant; Quantitative; Random; Refract; Refract.auto; Sp Gr; UA; UR; URINALYSIS; Urn,Sp Gr Ur Refract.auto,,Specific gravity of Urine by Refractometry automated,{Spec grav},Specific gravity Refractometry automated (U)
33511-7,Observation,SPEC,Appearance; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified,Appearance Spec,,Appearance of Specimen,,Appearance (Specimen)
27297-1,Leukocyte esterase,UA,Arbitrary concentration; Leuc; Leuk; Leukocytes; Lkcs; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells,Leukocyte esterase Ur-aCnc,,Leukocyte esterase [Units/volume] in Urine,,Leukocyte esterase Qn (U)
2157-6,Creatine kinase,CHEM,Cardio; Cardiology; Catalytic Concentration; Chemistry; CK; CPK; Creatine phosphokinase; Heart Disease; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,CK SerPl-cCnc,arb U/L,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,U/L,CK [Catalytic activity/Vol]
5804-0,Protein,UA,Dip stick; Dipstick; Kidney; Level; Mass concentration; Nephrology; Point in time; PR; Prot; Random; Renal; SmQn; UA; UR; URINALYSIS; Urn,Prot Ur Strip-mCnc,mg/dL,Protein [Mass/volume] in Urine by Test strip,mg/dL,Protein Test strip (U) [Mass/Vol]
5787-7,Epithelial cells,UA,#/area; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Epi Cells #/area UrnS HPF,/HPF,Epithelial cells [#/area] in Urine sediment by Microscopy high power field,/[HPF],Epithelial cells LM.HPF (Urine sed) [#/Area]
20454-5,Protein,UA,Dip stick; Dipstick; Kidney; Nephrology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urn,Prot Ur Ql Strip,,Protein [Presence] in Urine by Test strip,,Protein Test strip Ql (U)
53327-3,Bilirubin,UA,Auto; Automated detection; Bili; Bilirubins; Billirubin; Dip stick; Dipstick; Elec; Elect; Electr; Level; Mass concentration; Point in time; Random; SmQn; TBIL; UA; UR; URINALYSIS; Urn,Bilirub Ur Strip.auto-mCnc,mg/dL,Bilirubin.total [Mass/volume] in Urine by Automated test strip,mg/dL,Bilirubin Auto test strip (U) [Mass/Vol]
2498-4,Iron,CHEM,Chemistry; Fe; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Iron SerPl-mCnc,ug/L,Iron [Mass/volume] in Serum or Plasma,ug/dL,Iron [Mass/Vol]
714-6,Eosinophils/Leukocytes,HEM/BC,Blood; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Eosinophil NFr Bld Manual,%,Eosinophils/Leukocytes in Blood by Manual count,%,Eosinophils/Leukocytes Manual cnt (Bld)
2857-1,Prostate specific Ag,CHEM,Antigen; Antigens; Chemistry; Genitourinary; GU; Kallikrein 3; Level; Mass concentration; Oncology; P-30 antigen; Pl; Plasma; Plsm; Point in time; PS; PSA; QNT; Quan; Quant; Quantitative; Random; Seminin; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Tumor marker; UniversalLabOrders; URO; Urology,PSA SerPl-mCnc,ug/L;ng/mL,Prostate specific Ag [Mass/volume] in Serum or Plasma,ng/mL,Prostate specific Ag [Mass/Vol]
771-6,Erythrocytes.nucleated,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Normoblasts; nRBC; nRBCs; Nuc; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,nRBC # Bld Auto,10*9/L,Nucleated erythrocytes [#/volume] in Blood by Automated count,10*3/uL,Nucleated RBC Auto (Bld) [#/Vol]
2019-8,Carbon dioxide,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Carbonic anhydride; Chemistry; CO2; PaCO2; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random,pCO2 BldA,mm Hg,Carbon dioxide [Partial pressure] in Arterial blood,mm[Hg],CO2 (BldA) [Partial pressure]
30934-4,Natriuretic peptide.B,CHEM,Beta Natriuretic Peptide; BNP; Brain Natriuretic Peptide; B-type natriuretic peptide; Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Natriutietic peptide.B; Pept; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,BNP SerPl-mCnc,ng/L;pg/mL,Natriuretic peptide B [Mass/volume] in Serum or Plasma,pg/mL,Natriuretic peptide B [Mass/Vol]
3084-1,Urate,CHEM,Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UniversalLabOrders; Urates; Uric acid,Urate SerPl-mCnc,mg/dL,Urate [Mass/volume] in Serum or Plasma,mg/dL,Urate [Mass/Vol]
26511-6,Neutrophils/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neutrophils NFr Bld,%,Neutrophils/Leukocytes in Blood,%,Neutrophils/Leukocytes (Bld)
1971-1,Bilirubin.non-glucuronidated,CHEM,Bili; Bilirub Indirect; Bilirubin indirect; Bilirubin non-conjugated; Bilirubin primary; Bilirubin unconjugated; Bilirubins; Billirubin; Bu; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL,Bilirub Indirect SerPl-mCnc,mg/dL,Bilirubin.indirect [Mass/volume] in Serum or Plasma,mg/dL,Bilirubin.indirect [Mass/Vol]
2744-1,pH,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Kidney; Log molar concentration; Lung; Nephrology; Point in time; Pulmonary; Pulmonology; Random; Renal; Respiratory; SmQn,pH BldA,pH,pH of Arterial blood,[pH],pH (BldA)
664-3,Observation,MICRO,Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; UniversalLabOrders; Unspecified,Gram Stn Spec,,Microscopic observation [Identifier] in Specimen by Gram stain,,Microscopic observation Gram stain Nom (Specimen)
769-0,Neutrophils.segmented/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neuts Seg NFr Bld Manual,%,Segmented neutrophils/Leukocytes in Blood by Manual count,%,Segmented neutrophils/Leukocytes Manual cnt (Bld)
744-3,Monocytes/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Monocytes NFr Bld Manual,%,Monocytes/Leukocytes in Blood by Manual count,%,Monocytes/Leukocytes Manual cnt (Bld)
737-7,Lymphocytes/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Lymphocytes NFr Bld Manual,%,Lymphocytes/Leukocytes in Blood by Manual count,%,Lymphocytes/Leukocytes Manual cnt (Bld)
9317-9,Platelets,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Platelet; Platelet adequacy; Platelet estimate; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood,Platelet Bld Ql Smear,,Platelet adequacy [Presence] in Blood by Light microscopy,,Platelets LM Ql (Bld)
5769-5,Bacteria,UA,#/area; Bact; ID; Infectious Disease; InfectiousDisease; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Bacteria #/area UrnS HPF,/HPF,Bacteria [#/area] in Urine sediment by Microscopy high power field,/[HPF],Bacteria LM.HPF (Urine sed) [#/Area]
2502-3,Iron saturation,CHEM,Chemistry; Fe; FE/TIBC; Iron Satn; Iron/Iron binding capacity.total; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SAT; Satn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Transferrin saturation,Iron Satn MFr SerPl,%,Iron saturation [Mass Fraction] in Serum or Plasma,%,Iron saturation [Mass fraction]
2500-7,Iron binding capacity,CHEM,Bind; Chemistry; dTIBC; Fe; IBC; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TIBC; Total iron binding; UniversalLabOrders,TIBC SerPl-mCnc,ug/dL,Iron binding capacity [Mass/volume] in Serum or Plasma,ug/dL,Iron binding capacity [Mass/Vol]
6463-4,Bacteria,MICRO,Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,Bacteria Spec Cult,,Bacteria identified in Specimen by Culture,,Bacteria identified Cx Nom (Specimen)
62292-8,Calcidiol+ercalcidiol,CHEM,"25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25(OH)D3; 25(OH)D3+25(OH)D2; 25-Hydroxy calciferol; 25-Hydroxy Vit D total; 25-Hydroxycalciferol; 25-hydroxycholecalciferol; 25-Hydroxyergocalciferol; 25-hydroxyvitamin D; 25-Hydroxyvitamin D 2; 25-hydroxyvitamin D 3; 25-Hydroxyvitamin D2; 25-hydroxyvitamin D3; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Calciderol; Calcidiol+Calciferol; Calcidiol+Ercalcidiol; Calcifediol; Chemistry; Ercalcidiol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vitamin D 25 hydroxy",25(OH)D3+25(OH)D2 SerPl-mCnc,ng/mL,25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma,ng/mL,25-hydroxyvitamin D [Mass/Vol]
30539-1,Neutrophil cytoplasmic Ab.perinuclear,SERO,ACNA; ACPA; ANCA; Cytopl; Cytoplas; Granulocyte ab; Granulocyte nucleus ab; Neut; Neutr; Neutrophils; NSNA; Ordinal; pANCA; p-ANCA; Perinuclear ANCA; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Vasculitis,p-ANCA Ser Ql,,Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum,,Neutrophil cytoplasmic Ab.perinuclear Ql (S)
2703-7,Oxygen,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Lung; O2; O2 partial pressure; PaO2; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2,pO2 BldA,mm Hg,Oxygen [Partial pressure] in Arterial blood,mm[Hg],Oxygen (BldA) [Partial pressure]
46702-7,Leukocytes,UA,#/area; Auto; Automated detection; Elec; Elect; Electr; Kidney; Leuc; Leuk; Leukocyte; Lkcs; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBCs; White blood cell; White blood cells,WBC #/area UrnS Auto,/HPF,Leukocytes [#/area] in Urine sediment by Automated count,/[HPF],WBC Auto (Urine sed) [#/Area]
1960-4,Bicarbonate,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; BIC; bicar; Bicarb; Blood arterial; Chemistry; HCO3; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration,HCO3 BldA-sCnc,mmol/L,Bicarbonate [Moles/volume] in Arterial blood,mmol/L,HCO3 (BldA) [Moles/Vol]
1753-3,Albumin,CHEM,Alb; Chemistry; Kidney; Nephrology; Ordinal; Point in time; PR; Protein.albumin; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; Urn,Albumin Ur Ql,,Albumin [Presence] in Urine,,Albumin Ql (U)
25428-4,Glucose,UA,Dip stick; Dipstick; Glu; Gluc; Glucoseur; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; URINALYSIS; Urn,Glucose Ur Ql Strip,,Glucose [Presence] in Urine by Test strip,,Glucose Test strip Ql (U)
1977-8,Bilirubin,CHEM,Bili; Bilirubins; Billirubin; Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TBIL; UA; UniversalLabOrders; UR; Urn,Bilirub Ur Ql,,Bilirubin.total [Presence] in Urine,,Bilirubin Ql (U)
30239-8,Aspartate aminotransferase,CHEM,Asp; Aspartate amino transferase; Aspartate transaminase; Aspartic acid; AST; Catalytic Concentration; Chemistry; Glutamic oxaloacetic transaminase; Hepatology; Liver; P prime; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGOT; SR; w P-5'-P,AST SerPl w P-5'-P-cCnc,arb U/L,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,U/L,AST With P-5'-P [Catalytic activity/Vol]
46419-8,Erythrocytes,UA,#/area; Auto; Automated detection; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,RBC #/area UrnS Auto,,Erythrocytes [#/area] in Urine sediment by Automated count,/[HPF],RBC Auto (Urine sed) [#/Area]
1994-3,Calcium.ionized,CHEM,Blood; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UniversalLabOrders; WB; Whole blood,Ca-I Bld-sCnc,mmol/L,Calcium.ionized [Moles/volume] in Blood,mmol/L,Calcium.ionized (Bld) [Moles/Vol]
38875-1,Coagulation tissue factor induced.INR,COAG,Blood; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Hematology; Heme; Internat norm ratio; International normal ratio; International normalization ratio; International normalized ratio; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Prothrombin time INR; Protime; Protime INR; PT; PT INR; QNT; Quan; Quant; Quantitative; Random; RlTm; Tilt tube; WB; Whole blood,INR PPP/Bld,,INR in Platelet poor plasma or blood by Coagulation assay,{INR},INR Coag (Platelet poor plasma or blood) [Relative time]
1963-8,Bicarbonate,CHEM,BIC; bicar; Bicarb; Chemistry; HCO3; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SBC; SBIC; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,HCO3 SerPl-sCnc,mmol/L,Bicarbonate [Moles/volume] in Serum or Plasma,mmol/L,HCO3 [Moles/Vol]
882-1,ABO & Rh group,BLDBK,ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; UniversalLabOrders; WB; Whole blood,ABO + Rh Bld,,ABO and Rh group [Type] in Blood,,ABO and Rh group (Bld)
24331-1,Lipid 1996 panel,PANEL.CHEM,96; Cardio; Cardiology; Chemistry; Heart Disease; Lipid 1996 Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Lipid 1996 Pnl SerPl,,Lipid 1996 panel - Serum or Plasma,,Lipid 1996 panel
60026-2,Leukocyte esterase,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Leuc; Leuk; Leukocytes; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells,Leukocyte esterase Ur Ql Strip.auto,,Leukocyte esterase [Presence] in Urine by Automated test strip,,Leukocyte esterase Auto test strip Ql (U)
57021-8,Complete blood count W Auto Differential panel,PANEL.HEM/BC,Auto Diff Pnl; Blood; CBC W Auto Diff; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,CBC W Auto Diff Bld,,CBC W Auto Differential panel - Blood,,CBC W Auto Differential panel (Bld)
2106-3,Choriogonadotropin,CHEM,CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; Gyn; Gynecology; HCG; Human chorionic gonadotropin; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,HCG Ur Ql,,Choriogonadotropin [Presence] in Urine,,HCG Ql (U)
26444-0,Basophils,HEM/BC,#; ABS; absolute; absolutes; Baso; Basophil; Basos; Blood; Bph; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Basophils # Bld,10*3/mm3,Basophils [#/volume] in Blood,10*3/uL,Basophils (Bld) [#/Vol]
32133-1,Lactate,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Lactate PlasV-sCnc,mmol/L,Lactate [Moles/volume] in Plasma venous,mmol/L,Lactate (P ven) [Moles/Vol]
2336-6,Globulin,CHEM,Chemistry; GLB; Glob; Glob%; Globul; Globulins; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR,Globulin Ser-mCnc,g/dL,Globulin [Mass/volume] in Serum,g/dL,Globulin (S) [Mass/Vol]
61152-5,Albumin,CHEM,Alb; Chemistry; Hepatology; Kidney; Level; Liver; Mass Concentration; Nephrology; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Albumin SerPl BCP-mCnc,g/dl,Albumin [Mass/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method,g/dL,Albumin BCP dye [Mass/Vol]
1743-4,Alanine aminotransferase,CHEM,Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; Hepatology; L-alanine; Liver; P prime; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGPT; SR; w P-5'-P,ALT SerPl w P-5'-P-cCnc,arb U/L,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P,U/L,ALT With P-5'-P [Catalytic activity/Vol]
6742-1,Erythrocyte,HEM/BC,Blood; Discocyte; Erc; Erythrocytes; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Morphology; Nominal; Point in time; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,RBC morph Bld,,Erythrocyte [Morphology] in Blood,,RBC morphology finding Nom (Bld)
54094-8,Triage note,DOC.ONTOLOGY,DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note,ED Triage note,,Emergency department Triage note,,
6298-4,Potassium,CHEM,Blood; Chemistry; k; K+; Level; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UniversalLabOrders; WB; Whole blood,Potassium Bld-sCnc,mmol/L,Potassium [Moles/volume] in Blood,mmol/L,Potassium (Bld) [Moles/Vol]
2888-6,Protein,UA,Kidney; Level; Mass concentration; Nephrology; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UniversalLabOrders; UR; URINALYSIS; Urn,Prot Ur-mCnc,g/L;mg/dL,Protein [Mass/volume] in Urine,g/dL,Protein (U) [Mass/Vol]
19161-9,Urobilinogen,UA,Arbitrary concentration; Dip stick; Dipstick; Point in time; Random; SmQn; UA; UBG; UniversalLabOrders; UR; URINALYSIS; Urn; Urobili; Urobilngn,Urobilinogen Ur Strip-aCnc,Ehrlich units/dL,Urobilinogen [Units/volume] in Urine by Test strip,{Ehrlich'U}/dL,Urobilinogen Test strip SemiQn (U)
8328-7,Body temperature,BDYTMP.MOLEC,Ax; Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature,Axil temp,deg F; deg C,Axillary temperature,Cel;[degF],
5796-8,Hyaline casts,UA,#/area; Cast; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Hyaline Casts #/area UrnS LPF,/LPF,Hyaline casts [#/area] in Urine sediment by Microscopy low power field,/[LPF],Hyaline casts LM.LPF (Urine sed) [#/Area]
56888-1,HIV 1+2 Ab+HIV1 p24 Ag,MICRO,AIDS; Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 & 2; HIV 1 and 2 Ab; HIV 1+2 Ab+HIV1p24; HIV type 1; HIV type I; HIV1; HIV1+2; HIV1+2 Ab+HIV1p24Ag; Human immunodeficiency virus; i; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS,HIV 1+2 Ab+HIV1 p24 Ag SerPl Ql IA,,HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,,HIV 1+2 Ab+HIV1 p24 Ag IA Ql
21418-9,Neutrophil Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Granulocytic Ab; Hematology; Heme; Neut; Neutr; Neutrophils; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR,Neutrophil Ab Ser Ql,,Neutrophil Ab [Presence] in Serum,,Neutrophil Ab Ql (S)
707-0,Basophils/Leukocytes,HEM/BC,Baso; Basophil; Basos; Blood; Bph; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Basophils NFr Bld Manual,%,Basophils/Leukocytes in Blood by Manual count,%,Basophils/Leukocytes Manual cnt (Bld)
53326-5,Observation,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Point in time; Random; SmQn; Sp Gr; UA; UR; URINALYSIS; Urn,Sp Gr Ur Strip.auto,,Specific gravity of Urine by Automated test strip,{Spec grav},Specific gravity Auto test strip (U)
11253-2,Tacrolimus,DRUG/TOX,Blood; DRUG/TOXICOLOGY; Drugs; FK506; FK-506; Fujimycin; Hecoria; L04AD02; Level; Mass concentration; Point in time; Prograf; Protopic; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Tacrolimus Bld-mCnc,ug/L;ng/mL,Tacrolimus [Mass/volume] in Blood,ng/mL,Tacrolimus (Bld) [Mass/Vol]
35706-1,Albumin/Protein.total,CHEM,Alb; Albumin fraction; Albumin%; Chemistry; Hepatology; Kidney; Liver; Mass Fraction; Nephrology; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl; TP,Albumin MFr SerPl,%,Albumin/Protein.total in Serum or Plasma,%,Albumin [Mass fraction]
2756-5,pH,CHEM,Chemistry; Kidney; Log molar concentration; Nephrology; Point in time; Random; Renal; SmQn; UA; UniversalLabOrders; UR; Urn,pH Ur,pH,pH of Urine,[pH],pH (U)
2705-2,Oxygen,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Lung; O2; O2 partial pressure; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Venous,pO2 BldV,mm Hg,Oxygen [Partial pressure] in Venous blood,mm[Hg],Oxygen (BldV) [Partial pressure]
2746-6,pH,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Kidney; Log molar concentration; Lung; Nephrology; Point in time; Pulmonary; Pulmonology; Random; Renal; Respiratory; SmQn; Venous,pH BldV,pH,pH of Venous blood,[pH],pH (BldV)
15152-2,Bilirubin.glucuronidated,CHEM,Bc; Bili; Bilirub Conj; Bilirubin conjugated; Bilirubin glucuronides; Bilirubins; Billirubin; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL,Bilirub Conj SerPl-mCnc,mg/dL,Bilirubin.conjugated [Mass/volume] in Serum or Plasma,mg/dL,Bilirubin.conjugated [Mass/Vol]
1744-2,Alanine aminotransferase,CHEM,Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; Hepatology; L-alanine; Liver; P prime; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGPT; SR; w/o P-5'-P,ALT SerPl w/o P-5'-P-cCnc,arb U/L,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P,U/L,ALT No additional P-5'-P [Catalytic activity/Vol]
19048-8,Erythrocytes.nucleated/Leukocytes,HEM/BC,Blood; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Normoblasts; nRBC; nRBCs; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Rto; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,nRBC Bld-Rto,/100 WBC,Nucleated erythrocytes/Leukocytes [Ratio] in Blood,/100{WBCs},Nucleated RBC/Leukocytes (Bld) [Ratio]
1959-6,Bicarbonate,CHEM,BIC; bicar; Bicarb; Blood; Chemistry; HCO3; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; WB; Whole blood,HCO3 Bld-sCnc,mmol/L,Bicarbonate [Moles/volume] in Blood,mmol/L,HCO3 (Bld) [Moles/Vol]
2021-4,Carbon dioxide,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Carbonic anhydride; Chemistry; CO2; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous,pCO2 BldV,mm Hg,Carbon dioxide [Partial pressure] in Venous blood,mm[Hg],CO2 (BldV) [Partial pressure]
2532-0,Lactate dehydrogenase,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker,LDH SerPl-cCnc,arb U/L,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma,U/L,LDH [Catalytic activity/Vol]
62238-1,Glomerular filtration rate,CHEM,"Blood; Chemistry; GFR; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood",GFR SerPlBld Creatinine-bsd fmla CKD-EPI,mL/min/1.73 sq M,"Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M",mL/min/{1.73_m2},GFR Creatinine-based formula (CKD-EPI)/1.73 sq M (S/P/Bld) [Vol rate/Area]
50551-1,Bilirubin,UA,Auto; Automated detection; Bili; Bilirubins; Billirubin; Dip stick; Dipstick; Elec; Elect; Electr; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TBIL; UA; UR; URINALYSIS; Urn,Bilirub Ur Ql Strip.auto,,Bilirubin.total [Presence] in Urine by Automated test strip,,Bilirubin Auto test strip Ql (U)
11283-9,Acuity assessment,CLIN,1st; CLIN; Encounter; Function; Nominal,Acuity assess 1st enctr,,Acuity assessment [Function] at First encounter,,
11277-1,Epithelial cells.squamous,UA,#/area; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Squamous #/area UrnS HPF,/HPF,Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field,/[HPF],Epithelial cells.squamous LM.HPF (Urine sed) [#/Area]
9318-7,Albumin/Creatinine,CHEM,Alb; Chemistry; CR; Crea; Creat; Kidney; Mass concentration ratio; Mass ratio; MCRto; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UCr; UR; Urn,Albumin/Creat Ur,ug/mg creatinine,Albumin/Creatinine [Mass Ratio] in Urine,ug/mg{creat},Albumin/Creatinine (U) [Mass ratio]
20509-6,Hemoglobin,HEM/BC,Blood; Calc; Calculation; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Hgb Bld Calc-mCnc,g/dL,Hemoglobin [Mass/volume] in Blood by calculation,g/dL,Hemoglobin Calc (Bld) [Mass/Vol]
8459-0,Intravascular systolic^sitting,BP.PSTN.MOLEC,Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.POSITION.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Position; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP,BP sys--sitting,mm Hg,Systolic blood pressure--sitting,mm[Hg],
8453-3,Intravascular diastolic^sitting,BP.PSTN.MOLEC,Art sys; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.POSITION.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Point in time; Position; Pressure; QNT; Quan; Quant; Quantitative; Random,BP dias--sitting,mm Hg,Diastolic blood pressure--sitting,mm[Hg],
33219-7,Epithelial cells.squamous,UA,#/area; Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; Epi; Epi Cells; Epith; Epithelia; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Squamous #/area UrnS Auto,/HPF,Epithelial cells.squamous [#/area] in Urine sediment by Automated count,/[HPF],Epithelial cells.squamous Auto (Urine sed) [#/Area]
2708-6,Oxygen saturation,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2,SaO2 % BldA,%,Oxygen saturation in Arterial blood,%,SaO2% (BldA) [Mass fraction]
2731-8,Parathyrin.intact,CHEM,Chemistry; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Mass concentration; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,PTH-Intact SerPl-mCnc,ng/L;pg/mL,Parathyrin.intact [Mass/volume] in Serum or Plasma,pg/mL,Parathyrin.intact [Mass/Vol]
20507-0,Reagin Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Charcoal flocculation; ID; Infectious Disease; InfectiousDisease; Microbiology; Neurosyphilis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rapid plasma reagin; Screen; Serum; SR; Syphilis; Treponema; UniversalLabOrders,RPR Ser Ql,,Reagin Ab [Presence] in Serum by RPR,,Reagin Ab RPR Ql (S)
543-9,Mycobacterium sp,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Myco; Mycobact; Nominal; Other; Point in time; Random; Spec; species; spp; To be specified in another part of the message; Tuberculosis; UniversalLabOrders; Unspecified,Mycobacterium Spec Cult,,Mycobacterium sp identified in Specimen by Organism specific culture,,Mycobacterium sp identified Org specific cx Nom (Specimen)
38483-4,Creatinine,CHEM,Blood; Chemistry; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UniversalLabOrders; WB; Whole blood,Creat Bld-mCnc,mg/dL,Creatinine [Mass/volume] in Blood,mg/dL,Creatinine (Bld) [Mass/Vol]
39789-3,Potassium,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; k; K+; Level; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous,Potassium BldV-sCnc,mmol/L,Potassium [Moles/volume] in Venous blood,mmol/L,Potassium (BldV) [Moles/Vol]
24111-7,Neisseria gonorrhoeae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified,N gonorrhoea DNA Spec Ql NAA+probe,,Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection,,N. gonorrhoeae DNA NAA+probe Ql (Specimen)
764-1,Neutrophils.band form/Leukocytes,HEM/BC,Bands; Blood; bnd; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number Fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neuts Band NFr Bld Manual,%,Band form neutrophils/Leukocytes in Blood by Manual count,%,Band form neutrophils/Leukocytes Manual cnt (Bld)
9322-9,Cholesterol.total/Cholesterol.in HDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Lipid; Percentile; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; TC; TCHHDL; Tot; Totl,Cholest/HDLc Prctl SerPl,,Cholesterol.total/Cholesterol in HDL [Percentile],,Cholesterol.total/Cholesterol in HDL [%]
39791-9,Sodium,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Level; Na; Na+; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous,Sodium BldV-sCnc,mmol/L,Sodium [Moles/volume] in Venous blood,mmol/L,Sodium (BldV) [Moles/Vol]
53553-4,Estimated average glucose,CHEM,Blood; Chemistry; eAG; eAVG; Endocrine; Endocrinology; Est; Est. average glucose; estimation; gHb Est; Glu; Gluc; Glucose mean value; Glucoseur; Glycos; Glycosylated; Level; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood,Est. average glucose Bld gHb Est-sCnc,mmol/L,Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin,mmol/L,Average glucose Estimated from glycated hemoglobin (Bld) [Moles/Vol]
16128-1,Hepatitis C virus Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HCV; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,HCV Ab Ser Ql,,Hepatitis C virus Ab [Presence] in Serum,,HCV Ab Ql (S)
20565-8,Carbon dioxide,CHEM,Blood; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2; WB; Whole blood,CO2 Bld-sCnc,mmol/L,"Carbon dioxide, total [Moles/volume] in Blood",mmol/L,CO2 (Bld) [Moles/Vol]
2947-0,Sodium,CHEM,Blood; Chemistry; Level; Na; Na+; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UniversalLabOrders; WB; Whole blood,Sodium Bld-sCnc,mmol/L,Sodium [Moles/volume] in Blood,mmol/L,Sodium (Bld) [Moles/Vol]
11555-0,Base excess,CHEM,Base ex; BE; Blood; BSE; Calc; Calculation; Chemistry; EXS; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; WB; Whole blood,Base excess Bld Calc-sCnc,mmol/L,Base excess in Blood by calculation,mmol/L,Base excess Calc (Bld) [Moles/Vol]
2089-1,Cholesterol.in LDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,LDLc SerPl-mCnc,mg/dL,Cholesterol in LDL [Mass/volume] in Serum or Plasma,mg/dL,Cholesterol in LDL [Mass/Vol]
39004-7,Epidermal growth factor receptor Ag,PATH,"Antigen; Antigens; EGF; EGFR; Fac; Fact; HER1; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Tissue; Tissue, unspecified",EGFR Ag Tiss Ql,,Epidermal growth factor receptor Ag [Presence] in Tissue,,Epidermal growth factor receptor Ag Ql (Tiss)
2284-8,Folate,CHEM,Chemistry; Folat; Folic acid; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pteroylglutamate; Pteroylglutamic acid; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vit M; Vitamin M,Folate SerPl-mCnc,ng/mL,Folate [Mass/volume] in Serum or Plasma,ng/mL,Folate [Mass/Vol]
743-5,Monocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Mono; Monocyte; Monos; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Monocytes # Bld Manual,10*9/L,Monocytes [#/volume] in Blood by Manual count,10*3/uL,Monocytes Manual cnt (Bld) [#/Vol]
48058-2,Fibrin D-dimer,COAG,COAGULATION; D Dimer; Dextro; EIA; ELFA; ELISA; Enzyme immunoassay; Fragment D-dimer; Hematology; Heme; IAA; Level; Mass concentration; MEIA; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; UniversalLabOrders,D Dimer PPP IA.DDU-mCnc,ug/L DDU,Fibrin D-dimer [Mass/volume] in Platelet poor plasma by Immunoassay.DDU,ug/L{DDU},Fibrin D-dimer IA.DDU (PPP) [Mass/Vol]
31100-1,Erythrocyte/Blood,HEM/BC,Blood; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Volfr; Volume fraction; WB; Whole blood,Hct VFr Bld Imped,%,Hematocrit [Volume Fraction] of Blood by Impedance,%,Hematocrit Impedance (Bld) [Volume fraction]
1798-8,Amylase,CHEM,Alpha amylase; Ams; Amyl; Catalytic Concentration; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Amylase SerPl-cCnc,arb U/L,Amylase [Enzymatic activity/volume] in Serum or Plasma,U/L,Amylase [Catalytic activity/Vol]
30350-3,Hemoglobin,HEM/BC,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous,Hgb BldV-mCnc,g/L;g/dL,Hemoglobin [Mass/volume] in Venous blood,g/dL,Hemoglobin (BldV) [Mass/Vol]
732-8,Lymphocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Lymphocytes # Bld Manual,10*9/L,Lymphocytes [#/volume] in Blood by Manual count,10*3/uL,Lymphocytes Manual cnt (Bld) [#/Vol]
1754-1,Albumin,CHEM,Alb; Chemistry; Kidney; Level; Mass concentration; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urn,Albumin Ur-mCnc,mg/L;mcg/mL,Albumin [Mass/volume] in Urine,g/dL,Albumin (U) [Mass/Vol]
11368-8,Illness or injury onset date and time,H&P.HX,AOEObservation; Date and time; Date+time; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp; Ulcer,Illness or injury onset date and time,,Illness or injury onset date and time,,
2324-2,Gamma glutamyl transferase,CHEM,Catalytic Concentration; Chemistry; Gamma glutamyl transpeptidase; Gamma-GTP; GGT; GGTP; GT; Hepatology; Liver; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,GGT SerPl-cCnc,arb U/L,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,U/L,Gamma glutamyl transferase [Catalytic activity/Vol]
3107-0,Urobilinogen,CHEM,Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UBG; UniversalLabOrders; UR; Urn; Urobili; Urobilngn,Urobilinogen Ur-mCnc,mg/dL,Urobilinogen [Mass/volume] in Urine,mg/dL,Urobilinogen (U) [Mass/Vol]
35674-1,Creatinine,CHEM,?Tm; Chemistry; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UniversalLabOrders; UR; Urn,Creat ?Tm Ur-mCnc,g/L; mcg/mL; mg/dL; mg/mL,Creatinine [Mass/volume] in Urine collected for unspecified duration,mg/dL,Creatinine Unsp time (U) [Mass/Vol]
14627-4,Bicarbonate,CHEM,BIC; bicar; Bicarb; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; HCO3; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous,HCO3 BldV-sCnc,mmol/L,Bicarbonate [Moles/volume] in Venous blood,mmol/L,HCO3 (BldV) [Moles/Vol]
49936-8,Calcium.ionized/Calcium.total^^corrected for albumin,CHEM,Alb; Album cor; Blood; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Mass fraction; Percent; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,Ca-I Album cor MFr Bld,%,Calcium.ionized/Calcium.total corrected for albumin in Blood,%,Calcium.ionized/Total Ca corrected for albumin (Bld) [Mass fraction]
1978-6,Bilirubin,CHEM,Bili; Bilirubins; Billirubin; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TBIL; UA; UniversalLabOrders; UR; Urn,Bilirub Ur-mCnc,mg/dL,Bilirubin.total [Mass/volume] in Urine,mg/dL,Bilirubin (U) [Mass/Vol]
30341-2,Erythrocyte,HEM/BC,Blood; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Sed Rat; UniversalLabOrders; WB; Whole blood,Erythrocyte Sed Rat Bld,mm/h,Erythrocyte [Sedimentation Rate] in Blood,mm/h,Erythrocyte (Bld) [Sedimentation Rate]
5643-2,Ethanol,DRUG/TOX,Alc; Alcohol; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Ethanol SerPl-mCnc,mg/dL,Ethanol [Mass/volume] in Serum or Plasma,mg/dL,Ethanol [Mass/Vol]
21198-7,Choriogonadotropin.beta subunit,CHEM,Arbitrary concentration; B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,B-HCG SerPl-aCnc,IU/L; mU/mL,Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma,m[IU]/mL;[IU]/mL,HCG.beta subunit Qn
3879-4,Opiates,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Opiates Ur Ql,,Opiates [Presence] in Urine,,Opiates Ql (U)
580-1,Fungus,MICRO,C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,Fungus Spec Cult,,Fungus identified in Specimen by Culture,,Fungus identified Cx Nom (Specimen)
2890-2,Protein/Creatinine,CHEM,Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UniversalLabOrders; UR; Urn,Prot/Creat Ur,mg/g creatinine,Protein/Creatinine [Mass Ratio] in Urine,mg/g{creat},Protein/Creatinine (U) [Mass ratio]
3377-9,Barbiturates,DRUG/TOX,Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Barbiturates Ur Ql,,Barbiturates [Presence] in Urine,,Barbiturates Ql (U)
5195-3,Hepatitis B virus surface Ag,MICRO,Antigen; Antigens; Australia antigen; HBs; HBsAG; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Surf; UniversalLabOrders,HBV surface Ag Ser Ql,,Hepatitis B virus surface Ag [Presence] in Serum,,HBV surface Ag Ql (S)
936-5,Observation,BLDBK,BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Ident; Identifier; Nominal; Point in time; Random,Bld Unit Id BPU,,Blood product unit [Identifier],,Blood product unit Nom (BPU) [ID]
5196-1,Hepatitis B virus surface Ag,MICRO,Antigen; Antigens; Australia antigen; EIA; ELFA; ELISA; Enzyme immunoassay; HBs; HBsAG; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Surf; UniversalLabOrders,HBV surface Ag SerPl Ql IA,,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,,HBV surface Ag IA Ql
44734-2,Urea nitrogen/Creatinine,CHEM,Blood; Blood urea nitrogen; BUN; Chemistry; CR; Crea; Creat; Kidney; Mass concentration ratio; Mass ratio; MCRto; N; N2; Nephrology; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UN; WB; Whole blood,BUN/Creat Bld,g/g creatinine,Urea nitrogen/Creatinine [Mass Ratio] in Blood,g/g{creat},Urea nitrogen/Creatinine (Bld) [Mass ratio]
2519-7,Lactate,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous,Lactate BldV-sCnc,mmol/L,Lactate [Moles/volume] in Venous blood,mmol/L,Lactate (BldV) [Moles/Vol]
1752-5,Albumin,CHEM,Alb; Chemistry; Joint aspirate; Joint fld; Joint flu; Joint fluid; Level; Mass concentration; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid,Albumin Snv-mCnc,g/dL,Albumin [Mass/volume] in Synovial fluid,g/dL,Albumin (Syn fld) [Mass/Vol]
881-3,ABO & Rh group,BLDBK,ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); D phenotyping; D typing; Hematology; Heme; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood,ABO + Rh Bld BPU,,ABO and Rh group [Type] in Blood from Blood product unit,,ABO and Rh group (Bld BPU)
82589-3,Highest level of education,ADMIN.PATIENT.DEMOG,ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; History; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH,Highest level of educ,,Highest level of education,,
54567-3,Height and weight,PANEL.SURVEY.MDS,Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS; Wt,,,Height and weight,,
41995-2,Hemoglobin A1c,CHEM,Blood; Chemistry; Endocrine; Endocrinology; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; Hgb; Hgb A1c; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,HbA1c Bld-mCnc,g/dL,Hemoglobin A1c [Mass/volume] in Blood,g/dL,HbA1c (Bld) [Mass/Vol]
33223-9,Hyaline casts,UA,#/area; Auto; Automated detection; Cast; Elec; Elect; Electr; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Hyaline Casts #/area UrnS Auto,/HPF,Hyaline casts [#/area] in Urine sediment by Automated count,/[HPF],Hyaline casts Auto (Urine sed) [#/Area]
2524-7,Lactate,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Lact; Lactic acid; Level; L-lactate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Lactate SerPl-sCnc,mmol/L,Lactate [Moles/volume] in Serum or Plasma,mmol/L,Lactate [Moles/Vol]
32717-1,Sodium,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Level; Na; Na+; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Sodium BldA-sCnc,mmol/L,Sodium [Moles/volume] in Arterial blood,mmol/L,Sodium (BldA) [Moles/Vol]
22637-3,Path report.final diagnosis,TUMRRGT,Dx; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Oncology; Path report.final Dx; Point in time; Random; Report; Spec; TUMOR REGISTRY(NAACCR),Path report.final Dx Spec,,Pathology report final diagnosis Narrative,,
18282-4,Cannabinoids,DRUG/TOX,Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC; UA; UniversalLabOrders; UR; Urn,Cannabinoids Ur Ql Scn,,Cannabinoids [Presence] in Urine by Screen method,,Cannabinoids Screen Ql (U)
33218-9,Bacteria,UA,#/area; Auto; Automated detection; Bact; Elec; Elect; Electr; ID; Infectious Disease; InfectiousDisease; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Bacteria #/area UrnS Auto,/HPF,Bacteria [#/area] in Urine sediment by Automated count,/[HPF],Bacteria Auto (Urine sed) [#/Area]
3255-7,Fibrinogen,COAG,Clot; Clottable; COAGULATION; Coagulation assay; Coagulation factor I; FGN; Hematology; Heme; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Tilt tube; UniversalLabOrders,Fibrinogen PPP-mCnc,g/L;mg/dL,Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,mg/dL,Fibrinogen Coag (PPP) [Mass/Vol]
30392-5,Erythrocytes.nucleated,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Normoblasts; nRBC; nRBCs; Nuc; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,nRBC # Bld,10*9/L,Nucleated erythrocytes [#/volume] in Blood,10*3/uL,Nucleated RBC (Bld) [#/Vol]
5818-0,Urobilinogen,CHEM,Chemistry; Dip stick; Dipstick; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UBG; UR; Urn; Urobili; Urobilngn,Urobilinogen Ur Ql Strip,,Urobilinogen [Presence] in Urine by Test strip,,Urobilinogen Test strip Ql (U)
705-4,Basophils,HEM/BC,#; ABS; absolute; absolutes; Baso; Basophil; Basos; Blood; Bph; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Basophils # Bld Manual,10*9/L,Basophils [#/volume] in Blood by Manual count,10*3/uL,Basophils Manual cnt (Bld) [#/Vol]
14957-5,Albumin,CHEM,Alb; Chemistry; DL=20 mg/L; Kidney; Left; Level; Levo; MA; Malb; Mass concentration; Micro albumin; Microalbumin; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UniversalLabOrders; UR; Urn,Microalbumin Ur-mCnc,mg/L;mcg/mL; mg/dL,Microalbumin [Mass/volume] in Urine,ug/mL;mg/dL,Albumin DL <= 20 mg/L (U) [Mass/Vol]
56850-1,Interpretation and review of laboratory results,ED,DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Imp & review of lab results; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; Point in time; Random,Imp & review of lab results,,Interpretation and review of laboratory results,,
2986-8,Testosterone,CHEM,Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost; UniversalLabOrders,Testost SerPl-mCnc,ng/dL; ng/mL,Testosterone [Mass/volume] in Serum or Plasma,ng/dL,Testosterone [Mass/Vol]
32713-0,Potassium,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; k; K+; Level; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Potassium BldA-sCnc,mmol/L,Potassium [Moles/volume] in Arterial blood,mmol/L,Potassium (BldA) [Moles/Vol]
712-0,Eosinophils,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Eosinophil # Bld Manual,10*9/L,Eosinophils [#/volume] in Blood by Manual count,10*3/uL,Eosinophils Manual cnt (Bld) [#/Vol]
10378-8,Polychromasia,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; Polychro; Polychromatophilia; Polychromic; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Polychromasia Bld Ql Smear,,Polychromasia [Presence] in Blood by Light microscopy,,Polychromasia LM Ql (Bld)
32693-4,Lactate,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Blood; Chemistry; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UniversalLabOrders; WB; Whole blood,Lactate Bld-sCnc,mmol/L,Lactate [Moles/volume] in Blood,mmol/L,Lactate (Bld) [Moles/Vol]
12180-6,Calcium.ionized,CHEM,Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,Ca-I SerPl ISE-sCnc,mmol/L,Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE),mmol/L,Calcium.ionized ISE [Moles/Vol]
2069-3,Chloride,CHEM,Blood; Chemistry; Cl; Cl-; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UniversalLabOrders; WB; Whole blood,Chloride Bld-sCnc,mmol/L,Chloride [Moles/volume] in Blood,mmol/L,Chloride (Bld) [Moles/Vol]
49497-1,Platelets,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; estimation; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood,Platelet # Bld Est,10*3/mm3,Platelets [#/volume] in Blood by Estimate,10*3/uL,Platelets Estimate (Bld) [#/Vol]
702-1,Anisocytosis,HEM/BC,Aniso; Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Anisocytosis Bld Ql Smear,,Anisocytosis [Presence] in Blood by Light microscopy,,Anisocytosis LM Ql (Bld)
933-2,Observation,BLDBK,BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Nominal; Point in time; Random; Typ,Bld Prod Typ BPU,,Blood product type,,Observation Nom (BPU)
624-7,Bacteria,MICRO,Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lower respiratory; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Resp Cult; Respiratory; Spt; Sputum; UniversalLabOrders,Bacteria Spt Resp Cult,,Bacteria identified in Sputum by Respiratory culture,,Bacteria identified Respiratory culture Nom (Sput)
3051-0,Triiodothyronine.free,CHEM,Chemistry; Endocrine; Endocrinology; FR; Free T3; FT3; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3; T-3; T3Free; thyroid hormone; Total T3; Triodothyrne; UniversalLabOrders,T3Free SerPl-mCnc,ng/L;pg/mL,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,pg/mL,Free T3 [Mass/Vol]
28541-1,Metamyelocytes/Leukocytes,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Metamyelocytes NFr Bld,%,Metamyelocytes/Leukocytes in Blood,%,Metamyelocytes/Leukocytes (Bld)
33256-9,Leukocytes^^corrected for nucleated erythrocytes,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; nRBC cor; Nuc; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,WBC nRBC cor # Bld Auto,10*3/uL,Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood by Automated count,10*3/uL,WBC corrected for nucl RBC Auto (Bld) [#/Vol]
6299-2,Urea nitrogen,CHEM,Blood; Blood urea nitrogen; BUN; Chemistry; Kidney; Level; Mass concentration; N; N2; Nephrology; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UN; UniversalLabOrders; WB; Whole blood,BUN Bld-mCnc,mg/dL,Urea nitrogen [Mass/volume] in Blood,mg/dL,Urea nitrogen (Bld) [Mass/Vol]
43304-5,Chlamydia trachomatis rRNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Trachoma; Transcription mediated amplification; UniversalLabOrders; Unspecified,C trach rRNA Spec Ql NAA+probe,,Chlamydia trachomatis rRNA [Presence] in Specimen by NAA with probe detection,,C. trachomatis rRNA NAA+probe Ql (Specimen)
925-8,Observation,BLDBK,BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Nominal; Point in time; Random,Bld Prod Disposition BPU,,Blood product disposition [Type],,Blood product disposition Nom (BPU)
3274-8,Heparin.unfractionated,COAG,Anti-Xa; Arbitrary concentration; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Hep; Hepar; Heparn; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; UFH; UniversalLabOrders,UFH PPP Chro-aCnc,arb U/mL,Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method,[arb'U]/mL,Heparin unfractionated Chromogenic method Qn (PPP)
8478-0,Intravascular mean,BP.ATOM,Art sys; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.ATOM; BP; BP mean; Cardio; Cardiology; Heart Disease; Intravenous; IV; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random,BP mean,mm Hg,Mean blood pressure,mm[Hg],
50235-1,Mucus,UA,#/area; Auto; Automated detection; Elec; Elect; Electr; Kidney; Mucous; Mucous Threads; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Mucous Threads #/area UrnS Auto,/HPF,Mucus [#/area] in Urine sediment by Automated count,/[HPF],Mucus Auto (Urine sed) [#/Area]
2695-5,Observation,CHEM,Chemistry; Kidney; Nephrology; Osmo; Osmolality; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UniversalLabOrders; UR; Urn,Osmolality Ur,mmol/kg H2O;mOsm/L; mOsmol/kg,Osmolality of Urine,mosm/kg,Osmolality (U) [Osmolality]
24357-6,Urinalysis macro (dipstick) panel,PANEL.UA,Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UA Dipstick Pnl; UniversalLabOrders; UR; Urn,UA Dipstick Pnl Ur,,Urinalysis macro (dipstick) panel - Urine,,Urinalysis macro (dipstick) panel (U)
14155-6,Cholesterol.in LDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDLc; LDL-C; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Percentile; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR,LDLc Prctl SerPl,,Cholesterol in LDL [Percentile],,Cholesterol in LDL [%]
3390-2,Benzodiazepines,DRUG/TOX,Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Benzodiaz Ur Ql,,Benzodiazepines [Presence] in Urine,,Benzodiazepines Ql (U)
59574-4,Body mass index,BDYWGT.MOLEC,BMI; bod; Bodies; BODY WEIGHT.MOLEC; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Quetelet index; Random,BMI Prctl,%,Body mass index (BMI) [Percentile],%,
33959-8,Procalcitonin,CHEM,Chemistry; Level; Mass concentration; PCT; Pl; Plasma; Plsm; Point in time; proCT; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Procalcitonin SerPl-mCnc,ng/mL,Procalcitonin [Mass/volume] in Serum or Plasma,ng/mL,Procalcitonin [Mass/Vol]
26498-6,Myelocytes/Leukocytes,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Myel; Myelo; Myelocyte; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Myelocytes NFr Bld,%,Myelocytes/Leukocytes in Blood,%,Myelocytes/Leukocytes (Bld)
41652-9,Glucose,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous,Glucose BldV-mCnc,mg/dL,Glucose [Mass/volume] in Venous blood,mg/dL,Glucose (BldV) [Mass/Vol]
41645-3,Calcium.ionized,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous,Ca-I BldV-sCnc,mmol/L,Calcium.ionized [Moles/volume] in Venous blood,mmol/L,Calcium.ionized (BldV) [Moles/Vol]
12258-0,Epithelial cells.squamous,UA,Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Squamous UrnS Ql Micro,,Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy,,Epithelial cells.squamous LM Ql (Urine sed)
21197-9,Cholesterol esters/Cholesterol.total,CHEM,Chemistry; Chol; Choles; Cholest; Cholest Ester; Cholesterol total; Cholesterols; Ester; Lipid; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TC; Tot; Totl,Cholest Ester MFr SerPl,%,Cholesterol esters/Cholesterol.total in Serum or Plasma,%,Cholesterol esters/Total Cholesterol [Mass fraction]
20505-4,Bilirubin,UA,Bili; Bilirubins; Billirubin; Dip stick; Dipstick; Level; Mass concentration; Point in time; Random; SmQn; TBIL; UA; UR; URINALYSIS; Urn,Bilirub Ur Strip-mCnc,mg/dL,Bilirubin.total [Mass/volume] in Urine by Test strip,mg/dL,Bilirubin Test strip (U) [Mass/Vol]
21613-5,Chlamydia trachomatis DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Trachoma; Transcription mediated amplification; UniversalLabOrders; Unspecified,C trach DNA Spec Ql NAA+probe,,Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection,,C. trachomatis DNA NAA+probe Ql (Specimen)
30405-5,Leukocytes,UA,#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells,WBC # Ur,/uL,Leukocytes [#/volume] in Urine,/uL,WBC (U) [#/Vol]
8331-1,Body temperature,BDYTMP.MOLEC,Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Oral; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature,Oral temp,deg F; deg C,Oral temperature,Cel;[degF],
20409-9,Erythrocytes,UA,#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Dip stick; Dipstick; Discocytes; Erthrocyte; Erythrocyte; Number concentration; Number Concentration (count/vol); Point in time; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; SmQn; UA; UR; URINALYSIS; Urn,RBC # Ur Strip,ERY/uL; RBCS/uL,Erythrocytes [#/volume] in Urine by Test strip,/uL,RBC Test strip (U) [#/Vol]
43820-0,Bilirubin.glucuronidated+Bilirubin.albumin bound,CHEM,Alb; Associated; Bc; Bili; Bili.delta; Bili-alb; Bilirub Conj; Bilirub Delta; Bilirub Direct; Bilirubin conjugated; Bilirubin direct; Bilirubin glucuronides; Bilirubins; Billirubin; bnd; Chemistry; DELB; Delta bilirubin; Deltab; Hematology; Heme; Hepatology; Liver; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Protein.albumin; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL; TBIL-(Bu+Bc); TBIL-Bu,Bilirub Direct SerPl Ql,,Bilirubin.direct [Presence] in Serum or Plasma,,Bilirubin.direct Ql
2518-9,Lactate,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Lactate BldA-sCnc,mmol/L,Lactate [Moles/volume] in Arterial blood,mmol/L,Lactate (BldA) [Moles/Vol]
774-0,Ovalocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Ovalocyte; Ovalos; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Ovalocytes Bld Ql Smear,,Ovalocytes [Presence] in Blood by Light microscopy,,Ovalocytes LM Ql (Bld)
29769-7,Date vaccine information statement presented,VACCIN,Date vaccine info presented; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccine Info Stat; VIS,Date vaccine info presented,MMDDYY,Date vaccine information statement presented,,
3349-8,Amphetamines,DRUG/TOX,Addiction; Amph; Amphetam; Amphetamine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Speed; UA; UniversalLabOrders; UR; Urn,Amphetamines Ur Ql,,Amphetamines [Presence] in Urine,,Amphetamines Ql (U)
5820-6,Leukocyte casts,UA,#/area; Cast; Kidney; Leuc; Leuk; Leukocytes; Lkcs; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBC Casts; WBCs; White blood cell; White blood cells,WBC Casts #/area UrnS LPF,/LPF,WBC casts [#/area] in Urine sediment by Microscopy low power field,/[LPF],WBC casts LM.LPF (Urine sed) [#/Area]
43755-8,Casts,UA,#/area; Auto; Automated detection; Cast; Elec; Elect; Electr; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Casts #/area UrnS Auto,/HPF,Casts [#/area] in Urine sediment by Automated count,/[HPF],Casts Auto (Urine sed) [#/Area]
29768-9,Date vaccine information statement published,VACCIN,Date vaccine info published; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccine Info Stat; VIS,Date vaccine info published,MMDDYY,Date vaccine information statement published,,
33762-6,Natriuretic peptide.B prohormone N-Terminal,CHEM,Beta Natriuretic Peptide; BNP; Brain Natriuretic Peptide; B-type natriuretic peptide; Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Natriutietic peptide.B; NTproBNP; NT-proBNP; Pept; Pl; Plasma; Plsm; Point in time; proBNP; Pro-brain natriuretic peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,NT-proBNP SerPl-mCnc,pg/mL,Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,pg/mL,Natriuretic peptide.B prohormone N-Terminal [Mass/Vol]
783-1,Promyelocytes/Leukocytes,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Promyelocytes NFr Bld Manual,%,Promyelocytes/Leukocytes in Blood by Manual count,%,Promyelocytes/Leukocytes Manual cnt (Bld)
2865-4,Alpha 1 globulin,CHEM,A1; Alfa; Alpha1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Alpha1 Glob SerPl Elph-mCnc,g/L;g/dL,Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,g/dL,Alpha 1 globulin Elph [Mass/Vol]
17915-0,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Shlw Wnd; Wnd; Wound - shallow,Bacteria Shlw Wnd Aerobe Cult,,Bacteria identified in Wound shallow by Aerobe culture,,Bacteria identified Aer cx Nom (Shallow wound)
2868-8,Alpha 2 globulin,CHEM,A2; Alfa; Alpha2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Alpha2 Glob SerPl Elph-mCnc,g/L;g/dL,Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,g/dL,Alpha 2 globulin Elph [Mass/Vol]
2874-6,Gamma globulin,CHEM,Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Gamma glob SerPl Elph-mCnc,g/L;g/dL,Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis,g/dL,Gamma globulin Elph [Mass/Vol]
2871-2,Beta globulin,CHEM,B; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,B-Globulin SerPl Elph-mCnc,g/L;g/dL,Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis,g/dL,Beta globulin Elph [Mass/Vol]
1925-7,Base excess,CHEM,ABE; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Base ex; BE; Blood arterial; BSE; Calc; Calculation; Chemistry; EXS; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration,Base excess BldA Calc-sCnc,mmol/L,Base excess in Arterial blood by calculation,mmol/L,Base excess Calc (BldA) [Moles/Vol]
43822-6,Aspartate aminotransferase,CHEM,"Asp; Aspartate amino transferase; Aspartate transaminase; Aspartic acid; AST; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Glutamic oxaloacetic transaminase; Hepatology; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SGOT",AST Fld Ql,,Aspartate aminotransferase [Presence] in Body fluid,,AST Ql (Body fld)
740-1,Metamyelocytes/Leukocytes,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Metamyelocytes NFr Bld Manual,%,Metamyelocytes/Leukocytes in Blood by Manual count,%,Metamyelocytes/Leukocytes Manual cnt (Bld)
18262-6,Cholesterol.in LDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Dir; Heart Disease; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,LDLc SerPl Direct Assay-mCnc,mg/dL,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,mg/dL,Cholesterol in LDL Direct assay [Mass/Vol]
49054-0,Ercalcidiol,CHEM,"25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25-Hydroxy calciferol; 25-Hydroxycalciferol; 25-Hydroxyergocalciferol; 25-Hydroxyvitamin D 2; 25-Hydroxyvitamin D2; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Chemistry; Ercalcidiol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders",25(OH)D2 SerPl-mCnc,ng/mL,25-hydroxyvitamin D2 [Mass/volume] in Serum or Plasma,ng/mL,25-hydroxyvitamin D2 [Mass/Vol]
4092-3,Vancomycin^trough,DRUG/TOX,c162; DRUG/TOXICOLOGY; Drugs; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; VANC; Vancocin; Vancor,Vancomycin Trough SerPl-mCnc,mg/L;mcg/mL,Vancomycin [Mass/volume] in Serum or Plasma --trough,ug/mL,Vancomycin trough [Mass/Vol]
2713-6,Oxygen saturation,CHEM,Blood; Calc; calc from oxygen partial pressure; Calculation; Chemistry; from pO2; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2; WB; Whole blood,SaO2 % Bld from pO2,%,Oxygen saturation Calculated from oxygen partial pressure in Blood,%,SaO2% Calculated from oxygen partial pressure (Bld) [Mass fraction]
2862-1,Albumin,CHEM,Alb; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Albumin SerPl Elph-mCnc,g/L;g/dL,Albumin [Mass/volume] in Serum or Plasma by Electrophoresis,g/dL,Albumin Elph [Mass/Vol]
2349-9,Glucose,CHEM,Chemistry; Glu; Gluc; Glucoseur; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Glucose Ur Ql,,Glucose [Presence] in Urine,,Glucose Ql (U)
3298-7,Acetaminophen,DRUG/TOX,ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hepatology; Hydroxyacetanilide; Illicit; Level; Liver; Mass Concentration; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tylenol; u209; UniversalLabOrders,APAP SerPl-mCnc,ug/mL,Acetaminophen [Mass/volume] in Serum or Plasma,ug/mL,Acetaminophen [Mass/Vol]
2458-8,IgA,CHEM,Chemistry; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,IgA SerPl-mCnc,g/L;mg/dL,IgA [Mass/volume] in Serum or Plasma,mg/dL,IgA [Mass/Vol]
67151-1,Troponin T.cardiac,CHEM,Cardio; Cardiology; Chemistry; cTnT; Heart Disease; HS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin,Troponin T SerPl HS-mCnc,ng/L,Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method,ng/L,Troponin T.cardiac High sensitivity method [Mass/Vol]
3137-7,Body height,BDYHGT.ATOM,Axial length; bod; Bodies; BODY HEIGHT(LENGTH).ATOM; Body length; Length; Point in time; QNT; Quan; Quant; Quantitative; Random,Body height Measured,in;cm,Body height Measured,[in_us];cm;m,
3034-6,Transferrin,CHEM,Chemistry; Hematology; Heme; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SR; Tf; Trf; TRFRN; UniversalLabOrders,Transferrin SerPl-mCnc,g/L;mg/dL,Transferrin [Mass/volume] in Serum or Plasma,mg/dL,Transferrin [Mass/Vol]
20405-7,Urobilinogen,UA,Dip stick; Dipstick; Level; Mass concentration; Point in time; Random; SmQn; UA; UBG; UniversalLabOrders; UR; URINALYSIS; Urn; Urobili; Urobilngn,Urobilinogen Ur Strip-mCnc,mg/dL,Urobilinogen [Mass/volume] in Urine by Test strip,mg/dL,Urobilinogen Test strip (U) [Mass/Vol]
2118-8,Choriogonadotropin,CHEM,CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; Gyn; Gynecology; HCG; Human chorionic gonadotropin; OB; ObGyn; Obstetrics; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,HCG SerPl Ql,,Choriogonadotropin [Presence] in Serum or Plasma,,HCG Ql
16935-9,Hepatitis B virus surface Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBsAg; Arbitrary concentration; Autoantibodies; Autoantibody; HBs; HBsAB; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; HepB; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Surf; UniversalLabOrders,HBV surface Ab Ser-aCnc,mIU/mL,Hepatitis B virus surface Ab [Units/volume] in Serum,m[IU]/mL,HBV surface Ab Qn (S)
8884-9,Heart rate rhythm,HRTRATE.ATOM,Heart beat; HEART RATE.ATOM; Misc; Miscellaneous; Nominal; Other; Point in time; Pulse; Random; Spec; To be specified in another part of the message; Typ; Unspecified,Heart rate rhythm,,Heart rate rhythm,,
24325-3,Hepatic function 2000 panel,PANEL.CHEM,00; Chemistry; FCN; Func; Funct; Hep Func 2000 Pnl; Hepatology; Liver; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Hep Func 2000 Pnl SerPl,,Hepatic function 2000 panel - Serum or Plasma,,Hepatic function 2000 panel
32167-9,Clarity,SPEC,Nominal; Point in time; Random; SPEC; Typ; UA; UR; Urn,Clarity Ur,,Clarity of Urine,,Clarity (U)
19254-2,Oxygen^^adjusted to patient's actual temperature,CHEM,adj; Blood; Chemistry; Lung; O2; O2 partial pressure; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; S prime; Temp; temp adj; tO2; WB; Whole blood,pO2 temp adj Bld,mm Hg,Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood,mm[Hg],Oxygen adjusted to patient's actual temperature (Bld) [Partial pressure]
69405-9,Glomerular filtration rate,CHEM,"Blood; Chemistry; GFR; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood",GFR SerPlBld based on 1.73 sq M-ArVRat,mL/min,"Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M",mL/min,GFR based on 1.73 sq M (S/P/Bld) [Vol rate/Area]
8277-6,Body surface,BDYSURF.ATOM,Bdy surface; bod; Bodies; BODY SURFACE AREA.ATOM; BSA; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf,BSA,m2,Body surface area,m2,
3773-9,Methadone,DRUG/TOX,Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Methadone Ur Ql,,Methadone [Presence] in Urine,,Methadone Ql (U)
11529-5,Surgical pathology study,PANEL.MISC,Document; Finding; Findings; MISC; Pan; Panel; PANEL.MISC; Panl; Path; Path study; Pnl; Point in time; Random; Study report; Surg; Surg Path Study; Surg Pathology; UniversalLabOrders,Surgical pathology study,,Surgical pathology study,,Surgical pathology study
30376-8,Blasts,HEM/BC,#; ABS; absolute; absolutes; Blast; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Blasts # Bld,10*3/mm3,Blasts [#/volume] in Blood,10*3/uL,Blasts (Bld) [#/Vol]
4024-6,Salicylates,DRUG/TOX,2-Hydroxybenzoate; 2-Hydroxybenzoic Acid; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; o-Hydroxybenzoate; o-Hydroxybenzoic Acid; ortho-Hydroxybenzoate; ortho-Hydroxybenzoic Acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sali; Salicilates; Salicylate; Salicylic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Salicylates SerPl-mCnc,mg/dL,Salicylates [Mass/volume] in Serum or Plasma,mg/dL,Salicylates [Mass/Vol]
3414-0,Buprenorphine,DRUG/TOX,Addiction; BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; Illicit; Norspan; Ordinal; Point in time; PotentialForAbuse; PR; Prefin; QL; Qual; Qualitative; Random; Screen; Suboxone; Subutex; Temgesic; UA; UniversalLabOrders; UR; Urn,Buprenorphine Ur Ql,,Buprenorphine [Presence] in Urine,,Buprenorphine Ql (U)
35659-2,Age at specimen collection,TUMRRGT,AOEObservation; Coll; Collect; Collected; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; TUMOR REGISTRY(NAACCR),Age at specimen collection,mo,Age at specimen collection,mo,
31045-8,Creatinine/Urea nitrogen,CHEM,Blood urea nitrogen; BUN; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; N; N2; Nit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN,Creat/Urea nit SerPl,,Creatinine/Urea nitrogen [Mass Ratio] in Serum or Plasma,,Creatinine/Urea nitrogen [Mass ratio]
43134-6,Calcidiol & Calciferol & Calcitriol panel,PANEL.CHEM,"1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; 25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D metabolites; 25-hydroxyvitamin D2 + D3; 25-hydroxyvitamin D3; Activated ergosterol; C28H43OH; Calciderol; Calcidiol+Calciferol; Calcifediol; Chemistry; Ercalciol; Ergocalciferol; Level; Mass concentration; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Pro vitamin D; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Viosterol; Vit D 1 25 hydroxy; Vit D2; Vit D25+D1,25 OH+D1,25 Pnl; Vitamin D 25 hydroxy; Vitamin D2","Vit D25+D1,25 OH+D1,25 Pnl SerPl-mCnc",,Calcidiol and Calciferol and Calcitriol panel [Mass/volume] - Serum or Plasma,,"25-hydroxyvitamin D3 and Vitamin D2 and 1,25-dihydroxyvitamin D3 panel [Mass/Vol]"
635-3,Bacteria,MICRO,Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,Bacteria Spec Anaerobe Cult,,Bacteria identified in Specimen by Anaerobe culture,,Bacteria identified Anaer cx Nom (Specimen)
1003-3,Indirect antiglobulin test.complement specific reagent,BLDBK,Antiglob; BLOOD BANK; Comp; Complmt; Hematology; Heme; IAGT; IAT; IAT Comp-Sp Reag; IDC; Ind; Ind Coombs; Indir; Indirect Coomb; Indirect Coombs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; UniversalLabOrders,IAT Comp-Sp Reag SerPl Ql,,Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma,,Indirect antiglobulin test.complement specific reagent Ql
13955-0,Hepatitis C virus Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HCV; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HCV Ab SerPl Ql IA,,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,,HCV Ab IA Ql
3026-2,Thyroxine,CHEM,Chemistry; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4; UniversalLabOrders,T4 SerPl-mCnc,ug/dL,Thyroxine (T4) [Mass/volume] in Serum or Plasma,ug/dL,T4 [Mass/Vol]
28545-2,Mucus,UA,#/area; Kidney; LM; Micro; Micros; Microscopic; Mucous; Mucous Threads; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Mucous Threads #/area UrnS LPF,/LPF,Mucus [#/area] in Urine sediment by Microscopy low power field,/[LPF],Mucus LM.LPF (Urine sed) [#/Area]
45390-2,Epithelial cells.squamous,UA,#/area; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Squamous #/area UrnS LPF,/LPF,Epithelial cells.squamous [#/area] in Urine sediment by Microscopy low power field,/[LPF],Epithelial cells.squamous LM.LPF (Urine sed) [#/Area]
768-2,Neutrophils.segmented,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs; WB; Whole blood,Neuts Seg # Bld Manual,10*9/L,Segmented neutrophils [#/volume] in Blood by Manual count,10*3/uL,Segmented neutrophils Manual cnt (Bld) [#/Vol]
779-9,Poikilocytosis,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Poikilo; Poikilocyte; Poikilocytes; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Poikilocytosis Bld Ql Smear,,Poikilocytosis [Presence] in Blood by Light microscopy,,Poikilocytosis LM Ql (Bld)
8341-0,Dry body weight,BDYWGT.MOLEC,Bdy weight; bod; Bodies; BODY WEIGHT.MOLEC; Dry weight; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt,Dry weight Measured,kg;lb,Dry body weight Measured,kg;[lb_av],
14314-9,Benzoylecgonine,DRUG/TOX,BEC; BEG; Benz; Benzoylec; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn,BZE Ur Ql Scn,,Benzoylecgonine [Presence] in Urine by Screen method,,Benzoylecgonine Screen Ql (U)
625-4,Bacteria,MICRO,Bact; Bowel movement; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Stl; Stool = Fecal; UniversalLabOrders,Bacteria Stl Cult,,Bacteria identified in Stool by Culture,,Bacteria identified Cx Nom (Stl)
45066-8,Creatinine & Glomerular filtration rate.predicted panel,PANEL.CHEM,"Blood; Chemistry; CR; Crea; Creat; Creatinine + eGFR Pnl; GFR; Glom; Pan; PANEL.CHEMISTRY; Panl; Pl; PlasBld; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; UniversalLabOrders; WB; Whole blood",Creatinine + eGFR Pnl SerPlBld,,"Creatinine and Glomerular filtration rate.predicted panel - Serum, Plasma or Blood",,Creatinine and Glomerular filtration rate.predicted panel (S/P/Bld)
12248-1,Epithelial cells.renal,UA,Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; Kidney cells; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; REC; Renal; Renal Epi Cells; Renal tubular cells; RTC; RTE; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Renal Epi Cells UrnS Ql Micro,,Epithelial cells.renal [Presence] in Urine sediment by Light microscopy,,Epithelial cells.renal LM Ql (Urine sed)
26508-2,Neutrophils.band form/Leukocytes,HEM/BC,Bands; Blood; bnd; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number Fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neuts Band NFr Bld,%,Band form neutrophils/Leukocytes in Blood,%,Band form neutrophils/Leukocytes (Bld)
34714-6,Coagulation tissue factor induced.INR,COAG,Blood; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Hematology; Heme; Internat norm ratio; International normal ratio; International normalization ratio; International normalized ratio; Point in time; Pro time; Prothrombin time; Prothrombin time INR; Protime; Protime INR; PT; PT INR; QNT; Quan; Quant; Quantitative; Random; RlTm; Tilt tube; WB; Whole blood,INR Bld,INR,INR in Blood by Coagulation assay,{INR},INR Coag (Bld) [Relative time]
58445-8,Manual differential comment,HEM/BC,Blood; cmmt; cmnt; Com; Comm; Comments; Commt; Diff; Differl; Differn; HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Manual dif comment; Narrative; Point in time; Random; Remarks; Report; WB; Whole blood,Manual dif comment Bld-Imp,,Manual differential comment [Interpretation] in Blood Narrative,,Manual differential comment Nar (Bld) [Interp]
753-4,Neutrophils,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Neut; Neutr; Neutrophil; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Neutrophils # Bld Manual,10*9/L,Neutrophils [#/volume] in Blood by Manual count,10*3/uL,Neutrophils Manual cnt (Bld) [#/Vol]
26446-5,Blasts/Leukocytes,HEM/BC,Blast; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Blasts NFr Bld,%,Blasts/Leukocytes in Blood,%,Blasts/Leukocytes (Bld)
35332-6,Neutrophils.band form/Leukocytes,HEM/BC,Auto; Automated detection; Bands; Blood; bnd; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number Fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neuts Band NFr Bld Auto,%,Band form neutrophils/Leukocytes in Blood by Automated count,%,Band form neutrophils/Leukocytes Auto (Bld)
1558-6,Glucose^post CFst,CHAL.ROUTINE,After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Fast; Fasting; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Glucose p fast SerPl-mCnc,mg/dL,Fasting glucose [Mass/volume] in Serum or Plasma,mg/dL,Glucose post fast [Mass/Vol]
934-0,Blood product unit ID,BLDBK,Bld Prod Unit Id; BLOOD BANK; Cnt; Count; Dose med or substance; Identifier; Intradermal; Number; Point in time; QNT; Quan; Quant; Quantitative; Random,BPU ID,,Blood product unit ID [#],{ID},Blood product unit ID (Dose) [#]
34581-9,Calcium.ionized,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Ca-I BldA-sCnc,mmol/L,Calcium.ionized [Moles/volume] in Arterial blood,mmol/L,Calcium.ionized (BldA) [Moles/Vol]
48671-2,Prostate cancer risk,CHEM,Chemistry; Est; estimation; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk,Prostate cancer risk Patient Est,,Prostate cancer risk [Likelihood] by Estimated,,Prostate cancer risk Est Qn
43407-6,Bacteria,MICRO,Bact; C&S; Cult; Cultures; Deep Wnd; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders; Wnd; Wound - deep,Bacteria Deep Wnd Cult,,Bacteria identified in Wound deep by Culture,,Bacteria identified Cx Nom (Deep wound)
64994-7,Vaccine funding program eligibility category,VACCIN,Finding; Findings; Nominal; Point in time; Random; Vaccine fund pgm elig cat,Vaccine fund pgm elig cat,,Vaccine funding program eligibility category,,
2465-3,IgG,CHEM,Chemistry; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,IgG SerPl-mCnc,g/L;mg/dL,IgG [Mass/volume] in Serum or Plasma,mg/dL,IgG [Mass/Vol]
24362-6,Renal function 2000 panel,PANEL.CHEM,00; Chemistry; FCN; Func; Funct; Kidney; Nephrology; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Renal Func 2000 Pnl; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Renal Func 2000 Pnl SerPl,,Renal function 2000 panel - Serum or Plasma,,Renal function 2000 panel
40646-2,Leukocytes other/Leukocytes,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Othr; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBC Other; WBCs; White blood cell; White blood cells; Whole blood,WBC Other NFr Bld Auto,%,Leukocytes other/Leukocytes in Blood by Automated count,%,WBC other/Leukocytes Auto (Bld)
776-5,Platelet,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; WB; Whole blood,PMV Bld Rees-Ecker,fL,Platelet [Entitic mean volume] in Blood by Rees-Ecker,fL,Platelet Rees-Ecker (Bld) [Entitic mean vol]
57751-0,Hemoglobin,UA,Auto; Automated detection; Blood; Dip stick; Dipstick; Elec; Elect; Electr; Haemoglobin; Hb; Hgb; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Hgb Ur Ql Strip.auto,,Hemoglobin [Presence] in Urine by Automated test strip,,Hemoglobin Auto test strip Ql (U)
2026-3,Carbon dioxide,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2,CO2 BldA-sCnc,mmol/L,"Carbon dioxide, total [Moles/volume] in Arterial blood",mmol/L,CO2 (BldA) [Moles/Vol]
58077-9,Urinalysis complete W Reflex Culture panel,PANEL.UA,Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UA complete W Reflex Culture pnl; UniversalLabOrders; UR; Urn,UA complete W Reflex Culture pnl Ur,,Urinalysis complete W Reflex Culture panel - Urine,,Urinalysis complete W Reflex Culture panel (U)
35503-2,Arterial patency^pre arterial puncture,PULM,Allen's test; Art; Before; Cardio; Cardiology; Carpal bone; Carpal bones; Carpal bones and joint; Heart Disease; Ordinal; Point in time; PR; PULMONARY; Ql; Qual; Qualitative; Random; Screen; Upper extremity joint,Arterial patency Wrist a,,Arterial patency Wrist artery --pre arterial puncture,,
42757-5,Troponin I.cardiac,CHEM,Blood; Cardio; Cardiology; Chemistry; cTnI; Heart Disease; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TnI; TrI; Trop I; Troponin; UniversalLabOrders; WB; Whole blood,Troponin I Bld-mCnc,ng/mL,Troponin I.cardiac [Mass/volume] in Blood,ng/mL,Troponin I.cardiac (Bld) [Mass/Vol]
17849-1,Reticulocytes/Erythrocytes,HEM/BC,Auto; Automated detection; Blood; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number Fraction; Percent; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Retic; Retics; Reticulocyte; UniversalLabOrders; WB; Whole blood,Retics/RBC NFr Auto,%,Reticulocytes/Erythrocytes in Blood by Automated count,%,Reticulocytes/Erythrocytes Auto (Bld)
1863-0,Anion gap,CHEM,Ag; AnGAP; Calc; Calculation; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,Anion Gap SerPl Calculated.4Ions-sCnc,mmol/L,Anion gap in Serum or Plasma by Calculated.4Ions,mmol/L,Anion gap Calculated.4Ions [Moles/Vol]
14805-6,Lactate dehydrogenase,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; P to L; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,LDH SerPl P to L-cCnc,arb U/L,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction,U/L,LDH Pyruvate to lactate reaction [Catalytic activity/Vol]
11558-4,pH,CHEM,Blood; Chemistry; Kidney; Log molar concentration; Lung; Nephrology; Point in time; Pulmonary; Pulmonology; Random; Renal; Respiratory; SmQn; WB; Whole blood,pH Bld,pH,pH of Blood,[pH],pH (Bld)
19659-2,Phencyclidine,DRUG/TOX,Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sernylan; UA; UniversalLabOrders; UR; Urn,PCP Ur Ql Scn,,Phencyclidine [Presence] in Urine by Screen method,,Phencyclidine Screen Ql (U)
46418-0,Coagulation tissue factor induced.INR,COAG,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Finger stick; Hematology; Heme; Internat norm ratio; International normal ratio; International normalization ratio; International normalized ratio; Point in time; Pro time; Prothrombin time; Prothrombin time INR; Protime; Protime INR; PT; PT INR; QNT; Quan; Quant; Quantitative; Random; RlTm; Tilt tube,INR BldC,,INR in Capillary blood by Coagulation assay,,INR Coag (BldC) [Relative time]
41651-1,Glucose,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random,Glucose BldA-mCnc,mg/dL,Glucose [Mass/volume] in Arterial blood,mg/dL,Glucose (BldA) [Mass/Vol]
738-5,Macrocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; LM; Macrocyte; Macrocytosis; Macros; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Macrocytes Bld Ql Smear,,Macrocytes [Presence] in Blood by Light microscopy,,Macrocytes LM Ql (Bld)
2714-4,Oxyhemoglobin/Hemoglobin.total,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; Mass Fraction; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SaO2; SO2; Tot; Totl,OxyHgb MFr BldA,%,Fractional oxyhemoglobin in Arterial blood,%,Oxyhemoglobin (BldA) [Mass fraction]
30313-1,Hemoglobin,HEM/BC,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random,Hgb BldA-mCnc,g/dL,Hemoglobin [Mass/volume] in Arterial blood,g/dL,Hemoglobin (BldA) [Mass/Vol]
2501-5,Iron binding capacity.unsaturated,CHEM,Bind; Chemistry; dTIBC; Fe; IBC; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TIBC; Total iron binding; UIBC; UniversalLabOrders; Unsat,UIBC SerPl-mCnc,ug/dL,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,ug/dL,Iron binding capacity.unsaturated [Mass/Vol]
11282-1,Cells counted.total,HEM/BC,Blood; Cell; Cellularity; Cnt; Count; HEMATOLOGY/CELL COUNTS; Non-aggregate; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Total cells; Total Cells Counted; Totl; WB; Whole blood,Total Cells Counted Bld,#,Cells Counted Total [#] in Blood,{#},Cells Counted Total (Bld) [#]
18481-2,Streptococcus pyogenes Ag,MICRO,Antigen; Antigens; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S pyogenes; Screen; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; Throat; UniversalLabOrders; Upper respiratory,S pyo Ag Throat Ql,,Streptococcus pyogenes Ag [Presence] in Throat,,S. pyogenes Ag Ql (Throat)
622-1,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lower respiratory; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spt; Sputum,Bacteria Spt Aerobe Cult,,Bacteria identified in Sputum by Aerobe culture,,Bacteria identified Aer cx Nom (Sput)
4498-2,Complement C4,HEM/BC,Beta 1 E-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,C4 SerPl-mCnc,g/L;mg/dL,Complement C4 [Mass/volume] in Serum or Plasma,mg/dL,Complement C4 [Mass/Vol]
41647-9,Carbon dioxide,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Calc; Calculation; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2,CO2 BldA Calc-sCnc,mmol/L,"Carbon dioxide, total [Moles/volume] in Arterial blood by calculation",mmol/L,CO2 Calc (BldA) [Moles/Vol]
30956-7,Type,VACCIN,Ident; Identifier; Nominal; Point in time; Random,Type Vaccine,,Type [Identifier] Vaccine,,
14959-1,Albumin/Creatinine,CHEM,Alb; Chemistry; CR; Crea; Creat; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass concentration ratio; Mass ratio; MCRto; Micro albumin; Microalbumin; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UCr; UR; Urn,Microalbumin/Creat Ur,mg/g creatinine,Microalbumin/Creatinine [Mass Ratio] in Urine,mg/g{creat},Albumin/Creatinine DL <= 20 mg/L (U) [Mass ratio]
48159-8,Hepatitis C virus Ab Signal/Cutoff,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; co; cut off; EIA; ELFA; ELISA; Enzyme immunoassay; HCV; HCV Ab s/co; HCV Ab Signal; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HCV Ab s/co SerPl IA,,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,,HCV Ab Signal/Cutoff IA [Rel units/Vol]
77202-0,Laboratory comment,MISC,cmmt; cmnt; Com; Comm; Comments; Commt; MISC; Narrative; Point in time; Random; Remarks; Report; Text,Laboratory comment Report,,Laboratory comment [Text] in Report Narrative,,Laboratory comment Nar (Report)
24365-9,Urinalysis microscopic panel,PANEL.UA,Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UA Microscopic Pnl; UR; Urine sediment; Urn; UrnS,UA Microscopic Pnl UrnS,,Urinalysis microscopic panel - Urine sediment,,Urinalysis microscopic panel (Urine sed)
13536-8,Globulin,CHEM,Chemistry; GLB; Glob; Glob%; Globul; Globulins; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random,Globulin Plas-mCnc,g/dL,Globulin [Mass/volume] in Plasma,g/dL,Globulin (P) [Mass/Vol]
1250-0,Major crossmatch,BLDBK,BLOOD BANK; Compatability testing; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Maj XM; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Maj XM SerPl-Imp,,Major crossmatch [Interpretation],,Major crossmatch [Interp]
4485-9,Complement C3,HEM/BC,Beta 1 C-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,C3 SerPl-mCnc,g/L;mg/dL,Complement C3 [Mass/volume] in Serum or Plasma,mg/dL,Complement C3 [Mass/Vol]
5909-7,Blood smear finding,HEM/BC,Bld Smear Interp; Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Identity or presence; LM; Micro; Micros; Microscopic; Nominal; Point in time; Random; smears; WB; Whole blood,Bld Smear Interp,,Blood smear finding [Identifier] in Blood by Light microscopy,,Blood smear finding LM Nom (Bld)
14775-1,Hemoglobin,HEM/BC,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Lung; Mass Concentration; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory,Hgb BldA Oximetry-mCnc,g/L,Hemoglobin [Mass/volume] in Arterial blood by Oximetry,g/dL,Hemoglobin Oximetry (BldA) [Mass/Vol]
71773-6,Mycobacterium tuberculosis stimulated gamma interferon,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Blood; ID; IFN; IGRA; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; M tb; M TB IFN-g; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TB; Tuberculosis; WB; Whole blood,M TB IFN-g Bld-Imp,,Mycobacterium tuberculosis stimulated gamma interferon [Interpretation] in Blood Qualitative,,M. tuberculosis stim IFN-g Ql (Bld) [Interp]
19343-3,Amphetamine,DRUG/TOX,Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Speed; UA; UniversalLabOrders; UR; Urn,Amphet Ur Ql Scn,,Amphetamine [Presence] in Urine by Screen method,,Amphetamine Screen Ql (U)
22634-0,Path report.gross observation,TUMRRGT,Finding; Findings; Narrative; Oncology; Point in time; Random; Report; Spec; TUMOR REGISTRY(NAACCR),Path report.gross Spec,,Pathology report gross observation Narrative,,
19993-5,Oxygen/Gas.total,PULM,Dil; Dilut; Gas Dil.rebreath; Gases; IhG; Inhaled Gas; Inspired; Lung; O2; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Tot; Totl; Volfr; Volume fraction,FIO2 Gas Dil.rebreath,%,Oxygen/Gas total Inhaled gas by Gas dilution.rebreath,%,
38488-3,IgG,CHEM,Arbitrary concentration; Chemistry; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR,IgG Ser-aCnc,arb U/mL,IgG [Units/volume] in Serum,[arb'U]/mL,IgG Qn (S)
16362-6,Ammonia,CHEM,Amm; Ammon; Amon; Chemistry; Hepatology; Kidney; Level; Liver; Nephrology; NH3; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration; UniversalLabOrders,Ammonia Plas-sCnc,umol/L,Ammonia [Moles/volume] in Plasma,umol/L,Ammonia (P) [Moles/Vol]
6462-6,Bacteria,MICRO,Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders; Wnd,Bacteria Wnd Cult,,Bacteria identified in Wound by Culture,,Bacteria identified Cx Nom (Wound)
30451-9,Neutrophils.segmented,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs; WB; Whole blood,Neuts Seg # Bld,10*9/L,Segmented neutrophils [#/volume] in Blood,10*3/uL,Segmented neutrophils (Bld) [#/Vol]
2039-6,Carcinoembryonic Ag,CHEM,Antigen; Antigens; CEA; Chemistry; Level; Mass concentration; Oncology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,CEA SerPl-mCnc,ug/L;ng/mL,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,ng/mL,Carcinoembryonic Ag [Mass/Vol]
749-2,Myelocytes/Leukocytes,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myel; Myelo; Myelocyte; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Myelocytes NFr Bld Manual,%,Myelocytes/Leukocytes in Blood by Manual count,%,Myelocytes/Leukocytes Manual cnt (Bld)
33509-1,Hemoglobin,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random",Hgb Fld-mCnc,g/L;g/dL,Hemoglobin [Mass/volume] in Body fluid,g/dL,Hemoglobin (Body fld) [Mass/Vol]
15067-2,Follitropin,CHEM,Arbitrary concentration; Chemistry; Follicle stimulating hormone; FSH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,FSH SerPl-aCnc,IU/L;mIU/mL,Follitropin [Units/volume] in Serum or Plasma,m[IU]/mL,Follitropin Qn
11125-2,Platelet morphology finding,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Identity or presence; Nominal; Pl; Plat morph; Platelets; Platelt; Plt; Point in time; Random; Thrombocyte; Thrombocytes; WB; Whole blood,Plat morph Bld,,Platelet morphology finding [Identifier] in Blood,,Platelet morphology finding Nom (Bld)
741-9,Microcytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Microcyte; Microcytosis; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Microcytes Bld Ql Smear,,Microcytes [Presence] in Blood by Light microscopy,,Microcytes LM Ql (Bld)
40982-1,Influenza virus B RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,FLUBV RNA Spec Ql NAA+probe,,Influenza virus B RNA [Presence] in Specimen by NAA with probe detection,,FLUBV RNA NAA+probe Ql (Specimen)
14316-4,Benzodiazepines,DRUG/TOX,Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn,Benzodiaz Ur Ql Scn,,Benzodiazepines [Presence] in Urine by Screen method,,Benzodiazepines Screen Ql (U)
610-6,Bacteria,MICRO,"Aerobe; Aerobe Cult; Aerobed; B/F; Bact; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders",Bacteria Fld Aerobe Cult,,Bacteria identified in Body fluid by Aerobe culture,,Bacteria identified Aer cx Nom (Body fld)
34165-1,Granulocytes.immature,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; Gran; Grans; Granulocyte; Granulocytes; HEMATOLOGY/CELL COUNTS; Imm; Imm Granulocytes; Immat; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Imm Granulocytes Bld Ql Auto,,Immature granulocytes [Presence] in Blood by Automated count,,Immature granulocytes Auto Ql (Bld)
24317-0,Hemogram & platelets WO differential panel,PANEL.HEM/BC,Blood; CBC WO diff; Complete Blood Count; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Platelet; Platelt; Plt; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood,CBC WO diff Bld,,Hemogram and platelets WO differential panel - Blood,,Hemogram and platelets WO differential panel (Bld)
13969-1,Creatine kinase.MB,CHEM,Cardio; Cardiology; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Heart Disease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,CK MB SerPl-mCnc,ng/mL; ug/L,Creatine kinase.MB [Mass/volume] in Serum or Plasma,ng/mL,CK.MB [Mass/Vol]
62409-8,PhenX - hip circumference protocol 020801,PANEL.PHENX,Girth; Lower extremity joint; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random,PhenX - hip circumference protocol,,PhenX - hip circumference protocol 020801,,
12235-8,Observation,UA,Identity or presence; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Nominal; Point in time; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Micro UrnS,,Microscopic observation [Identifier] in Urine sediment by Light microscopy,,Microscopic observation LM Nom (Urine sed)
30522-7,C reactive protein,CHEM,Cardiac CRP; Cardio; Cardiology; Chemistry; CRP; Heart Disease; HS; hsCRP; hs-CRP; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Reac; React; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,CRP SerPl HS-mCnc,mcg/mL; mg/dL; mg/L,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,mg/L,CRP High sensitivity method [Mass/Vol]
19764-0,Statement of adequacy,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Genital tract; Genital vaginal; Gyn; Gynecology; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; OB; ObGyn; Obstetrics; Pap Smear; Pap Stain; Papanicolaou smear; Papinacolou Smear; Point in time; Random; St; Stains; Stat of Adq; Stn; Vag fld; Vag fluid; Vagina; Vaginal fluid,Stat of Adq Cvx/Vag Cyto-Imp,,Statement of adequacy [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain,,Statement of adequacy Cyto stain (Cvx/Vag) [Interp]
2143-6,Cortisol,CHEM,17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Cortis SerPl-mCnc,ug/dL,Cortisol [Mass/volume] in Serum or Plasma,ug/dL,Cortisol [Mass/Vol]
733-6,Lymphocytes.variant,HEM/BC,Atypical lymphocytes; Blood; HEMATOLOGY/CELL COUNTS; LM; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reactive lymphocytes; Screen; Variant lymphocytes; Variant Lymphs; WB; Whole blood,Variant Lymphs Bld Ql Smear,,Variant lymphocytes [Presence] in Blood by Light microscopy,,Variant lymphocytes LM Ql (Bld)
633-8,Bacteria,MICRO,Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Wnd,Bacteria Wnd Anaerobe Cult,,Bacteria identified in Wound by Anaerobe culture,,Bacteria identified Anaer cx Nom (Wound)
52969-3,Staphylococcus aureus.methicillin resistant isolate,MICRO,C&S; Celbenin; Cult; Cultures; Dimethoxypenicillin; ID; Infectious Disease; InfectiousDisease; Metacillin; Metin; Microbiology; MRSA; MRSA screen; Nasal; Nos; Nose (nasal passage); o71; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S aureus; Screen; Smell; Spec; Staficyn; Staph; Staphicillin,MRSA Nose Ql Cult,,Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture,,MRSA isol Org specific cx Ql (Nose)
2615-3,Methemoglobin/Hemoglobin.total,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Mass fraction; Methaemoglobin; MetHb; Methgb; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl,MetHgb MFr BldA,%,Methemoglobin/Hemoglobin.total in Arterial blood,%,Methemoglobin (BldA) [Mass fraction]
634-6,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,Bacteria Spec Aerobe Cult,,Bacteria identified in Specimen by Aerobe culture,,Bacteria identified Aer cx Nom (Specimen)
2030-5,Carboxyhemoglobin/Hemoglobin.total,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Mass Fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl,COHgb MFr BldA,%,Carboxyhemoglobin/Hemoglobin.total in Arterial blood,%,Carboxyhemoglobin (BldA) [Mass fraction]
3053-6,Triiodothyronine,CHEM,Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3; T-3; thyroid hormone; Total T3; Triodothyrne; UniversalLabOrders,T3 SerPl-mCnc,ng/dL; ng/mL,Triiodothyronine (T3) [Mass/volume] in Serum or Plasma,ng/dL,T3 [Mass/Vol]
11268-0,Streptococcus pyogenes,MICRO,C&S; Cult; Cultures; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S pyogenes; Screen; Spec; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; Throat; UniversalLabOrders; Upper respiratory,S pyo Throat Ql Cult,,Streptococcus pyogenes [Presence] in Throat by Organism specific culture,,S. pyogenes Org specific cx Ql (Throat)
29771-3,Hemoglobin.gastrointestinal.lower,CHEM,Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FIT; FOB; FOBT; Gastrocult; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; IAA; iFOBT; Low; MEIA; Occult blood; Occult blood in stool; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS; UniversalLabOrders,Hemoccult Stl Ql IA,,Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay,,Lower GI hemoglobin IA Ql (Stl)
2243-4,Estradiol,CHEM,17-beta estradiol; Chemistry; E2; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Estradiol SerPl-mCnc,ng/L;pg/mL,Estradiol (E2) [Mass/volume] in Serum or Plasma,pg/mL,E2 [Mass/Vol]
2955-3,Sodium,CHEM,Chemistry; Level; Na; Na+; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UniversalLabOrders; UR; Urn,Sodium Ur-sCnc,mmol/L,Sodium [Moles/volume] in Urine,mmol/L,Sodium (U) [Moles/Vol]
800-3,Schistocytes,HEM/BC,Blood; Fragmented cells; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Schisto; Schistocyte; Screen; WB; Whole blood,Schistocytes Bld Ql Smear,,Schistocytes [Presence] in Blood by Light microscopy,,Schistocytes LM Ql (Bld)
19763-2,Specimen source,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Genital tract; Genital vaginal; Identity or presence; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; Spec; Srce; St; Stains; Stn; Vag fld; Vag fluid; Vagina; Vaginal fluid,Specimen source Cvx/Vag Cyto,,Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain,,Specimen source Cyto stain Nom (Cvx/Vag)
35492-8,Staphylococcus aureus.methicillin resistant DNA,ABXBACT,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Celbenin; Deoxyribonucleic acid; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; Misc; Miscellaneous; MRSA; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; Screen; SDA; Spec; Staficyn; Staph; Staphicillin; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified,MRSA DNA Spec Ql NAA+probe,,Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection,,MRSA DNA NAA+probe Ql (Specimen)
19295-5,Opiates,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn,Opiates Ur Ql Scn,,Opiates [Presence] in Urine by Screen method,,Opiates Screen Ql (U)
47527-7,Cytology report,CYTO,Cervix; Cytology stain; Cytostain; Document; Finding; Findings; Genital tract; Genital vaginal; Gyn; Gynecology; OB; ObGyn; Obstetrics; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn; UniversalLabOrders; Vag fld; Vag fluid; Vagina; Vaginal fluid,Cytology Cvx/Vag Doc Thin Prep,,Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep,,Cytology report Cyto stain.thin prep Doc (Cvx/Vag)
2991-8,Testosterone.free,CHEM,Chemistry; FR; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost; Testost Free; Testosterone.unconjugated; UniversalLabOrders,Testost Free SerPl-mCnc,pg/mL,Testosterone Free [Mass/volume] in Serum or Plasma,pg/mL,Testosterone Free [Mass/Vol]
34535-5,Microalbumin/Creatinine ratio panel,PANEL.CHEM,Chemistry; CR; Crea; Creat; Creat ratio pnl; Kidney; Microalbumin/creat Pnl; Nephrology; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UCr; UniversalLabOrders; UR; Urn,Microalbumin/Creat ratio pnl Ur,,Microalbumin/Creatinine panel in random Urine,,Microalbumin/Creatinine ratio panel (U)
50545-3,Bacterial susceptibility panel,PANEL.ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial Susc Pnl; Islt; Isol; Minimum inhibitory concentration; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pnl; Point in time; Random; Sus; Susc; Suscept; Susceptibilities; Susceptibilty,Bacterial Susc Pnl Islt MIC,,Bacterial susceptibility panel by Minimum inhibitory concentration (MIC),,Bacterial susceptibility panel MIC (Isol)
3393-6,Benzoylecgonine,DRUG/TOX,BEC; BEG; Benz; Benzoylec; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,BZE Ur Ql,,Benzoylecgonine [Presence] in Urine,,Benzoylecgonine Ql (U)
2000-8,Calcium,CHEM,Ca; Cal; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,Calcium SerPl-sCnc,mmol/L;mEq/L,Calcium [Moles/volume] in Serum or Plasma,mmol/L,Calcium [Moles/Vol]
11572-5,Rheumatoid factor,SERO,Arbitrary concentration; Fac; Fact; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RF; Rheum; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Rheumatoid fact SerPl-aCnc,IU/mL;units/mL,Rheumatoid factor [Units/volume] in Serum or Plasma,[IU]/mL,Rheumatoid factor Qn
75263-4,Blood group antibody,BLDBK,Ab; Bld gp Ab Scn; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Bld gp Ab Scn SerPl Ql GEL,,Blood group antibody screen [Presence] in Serum or Plasma by GEL,,Blood group antibody screen GEL Ql
25514-1,Rubella virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Congenital rubella syndrome; German measles; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RUBV; Screen; Serum; SR,RUBV IgG Ser Ql,,Rubella virus IgG Ab [Presence] in Serum,,Rubella virus IgG Ql (S)
23761-0,Neutrophils/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neutrophils NFr Bld Manual,%,Neutrophils/Leukocytes in Blood by Manual count,%,Neutrophils/Leukocytes Manual cnt (Bld)
20408-1,Leukocytes,UA,#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Dip stick; Dipstick; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells,WBC # Ur Strip,Leu/uL; WBCS/uL,Leukocytes [#/volume] in Urine by Test strip,/uL,WBC Test strip (U) [#/Vol]
1834-1,Alpha-1-Fetoprotein,CHEM,A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; Feto; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,AFP SerPl-mCnc,ug/L;ng/mL,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,ng/mL,AFP [Mass/Vol]
2472-9,IgM,CHEM,Chemistry; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,IgM SerPl-mCnc,g/L;mg/dL,IgM [Mass/volume] in Serum or Plasma,mg/dL,IgM [Mass/Vol]
50552-9,Clarity,UA,Auto; Automated detection; Elec; Elect; Electr; Nominal; Point in time; Random; Refract; Refract.auto; Typ; UA; UR; URINALYSIS; Urn,Clarity Ur Refract.auto,,Clarity in Urine by Refractometry automated,,Clarity Refractometry automated (U)
32771-8,Carbon dioxide^^adjusted to patient's actual temperature,CHEM,ABG; adj; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Carbonic anhydride; Chemistry; CO2; Lung; PaCO2; Partial pressure; PCO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; S prime; Temp; temp adj,pCO2 temp adj BldA,mm Hg,Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood,mm[Hg],CO2 adjusted to patient's actual temperature (BldA) [Partial pressure]
2091-7,Cholesterol.in VLDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Very low density lipoprotein cholesterols; VLDLc,VLDLc SerPl-mCnc,mg/dL,Cholesterol in VLDL [Mass/volume] in Serum or Plasma,mg/dL,Cholesterol in VLDL [Mass/Vol]
33051-4,Erythrocytes,UA,Discocytes; Erthrocyte; Erythrocyte; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen; UA; UR; URINALYSIS; Urn,RBC Ur Ql,,Erythrocytes [Presence] in Urine,,RBC Ql (U)
2842-3,Prolactin,CHEM,Chemistry; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Prolactin SerPl-mCnc,ug/L;ng/mL,Prolactin [Mass/volume] in Serum or Plasma,ng/mL,Prolactin [Mass/Vol]
33944-0,Immunoglobulin light chains.lambda.free,CHEM,Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; FR; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Lambda LC; Lambda LC Free; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Lambda LC Free SerPl-mCnc,mg/L,Lambda light chains.free [Mass/volume] in Serum or Plasma,mg/L,Immunoglobulin light chains.lambda.free [Mass/Vol]
19270-8,Barbiturates,DRUG/TOX,Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn,Barbiturates Ur Ql Scn,,Barbiturates [Presence] in Urine by Screen method,,Barbiturates Screen Ql (U)
19550-3,Methadone,DRUG/TOX,Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn,Methadone Ur Ql Scn,,Methadone [Presence] in Urine by Screen method,,Methadone Screen Ql (U)
8866-6,Arterial pulse quality,HRTRATE.ATOM,Heart Rate; HEART RATE.ATOM; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Typ; Unspecified,Arterial pulse quality Type Palpation,,Arterial pulse quality by palpation,,
728-6,Hypochromia,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Hypochro; Hypochromic; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Hypochromia Bld Ql Smear,,Hypochromia [Presence] in Blood by Light microscopy,,Hypochromia LM Ql (Bld)
19255-9,Oxygen^^adjusted to patient's actual temperature,CHEM,ABG; adj; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Lung; O2; O2 partial pressure; PaO2; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; S prime; Temp; temp adj; tO2,pO2 temp adj BldA,mm Hg,Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood,mm[Hg],Oxygen adjusted to patient's actual temperature (BldA) [Partial pressure]
632-0,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Wnd,Bacteria Wnd Aerobe Cult,,Bacteria identified in Wound by Aerobe culture,,Bacteria identified Aer cx Nom (Wound)
24356-8,Urinalysis complete panel,PANEL.UA,Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UniversalLabOrders; UR; Urinalysis complete pnl; Urn,Urinalysis complete pnl Ur,,Urinalysis complete panel - Urine,,Urinalysis complete panel (U)
50221-1,Bacteria,UA,Auto; Automated detection; Bact; Elec; Elect; Electr; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Bacteria Ur Ql Auto,,Bacteria [Presence] in Urine by Automated,,Bacteria Auto Ql (U)
59470-5,Calcium.ionized,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random,Ca-I BldA-mCnc,mg/dL,Calcium.ionized [Mass/volume] in Arterial blood,mg/dL,Calcium.ionized (BldA) [Mass/Vol]
75357-4,Bacteria,MICRO,Absc; Aerobe; Aerobe Cult; Aerobed; Anaerobe+Aerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random,Bacteria Absc Anaerobe+Aerobe Cult,,Bacteria identified in Abscess by Anaerobe+Aerobe culture,,Bacteria identified Anaer+Aer cx Nom (Abscess)
59420-0,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA,MICRO,Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HC; HPA; HPV; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; HPV16+18+HRisk12DNA; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen,HPV I/H Risk 4 DNA Cvx Ql Probe+sig amp,,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification,,HPV 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA Probe+sig amp Ql (Cvx)
50190-8,Iron & Iron binding capacity panel,PANEL.CHEM,Bind; Chemistry; dTIBC; Fe; IBC; Iron+TIBC Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TIBC; Total iron binding; UniversalLabOrders,Iron+TIBC Pnl SerPl,,Iron and Iron binding capacity panel - Serum or Plasma,,Iron and Iron binding capacity panel
36916-5,Immunoglobulin light chains.kappa.free,CHEM,Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; FR; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Kappa LC Free; Level; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Kappa LC Free Ser-mCnc,mg/L,Kappa light chains.free [Mass/volume] in Serum,mg/L,Immunoglobulin light chains.kappa.free (S) [Mass/Vol]
34487-9,Influenza virus A RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,FLUAV RNA Spec Ql NAA+probe,,Influenza virus A RNA [Presence] in Specimen by NAA with probe detection,,FLUAV RNA NAA+probe Ql (Specimen)
546-2,Streptococcus.beta-hemolytic,MICRO,B; B-Hem Strep; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Strep; Strept; Throat; UniversalLabOrders; Upper respiratory,B-Hem Strep Throat Ql Cult,,Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture,,Streptococcus.beta-hemolytic Org specific cx Ql (Throat)
19642-8,oxyCODONE,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn; Vicodin,oxyCODONE Ur Ql Scn,,oxyCODONE [Presence] in Urine by Screen method,,oxyCODONE Screen Ql (U)
14804-9,Lactate dehydrogenase,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,LDH SerPl L to P-cCnc,arb U/L,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction,U/L,LDH Lactate to pyruvate reaction [Catalytic activity/Vol]
12190-5,Creatinine,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; CR; Crea; Creat; Fl; Fld; FLU; Fluid; Kidney; Level; Mass concentration; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UniversalLabOrders",Creat Fld-mCnc,mg/dL,Creatinine [Mass/volume] in Body fluid,mg/dL,Creatinine (Body fld) [Mass/Vol]
19767-3,Cytologist,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Genital tract; Genital vaginal; Ident; Identifier; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn; Vag fld; Vag fluid; Vagina; Vaginal fluid,Cytologist Cvx/Vag Cyto,,Cytologist who read Cyto stain of Cervical or vaginal smear or scraping,,Cytologist Cyto stain Nom (Cvx/Vag) [ID]
13316-5,Enterococcus species.vancomycin resistant,MICRO,C&S; c162; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; VANC; Vancocin; Vancor; VRE; VRE screen,VRE Spec Ql Cult,,Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture,,Vancomycin resistant enterococcus Org specific cx Ql (Specimen)
763-3,Neutrophils.band form,HEM/BC,#; ABS; absolute; absolutes; Bands; Blood; bnd; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Neuts Band # Bld Manual,10*9/L,Band form neutrophils [#/volume] in Blood by Manual count,10*3/uL,Band form neutrophils Manual cnt (Bld) [#/Vol]
40988-8,Respiratory syncytial virus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RSV; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,RSV RNA Spec Ql NAA+probe,,Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection,,RSV RNA NAA+probe Ql (Specimen)
32146-3,Platelets.large,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Lg Platelets; LM; Micro; Micros; Microscopic; Ordinal; Platelet; Platelet adequacy; Platelet estimate; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood,Lg Platelets Bld Ql Smear,,Platelets Large [Presence] in Blood by Light microscopy,,Platelets Large LM Ql (Bld)
43441-5,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; Bronchial alveolar lavage; Bronchoalveolar lavage; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; UniversalLabOrders,Bacteria BAL Aerobe Cult,,Bacteria identified in Bronchoalveolar lavage by Aerobe culture,,Bacteria identified Aer cx Nom (BAL)
5334-8,Rubella virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Congenital rubella syndrome; EIA; ELFA; ELISA; Enzyme immunoassay; German measles; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RUBV; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,RUBV IgG SerPl IA-aCnc,EIA Index; units/mL,Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,[arb'U]/mL,Rubella virus IgG IA Qn
73752-8,Reagin Ab & Treponema pallidum Ab.IgG & IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Neurosyphilis; Nominal; Pl; Plasma; Plsm; Point in time; Random; Reagin+T pallidum; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Syphilis; T pallidum; Treponema; Treponemal,Reagin+T pallidum IgG+IgM SerPl-Imp,,Reagin and Treponema pallidum IgG and IgM [Interpretation] in Serum or Plasma,,Reagin and T. pallidum IgG and IgM [Interp]
11031-2,Lymphocytes/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Lymphocytes NFr Fld,%,Lymphocytes/Leukocytes in Body fluid,%,Lymphocytes/Leukocytes (Body fld)
44429-9,Albumin/Globulin,CHEM,Alb; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Albumin/Glob SerPl Elph,ratio,Albumin/Globulin [Mass Ratio] in Serum or Plasma by Electrophoresis,{ratio},Albumin/Globulin Elph [Mass ratio]
10900-9,Hepatitis B virus surface Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBsAg; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HBs; HBsAB; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Surf; UniversalLabOrders,HBV surface Ab Ser Ql IA,,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,,HBV surface Ab IA Ql (S)
22638-1,Path report.comments,TUMRRGT,Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Oncology; Point in time; Random; Report; Spec; TUMOR REGISTRY(NAACCR),Path report.comments Imp Spec,,Pathology report comments [Interpretation] Narrative,,
19261-7,Amphetamines,DRUG/TOX,Addiction; Amph; Amphetam; Amphetamine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Speed; UA; UniversalLabOrders; UR; Urn,Amphetamines Ur Ql Scn,,Amphetamines [Presence] in Urine by Screen method,,Amphetamines Screen Ql (U)
32776-7,Erythrocytes,UA,Discocytes; Erthrocyte; Erythrocyte; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,RBC UrnS Ql Micro,,Erythrocytes [Presence] in Urine sediment by Light microscopy,,RBC LM Ql (Urine sed)
34530-6,ABO & Rh group panel,PANEL.BLDBK,ABO + Rh; ABO + Rh Pnl; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing; UniversalLabOrders; WB; Whole blood,ABO + Rh Pnl Bld,,ABO and Rh group panel - Blood,,ABO and Rh group panel (Bld)
46740-7,Hemoglobin disorders,CHEM,Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; Haemoglobin; Hb; Hemoglobinopathies; Hgb; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; WB; Whole blood,Hemoglobin disorders DBS-Imp,,Hemoglobin disorders newborn screen interpretation,,Hemoglobin disorders (DBS) [Interp]
803-7,Toxic granules,HEM/BC,Blood; Granule; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Toxic granulation; WB; Whole blood,Toxic Granules Bld Ql Smear,,Toxic granules [Presence] in Blood by Light microscopy,,Toxic granules LM Ql (Bld)
26505-8,Neutrophils.segmented/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neuts Seg NFr Bld,%,Segmented neutrophils/Leukocytes in Blood,%,Segmented neutrophils/Leukocytes (Bld)
50559-4,Hemoglobin,UA,Auto; Automated detection; Blood; Dip stick; Dipstick; Elec; Elect; Electr; Haemoglobin; Hb; Hgb; Level; Mass concentration; Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn,Hgb Ur Strip.auto-mCnc,mg/L,Hemoglobin [Mass/volume] in Urine by Automated test strip,mg/L,Hemoglobin Auto test strip (U) [Mass/Vol]
2716-9,Oxyhemoglobin/Hemoglobin.total,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; Mass Fraction; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SO2; Tot; Totl; Venous,OxyHgb MFr BldV,%,Fractional oxyhemoglobin in Venous blood,%,Oxyhemoglobin (BldV) [Mass fraction]
32354-3,Erythrocyte/Arterial blood,HEM/BC,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Calc; Calculation; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Volfr; Volume fraction,Hct VFr BldA Calc,%,Hematocrit [Volume Fraction] of Arterial blood by calculation,%,Hematocrit Calc (BldA) [Volume fraction]
11054-4,Cholesterol.in LDL/Cholesterol.in HDL,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; LDLc; LDL-C; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL,LDLc/HDLc SerPl,ratio,Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma,{ratio},Cholesterol in LDL/Cholesterol in HDL [Mass ratio]
55197-8,Transfusion status,BLDBK,BLOOD BANK; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tx,Transfusion status Patient Ql,,Transfusion status Qualitative,,Transfusion status Ql
8099-4,Thyroperoxidase Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Endocrine; Endocrinology; Iodide peroxidase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid Microsomal; Thyroid microsomes; Thyroid peroxidase; TPO; UniversalLabOrders,Thyroperoxidase Ab SerPl-aCnc,IU/mL;units/mL,Thyroperoxidase Ab [Units/volume] in Serum or Plasma,[IU]/mL,TPO Ab Qn
34574-4,Path report.final diagnosis,TUMRRGT,Dx; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Oncology; Path report.final Dx; Point in time; Random; Spec; TUMOR REGISTRY(NAACCR),Path report.final Dx Spec,,Pathology report final diagnosis,,
10331-7,Rh,BLDBK,Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; UniversalLabOrders; WB; Whole blood,Rh Bld,,Rh [Type] in Blood,,Rh Nom (Bld)
10998-3,oxyCODONE,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn; Vicodin,oxyCODONE Ur Ql,,oxyCODONE [Presence] in Urine,,oxyCODONE Ql (U)
64084-7,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells^^corrected for background,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Arbitrary concentration; bckgrd cor; Blood; Cell; Cellularity; Helper T cells; ID; IFN; IGRA; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Lung; M tb; M TB IFN-g; M TB IFN-g CD4+ T-cells; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; T prime; T4; T-4; TB; Tuberculosis; W3/25; WB; Whole blood,M TB IFN-g CD4+ bckgrnd cor Bld-aCnc,IU/mL,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood,[IU]/mL,M. tuberculosis stim IFN-g by CD4+ T-cells corrected for background Qn (Bld)
516-5,Trimethoprim+Sulfamethoxazole,ABXBACT,Acetylsulfamethoxazole; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bactrim; c202; c203; c223; c242; C61; C62; Cotrim; Cotrimoxazole; Co-trimoxazole; Gantanol; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Polytrim; Primsol; Proloprim; Random; Septra; SMX; SMX-TMP; Sulfa; Sulfamethox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; SXT; TMP; TMP SMX; TMP-SMX; Trimeth; Trimpex,TMP SMX Islt MIC,,Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC),,Trimethoprim+Sulfamethoxazole MIC [Susc]
2839-9,Progesterone,CHEM,Chemistry; Level; Mass concentration; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Progest SerPl-mCnc,ng/dL; ng/mL,Progesterone [Mass/volume] in Serum or Plasma,ng/mL,Progesterone [Mass/Vol]
30318-0,Base deficit,CHEM,Base ex neg; Blood; BSE; Chemistry; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; WB; Whole blood,Base deficit Bld-sCnc,mmol/L,Base deficit in Blood,mmol/L,Base deficit (Bld) [Moles/Vol]
3562-6,Digoxin.free,DRUG/TOX,Cardio; Cardiology; DGXN; Digoxin Free; DRUG/TOXICOLOGY; Drugs; FR; Heart Disease; Lanoxin; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Digoxin Free SerPl-mCnc,ng/mL,Digoxin Free [Mass/volume] in Serum or Plasma,ng/mL,Digoxin Free [Mass/Vol]
10381-2,Target cells,HEM/BC,Blood; Cell; Cellularity; Codocyte; Codocytes; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Targets; WB; Whole blood,Targets Bld Ql Smear,,Target cells [Presence] in Blood by Light microscopy,,Target cells LM Ql (Bld)
267-5,Gentamicin,ABXBACT,Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c213; Garamycin; Genirr; Genj; Gent; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Gentamicin Islt MIC,ug/mL,Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC),ug/mL,Gentamicin MIC [Susc]
43305-2,Neisseria gonorrhoeae rRNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified,N gonorrhoea rRNA Spec Ql NAA+probe,,Neisseria gonorrhoeae rRNA [Presence] in Specimen by NAA with probe detection,,N. gonorrhoeae rRNA NAA+probe Ql (Specimen)
46154-1,Trichomonas vaginalis rRNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; T vaginalis; TMA; To be specified in another part of the message; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; UniversalLabOrders; Unspecified,T vaginalis rRNA Spec Ql NAA+probe,,Trichomonas vaginalis rRNA [Presence] in Specimen by NAA with probe detection,,T. vaginalis rRNA NAA+probe Ql (Specimen)
50556-0,Urinalysis dipstick panel,PANEL.UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UA dipstick Pnl; UR; Urn,UA dipstick Pnl Ur Strip.auto,,Urinalysis dipstick panel - Urine by Automated test strip,,Urinalysis dipstick panel Auto test strip (U)
34528-0,PT panel,PANEL.COAG,Clot; Clottable; COAGULATION; Coagulation assay; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; Protime; PT Pnl; QNT; Quan; Quant; Quantitative; Random; Tilt tube; UniversalLabOrders,PT Pnl PPP,,PT panel - Platelet poor plasma by Coagulation assay,,PT panel Coag (PPP)
3184-9,Activated clotting time,COAG,ACT; Activ; Activated coagulation time; Blood; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation assay; Coagulation time; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; Tilt tube; UniversalLabOrders; WB; Whole blood,ACT Bld,s,Activated clotting time (ACT) of Blood by Coagulation assay,s,ACT Coag (Bld)
10501-5,Lutropin,CHEM,Arbitrary concentration; Chemistry; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,LH SerPl-aCnc,mIU/mL,Lutropin [Units/volume] in Serum or Plasma,m[IU]/mL,Lutropin Qn
46771-2,Classical galactosemia,CHEM,Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; GALT; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,GALT DBS-Imp,,Classical galactosemia newborn screen interpretation,,Classical galactosemia Ql (DBS) [Interp]
3397-7,Cocaine,DRUG/TOX,Addiction; Benzoylmethylecgonine; Coke; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Snow; UA; UniversalLabOrders; UR; Urn,Cocaine Ur Ql,,Cocaine [Presence] in Urine,,Cocaine Ql (U)
44833-2,Diagnosis.preliminary,H&P.PX,Dx; Dx preliminary; H+P; H+P.PX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; P prime; Point in time; Random,Dx preliminary,,Preliminary diagnosis,,
2344-0,Glucose,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders",Glucose Fld-mCnc,mg/dL,Glucose [Mass/volume] in Body fluid,mg/dL,Glucose (Body fld) [Mass/Vol]
39111-0,Body site,H&P.HX,Anatomy; Bdy site; bod; Bodies; H+P; H+P.HX; Nominal; P prime; Point in time; Random,Bdy site,,Body site,,
14196-0,Reticulocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number concentration; Number Concentration (count/vol); Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; Retic; Retics; Reticulocyte; WB; Whole blood,Retics #,10*9/L,Reticulocytes [#/volume] in Blood,10*3/uL,Reticulocytes (Bld) [#/Vol]
72166-2,Tobacco smoking status,H&P.HX,Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Tobac smoke stat,Tobac smoke stat,,Tobacco smoking status,,
71774-4,Mitogen stimulated gamma interferon^^corrected for background,MICRO,Arbitrary concentration; bckgrd cor; Blood; ID; IFN; IGRA; Infectious Disease; InfectiousDisease; Lung; Microbiology; Mitogen IGNF; Point in time; Pulmonary; Pulmonology; QFT; QNT; Quan; Quant; Quantiferon; Quantitative; Random; Respiratory; WB; Whole blood,Mitogen IGNF bckgrd cor Bld-aCnc,IU/mL,Mitogen stimulated gamma interferon [Units/volume] corrected for background in Blood,[IU]/mL,Mitogen stimulated gamma interferon corrected for background Qn (Bld)
8716-3,Vital signs note,H&P.PX,Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H+P; H+P.PX; notes; P prime; Point in time; Random; Visit note,Vital signs note,,Vital signs note,,
13950-1,Hepatitis A virus Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HAV; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; Hepatology; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HAV IgM SerPl Ql IA,,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,,HAV IgM IA Ql
20455-2,Leukocytes,UA,Kidney; Leuc; Leuk; Leukocyte; Lkcs; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBCs; White blood cell; White blood cells,WBC UrnS Ql Micro,,Leukocytes [Presence] in Urine sediment by Light microscopy,,WBC LM Ql (Urine sed)
18774-0,Staff practitioner name,ATTACH.CLINRPT,ATTACH; ATTACH.CLINRPT; Nominal; Person name; Point in time; Random; Staff pract name,,,Staff practitioner name,,
31144-9,Thyroxine,CHEM,Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4; UniversalLabOrders; WB; Whole blood,T4 DBS-mCnc,ug/dL,Thyroxine (T4) [Mass/volume] in DBS,ug/dL,T4 (DBS) [Mass/Vol]
29575-8,Thyrotropin,CHEM,Arbitrary concentration; Blood; Chemistry; DBS; Dried blood spot; Endocrine; Endocrinology; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Thyroid stimulating hormone; Thyrotropic hormone; TSH; WB; Whole blood,TSH DBS-aCnc,mIU/L,Thyrotropin [Units/volume] in DBS,m[IU]/L,TSH Qn (DBS)
2761-5,Phenylketones,CHEM,Blood; Chemistry; Ordinal; Phenyl ketones; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Phenylketones Bld Ql,,Phenylketones [Presence] in Blood,,Phenylketones Ql (Bld)
48065-7,Fibrin D-dimer,COAG,COAGULATION; D Dimer; Dextro; Fragment D-dimer; Hematology; Heme; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders,D Dimer PPP FEU-mCnc,ug/L FEU,Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma,ng{FEU}/mL;mg{FEU}/L,Fibrin D-dimer FEU (PPP) [Mass/Vol]
48066-5,Fibrin D-dimer,COAG,COAGULATION; D Dimer; Dextro; Fragment D-dimer; Hematology; Heme; Level; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders,D Dimer PPP DDU-mCnc,ug/L DDU,Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma,ug/L{DDU},Fibrin D-dimer DDU (PPP) [Mass/Vol]
34468-9,Clostridioides difficile toxin A+B,MICRO,"A,B; Bowel movement; C diff; C diff Tox; C diff Tox A; C diff Tox A+B; C difficile; Clostridium difficile; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS; UniversalLabOrders",C diff Tox A+B Stl Ql IA,,Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,,C. difficile toxin A+B IA Ql (Stl)
79425-5,Bacteria,MICRO,Bact; Breathing; C&S; CF Resp Cult; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Lungs; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Resp Cult; Respiratory; RS; Spec,Bacteria Lower resp CF Resp Cult,,Bacteria identified in Lower respiratory specimen by Cystic fibrosis respiratory culture,,Bacteria identified Cystic fibrosis respiratory culture Nom (Lower resp)
3427-2,Cannabinoids,DRUG/TOX,Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; THC; UA; UR; Urn,Cannabinoids Ur Ql,,Cannabinoids [Presence] in Urine,,Cannabinoids Ql (U)
41650-3,Chloride,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Cl; Cl-; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Chloride BldA-sCnc,mmol/L,Chloride [Moles/volume] in Arterial blood,mmol/L,Chloride (BldA) [Moles/Vol]
38230-9,Calcium.ionized,CHEM,Blood; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Ca-I Bld-mCnc,mg/dL,Calcium.ionized [Mass/volume] in Blood,mg/dL,Calcium.ionized (Bld) [Mass/Vol]
24348-5,Free T4 & TSH panel,PANEL.CHEM,Chemistry; Endocrine; Endocrinology; FR; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4 Free+ TSH Pnl,T4 Free+ TSH Pnl SerPl,,Free T4 and TSH panel - Serum or Plasma,,Free T4 and TSH panel
1922-4,Base deficit,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Base ex neg; Blood arterial; BSE; Chemistry; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration,Base deficit BldA-sCnc,mmol/L,Base deficit in Arterial blood,mmol/L,Base deficit (BldA) [Moles/Vol]
41649-5,Chloride,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Cl; Cl-; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous,Chloride BldV-sCnc,mmol/L,Chloride [Moles/volume] in Venous blood,mmol/L,Chloride (BldV) [Moles/Vol]
30391-7,Erythrocytes,UA,#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UA; UR; URINALYSIS; Urn,RBC # Ur,/uL,Erythrocytes [#/volume] in Urine,/uL,RBC (U) [#/Vol]
32337-8,Protein,CHEM,Chemistry; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified,Prot Spec-mCnc,g/L;gm/L,Protein [Mass/volume] in Specimen,g/L,Protein (Specimen) [Mass/Vol]
4086-5,Valproate,DRUG/TOX,Depakene; Divalproex; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; VALP; Valproic acid,Valproate SerPl-mCnc,ug/mL,Valproate [Mass/volume] in Serum or Plasma,ug/mL,Valproate [Mass/Vol]
71776-9,Gamma interferon background,MICRO,Arbitrary concentration; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; IFN; Infectious Disease; InfectiousDisease; Lung; MEIA; Microbiology; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SUDS; WB; Whole blood,Gamma interferon background Bld IA-aCnc,IU/mL,Gamma interferon background [Units/volume] in Blood by Immunoassay,[IU]/mL,Gamma interferon background IA Qn (Bld)
20453-7,Epithelial cells,UA,Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Epi Cells UrnS Ql Micro,,Epithelial cells [Presence] in Urine sediment by Light microscopy,,Epithelial cells LM Ql (Urine sed)
26052-1,Epithelial cells.renal,UA,#/area; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; Kidney cells; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; REC; Renal; Renal Epi Cells; Renal tubular cells; RTC; RTE; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Renal Epi Cells #/area UrnS HPF,/HPF,Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field,/[HPF],Epithelial cells.renal LM.HPF (Urine sed) [#/Area]
28009-9,Specimen volume,SPEC,AOEObservation; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; UA; UR; Urn; Vol; Volume,Specimen vol Ur,mL,Volume of Urine,mL,Specimen volume (U)
8246-1,Amorphous sediment,UA,AM; Amorph; Amorph Sed; Amorphic; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Amorph Sed UrnS Ql Micro,,Amorphous sediment [Presence] in Urine sediment by Light microscopy,,Amorphous sediment LM Ql (Urine sed)
185-9,Ciprofloxacin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Ciprofloxacin Islt MIC,,Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC),,Ciprofloxacin MIC [Susc]
10334-1,Cancer Ag 125,CHEM,Arbitrary concentration; CA; CA 125; Cancer Ag125; Cancer antigen 125; Carbohydrate antigen; Carbohydrate antigen 125; Chemistry; Gyn; Gynecology; OB; ObGyn; Obstetrics; OC125; Oncology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,Cancer Ag125 SerPl-aCnc,IU/L;IU/mL,Cancer Ag 125 [Units/volume] in Serum or Plasma,[arb'U];[arb'U]/mL,Cancer Ag 125 Qn
22636-5,Path report.relevant Hx,TUMRRGT,Finding; Findings; Narrative; Oncology; Point in time; Random; Report; Spec; TUMOR REGISTRY(NAACCR),Path report.relevant Hx Spec,,Pathology report relevant history Narrative,,
6598-7,Troponin T.cardiac,CHEM,Cardio; Cardiology; Chemistry; cTnT; Heart Disease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin; UniversalLabOrders,Troponin T SerPl-mCnc,ug/L,Troponin T.cardiac [Mass/volume] in Serum or Plasma,ug/L;ng/mL,Troponin T.cardiac [Mass/Vol]
2692-2,Observation,CHEM,Chemistry; Osmo; Osmolality; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Osmolality SerPl,mmol/kg H2O;mOsm/L; mOsmol/kg,Osmolality of Serum or Plasma,mosm/kg,Osmolality [Osmolality]
24113-3,Hepatitis B virus core Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBc; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HBc; HBV; HBV core; Hep; Hep B; Hepatis; Hepatit; Hepatitis Bc; Hepatology; HepB; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HBV core IgM SerPl Ql IA,,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,,HBV core IgM IA Ql
16933-4,Hepatitis B virus core Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBc; Autoantibodies; Autoantibody; HBc; HBV; HBV core; Hep; Hep B; Hepatis; Hepatit; Hepatitis Bc; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,HBV core Ab Ser Ql,,Hepatitis B virus core Ab [Presence] in Serum,,HBV core Ab Ql (S)
54247-2,Drug screen comment,DRUG/TOX,cmmt; cmnt; Com; Comm; Comments; Commt; DRUG/TOXICOLOGY; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Remarks; Scn; Scr; Scrn; UA; UR; Urn,Drug screen comment Ur-Imp,,Drug screen comment [Interpretation] in Urine,,Drug screen comment (U) [Interp]
19146-0,Referral lab test results,MISC,Finding; Findings; MISC; Narrative; Point in time; Random; Ref Lab Test; Ref Lab Test Results; Report,Ref Lab Test Results,,Referral lab test results,,Referral lab test results
8123-2,Cells.CD3+CD4+/Cells,CELLMARK,Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; W3/25; WB; Whole blood,CD3+CD4+ Cells NFr Bld,%,CD3+CD4+ (T4 helper) cells/cells in Blood,%,CD3+CD4+ (T4 helper) cells/cells (Bld)
8479-8,Intravascular systolic,BP.ATOM,Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.ATOM; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP,BP sys by Palpation,mm Hg,Systolic blood pressure by palpation,mm[Hg],
7790-9,Burr cells,HEM/BC,Blood; Cell; Cellularity; Echinocyte; Echinocytes; Erythrocytes.crenated; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sea urchin cells; WB; Whole blood,Burr Cells Bld Ql Smear,,Burr cells [Presence] in Blood by Light microscopy,,Burr cells LM Ql (Bld)
23658-8,Antibiotic XXX,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Other Antibiotic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Other Antibiotic Susc Islt,,Other Antibiotic [Susceptibility],,Other Antibiotic [Susc]
71693-6,Platelets.reticulated/Platelets,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Immature platelets; Number fraction; Percent; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RP; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood; Young platelets,Platelets.reticulated NFr Bld Auto,%,Platelets reticulated/Platelets in Blood by Automated count,%,Platelets reticulated/Platelets Auto (Bld)
19991-9,Oxygen.alveolar - arterial,PULM,A-a gradient; A-ADO2; ALV; Breathing; Lung; Lungs; O2; O2 A-a; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; tO2,O2 A-a PPresDiff Respiratory,mm Hg,Alveolar-arterial oxygen Partial pressure difference,mm[Hg],
19279-9,Benzodiazepines tested for,DRUG/TOX,Benz; Benzodiaz; Benzodiaz Tested; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn,Benzodiaz Tested Ur Scn,,Benzodiazepines tested for in Urine by Screen method Nominal,,Benzodiazepines tested Screen Nom (U)
883-9,ABO group,BLDBK,Blood; BLOOD BANK; Hematology; Heme; Nominal; Point in time; Random; Typ; UniversalLabOrders; WB; Whole blood,ABO Group Bld,,ABO group [Type] in Blood,,ABO group (Bld)
11526-1,Pathology study,PATH,Document; Finding; Findings; Path; Path study; Pathology; Point in time; Random; Study report,Pathology study,,Pathology study,,Pathology study
8098-6,Thyroglobulin Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Antithyroglob; Arbitrary concentration; Autoantibodies; Autoantibody; Endocrine; Endocrinology; Hashimoto's thyroiditis; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; TgAbs; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker; UniversalLabOrders,Thyroglob Ab SerPl-aCnc,IU/mL;units/mL,Thyroglobulin Ab [Units/volume] in Serum or Plasma,[IU]/mL,Thyroglobulin Ab Qn
88517-8,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells^^corrected for background,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Arbitrary concentration; bckgrd cor; Blood; Cell; Cellularity; Helper T cells; ID; IFN; IGRA; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu2; Leu-2; Leu3; Leu-3; Lung; M tb; M TB IFN-g; M TBIFN-g CD4+ CD8+T-cells; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Suppressor T cells; T prime; T4; T-4; T8; T-8; TB; Tsuppressor; Tuberculosis; W3/25; WB; Whole blood,M TB IFN-g CD4+CD8+ bckgrnd cor Bld-aCnc,IU/mL,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood,[IU]/mL,M. tuberculosis stim IFN-g by CD4+ CD8+ T-cells corrected for background Qn (Bld)
24467-3,Cells.CD3+CD4+,CELLMARK,#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; W3/25; WB; Whole blood,CD3+CD4+ Cells # Bld,10*9/L,CD3+CD4+ (T4 helper) cells [#/volume] in Blood,/uL,CD3+CD4+ (T4 helper) cells (Bld) [#/Vol]
30003-8,Albumin,CHEM,1 day; 24 hours; 24HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Level; Levo; MA; Malb; Mass concentration; Micro albumin; Microalbumin; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UniversalLabOrders; UR; Urn,Microalbumin 24h Ur-mCnc,mg/L;mcg/mL,Microalbumin [Mass/volume] in 24 hour Urine,ug/mL;mg/dL,Albumin DL <= 20 mg/L (24H U) [Mass/Vol]
5964-2,Coagulation tissue factor induced,COAG,Blood; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Hematology; Heme; Point in time; Pro time; Prothrombin time; Protime; PT; QNT; Quan; Quant; Quantitative; Random; Tilt tube; WB; Whole blood,PT Bld,s,Prothrombin time (PT) in Blood by Coagulation assay,s,PT Coag (Bld) [Time]
10352-3,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; Gen; Genital tract; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders; Urogenit; Urogenital,Bacteria Genital Aerobe Cult,,Bacteria identified in Genital specimen by Aerobe culture,,Bacteria identified Aer cx Nom (Genital specimen)
4542-7,Haptoglobin,HEM/BC,Haptoglob; HEMATOLOGY/CELL COUNTS; HP; Hpt; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Haptoglob SerPl-mCnc,g/L;mg/dL,Haptoglobin [Mass/volume] in Serum or Plasma,mg/dL,Haptoglobin [Mass/Vol]
21003-9,Fungus,MICRO,Fung; Fungal; Fungi; Fungus Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; UniversalLabOrders; Unspecified,Fungus Spec Fungus Stn,,Fungus identified in Specimen by Fungus stain,,Fungus identified Fungus stain Nom (Specimen)
2335-8,Hemoglobin.gastrointestinal,CHEM,Bowel movement; Chemistry; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FOB; Gastro; Gastrocult; Gastroenterology; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; Occult blood; Occult blood in stool; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; UniversalLabOrders,Hemoccult Stl Ql,,Hemoglobin.gastrointestinal [Presence] in Stool,,Hemoglobin.gastrointestinal Ql (Stl)
141-2,cefTRIAXone,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c9; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Rocephin; ROCJ; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,cefTRIAXone Islt MIC,,cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC),,cefTRIAXone MIC [Susc]
1504-0,Glucose^1H post 50 g glucose PO,CHAL.ROUTINE,1 hour; 1.0Hr; 1h p 50 g Glc PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 50 g Glc; p 50 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Glucose 1h p 50 g Glc PO SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO,mg/dL,Glucose 1 Hr post 50 g glucose PO [Mass/Vol]
627-0,Bacteria,MICRO,"Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Tissue; Tissue, unspecified; UniversalLabOrders",Bacteria Tiss Aerobe Cult,,Bacteria identified in Tissue by Aerobe culture,,Bacteria identified Aer cx Nom (Tiss)
3167-4,Specimen volume,SPEC,1 day; 24 hours; 24HR; QNT; Quan; Quant; Quantitative; Spec; UA; UR; Urn; Vol; Volume,Specimen vol 24h Ur,Liters; mL,Volume of 24 hour Urine,L,Specimen volume (24H U)
9335-1,Observation,SPEC,"Appearance; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Nominal; Point in time; Random; SPEC",Appearance Fld,,Appearance of Body fluid,,Appearance (Body fld)
26507-4,Neutrophils.band form,HEM/BC,#; ABS; absolute; absolutes; Bands; Blood; bnd; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Neuts Band # Bld,10*3/mm3,Band form neutrophils [#/volume] in Blood,10*3/uL,Band form neutrophils (Bld) [#/Vol]
31204-1,Hepatitis B virus core Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBc; Autoantibodies; Autoantibody; HBc; HBV; HBV core; Hep; Hep B; Hepatis; Hepatit; Hepatitis Bc; Hepatology; HepB; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,HBV core IgM Ser Ql,,Hepatitis B virus core IgM Ab [Presence] in Serum,,HBV core IgM Ql (S)
19769-9,Pathologist,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Genital tract; Genital vaginal; Ident; Identifier; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Path; Point in time; Random; St; Stains; Stn; Vag fld; Vag fluid; Vagina; Vaginal fluid,Pathologist Cvx/Vag Cyto,,Pathologist who read Cyto stain of Cervical or vaginal smear or scraping,,Pathologist Cyto stain Nom (Cvx/Vag) [ID]
19145-2,Referral lab test name,MISC,MISC; Narrative; Point in time; Random; Ref Lab Test; Ref Lab Test Name; Report; Typ,Ref Lab Test Name,,Referral lab test name,,Referral Lab Test Name
1995-0,Calcium.ionized,CHEM,Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Ca-I SerPl-sCnc,mmol/L,Calcium.ionized [Moles/volume] in Serum or Plasma,mmol/L,Calcium.ionized [Moles/Vol]
7791-7,Dacryocytes,HEM/BC,Blood; Dacrocyte; Dacrocytes; Dacryocyte; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tear drops; Teardrop cells; Teardrops; WB; Whole blood,Dacryocytes Bld Ql Smear,,Dacrocytes [Presence] in Blood by Light microscopy,,Dacrocytes LM Ql (Bld)
18390-5,Opiates,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin; Illicit; LC/MS/MS; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Opiates Ur Ql Cfm,,Opiates [Presence] in Urine by Confirmatory method,,Opiates Confirm Ql (U)
6824-7,Observation,SPEC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Nominal; Point in time; Random; SPEC",Color Fld,,Color of Body fluid,,Color (Body fld)
508-2,Tobramycin,ABXBACT,Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; NEBCIN; NEBDIN; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TOBJ; TOBRA,Tobramycin Islt MIC,,Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC),,Tobramycin MIC [Susc]
5048-4,Nuclear Ab,SERO,ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; UniversalLabOrders,ANA Titr Ser IF,titer,Nuclear Ab [Titer] in Serum by Immunofluorescence,{titer},Nuclear Ab IF (S) [Titer]
48683-7,Streptococcus agalactiae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S agalactiae; Screen; SDA; Spec; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified,Gp B Strep DNA Spec Ql NAA+probe,,Streptococcus agalactiae DNA [Presence] in Specimen by NAA with probe detection,,S. agalactiae DNA NAA+probe Ql (Specimen)
19162-7,Varicella zoster virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Shingles; SR; UniversalLabOrders; VZ; VZV; Zoster,VZV IgG Ser Ql,,Varicella zoster virus IgG Ab [Presence] in Serum,,VZV IgG Ql (S)
19147-8,Referral lab test reference range,MISC,Finding; Findings; MISC; Nominal; Point in time; Random; Ref Lab Test; Ref Lab Test Ref Range; Rnge,Ref Lab Test Ref Range,,Referral lab test reference range,,Referral lab test reference range
13967-5,Sex hormone binding globulin,CHEM,Androgen binding protein; Bind; Chemistry; Estradiol binding globulin; Gender; GLB; Glob; Glob%; Globul; Globulins; Horm; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SBP; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sex steroid binding globulin; Sex steroid binding protein; SHBG; SR; SSBG; Substance concentration; TeBG; Testosterone binding globulin; Testosterone/estradiol binding globulin; UniversalLabOrders,SHBG SerPl-sCnc,nmol/L,Sex hormone binding globulin [Moles/volume] in Serum or Plasma,nmol/L,Sex hormone binding globulin [Moles/Vol]
22314-9,Hepatitis A virus Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HAV; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; Hepatology; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,HAV IgM Ser Ql,,Hepatitis A virus IgM Ab [Presence] in Serum,,HAV IgM Ql (S)
53764-7,Prostate specific Ag panel,PANEL.CHEM,Chemistry; Kallikrein 3; P-30 antigen; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PS; PSA; PSA Pnl; Random; Seminin; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Tumor marker,PSA Pnl SerPl,,Prostate specific Ag panel - Serum or Plasma,,PSA panel
3043-7,Triglyceride,CHEM,Blood; Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tg; Trig; Trigly; Triglycerides; Triglycrides; UniversalLabOrders; WB; Whole blood,Trigl Bld-mCnc,mg/dL,Triglyceride [Mass/volume] in Blood,mg/dL,Triglyceride (Bld) [Mass/Vol]
19360-7,Cocaine,DRUG/TOX,Addiction; Benzoylmethylecgonine; Cfm; CNFR; CNFRM; Coke; Conf; Confirmation; Confirmatory; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; LC/MS/MS; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Snow; UA; UR; Urn,Cocaine Ur Ql Cfm,,Cocaine [Presence] in Urine by Confirmatory method,,Cocaine Confirm Ql (U)
19941-4,Gas flow.oxygen,PULM,Dynamic; Flow; Gas flow.O2; Gases; Lung; O2; O2 delivery sys; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Volume rate; vRate,Gas flow.O2 O2 delivery sys,L/min,Oxygen gas flow Oxygen delivery system,L/min,
72888-1,3-epi-25-Hydroxyvitamin D3/25-hydroxyvitamin D.total,CHEM,25-OH Vit D; 3-epi-25(OH)D3; 3-epi-25-Hydroxy vitamin D3; C-3 epimer of 25OHD3; Chemistry; Dextro; III; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl,3-epi-25(OH)D3/25-OH Vit D MFr SerPl,%,3-epi-25-Hydroxyvitamin D3/25-hydroxyvitamin D.total in Serum or Plasma,%,3-epi-25-hydroxyvitamin D3/Total 25-hydroxyvitamin D [Mass fraction]
32016-8,Glucose,CHEM,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Endocrine; Endocrinology; Finger stick; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders,Glucose BldC-mCnc,mg/dL,Glucose [Mass/volume] in Capillary blood,mg/dL,Glucose (BldC) [Mass/Vol]
14743-9,Glucose,CHEM,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Endocrine; Endocrinology; Finger stick; Glu; Gluc; Glucomtr; Glucoseur; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Glucose BldC Glucomtr-sCnc,mmol/L,Glucose [Moles/volume] in Capillary blood by Glucometer,mmol/L,Glucose Glucometer (BldC) [Moles/Vol]
74097-7,Tacrolimus,DRUG/TOX,Blood; DRUG/TOXICOLOGY; Drugs; FK506; FK-506; Fujimycin; Hecoria; L04AD02; Level; Mass concentration; Point in time; Prograf; Protopic; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Tacrolimus Bld LC/MS/MS-mCnc,ng/mL,Tacrolimus [Mass/volume] in Blood by LC/MS/MS,ng/mL,Tacrolimus LC/MS/MS (Bld) [Mass/Vol]
47236-5,Treponema pallidum Ab.IgG+IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Syphilis; T pallidum; Treponemal,T pallidum IgG+IgM SerPl Ql IA,,Treponema pallidum IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay,,T. pallidum IgG+IgM IA Ql
14309-9,Amphetamines,DRUG/TOX,Addiction; Amph; Amphetam; Amphetamine; Cfm; Cfm&gt;200 ng/mL; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Speed; UA; UR; Urn,Amphetamines Ur Ql Cfm>200 ng/mL,,Amphetamines [Presence] in Urine by Confirm method >200 ng/mL,,Amphetamines Confirm method >200 ng/mL Ql (U)
17656-0,Streptococcus pyogenes,MICRO,C&S; Cult; Cultures; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; S pyogenes; Screen; Spec; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; To be specified in another part of the message; Unspecified,S pyo Spec Ql Cult,,Streptococcus pyogenes [Presence] in Specimen by Organism specific culture,,S. pyogenes Org specific cx Ql (Specimen)
26455-6,Erythrocytes,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells",RBC # Fld,10*3/uL,Erythrocytes [#/volume] in Body fluid,10*3/uL,RBC (Body fld) [#/Vol]
28-1,Ampicillin,ABXBACT,Amcil; Amicil; Amp; Ampicilloyl; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c5; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Omnipen; Penbritin; Point in time; Polycillin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Ampicillin Islt MIC,ug/mL,Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC),ug/mL,Ampicillin MIC [Susc]
611-4,Bacteria,MICRO,"B/F; Bact; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders",Bacteria Fld Cult,,Bacteria identified in Body fluid by Culture,,Bacteria identified Cx Nom (Body fld)
11545-1,Observation,MICRO,Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; UniversalLabOrders; Unspecified,Acid fast Stn Spec,,Microscopic observation [Identifier] in Specimen by Acid fast stain,,Microscopic observation Acid fast stain Nom (Specimen)
20563-3,Carboxyhemoglobin/Hemoglobin.total,CHEM,Blood; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Mass Fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl; UniversalLabOrders; WB; Whole blood,COHgb MFr Bld,%,Carboxyhemoglobin/Hemoglobin.total in Blood,%,Carboxyhemoglobin (Bld) [Mass fraction]
8014-3,Rubella virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Congenital rubella syndrome; German measles; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; RUBV; Serum; SR; UniversalLabOrders,RUBV IgG Ser-aCnc,IU/mL,Rubella virus IgG Ab [Units/volume] in Serum,[IU]/mL,Rubella virus IgG Qn (S)
412-7,Piperacillin+Tazobactam,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Pip+Tazo; Piper; PIPJ; Pipracil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazobac; Tazocilline; Tazocin; Zosyn,Pip+Tazo Islt MIC,,Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC),,Piperacillin+Tazobactam MIC [Susc]
9643-8,Creatine kinase.MM/Creatine kinase.total,CHEM,Cardio; Cardiology; Catalytic Fraction; Chemistry; CK; CK 3; CK MM; CK-MM; CPK; Creatine phosphokinase; Heart Disease; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl,CK MM CFr SerPl,%,Creatine kinase.MM/Creatine kinase.total in Serum or Plasma,%,CK.MM [Catalytic fraction]
50957-0,Manual differential performed,HEM/BC,Blood; Diff; Differl; Differn; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Manual differential performed Bld Ql,,Manual differential performed [Presence] in Blood,,Manual differential performed Ql (Bld)
24336-0,Gas panel,PANEL.CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; BGas; Blood arterial; Blood gas; Blood gases; Chemistry; Gas Pnl; Gases; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random,Gas Pnl BldA,,Gas panel - Arterial blood,,Gas panel (BldA)
32215-6,Thyroxine free index,CHEM,Calc; Calculation; Chemistry; Endocrine; Endocrinology; FR; FreeT4; FT4; FT4I; FTI; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; T7; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4,FT4I SerPl Calc-mCnc,Index,Thyroxine (T4) free index in Serum or Plasma by calculation,{Index_val},Free T4 index Calc [Mass/Vol]
7798-2,Smudge cells,HEM/BC,Basket cells; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Smudge Cells Bld Ql Smear,,Smudge cells [Presence] in Blood by Light microscopy,,Smudge cells LM Ql (Bld)
59471-3,Calcium.ionized,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous,Ca-I BldV-mCnc,mg/dL,Calcium.ionized [Mass/volume] in Venous blood,mg/dL,Calcium.ionized (BldV) [Mass/Vol]
34474-7,ABO & Rh group,BLDBK,ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood - (umbilical) cord; BLOOD BANK; Cord (umbilical) blood; Cord bld; Cord blood; D phenotyping; D typing; Gyn; Gynecology; Hematology; Heme; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Rh phenotyping; Rh typing; Typ,ABO + Rh BldCo,,ABO and Rh group [Type] in Cord blood,,ABO and Rh group (BldCo)
57719-7,Conditions tested for in this newborn screening study,CHEM,Asympt; Asymptomatic; Blood; Chemistry; Conditions tested for in NBS study; DBS; Dried blood spot; Filter paper; FP; Ident; Identifier; New born; Nominal; Point in time; Random; Scn; Study report; WB; Whole blood,Conditions tested for in NBS study DBS,,Conditions tested for in this newborn screening study [Identifier] in DBS,,Conditions tested for in this NBS study Nom (DBS) [ID]
55420-4,Hours after meal,CHAL,CHEMISTRY.CHALLENGE TESTING; Hours p meal; Point in time; QNT; Quan; Quant; Quantitative; Random,Hours p meal Time Patient,H,Hours after meal [Time],h,Hours after meal [Time]
14338-8,Prealbumin,CHEM,Chemistry; Level; Mass concentration; PALB; Pl; Plasma; Plsm; Point in time; Pre albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Transthyretin; UniversalLabOrders,Prealb SerPl-mCnc,g/L;mg/dL,Prealbumin [Mass/volume] in Serum or Plasma,mg/dL;g/dL,Prealbumin [Mass/Vol]
76-0,ceFAZolin,ABXBACT,Ancef; ANTIBIOTIC SUSCEPTIBILITIES; AST; C32; Cefamezin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kefj; Kefzol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Totacef; Zolicef,ceFAZolin Islt MIC,,ceFAZolin [Susceptibility] by Minimum inhibitory concentration (MIC),,ceFAZolin MIC [Susc]
34961-3,Rh,BLDBK,Blood; BLOOD BANK; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; D phenotyping; D typing; GCMS; Hematology; Heme; LC/MS/MS; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood,Rh Bld Cfm,,Rh [Type] in Blood by Confirmatory method,,Rh Confirm Nom (Bld)
14118-4,Lactate,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Lact; Lactic acid; Level; L-lactate; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Lactate SerPl-mCnc,mg/dL,Lactate [Mass/volume] in Serum or Plasma,mg/dL,Lactate [Mass/Vol]
31017-7,Tissue transglutaminase Ab.IgA,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; Fibrin stabilizing factor; Gastro; Gastroenterology; GI; Immune globulin A; Immunoglobulin A; Point in time; Protein-glutamine gamma glutamyltransferase; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; TG2; tTG; UniversalLabOrders,tTG IgA Ser-aCnc,kEU/L;EIA units,Tissue transglutaminase IgA Ab [Units/volume] in Serum,[arb'U]/L,tTG IgA Qn (S)
46133-5,Epithelial cells,UA,#/area; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Epi Cells #/area UrnS LPF,/lpf,Epithelial cells [#/area] in Urine sediment by Microscopy low power field,/[LPF],Epithelial cells LM.LPF (Urine sed) [#/Area]
5774-5,Calcium oxalate crystals,UA,Ca; CaC2O4; Cal; CaOx; CaOx Cry; Crys; Cryst; Crystal; Ethanedioate; Ethanedioic acid; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Oxal; Oxalic acid; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,CaOx Cry UrnS Ql Micro,,Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy,,Calcium oxalate crystals LM Ql (Urine sed)
53332-3,Crystals.amorphous,UA,#/area; AM; Amorph; Amorph Cry; Amorphic; Artificial Intelligence; Automated detection; Comp Assist; Crys; Cryst; Crystal; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn,Amorph Cry #/area Ur Comp Assist,,Crystals.amorphous [#/area] in Urine by Computer assisted method,/[HPF];/[LPF],Crystals.amorphous Computer assisted (U) [#/Area]
23860-0,Erythrocytes,HEM/BC,"#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells",RBC # Fld Auto,10*3/uL,Erythrocytes [#/volume] in Body fluid by Automated count,10*3/uL,RBC Auto (Body fld) [#/Vol]
20578-1,Vancomycin,DRUG/TOX,c162; DRUG/TOXICOLOGY; Drugs; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; VANC; Vancocin; Vancor,Vancomycin SerPl-mCnc,ug/mL,Vancomycin [Mass/volume] in Serum or Plasma,ug/mL,Vancomycin [Mass/Vol]
606-4,Bacteria,MICRO,Bact; C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; UniversalLabOrders,Bacteria CSF Cult,,Bacteria identified in Cerebral spinal fluid by Culture,,Bacteria identified Cx Nom (CSF)
8280-0,Circumference.at umbilicus,BDYCRC.MOLEC,Abd; Abdo; Abdomen+; Abdominal; BODY CIRCUMFERENCE.MOLEC; Circumf.at umbilicus; Girth; Length; Maximum mid-abdomen girth; Point in time; QNT; Quan; Quant; Quantitative; Random,Circumf.at umbilicus by Tape measure,cm,Waist Circumference at umbilicus by Tape measure,cm,
13951-9,Hepatitis A virus Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HAV; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; Hepatology; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; UniversalLabOrders,HAV Ab Ser Ql IA,,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,,HAV Ab IA Ql (S)
15189-4,Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda,CHEM,Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Lambda LC; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR,Kappa LC/Lambda Ser,ratio,Kappa light chains/Lambda light chains [Mass Ratio] in Serum,{ratio},Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda (S) [Mass ratio]
28643-5,Oxygen saturation,CHEM,Bld cord; Chemistry; Cord BldV; Cord venous blood; Gyn; Gynecology; Mass fraction; O2; OB; ObGyn; Obstetrics; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SaO2; SAT; Satn; SO2; tO2,SaO2 % BldCoV,%,Oxygen saturation in Venous cord blood,%,SaO2% (BldCoV) [Mass fraction]
48767-8,Annotation comment,DOC.MISC,cmmt; cmnt; Com; Comm; Comments; Commt; DOC.MISC; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MISC; Narrative; Point in time; Random; Remarks; Report,Annotation comment Imp,,Annotation comment [Interpretation] Narrative,,
20878-5,Bacteria,MICRO,Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; InternalLabUse; Islt; Isol; Microbiology; Nominal; Point in time; Random,Bacteria Islt Anaerobe Cult,,Bacteria identified in Isolate by Anaerobe culture,,Bacteria identified Anaer cx Nom (Isol)
18043-0,Ejection fraction,CARD.US,CARD.US; Cardiac; Cardio; Cardiology; Echography; EF; Frac; Fract; Fractionation; Fractions; Heart Disease; Hrt; Hrt ventr; L; LT; LV; LVEF; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular; Volfr; Volume fraction,LV EF US,%,Left ventricular Ejection fraction by US,%,
77397-8,ABO & Rh group,BLDBK,ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; D phenotyping; D typing; GCMS; Hematology; Heme; LC/MS/MS; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood,ABO + Rh Bld Cfm,,ABO and Rh group [Type] in Blood by Confirmatory method,,ABO and Rh group Confirm (Bld)
53612-8,Urate,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; Urates; Uric acid",Urate Fld-mCnc,mg/dL,Urate [Mass/volume] in Body fluid,mg/dL,Urate (Body fld) [Mass/Vol]
363-2,Nitrofurantoin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Furadantin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Macrobid; Macrodantin; Minimum inhibitory concentration; Nitrofurant; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Nitrofurantoin Islt MIC,,Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC),,Nitrofurantoin MIC [Susc]
2614-6,Methemoglobin/Hemoglobin.total,CHEM,Blood; Chemistry; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Mass fraction; Methaemoglobin; MetHb; Methgb; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; UniversalLabOrders; WB; Whole blood,MetHgb MFr Bld,%,Methemoglobin/Hemoglobin.total in Blood,%,Methemoglobin (Bld) [Mass fraction]
30452-7,Neutrophils.segmented,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs",Neuts Seg # Fld,10*3/uL,Segmented neutrophils [#/volume] in Body fluid,10*3/uL,Segmented neutrophils (Body fld) [#/Vol]
64017-7,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel,PANEL.MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Trachoma; Transcription mediated amplification; UniversalLabOrders; Unspecified,C trach+GC pnl Spec NAA+probe,,Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Specimen by NAA with probe detection,,C. trachomatis and N. gonorrhoeae rRNA panel NAA+probe (Specimen)
14135-8,Cells.CD3+CD8+,CELLMARK,#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Leu2; Leu-2; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood,CD3+CD8+ Cells # Bld,10*9/L,CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood,/uL,CD3+CD8+ (T8 suppressor) cells (Bld) [#/Vol]
42254-3,Nuclear Ab,SERO,ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF,ANA Ser Ql IF,,Nuclear Ab [Presence] in Serum by Immunofluorescence,,Nuclear Ab IF Ql (S)
1927-3,Base excess,CHEM,Base ex; BE; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; BSE; Calc; Calculation; Chemistry; EXS; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; Venous,Base excess BldV Calc-sCnc,mmol/L,Base excess in Venous blood by calculation,mmol/L,Base excess Calc (BldV) [Moles/Vol]
41284-1,Epithelial cells.non-squamous,UA,#/area; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Non-sq Epi Cells; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Round epithelial cells; Small epithelial cells; Sq; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Non-sq Epi Cells #/area UrnS HPF,/HPF,Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy high power field,/[HPF],Epithelial cells.non-squamous LM.HPF (Urine sed) [#/Area]
32200-8,Neutrophils.segmented/Leukocytes,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neuts Seg NFr Bld Auto,%,Segmented neutrophils/Leukocytes in Blood by Automated count,%,Segmented neutrophils/Leukocytes Auto (Bld)
798-9,Erythrocytes,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UA; UR; URINALYSIS; Urn,RBC # Ur Auto,/uL,Erythrocytes [#/volume] in Urine by Automated count,/uL,RBC Auto (U) [#/Vol]
15432-8,Testosterone.free/Testosterone.total,CHEM,Chemistry; FR; Mass fraction; Non-protein bound; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost; Testost Free; Testosterone.unconjugated; Tot; Totl,Testost Free MFr SerPl,%,Testosterone Free/Testosterone.total in Serum or Plasma,%,Testosterone Free/Testosterone.total [Mass fraction]
11011-4,Hepatitis C virus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; DNA NUCLEIC ACID PROBE; DNA probe; HCV; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders; Viral load,HCV RNA SerPl NAA+probe-aCnc,Thous IU/mL; units/mL,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,k[IU]/mL,HCV RNA NAA+probe Qn
24349-3,Drugs of abuse 5 panel,PANEL.DRUG/TOX,DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of Abuse 5 Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn,Drugs of Abuse 5 Pnl Ur,,Drugs of abuse 5 panel - Urine,,Drugs of abuse 5 panel (U)
2191-5,Dehydroepiandrosterone sulfate,CHEM,adrenal dysfunction; Chemistry; DHEA; DHEAS; DHEA-S; DHEA-SO4; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Prasterone; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf; UniversalLabOrders,DHEA-S SerPl-mCnc,mcg/dL; mcg/mL,Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma,ug/dL,DHEA-S [Mass/Vol]
61188-9,Clindamycin.induced,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c306; Cleocin; CLIJ; Dalacin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sobelin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Topical,Clindamycin.induced Susc Islt,,Clindamycin.induced [Susceptibility],,Clindamycin.induced [Susc]
15205-8,Rheumatoid factor,SERO,Arbitrary concentration; Fac; Fact; Light scattering; Nephelom; Point in time; QNT; Quan; Quant; Quantitative; Random; RF; Serology; Serum; SR; UniversalLabOrders,Rheumatoid fact Ser Neph-aCnc,IU/mL,Rheumatoid factor [Units/volume] in Serum by Nephelometry,[IU]/mL,Rheumatoid factor Nephelometry Qn (S)
17928-3,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; Blood; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; WB; Whole blood,Bacteria Bld Aerobe Cult,,Bacteria identified in Blood by Aerobe culture,,Bacteria identified Aer cx Nom (Bld)
18482-0,Yeast,MICRO,C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,Yeast Spec Ql Cult,,Yeast [Presence] in Specimen by Organism specific culture,,Yeast Org specific cx Ql (Specimen)
33935-8,Cyclic citrullinated peptide Ab.IgG,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-CCP; Arbitrary concentration; Autoantibodies; Autoantibody; cCP; CCP3; Cyclic Citrulinated Peptide; Immune globulin G; Immunoglobulin G; Pept; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatoid arthritis; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,cCP IgG SerPl-aCnc,arb U/mL,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,[arb'U]/mL,Cyclic citrullinated peptide IgG Qn
2032-1,Carboxyhemoglobin/Hemoglobin.total,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Lung; Mass Fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl; Venous,COHgb MFr BldV,%,Carboxyhemoglobin/Hemoglobin.total in Venous blood,%,Carboxyhemoglobin (BldV) [Mass fraction]
20493-3,Histiocytes/Cells,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Histiocyte; Histocytes; LM; Micro; Micros; Microscopic; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random",Histiocytes NFr Fld Micro,%,Histiocytes/cells in Body fluid by Light microscopy,%,Histiocytes/cells LM (Body fld)
3050-2,Triiodothyronine resin uptake (T3RU),CHEM,Chemistry; Endocrine; Endocrinology; Number Fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RT3U; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T uptake; T3; T-3; T3 binding ratio; T3 RU; T3 uptake; T3RU; T3uptake; thyroid hormone; Total T3; Triiodothyroinine uptake; Triodothyrne; UniversalLabOrders,T3RU NFr SerPl,%,Triiodothyronine resin uptake (T3RU) in Serum or Plasma,%,T3RU
5028-6,Neisseria gonorrhoeae rRNA,MICRO,DNA NUCLEIC ACID PROBE; DNA probe; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; N gonorrhoea; N gonorrhoeae; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,N gonorrhoea rRNA Spec Ql Probe,,Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe,,N. gonorrhoeae rRNA Probe Ql (Specimen)
34532-2,Blood type & Indirect antibody screen panel,PANEL.BLDBK,Ab; Blood; BLOOD BANK; Ind; Indir; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Type + Ab Scn Pnl; UniversalLabOrders; WB; Whole blood,Type + Ab Scn Pnl Bld,,Blood type and Indirect antibody screen panel - Blood,,Blood type and Indirect antibody screen panel (Bld)
8101-8,Cells.CD3+CD8+/Cells,CELLMARK,Blood; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Leu2; Leu-2; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood,CD3+CD8+ Cells NFr Bld,%,CD3+CD8+ (T8 suppressor) cells/cells in Blood,%,CD3+CD8+ (T8 suppressor) cells/cells (Bld)
8061-4,Nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; UniversalLabOrders,ANA Ser Ql,,Nuclear Ab [Presence] in Serum,,Nuclear Ab Ql (S)
2342-4,Glucose,CHEM,Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Glu; Gluc; Glucoseur; Level; Mass concentration; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; UniversalLabOrders,Glucose CSF-mCnc,mg/dL,Glucose [Mass/volume] in Cerebral spinal fluid,mg/dL,Glucose (CSF) [Mass/Vol]
20447-9,HIV 1 RNA,MICRO,#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AIDS; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders; Viral load,HIV1 RNA # SerPl NAA+probe,copies/mL,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,{copies}/mL,HIV 1 RNA NAA+probe [#/Vol]
6644-9,Cefepime,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefipime; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Maxipime; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Cefepime Islt MIC,,Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC),,Cefepime MIC [Susc]
32-3,Ampicillin+Sulbactam,ABXBACT,Amcil; Amicil; Amp; Ampicilloyl; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c5; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Omnipen; Penbritin; Point in time; Polycillin; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Unasyn,Ampicillin+Sulbac Islt MIC,,Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC),,Ampicillin+Sulbactam MIC [Susc]
13952-7,Hepatitis B virus core Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBc; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HBc; HBV; HBV core; Hep; Hep B; Hepatis; Hepatit; Hepatitis Bc; Hepatology; HepB; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HBV core Ab SerPl Ql IA,,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,,HBV core Ab IA Ql
54218-3,Cells.CD3+CD4+/Cells.CD3+CD8+,CELLMARK,Blood; CD3 Cells; CD3+CD4+ Cells; CD3+CD8+ Cells; CD3+CD8+ Cll; CD3-CD4+; CD4+ T cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu2; Leu-2; Leu3; Leu-3; Leu4; Leu-4; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T4; T-4; T4 helper/inducer cells; T8; T-8; T8 suppressor cells; Tsuppressor; W3/25; WB; Whole blood,CD3+CD4+ Cells/CD3+CD8+ Cll Bld,ratio,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood,%,CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells (Bld) [# ratio]
35192-4,Bilirubin.non-glucuronidated,CHEM,Bili; Bilirub Indirect; Bilirubin indirect; Bilirubin non-conjugated; Bilirubin primary; Bilirubin unconjugated; Bilirubins; Billirubin; Bu; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL,Bilirub Indirect SerPl-msCnc,,Bilirubin.indirect [Mass or Moles/volume] in Serum or Plasma,mg/dL,Bilirubin.indirect [Mass or moles/Vol]
60340-7,Crystals.amorphous,UA,AM; Amorph; Amorph Cry; Amorphic; Crys; Cryst; Crystal; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Amorph Cry UrnS Ql Micro,,Crystals.amorphous [Presence] in Urine sediment by Light microscopy,,Crystals.amorphous LM Ql (Urine sed)
3013-0,Thyroglobulin,CHEM,Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker; UniversalLabOrders,Thyroglob SerPl-mCnc,ug/L;ng/dL; ng/mL,Thyroglobulin [Mass/volume] in Serum or Plasma,ng/dL,Thyroglobulin [Mass/Vol]
19080-1,Choriogonadotropin,CHEM,Arbitrary concentration; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,HCG SerPl-aCnc,mIU/mL; mU/mL; Thous mIU/mL,Choriogonadotropin [Units/volume] in Serum or Plasma,m[IU]/mL,HCG Qn
72268-6,Streptococcus pyogenes exotoxin B speB gene,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; S pyogenes speB; Screen; SDA; Spec; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; streptococcal pyrogenic exotoxin B; Streptococci group A; Streptococcus group A; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,S pyogenes speB Spec Ql NAA+probe,,Streptococcus pyogenes exotoxin B speB gene [Presence] in Specimen by NAA with probe detection,,S. pyogenes exotoxin B speB gene NAA+probe Ql (Specimen)
8303-0,Body height,BDYHGT.MOLEC,Axial length; bod; Bodies; BODY HEIGHT(LENGTH).MOLEC; Body length; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Random,Body height Prctl,%,Body height [Percentile],%,
48345-3,HIV 1+O+2 Ab,MICRO,ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,HIV 1+O+2 Ab SerPl Ql,,HIV 1+O+2 Ab [Presence] in Serum or Plasma,,HIV 1+O+2 Ab Ql
2617-9,Methemoglobin/Hemoglobin.total,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Haemoglobin; Hb; Hemiglobin; Hgb; Hi; Mass fraction; Methaemoglobin; MetHb; Methgb; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Venous,MetHgb MFr BldV,%,Methemoglobin/Hemoglobin.total in Venous blood,%,Methemoglobin (BldV) [Mass fraction]
5808-1,Erythrocytes,UA,#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,RBC # UrnS HPF,/mL,Erythrocytes [#/volume] in Urine sediment by Microscopy high power field,/mL,RBC LM.HPF (Urine sed) [#/Vol]
2880-3,Protein,CHEM,Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Neuro; Neurology; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; UniversalLabOrders,Prot CSF-mCnc,g/L;mg/dL,Protein [Mass/volume] in Cerebral spinal fluid,mg/dL,Protein (CSF) [Mass/Vol]
57845-0,Leukocytes,HEM/BC,"#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",WBC # Fld Auto,10*9/L,Leukocytes [#/volume] in Body fluid by Automated count,10*3/uL,WBC Auto (Body fld) [#/Vol]
19359-9,Cocaine,DRUG/TOX,Addiction; Benzoylmethylecgonine; Coke; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Snow; UA; UR; Urn,Cocaine Ur Ql Scn,,Cocaine [Presence] in Urine by Screen method,,Cocaine Screen Ql (U)
51880-3,Packed erythrocytes units given,BLDBK,BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Discocytes; Erthrocyte; Erythrocyte; Gvn; Number; Packed RBC; Point in time; PRBC; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells,Packed RBC Gvn BPU,,Packed erythrocytes units given [#],{#};{# units},Packed RBC units given (BPU) [#]
30167-1,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA,MICRO,Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HC; HPA; HPV; HPV I/H Risk 1; HPV IHR; HPV16; HPV16 and 18; HPV16+18; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Papilloma virus intermediate/high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; UniversalLabOrders,HPV I/H Risk 1 DNA Cvx Ql Probe+sig amp,,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification,,HPV 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA Probe+sig amp Ql (Cvx)
57022-6,Complete blood count W Reflex Manual Differential panel,PANEL.HEM/BC,Blood; CBC W Reflex Manual Diff; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,CBC W Reflex Manual Diff Bld,,CBC W Reflex Manual Differential panel - Blood,,CBC W Reflex Manual Differential panel (Bld)
5768-7,Ascorbate,UA,Ascorbic acid; c702; Dip stick; Dipstick; Level; Mass concentration; Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn; Vit C; Vitamin C,Vit C Ur Strip-mCnc,mg/dL,Ascorbate [Mass/volume] in Urine by Test strip,mg/dL,Ascorbate Test strip (U) [Mass/Vol]
52797-8,Diagnosis ICD code,CLIN,CLIN; Dx; Dx ICD code; Identity or presence; International Classification of Diseases; Nominal; Point in time; Random,Dx ICD code,,Diagnosis ICD code [Identifier],,
7792-5,Dohle body,HEM/BC,Blood; bod; Bodies; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Dohle Bod Bld Ql Smear,,Dohle body [Presence] in Blood by Light microscopy,,Dohle body LM Ql (Bld)
4679-7,Reticulocytes/Erythrocytes,HEM/BC,Blood; Discocytes; Erthrocyte; Erythrocyte; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number Fraction; Percent; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Retic; Retics; Reticulocyte; UniversalLabOrders; WB; Whole blood,Retics/RBC NFr,%,Reticulocytes/Erythrocytes in Blood,%,Reticulocytes/Erythrocytes (Bld)
28543-7,Basophils/Leukocytes,HEM/BC,"B/F; Baso; Basophil; Basos; BF; bod; Bodies; Body fluid; Body fluid, unsp; Bph; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Basophils NFr Fld,%,Basophils/Leukocytes in Body fluid,%,Basophils/Leukocytes (Body fld)
5193-8,Hepatitis B virus surface Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBsAg; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HBs; HBsAB; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; HepB; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Surf; UniversalLabOrders,HBV surface Ab SerPl IA-aCnc,mIU/mL,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,m[IU]/mL,HBV surface Ab IA Qn
51637-7,Plateletcrit,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Pct; Percent; Platelet mass; plateletocrit; Point in time; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction; WB; Whole blood,Plateletcrit VFr Bld,%,Plateletcrit [Volume Fraction] in Blood,%,Plateletcrit (Bld) [Volume fraction]
8122-4,Cells.CD3,CELLMARK,#; ABS; absolute; absolutes; Blood; CD3 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood,CD3 Cells # Bld,10*9/L,CD3 cells [#/volume] in Blood,/uL,CD3 cells (Bld) [#/Vol]
21026-0,Pathologist interpretation,PATH,Blood; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; Path; Path Interp; PATHOLOGY; Point in time; Random; WB; Whole blood,Path Interp Bld-Imp,,Pathologist interpretation of Blood tests,,Pathologist interpretation (Bld) [Interp]
39017-9,Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Blood; ID; IFN; IGRA; Infectious Disease; InfectiousDisease; Lung; M tb; M TB tuberc IFN-g; M tuberculosis; Microbiology; Mitogen IGNF; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Point in time; PPD; Pulmonary; Pulmonology; Purified protein derivative; QFT; QNT; Quan; Quant; Quantiferon; Quantitative; Random; Respiratory; RlACnc; TB; Tuberculosis; Tuberculosis antigen; WB; Whole blood,M TB tuberc IFN-g/Mitogen IGNF Bld,,Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon in Blood,,M. tuberculosis tuberculin stim IFN-g/Mitogen stimulated gamma interferon (Bld) [Rel units/Vol]
32710-6,Nitrite,UA,NO2; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Nitrite Ur Ql,,Nitrite [Presence] in Urine,,Nitrite Ql (U)
11126-0,Platelets,HEM/BC,BM; BON; Bone marrow; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Morphology; Nominal; Platelet; Platelt; Plt; Point in time; Random; Thrb; Thrombocyte; Thrombocytes,Platelet Mar,,Platelets [Morphology] in Bone marrow,,Platelets Nom (BM)
54143-3,Gardnerella vaginalis DNA,MICRO,Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; G vaginalis; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid,G vaginalis DNA Vag Ql Probe+sig amp,,Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification,,G. vaginalis DNA Probe+sig amp Ql (Vag fld)
2990-0,Testosterone.free+weakly bound,CHEM,Associated; bnd; Chemistry; FR; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost; Testost Free; Testosterone free+weakly bound; Testosterone.bioavailable; Testosterone.free+WB; Testosterone.unconjugated; Tumor marker,Testosterone.free+WB SerPl-mCnc,ng/dL,Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma,ng/dL,Testosterone.free+weakly bound [Mass/Vol]
8124-0,Cells.CD3/Cells,CELLMARK,Blood; CD3 Cells; Cell; CELL MARKERS; Cellularity; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood,CD3 Cells NFr Bld,%,CD3 cells/cells in Blood,%,CD3 cells/cells (Bld)
40569-6,Eosinophils,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Eos; Eosin; Eosino; Eosinophil; Eosins; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random",Eosinophil # Fld Manual,10*9/L,Eosinophils [#/volume] in Body fluid by Manual count,10*3/uL,Eosinophils Manual cnt (Body fld) [#/Vol]
42216-2,Referral lab name,MISC,Ident; Identifier; MISC; Narrative; Point in time; Random; Ref Lab Test; Report,Ref Lab Name,,Referral lab name [Identifier],,Referral lab name
30433-7,Metamyelocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Metamyelocytes # Bld,10*3/mm3,Metamyelocytes [#/volume] in Blood,10*3/uL,Metamyelocytes (Bld) [#/Vol]
51585-8,Other cells,HEM/BC,#; ABS; absolute; absolutes; Blood; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Other cells # Bld Manual,10*9/L,Other cells [#/volume] in Blood by Manual count,10*3/uL,Other cells Manual cnt (Bld) [#/Vol]
17803-8,Plasma cells/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Plasma Cells NFr Fld,%,Plasma cells/Leukocytes in Body fluid,%,Plasma cells/Leukocytes (Body fld)
19113-0,IgE,CHEM,Arbitrary concentration; Chemistry; Immune globulin E; Immunoglobulin E; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,IgE SerPl-aCnc,kIU/L; units; units/mL,IgE [Units/volume] in Serum or Plasma,[IU]/L,IgE Qn
33800-4,DNA double strand Ab.IgG,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Immune globulin G; Immunoglobulin G; Native DNA; N-DNA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Stranded; Strnd,dsDNA IgG Ser-aCnc,IU/mL,DNA double strand IgG Ab [Units/volume] in Serum,[IU]/mL,DNA double strand IgG Qn (S)
582-7,Streptococcus agalactiae,MICRO,C&S; Cult; Cultures; GBS; Gen; Genital tract; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S agalactiae; Screen; Spec; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; UniversalLabOrders; Urogenit; Urogenital,Gp B Strep Genital Ql Cult,,Streptococcus agalactiae [Presence] in Genital specimen by Organism specific culture,,S. agalactiae Org specific cx Ql (Genital specimen)
18309-5,Erythrocytes.nucleated/Leukocytes,HEM/BC,Blood; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Normoblasts; nRBC; nRBCs; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Rto; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,nRBC Bld Manual-Rto,%,Nucleated erythrocytes/Leukocytes [Ratio] in Blood by Manual count,%,Nucleated RBC/Leukocytes Manual cnt (Bld) [Ratio]
33254-4,pH^^adjusted to patient's actual temperature,CHEM,ABG; adj; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Kidney; Log molar concentration; Lung; Nephrology; Point in time; Pulmonary; Pulmonology; Random; Renal; Respiratory; S prime; SmQn; Temp; temp adj,pH temp adj BldA,pH,pH of Arterial blood adjusted to patient's actual temperature,[pH],pH adjusted to patient's actual temperature (BldA)
13522-8,Blasts/Leukocytes,HEM/BC,"B/F; BF; Blast; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Blasts NFr Fld Manual,%,Blasts/Leukocytes in Body fluid by Manual count,%,Blasts/Leukocytes Manual cnt (Body fld)
22639-9,Path report.supplemental reports,TUMRRGT,Finding; Findings; Narrative; Oncology; Point in time; Random; Report; Spec; TUMOR REGISTRY(NAACCR),Path report.supplemental reports Spec,,Pathology report supplemental reports Narrative,,
11153-4,Erythrocyte/Body fluid,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Calc; Calculation; Discocyte; Erc; Erythrocytes; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UniversalLabOrders; Volfr; Volume fraction",Hct VFr Fld Calc,L/L;%,Hematocrit [Volume Fraction] of Body fluid by calculation,%,Hematocrit Calc (Body fld) [Volume fraction]
5130-0,DNA double strand Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Native DNA; N-DNA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Stranded; Strnd; UniversalLabOrders,dsDNA Ab Ser-aCnc,IU/mL;units/mL,DNA double strand Ab [Units/volume] in Serum,[IU]/mL,DNA double strand Ab Qn (S)
26466-3,Leukocytes,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",WBC # Fld,/uL,Leukocytes [#/volume] in Body fluid,10*3/uL,WBC (Body fld) [#/Vol]
20567-4,Ferritin,CHEM,Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Ferr; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS,Ferritin SerPl IA-mCnc,ng/mL,Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,ng/mL,Ferritin IA [Mass/Vol]
735-1,Lymphocytes.variant/Leukocytes,HEM/BC,Atypical lymphocytes; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive lymphocytes; Variant lymphocytes; Variant Lymphs; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Variant Lymphs NFr Bld Manual,%,Variant lymphocytes/Leukocytes in Blood by Manual count,%,Variant lymphocytes/Leukocytes Manual cnt (Bld)
734-4,Lymphocytes.variant,HEM/BC,#; ABS; absolute; absolutes; Atypical lymphocytes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive lymphocytes; Variant lymphocytes; Variant Lymphs; WB; Whole blood,Variant Lymphs # Bld Manual,10*9/L,Variant lymphocytes [#/volume] in Blood by Manual count,10*3/uL,Variant lymphocytes Manual cnt (Bld) [#/Vol]
3142-7,Body weight,BDYWGT.ATOM,Bdy weight; bod; Bodies; BODY WEIGHT.ATOM; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt,Weight Stated,gm;lb-oz,Body weight Stated,[lb_av];kg,
54144-1,Trichomonas vaginalis DNA,MICRO,Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Vag fld; Vag fluid; Vagina; Vaginal fluid,T vaginalis DNA Vag Ql Probe+sig amp,,Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification,,T. vaginalis DNA Probe+sig amp Ql (Vag fld)
2753-2,pH,CHEM,Chemistry; Log molar concentration; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR,pH SerPl,pH,pH of Serum or Plasma,[pH],pH
39528-5,Adenovirus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HAdV DNA Spec Ql NAA+probe,,Adenovirus DNA [Presence] in Specimen by NAA with probe detection,,Adenovirus DNA NAA+probe Ql (Specimen)
34473-9,Neutrophils.vacuolated+Segmented,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Neut; Neut Vac+Seg; Neutr; Neutrophil; Neuts Vac; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seg; Vaculated; WB; Whole blood,Neut Vac+Seg Bld Ql,,Neutrophils.vacuolated+Segmented [Presence] in Blood,,Neutrophils.vacuolated+Segmented Ql (Bld)
20585-6,Lymphocytes,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Misc; Miscellaneous; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified,Lymphocytes # Spec Auto,/uL,Lymphocytes [#/volume] in Specimen by Automated count,10*3/uL,Lymphocytes Auto (Specimen) [#/Vol]
95209-3,SARS coronavirus+SARS coronavirus 2 Ag,MICRO,2019 Novel Coronavirus; 2019-nCoV; Antigen; Antigens; Breathing; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; Lungs; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV+SARS-CoV-2; SARS-CoV+SARS-CoV-2 Ag; SARS-CoV-1; SARS-CoV-2; Screen; Severe Acute Respiratory Syndrome; Spec; SUDS; Viral Pneumonias; Wuhan coronavirus,SARS-CoV+SARS-CoV-2 Ag Resp Ql IA.rapid,,SARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay,,SARS-CoV+SARS-CoV-2 (COVID-19) Ag IA.rapid Ql (Respiratory system specimen)
648-6,Observation,MICRO,Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lower respiratory; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spt; Sputum; St; Stains; Stn,Gram Stn Spt,,Microscopic observation [Identifier] in Sputum by Gram stain,,Microscopic observation Gram stain Nom (Sput)
51733-4,Oxygen saturation,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Calc; calc from oxygen partial pressure; Calculation; Chemistry; from pO2; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2,SaO2 % BldA from pO2,%,Oxygen saturation Calculated from oxygen partial pressure in Arterial blood,%,SaO2% Calculated from oxygen partial pressure (BldA) [Mass fraction]
12183-0,Cholesterol,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Fl; Fld; FLU; Fluid; Level; Lipid; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random",Cholest Fld-mCnc,mg/dL,Cholesterol [Mass/volume] in Body fluid,mg/dL,Cholesterol (Body fld) [Mass/Vol]
676-7,Observation,MICRO,AFB stain; Auramine stain; Auramine-Rhodamine stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Rhodamine-auramine Stn; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified,Rhodamine-auramine Stn Spec,,Microscopic observation [Identifier] in Specimen by Rhodamine-auramine fluorochrome stain,,Microscopic observation Rhodamine-auramine fluorochrome stain Nom (Specimen)
19072-8,Calcium.ionized^^adjusted to pH 7.4,CHEM,adj; adj pH7.4; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,Ca-I adj pH7.4 SerPl-sCnc,mmol/L,Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma,mmol/L,Calcium.ionized adjusted to pH 7.4 [Moles/Vol]
48378-4,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free,CHEM,Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; FR; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Kappa LC Free; Lambda Free; Lambda LC; Lambda LC Free; Mass concentration ratio; Mass ratio; MCRto; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR,Kappa LC Free/Lambda Free Ser,,Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum,{ratio},Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free (S) [Mass ratio]
13965-9,Homocysteine,CHEM,Cardio; Cardiology; Chemistry; HCY; Hcys; Hcyst; Heart Disease; Homocyst(e)ine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Hcys SerPl-sCnc,umol/L;mcmol/dL; mcmol/L,Homocysteine [Moles/volume] in Serum or Plasma,umol/L,Homocysteine [Moles/Vol]
94505-5,SARS coronavirus 2 Ab.IgG,MICRO,2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; Wuhan coronavirus,SARS-CoV-2 IgG SerPl IA-aCnc,arb U/mL,SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,[arb'U]/mL,SARS-CoV-2 (COVID-19) IgG IA Qn
1649-3,Calcitriol,CHEM,"1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders","1,25(OH)2D3 SerPl-mCnc",pg/mL,Calcitriol [Mass/volume] in Serum or Plasma,pg/mL,"1,25-dihydroxyvitamin D3 [Mass/Vol]"
19773-1,Recommended follow-up,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Genital tract; Genital vaginal; Identity or presence; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Papinacolou Smear; Point in time; Random; Recom F/U; St; Stains; Stn; Vag fld; Vag fluid; Vagina; Vaginal fluid,Recom F/U Cvx/Vag Cyto,,Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain,,Recommended follow-up Cyto stain Nom (Cvx/Vag)
40493-9,Methylenedioxymethamphetamine,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,MDMA SerPl Ql,,Methylenedioxymethamphetamine [Presence] in Serum or Plasma,,Methylenedioxymethamphetamine Ql
94507-1,SARS coronavirus 2 Ab.IgG,MICRO,"2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus",SARS-CoV-2 IgG SerPlBld Ql IA.rapid,,"SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay",,SARS-CoV-2 (COVID-19) IgG IA.rapid Ql (S/P/Bld)
496-0,Tetracycline,ABXBACT,Achromycin V; ANTIBIOTIC SUSCEPTIBILITIES; AST; C18; c211; C75; Chemiciclina; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Panmycin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tetrabioptal,Tetracycline Islt MIC,,Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC),,Tetracycline MIC [Susc]
10886-0,Prostate specific Ag.free,CHEM,Chemistry; fPSA; FR; Genitourinary; GU; Kallikrein 3; Level; Mass concentration; Non-protein bound; Oncology; P-30 antigen; Pl; Plasma; Plsm; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Tumor marker; UniversalLabOrders; URO; Urology,PSA Free SerPl-mCnc,ug/L;ng/mL,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,ng/mL,Free PSA [Mass/Vol]
12228-3,Triglyceride,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tg; Trig; Trigly; Triglycerides; Triglycrides",Trigl Fld-mCnc,mg/dL,Triglyceride [Mass/volume] in Body fluid,mg/dL,Triglyceride (Body fld) [Mass/Vol]
88294-4,Glomerular filtration rate,CHEM,"Blood; Chemistry; GFR; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood",GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat,mL/min/1.73 sq M,"Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M among non black population",mL/min/{1.73_m2},GFR Creatinine-based formula (CKD-EPI)/1.73 sq M among non black population (S/P/Bld) [Vol rate/Area]
20521-1,Carboxy tetrahydrocannabinol,DRUG/TOX,11-nor-9-carboxy-delta-9-THC; 11-nor-9-carboxy-THC; 11-nor-delta-9-THC-9-COOH; 9-carboxy-11-nor-delta-9-tetrahydrocannabinol; Addiction; Carboxytetrahydrocannabinol; CarboxyTHC; Carboxy-THC-delta-9; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Marijuana; Mass concentration; Nabilone; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; THC; THCA; THCC; THCCOOH; THC-COOH; UA; UniversalLabOrders; UR; Urn,CarboxyTHC Ur Cfm-mCnc,ng/mL,Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method,ng/mL,Carboxy tetrahydrocannabinol Confirm (U) [Mass/Vol]
585-0,Streptococcus agalactiae,MICRO,C&S; Cult; Cultures; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S agalactiae; Screen; Spec; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; Throat; UniversalLabOrders; Upper respiratory,Gp B Strep Throat Ql Cult,,Streptococcus agalactiae [Presence] in Throat by Organism specific culture,,S. agalactiae Org specific cx Ql (Throat)
54142-5,Candida sp DNA,MICRO,Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Monilia; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; species; spp; Thrush; Vag fld; Vag fluid; Vagina; Vaginal fluid,Candida DNA Vag Ql Probe+sig amp,,Candida sp DNA [Presence] in Vaginal fluid by Probe with signal amplification,,Candida sp DNA Probe+sig amp Ql (Vag fld)
30446-9,Myelocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Myel; Myelo; Myelocyte; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Myelocytes # Bld,10*3/mm3,Myelocytes [#/volume] in Blood,10*3/uL,Myelocytes (Bld) [#/Vol]
11156-7,Leukocyte morphology finding,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Identity or presence; Leuc; Leuk; Leukocytes; Lkcs; Nominal; Point in time; Random; WB; WBC; WBC morph; WBCs; White blood cell; White blood cells; Whole blood,WBC morph Bld,,Leukocyte morphology finding [Identifier] in Blood,,Leukocyte morphology finding Nom (Bld)
41654-5,Erythrocyte/Venous blood,HEM/BC,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Calc; Calculation; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Venous; Volfr; Volume fraction,Hct VFr BldV Calc,%,Hematocrit [Volume Fraction] of Venous blood by calculation,%,Hematocrit Calc (BldV) [Volume fraction]
19159-3,Urinalysis specimen collection method,UA,Coll; Collect; Collected; Identity or presence; Meth; Method of; Nominal; Point in time; Random; Spec; UA; UR; Urn; Urn Spec Collect Meth,Urn Spec Collect Meth Ur,,Urinalysis specimen collection method,,Urinalysis specimen collection method Nom (U)
19994-3,Oxygen/Gas.total setting,PULM,Gases; Lung; O2; O2/gas .tot set; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Tot; Total gas setting; Totl; Volfr; Volume fraction,O2/Total gas setting VFr Vent,%,Oxygen/Total gas setting [Volume Fraction] Ventilator,%,
50233-6,Leukocyte clumps,UA,#/area; Auto; Automated detection; Elec; Elect; Electr; Kidney; Leuc; Leuk; Leukocytes; Lkcs; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBC clumps; WBCs; White blood cell; White blood cells,WBC clumps #/area UrnS Auto,/HPF,Leukocyte clumps [#/area] in Urine sediment by Automated count,/[HPF],Leukocyte clumps Auto (Urine sed) [#/Area]
5763-8,Zinc,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Zn,Zinc SerPl-mCnc,mcg/dL; mg/dL; ng/mL,Zinc [Mass/volume] in Serum or Plasma,ug/mL,Zinc [Mass/Vol]
2711-0,Oxygen saturation,HEMODYN.MOLEC,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Hemodynamics; HEMODYNAMICS.MOLEC; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2; Venous,SaO2 % BldV,%,Oxygen saturation in Venous blood,%,
17864-0,Calcium.ionized,CHEM,Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Ca-I SerPl ISE-mCnc,mg/dL,Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE),mg/dL,Calcium.ionized ISE [Mass/Vol]
33393-0,Granular casts.coarse,UA,#/area; Cast; Coarse Gran Casts; Gran Casts; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Coarse Gran Casts #/area UrnS LPF,/LPF,Coarse Granular Casts [#/area] in Urine sediment by Microscopy low power field,/[LPF],Coarse Granular Casts LM.LPF (Urine sed) [#/Area]
3395-1,Cocaine,DRUG/TOX,Addiction; Benzoylmethylecgonine; Coke; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; Snow; SR,Cocaine SerPl Ql,,Cocaine [Presence] in Serum or Plasma,,Cocaine Ql
3878-6,Opiates,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Opiates SerPl Ql,,Opiates [Presence] in Serum or Plasma,,Opiates Ql
34705-4,Carbon dioxide^^adjusted to patient's actual temperature,CHEM,adj; Blood; Carbonic anhydride; Chemistry; CO2; Lung; Partial pressure; PCO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; S prime; Temp; temp adj; WB; Whole blood,pCO2 temp adj Bld,mm Hg,Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood,mm[Hg],CO2 adjusted to patient's actual temperature (Bld) [Partial pressure]
33903-6,Ketones,CHEM,Acetest; Acetoacetate; Acetoacetates; Acetone bodies; Chemistry; Ketone; Ketone bodies; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Ketones Ur Ql,,Ketones [Presence] in Urine,,Ketones Ql (U)
20396-8,levoFLOXacin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,levoFLOXacin Islt MIC,,levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC),,levoFLOXacin MIC [Susc]
14634-0,C reactive protein,CHEM,Chemistry; CRP; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; PR; Prot; Random; Reac; React; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr,CRP Titr SerPl,titer,C reactive protein [Titer] in Serum or Plasma,{titer},CRP [Titer]
38250-7,Calcium,CHEM,Ca; Cal; Chemistry; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified,Calcium Spec-mCnc,mg/dL,Calcium [Mass/volume] in Specimen,mg/dL,Calcium (Specimen) [Mass/Vol]
13046-8,Lymphocytes.variant/Leukocytes,HEM/BC,Atypical lymphocytes; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive lymphocytes; Variant lymphocytes; Variant Lymphs; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Variant Lymphs NFr Bld,%,Variant lymphocytes/Leukocytes in Blood,%,Variant lymphocytes/Leukocytes (Bld)
19235-1,Base excess^^standard,CHEM,ABE; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Base ex; BE; Blood arterial; BSE; Calc; Calculation; Chemistry; EXS; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SBE; std; Substance Concentration,Base excess std BldA Calc-sCnc,mmol/L,Base excess standard in Arterial blood by calculation,mmol/L,Base excess standard Calc (BldA) [Moles/Vol]
6652-2,Meropenem,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Meronem; Merrem; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Meropenem Islt MIC,,Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC),,Meropenem MIC [Susc]
22635-7,Path report.microscopic observation,TUMRRGT,Identity or presence; Narrative; Oncology; Other Stn; Point in time; Random; Report; Spec; St; Stains; Stn; TUMOR REGISTRY(NAACCR),Path report.microscopic Spec Other Stn,,Pathology report microscopic observation Narrative Other stain,,
88293-6,Glomerular filtration rate,CHEM,"Blood; Chemistry; GFR; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood",GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat,mL/min/1.73 sq m,"Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M among black population",mL/min/{1.73_m2},GFR Creatinine-based formula (CKD-EPI)/1.73 sq M among black population (S/P/Bld) [Vol rate/Area]
75358-2,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Anaerobe+Aerobe Cult; Bact; BON; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random,Bacteria Bone Anaerobe+Aerobe Cult,,Bacteria identified in Bone by Anaerobe+Aerobe culture,,Bacteria identified Anaer+Aer cx Nom (Bone)
2162-6,Creatinine,CHEM,1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Kidney; Mass Rate; mRate; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UR; Urn,Creat 24h Ur-mRate,g/24 H,Creatinine [Mass/time] in 24 hour Urine,g/(24.h),Creatinine (24H U) [Mass/Time]
18182-6,Observation,CHEM,Calc; Calc.Sum of Elec; Calculation; Chemistry; Osmo; Osmolality; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Osmolality SerPl Calc.Sum of Elec,mOsm/kg,Osmolality of Serum or Plasma by calculated by sum of electrolytes,mosm/kg,Osmolality calculated by sum of electrolytes [Osmolality]
47938-6,Specimen source,SPEC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Identity or presence; Nominal; Point in time; Random; Spec; Srce",Specimen source Fld,,Specimen source [Identifier] of Body fluid,,Specimen source Nom (Body fld)
709-6,Blasts/Leukocytes,HEM/BC,Blast; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Blasts NFr Bld Manual,%,Blasts/Leukocytes in Blood by Manual count,%,Blasts/Leukocytes Manual cnt (Bld)
29247-4,Sirolimus,DRUG/TOX,Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rapamune; Rapamycin; SRL; UniversalLabOrders; WB; Whole blood,Sirolimus Bld-mCnc,ug/L;ng/mL,Sirolimus [Mass/volume] in Blood,ng/mL,Sirolimus (Bld) [Mass/Vol]
3173-2,Coagulation surface induced,COAG,Activated partial thromboplastin time; aPTT; Blood; Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Little(A)PTT; Partial Thromboplastin Time; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube; UniversalLabOrders; WB; Whole blood,aPTT Bld,s,aPTT in Blood by Coagulation assay,s,aPTT Coag (Bld) [Time]
79426-3,Plasma cells/Leukocytes,HEM/BC,Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Plasma Cells NFr Bld Manual,%,Plasma cells/Leukocytes in Blood by Manual count,%,Plasma cells/Leukocytes Manual cnt (Bld)
34167-7,Platelets.large,HEM/BC,Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Lg Platelets; Ordinal; Platelet; Platelet adequacy; Platelet estimate; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood,Lg Platelets Bld Ql Auto,,Platelets Large [Presence] in Blood by Automated count,,Platelets Large Auto Ql (Bld)
32307-1,Chloride,CHEM,Chemistry; Cl; Cl-; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified,Chloride Spec-sCnc,mmol/L,Chloride [Moles/volume] in Specimen,mmol/L,Chloride (Specimen) [Moles/Vol]
40991-2,Rhinovirus+Enterovirus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; HRV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rhino virus; RHV; Ribonucleic acid; RV+EV; RV+EV RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,RV+EV RNA Spec Ql NAA+probe,,Rhinovirus+Enterovirus RNA [Presence] in Specimen by NAA with probe detection,,Rhinovirus+Enterovirus RNA NAA+probe Ql (Specimen)
6437-8,Influenza virus A+B Ag,MICRO,"A,B; Antigen; Antigens; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; UniversalLabOrders; Unspecified",FLUAV+FLUBV Ag Spec Ql IA,,Influenza virus A+B Ag [Presence] in Specimen by Immunoassay,,FLUAV+FLUBV Ag IA Ql (Specimen)
45335-7,Bacteria identification test,MICRO,Bact; Bacteria ID test; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen,Bacteria ID test Islt Ql Cult,,Bacteria Identification [Presence] in Isolate by Culture,,Bacteria Identification Cx Ql (Isol)
34713-8,Clostridioides difficile toxin A+B,MICRO,"A,B; Bowel movement; C diff; C diff Tox; C diff Tox A; C diff Tox A+B; C difficile; Clostridium difficile; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; UniversalLabOrders",C diff Tox A+B Stl Ql,,Clostridioides difficile toxin A+B [Presence] in Stool,,C. difficile toxin A+B Ql (Stl)
18314-5,Morphology,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; WB; Whole blood,Morphology Bld-Imp,,Morphology [Interpretation] in Blood Narrative,,Morphology Nar (Bld) [Interp]
5-Dec,Amikacin,ABXBACT,Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Amikacin Islt MIC,,Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC),,Amikacin MIC [Susc]
45323-3,Mycobacterium tuberculosis tuberculin stimulated gamma interferon,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Blood; ID; IFN; IGRA; Infectious Disease; InfectiousDisease; Lung; M tb; M TB tuberc IFN-g; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; Point in time; PPD; PR; Pulmonary; Pulmonology; Purified protein derivative; QFT; QL; Qual; Qualitative; Quantiferon; Random; Respiratory; Screen; TB; Tuberculosis; Tuberculosis antigen; WB; Whole blood,M TB tuberc IFN-g Bld Ql,,Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood,,M. tuberculosis tuberculin stim IFN-g Ql (Bld)
1255-9,Minor crossmatch,BLDBK,BLOOD BANK; Erythrocytes; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Min XM; Nominal; Point in time; Random; Red blood cells; Red blood corpusles,Min XM RBC-Imp,,Minor crossmatch [Interpretation],,Minor crossmatch (RBC) [Interp]
5353-8,Sjogrens syndrome-B extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-B; Enzyme immunoassay; HA; Ha AB; IAA; La AB; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; Sjogren; SR; SS; SSB; SS-B; SUDS; UniversalLabOrders,ENA SS-B Ab Ser Ql IA,,Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay,,Sjogrens syndrome-B extractable nuclear Ab IA Ql (S)
31627-3,Smith extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA SM; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SM; SR,ENA SM Ab Ser Ql,,Smith extractable nuclear Ab [Presence] in Serum,,Smith extractable nuclear Ab Ql (S)
636-1,Bacteria,MICRO,Bact; BFld Cult; bod; Bodies; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified,Bacteria Spec BFld Cult,,Bacteria identified in Specimen by Sterile body fluid culture,,Bacteria identified Sterile body fluid culture Nom (Specimen)
2881-1,Protein,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders",Prot Fld-mCnc,g/L;g/dL; mg/dL,Protein [Mass/volume] in Body fluid,g/dL,Protein (Body fld) [Mass/Vol]
33515-8,Clarity,SPEC,Misc; Miscellaneous; Nominal; Other; Point in time; Random; SPEC; To be specified in another part of the message; Typ; Unspecified,Clarity Spec,,Clarity of Specimen,,Clarity (Specimen)
3936-2,Phencyclidine,DRUG/TOX,Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Sernylan; UA; UniversalLabOrders; UR; Urn,PCP Ur Ql,,Phencyclidine [Presence] in Urine,,Phencyclidine Ql (U)
16234-7,Amphetamine,DRUG/TOX,Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Speed; UA; UR; Urn,Amphet Ur Cfm-mCnc,ng/mL,Amphetamine [Mass/volume] in Urine by Confirmatory method,ng/mL,Amphetamine Confirm (U) [Mass/Vol]
24351-9,Protein fractions panel,PANEL.CHEM,Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PR; Prot; Prot Elph Pnl; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum electrophoresis; Serum or plasma; SR; UniversalLabOrders,Prot Elph Pnl SerPl,,Protein electrophoresis panel - Serum or Plasma,,Protein electrophoresis panel
2704-5,Oxygen,CHEM,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; Lung; O2; O2 partial pressure; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2,pO2 BldC,mm Hg,Oxygen [Partial pressure] in Capillary blood,mm[Hg],Oxygen (BldC) [Partial pressure]
3095-7,Urea nitrogen,CHEM,Blood urea nitrogen; Chemistry; Level; Mass concentration; N; N2; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UN; UniversalLabOrders; UR; Urn; UUN,UUN Ur-mCnc,mg/dL,Urea nitrogen [Mass/volume] in Urine,mg/dL,Urea nitrogen (U) [Mass/Vol]
43985-1,Benzoylecgonine,DRUG/TOX,BEC; BEG; Benz; Benzoylec; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Nasogastric; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;300 ng/mL; Scr; Screen; Scrn; UA; UR; Urn,BZE Ur Ql Scn>300 ng/mL,,Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL,,Benzoylecgonine Screen method >300 ng/mL Ql (U)
12841-3,Prostate specific Ag.free/Prostate specific Ag.total,CHEM,Chemistry; fPSA; FR; Genitourinary; GU; Kallikrein 3; Mass fraction; Non-protein bound; Oncology; P-30 antigen; Percent; Pl; Plasma; Plsm; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Tot; Totl; Tumor marker; URO; Urology,PSA Free MFr SerPl,%,Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma,%,Free PSA/Total PSA [Mass fraction]
83112-3,Prostate specific Ag,CHEM,Antigen; Antigens; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Genitourinary; GU; IAA; Kallikrein 3; Level; Mass concentration; MEIA; Oncology; P-30 antigen; Pl; Plasma; Plsm; Point in time; PS; PSA; QNT; Quan; Quant; Quantitative; Random; Seminin; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; SUDS; Tumor marker; URO; Urology,PSA SerPl IA-mCnc,ng/mL,Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay,ng/mL,Prostate specific Ag IA [Mass/Vol]
13362-9,Collection duration,SPEC,Coll; Collect; Collect duration; Collected; Durat; QNT; Quan; Quant; Quantitative; SPEC; UA; UR; Urn,Collect duration Time Ur,hours;hr; min,Collection duration of Urine,h,Collection duration (U)
78012-2,Streptococcus pyogenes Ag,MICRO,Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; GAS; Group A Strep; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S pyogenes; Screen; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; SUDS; Throat; UniversalLabOrders; Upper respiratory,S pyo Ag Throat Ql IA.rapid,,Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay,,S. pyogenes Ag IA.rapid Ql (Throat)
14308-1,Amphetamines,DRUG/TOX,Addiction; Amph; Amphetam; Amphetamine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;1000 ng/mL; Scr; Screen; Scrn; Speed; UA; UR; Urn,Amphetamines Ur Ql Scn>1000 ng/mL,,Amphetamines [Presence] in Urine by Screen method >1000 ng/mL,,Amphetamines Screen method >1000 ng/mL Ql (U)
2020-6,Carbon dioxide,CHEM,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Carbonic anhydride; Chemistry; CO2; Finger stick; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random,pCO2 BldC,mm Hg,Carbon dioxide [Partial pressure] in Capillary blood,mm[Hg],CO2 (BldC) [Partial pressure]
41009-2,Human coronavirus OC43 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HCoV OC43 RNA Spec Ql NAA+probe,,Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection,,HCoV OC43 RNA NAA+probe Ql (Specimen)
3150-0,Oxygen/Gas.total,CLIN,CLIN; Gases; IhG; Inhaled Gas; Inspired; Lung; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Tot; Totl; Volfr; Volume fraction,Inhaled O2 concentration,%,Inhaled oxygen concentration,%,
2745-8,pH,CHEM,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; Kidney; Log molar concentration; Lung; Nephrology; Point in time; Pulmonary; Pulmonology; Random; Renal; Respiratory; SmQn,pH BldC,pH,pH of Capillary blood,[pH],pH (BldC)
19218-7,Oxygen content,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; ctO2; Level; Lung; O2; O2 Ct; O2CT; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; tO2,O2 Ct BldA-sCnc,mol/L,Oxygen content in Arterial blood,mol/L,Oxygen content (BldA) [Moles/Vol]
5351-2,Sjogrens syndrome-A extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-A; Enzyme immunoassay; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; SUDS; UniversalLabOrders,ENA SS-A Ab Ser Ql IA,,Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay,,Sjogrens syndrome-A extractable nuclear Ab IA Ql (S)
5822-2,Yeast,UA,#/area; ID; Infectious Disease; InfectiousDisease; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Yeast #/area UrnS HPF,/HPF,Yeast [#/area] in Urine sediment by Microscopy high power field,/[HPF],Yeast LM.HPF (Urine sed) [#/Area]
20448-7,Insulin,CHEM,Arbitrary concentration; Chemistry; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente; UniversalLabOrders,Insulin SerPl-aCnc,uIU/mL,Insulin [Units/volume] in Serum or Plasma,u[IU]/mL,Insulin Qn
50564-4,Urinalysis panel,PANEL.UA,Auto; Automated detection; Elec; Elect; Electr; Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UR; Urinalysis Pnl; Urn,Urinalysis Pnl Ur Auto,,Urinalysis panel - Urine by Automated,,Urinalysis panel Auto (U)
38227-5,Braden scale score.total,H&P.HX,Braden Scale Total Score; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl,Braden Scale Total Score,score,Braden scale total score,{score},
7796-6,Platelet clump,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Pl; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes; WB; Whole blood,Platelet Clump Bld Ql Smear,,Platelet clump [Presence] in Blood by Light microscopy,,Platelet clump LM Ql (Bld)
62423-9,Human coronavirus HKU1 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HCoV HKU1 RNA Spec Ql NAA+probe,,Human coronavirus HKU1 RNA [Presence] in Specimen by NAA with probe detection,,HCoV HKU1 RNA NAA+probe Ql (Specimen)
41005-0,Human coronavirus NL63 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV NL63; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HCoV NL63 RNA Spec Ql NAA+probe,,Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection,,HCoV NL63 RNA NAA+probe Ql (Specimen)
52123-7,Coagulation surface induced^post heparin neutralization,COAG,Activated partial thromboplastin time; After; aPTT; Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Hep; Hepar; Heparin Nt; Heparn; Little(A)PTT; Neut; Neutr; p hep neut; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube,aPTT p hep neut PPP,s,aPTT in Platelet poor plasma by Coagulation assay --post heparin neutralization,s,aPTT post heparin neutralization Coag (PPP) [Time]
748-4,Myelocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Manl; Myel; Myelo; Myelocyte; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Myelocytes # Bld Manual,10*9/L,Myelocytes [#/volume] in Blood by Manual count,10*3/uL,Myelocytes Manual cnt (Bld) [#/Vol]
2064-4,Ceruloplasmin,CHEM,Caeruloplasmin; Chemistry; Copper oxidase; Cp; Ferroxidase; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Ceruloplasmin SerPl-mCnc,mg/L;mg/dL,Ceruloplasmin [Mass/volume] in Serum or Plasma,mg/dL,Ceruloplasmin [Mass/Vol]
70155-7,Barbiturates,DRUG/TOX,Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;200 ng/mL; Scr; Screen; Scrn; UA; UR; Urn,Barbiturates Ur Ql Scn>200 ng/mL,,Barbiturates [Presence] in Urine by Screen method >200 ng/mL,,Barbiturates Screen method >200 ng/mL Ql (U)
3968-5,Phenytoin,DRUG/TOX,DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; Lehydan; Level; Mass concentration; Phenhydan; PHYT; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; UniversalLabOrders; Zentropil,Phenytoin SerPl-mCnc,ug/mL,Phenytoin [Mass/volume] in Serum or Plasma,ug/mL,Phenytoin [Mass/Vol]
1986-9,C peptide,CHEM,Chemistry; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,C peptide SerPl-mCnc,ug/L;ng/mL,C peptide [Mass/volume] in Serum or Plasma,ng/mL,C peptide [Mass/Vol]
11367-0,Tobacco use status,H&P.HX,H+P; H+P.HX; History; Nominal; P prime; Point in time; Random; Tob use status,Hx of Tobacco use,,History of Tobacco use,,
5866-9,Influenza virus B Ag,MICRO,Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; UniversalLabOrders; Unspecified,FLUBV Ag Spec Ql IA,,Influenza virus B Ag [Presence] in Specimen by Immunoassay,,FLUBV Ag IA Ql (Specimen)
41003-5,Human coronavirus 229E RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HCoV 229E RNA Spec Ql NAA+probe,,Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection,,HCoV 229E RNA NAA+probe Ql (Specimen)
8091-1,Ribonucleoprotein extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA RNP; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ribonuclear protein; RNP; Ro; Screen; Serology; Serum; SR; UniversalLabOrders,ENA RNP Ab Ser Ql,,Ribonucleoprotein extractable nuclear Ab [Presence] in Serum,,Ribonucleoprotein extractable nuclear Ab Ql (S)
31628-1,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA RNP; ENA SM; ENA SM+RNP; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ribonuclear protein; RNP; Ro; Screen; Serology; Serum; SM; SR,ENA SM+RNP Ab Ser Ql,,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum,,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab Ql (S)
32680-1,Granular casts.fine,UA,#/area; Cast; Fine Gran Casts; Gran Casts; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Fine Gran Casts #/area UrnS LPF,/LPF,Fine Granular Casts [#/area] in Urine sediment by Microscopy low power field,/[LPF],Fine Granular Casts LM.LPF (Urine sed) [#/Area]
5862-8,Influenza virus A Ag,MICRO,Antigen; Antigens; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; UniversalLabOrders; Unspecified,FLUAV Ag Spec Ql IA,,Influenza virus A Ag [Presence] in Specimen by Immunoassay,,FLUAV Ag IA Ql (Specimen)
24108-3,Cancer Ag 19-9,CHEM,Arbitrary concentration; CA; CA 19-9; Cancer Ag19-9; Cancer antigen 19-9; Carbohydrate antigen; Carbohydrate antigen 19-9; Chemistry; Oncology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,Cancer Ag19-9 SerPl-aCnc,kIU/L;units/mL,Cancer Ag 19-9 [Units/volume] in Serum or Plasma,[arb'U];[arb'U]/mL,Cancer Ag 19-9 Qn
32355-0,Bacteria,MICRO,Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Resp Cult; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,Bacteria Spec Resp Cult,,Bacteria identified in Specimen by Respiratory culture,,Bacteria identified Respiratory culture Nom (Specimen)
17763-4,Varicella zoster virus Ab.IgG,MICRO,ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; FA; Fluorescent antibody; Fluoresent; Herpes zoster; HHV-3; Human herpesvirus 3; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shingles; SR; Time Resolved Fluorescence; TRF; VZ; VZV; Zoster,VZV IgG Ser IF-aCnc,,Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence,[arb'U]/mL,VZV IgG IF Qn (S)
35505-7,Lipoprotein.beta.subparticle,CHEM,B; Chemistry; LDL; LDL phenotype; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Typ,LDL SerPl,,Lipoprotein.beta.subparticle [Type] in Serum or Plasma,,Lipoprotein.beta.subparticle Nom
19803-6,Specimen site,ENDO.GI,GI; GI.ENDOSCOPY; Narrative; Report; Spec; Studies; Study; Sutdies; Typ,Specimen site,,Specimen site Narrative,,
64013-6,Escherichia coli shiga-like toxin 1 & 2,MICRO,Bowel movement; E coli; E coli shiga-like toxin 1+2; E coli SLTEC; E coli SXT; E coli SXT1; E coli SXT1+2; EHEC; EIA; ELFA; ELISA; Enterohemorrhagic E coli; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; i; IAA; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Nominal; o002; Point in time; Random; SLTEC; Stl; Stool = Fecal; SUDS,E coli SXT1+2 Stl IA,,Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay,,E. coli shiga-like toxin 1 and 2 IA Nom (Stl)
1919-0,Aspartate aminotransferase,CHEM,"Asp; Aspartate amino transferase; Aspartate transaminase; Aspartic acid; AST; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Fl; Fld; FLU; Fluid; Glutamic oxaloacetic transaminase; Hepatology; Liver; Point in time; QNT; Quan; Quant; Quantitative; Random; SGOT",AST Fld-cCnc,arb U/L,Aspartate aminotransferase [Enzymatic activity/volume] in Body fluid,U/L,AST (Body fld) [Catalytic activity/Vol]
8458-2,Intravascular mean^supine,BP.PSTN.MOLEC,Art sys; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.POSITION.MOLEC; BP; BP mean; Cardio; Cardiology; Heart Disease; Intravenous; IV; Lying; MBP; Point in time; Position; Pressure; QNT; Quan; Quant; Quantitative; Random,BP mean--sup,mm Hg,Mean blood pressure--supine,mm[Hg],
34712-0,Clostridioides difficile,MICRO,Bowel movement; C diff; C difficile; Clostridium difficile; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; UniversalLabOrders,C diff Stl Ql,,Clostridioides difficile [Presence] in Stool,,C. difficile Ql (Stl)
10524-7,Observation,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Genital tract; Gyn; Gynecology; Identity or presence; Nominal; OB; ObGyn; Obstetrics; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn; UniversalLabOrders,Cyto Cvx,,Microscopic observation [Identifier] in Cervix by Cyto stain,,Microscopic observation Cyto stain Nom (Cvx)
10704-5,Ova & parasites,MICRO,Bowel movement; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Nominal; O&P; O+P; Ova and parasite; Ovum; Parasite; Point in time; Random; Stl; Stool = Fecal; UniversalLabOrders,O+P Stl Micro,,Ova and parasites identified in Stool by Light microscopy,,Ova and parasites identified LM Nom (Stl)
49041-7,Testosterone,CHEM,Chemistry; DL&lt;=1.0 ng/dL; Level; Mass concentration; Nasogastric; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost; UniversalLabOrders,Testost SerPl DL<=1.0 ng/dL-mCnc,ng/dL,Testosterone [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL,ng/dL,Testosterone DL <= 1.0 ng/dL [Mass/Vol]
1711-1,Acid phosphatase,CHEM,Ac Phos; Acd; Acid phosphatase.total; Acids; AcP; Blood; Catalytic Concentration; Chemistry; Phos; Phosphtase; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,ACP Bld-cCnc,arb U/L,Acid phosphatase [Enzymatic activity/volume] in Blood,U/L,Acid phosphatase (Bld) [Catalytic activity/Vol]
32293-3,Albumin,CHEM,Alb; Chemistry; Hepatology; Kidney; Level; Liver; Mass Concentration; Misc; Miscellaneous; Nephrology; Other; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; Spec; To be specified in another part of the message; Unspecified,Albumin Spec-mCnc,g/L;gm/L,Albumin [Mass/volume] in Specimen,g/L,Albumin (Specimen) [Mass/Vol]
13499-9,HIV 1 Ab band pattern,MICRO,Ab Patrn; ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bands; Blt; bnd; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; IMMUNE BLOT; Immunobl; Immunoblot; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Patrn; Point in time; Random; RIBA; Serum; SR; WB; WBLOT; West blot; West blt; Western blot,HIV1 Ab Patrn Ser IB-Imp,,HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot,,HIV 1 Ab band pattern IB (S) [Interp]
19415-9,Tetrahydrocannabinol,DRUG/TOX,Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Marijuana; Nabilone; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC; UA; UniversalLabOrders; UR; Urn,THC Ur Ql Scn,,Tetrahydrocannabinol [Presence] in Urine by Screen method,,Tetrahydrocannabinol Screen Ql (U)
19153-6,Specimen volume,SPEC,?Tm; AOEObservation; QNT; Quan; Quant; Quantitative; Spec; UA; UR; Urn; Vol; Volume,Specimen vol ?Tm Ur,mL,Volume in Urine collected for unspecified duration,mL,Specimen volume Unsp time (U)
279-0,Imipenem,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Imipeneum; Imp; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Imipenem Islt MIC,,Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC),,Imipenem MIC [Susc]
2828-2,Potassium,CHEM,Chemistry; k; K+; Level; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UniversalLabOrders; UR; Urn,Potassium Ur-sCnc,mmol/L,Potassium [Moles/volume] in Urine,mmol/L,Potassium (U) [Moles/Vol]
8665-2,Date last menstrual period,H&P.HX,AOEObservation; Gyn; Gynecology; H+P; H+P.HX; LMP; LMP Start date; OB; ObGyn; Obstetrics; P prime; Past; Point in time; QNT; Quan; Quant; Quantitative; Random,LMP Start date,MMDDYY,Last menstrual period start date,{date},
12851-2,Protein pattern,CHEM,Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; Plsm; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR,Prot Pattern SerPl Elph-Imp,,Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis,,Protein Fractions Elph [Interp]
53963-5,Blood,UA,Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Blood Ur Ql Visual,,Blood [Presence] in Urine by Visual,,Blood Visual Ql (U)
10335-8,Observation,SPEC,Cerebral spinal fluid; Cerebrospinal Fl; Nominal; Point in time; Random; SPEC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid,Color CSF,,Color of Cerebral spinal fluid,,Color (CSF)
53321-6,Mucus,UA,Auto; Automated detection; Elec; Elect; Electr; Mucous; Mucous Threads; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Mucous Threads Ur Ql Auto,,Mucus [Presence] in Urine by Automated,,Mucus Auto Ql (U)
42355-8,Tigecycline,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tygacil; Tygecycline,Tigecycline Islt MIC,,Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC),,Tigecycline MIC [Susc]
46130-1,Prealbumin,CHEM,Chemistry; Level; Light scattering; Mass concentration; Nephelom; PALB; Pl; Plasma; Plsm; Point in time; Pre albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Transthyretin,Prealb SerPl Neph-mCnc,mg/L,Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry,mg/dL;mg/L,Prealbumin Nephelometry [Mass/Vol]
1006-6,Direct antiglobulin test.IgG specific reagent,BLDBK,Antiglob; BLOOD BANK; DAGT; DAT; DAT IgG-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Immune globulin G; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Red blood cells; Red blood corpusles; Spec,DAT IgG-Sp Reag RBC-Imp,,Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells,,Direct antiglobulin test.IgG specific reagent (RBC) [Interp]
5671-3,Lead,DRUG/TOX,Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Lead Bld-mCnc,mcg/dL; mcg/mL,Lead [Mass/volume] in Blood,ug/dL,Lead (Bld) [Mass/Vol]
5793-5,Granular casts,UA,#/area; Cast; Gran Casts; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Gran Casts #/area UrnS LPF,/LPF,Granular casts [#/area] in Urine sediment by Microscopy low power field,/[LPF],Granular casts LM.LPF (Urine sed) [#/Area]
42719-5,Bilirubin,CHEM,Bili; Bilirubins; Billirubin; Blood; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TBIL; WB; Whole blood,Bilirub Bld-mCnc,mg/dL,Bilirubin.total [Mass/volume] in Blood,mg/dL,Bilirubin (Bld) [Mass/Vol]
721-1,Hemoglobin.free,HEM/BC,FR; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Free; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders,Hgb Free Plas-mCnc,mg/L,Free Hemoglobin [Mass/volume] in Plasma,mg/L,Free Hemoglobin (P) [Mass/Vol]
53962-7,Alpha-1-Fetoprotein.tumor marker,CHEM,A1; AFP; AFP-TM; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; Feto; i; Level; Mark; Mass concentration; Oncology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,AFP-TM SerPl-mCnc,ug/L;ng/mL,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,ng/mL,AFP.tumor marker [Mass/Vol]
1557-8,Glucose^post CFst,CHAL,After; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Fast; Fasting; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p fast; PC; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Venous,Glucose p fast BldV-mCnc,mg/dL,Fasting glucose [Mass/volume] in Venous blood,mg/dL,Glucose post fast (BldV) [Mass/Vol]
8336-0,Body weight,BDYWGT.MOLEC,Bdy weight; bod; Bodies; BODY WEIGHT.MOLEC; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt,Bdy weight Prctl Per Age,%,Body weight [Percentile] Per age,%,
38917-1,Human metapneumovirus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; hMPV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,hMPV RNA Spec Ql NAA+probe,,Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection,,hMPV RNA NAA+probe Ql (Specimen)
31545-7,Nuclear Ab.IgG,SERO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR,Nuclear IgG Ser Ql,,Nuclear IgG Ab [Presence] in Serum,,Nuclear IgG Ql (S)
29909-9,Parainfluenza virus 2 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV2; Human rubulavirus 2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PCR; PI2; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HPIV2 RNA Spec Ql NAA+probe,,Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection,,Parainfluenza virus 2 RNA NAA+probe Ql (Specimen)
2236-8,Calciferol,CHEM,Activated ergosterol; C28H43OH; Chemistry; Ercalciol; Ergocalciferol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pro vitamin D; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Viosterol; Vit D 1 25 hydroxy; Vit D2; Vitamin D2,Vitamin D2 SerPl-mCnc,pg/mL,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,pg/mL,Vitamin D2 [Mass/Vol]
19644-4,oxyCODONE cutoff,DRUG/TOX,CtO; DRUG/TOXICOLOGY; Drugs; Level; Lortab; Mass concentration; OxyContin; Percocet; Percodan; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn; Vicodin,oxyCODONE CtO Ur Scn-mCnc,ng/mL,oxyCODONE cutoff [Mass/volume] in Urine for Screen method,ng/mL,oxyCODONE cutoff Screen (U) [Mass/Vol]
14334-7,Lithium,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Eskalith; Level; Li; Lithane; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Lithium SerPl-sCnc,mmol/L; mEq/L,Lithium [Moles/volume] in Serum or Plasma,mmol/L,Lithium [Moles/Vol]
71833-8,Erythrocyte/Blood,HEM/BC,Auto; Automated detection; Blood; Discocyte; Elec; Elect; Electr; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,Hct VFr.DF Bld Auto,,Hematocrit [Pure volume fraction] of Blood by Automated count,,Hematocrit Auto (Bld) [Pure volume fraction]
26513-2,Neutrophils/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Neutrophils NFr Fld,%,Neutrophils/Leukocytes in Body fluid,%,Neutrophils/Leukocytes (Body fld)
20966-8,Staphylococcus sp,MICRO,C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; species; spp; Staph; To be specified in another part of the message; Unspecified,Staphylococcus Spec Cult,,Staphylococcus sp identified in Specimen by Organism specific culture,,Staphylococcus sp identified Org specific cx Nom (Specimen)
68380-5,Chromatin Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Chromatin Ab SerPl Ql,,Chromatin Ab [Presence] in Serum or Plasma,,Chromatin Ab Ql
29910-7,Parainfluenza virus 3 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HPIV3 RNA Spec Ql NAA+probe,,Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection,,Parainfluenza virus 3 RNA NAA+probe Ql (Specimen)
61037-8,Alpha hydroxyalprazolam,DRUG/TOX,Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; DRUG/TOXICOLOGY; Drugs; Hydroxy alprazolam; Hydroxyalpraz; Misc; Miscellaneous; OH-Alpraz; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified,A-OH Alpraz Spec Ql,,Alpha hydroxyalprazolam [Presence] in Specimen,,Alpha hydroxyalprazolam Ql (Specimen)
32218-0,Cyclic citrullinated peptide Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; cCP; CCP3; Cyclic Citrulinated Peptide; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatoid arthritis; Rheumatology; Serology; Serum; SR; SUDS; UniversalLabOrders,cCP Ab Ser IA-aCnc,arb U/mL,Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,Cyclic citrullinated peptide Ab IA Qn (S)
29908-1,Parainfluenza virus 1 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HPIV1 RNA Spec Ql NAA+probe,,Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection,,Parainfluenza virus 1 RNA NAA+probe Ql (Specimen)
16235-4,Methamphetamine,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Methamphet; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Methamphet Ur Cfm-mCnc,ug/mL,Methamphetamine [Mass/volume] in Urine by Confirmatory method,ug/mL,Methamphetamine Confirm (U) [Mass/Vol]
19312-8,Tricyclic antidepressants,DRUG/TOX,Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; TCA; Tricyclics; UA; UniversalLabOrders; UR; Urn,Tricyclics Ur Ql Scn,,Tricyclic antidepressants [Presence] in Urine by Screen method,,Tricyclic antidepressants Screen Ql (U)
29257-3,Mycoplasma pneumoniae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enzootic pneumonia; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M pneumo; M pneumonia; M pneumoniae; Microbiology; Misc; Miscellaneous; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified,M pneumo DNA Spec Ql NAA+probe,,Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection,,M. pneumoniae DNA NAA+probe Ql (Specimen)
53797-7,Neutrophils.immature/Leukocytes,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Imm; Immat; Leuc; Leuk; Leukocyte; Lkcs; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Neutrophils.immature NFr Bld,%,Neutrophils.immature/Leukocytes in Blood,%,Neutrophils.immature/Leukocytes (Bld)
10535-3,Digoxin,DRUG/TOX,Cardio; Cardiology; DGXN; DRUG/TOXICOLOGY; Drugs; Heart Disease; Lanoxin; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Digoxin SerPl-mCnc,ng/mL,Digoxin [Mass/volume] in Serum or Plasma,ng/mL,Digoxin [Mass/Vol]
18396-2,HIV 1 p24 Ag,MICRO,AIDS; Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; HIV type 1; HIV type I; HIV1; HIV1 p24; Human immunodeficiency virus; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS,HIV1 p24 Ag SerPl Ql IA,,HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay,,HIV 1 p24 Ag IA Ql
18500-9,Observation,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Genital tract; Gyn; Gynecology; Identity or presence; Nominal; OB; ObGyn; Obstetrics; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn; UniversalLabOrders,Thin Prep Cvx,,Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep,,Microscopic observation Cyto stain.thin prep Nom (Cvx)
72493-0,Cytomegalovirus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load,CMV DNA SerPl NAA+probe-aCnc,IU/mL,Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,[IU]/mL,CMV DNA NAA+probe Qn
31592-9,Ribosomal P Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Ribosomal P Protein; Rib-P; RPP; Screen; Serology; Serum; SR,Ribosomal P Ab Ser Ql,,Ribosomal P Ab [Presence] in Serum,,Ribosomal P Ab Ql (S)
8092-9,SCL-70 extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; DNA-Topoisomerase I; ENA; ENA Scl70; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scleroderma; Scleroderma ab; Screen; Serology; Serum; SR; Topo I; Topoisomerase I,ENA Scl70 Ab Ser Ql,,SCL-70 extractable nuclear Ab [Presence] in Serum,,SCL-70 extractable nuclear Ab Ql (S)
524-9,Vancomycin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c162; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; VANC; Vancocin; Vancor,Vancomycin Islt MIC,,Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC),,Vancomycin MIC [Susc]
5782-8,Crystals,UA,Crys; Cryst; Crystal; Identity or presence; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Nominal; Point in time; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Crystals UrnS Micro,,Crystals [type] in Urine sediment by Light microscopy,,Crystals LM Nom (Urine sed)
31843-6,Helicobacter pylori Ag,MICRO,Antigen; Antigens; Bowel movement; C pylori; Campylobacter pylori; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; H pyl; H pylori; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; UniversalLabOrders,H pylori Ag Stl Ql,,Helicobacter pylori Ag [Presence] in Stool,,H. pylori Ag Ql (Stl)
8076-2,Jo-1 extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA Jo1; Histidyl-tRNA synthease; i; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR,ENA Jo1 Ab Ser Ql,,Jo-1 extractable nuclear Ab [Presence] in Serum,,Jo-1 extractable nuclear Ab Ql (S)
22322-2,Hepatitis B virus surface Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBsAg; Autoantibodies; Autoantibody; HBs; HBsAB; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Surf; UniversalLabOrders,HBV surface Ab Ser Ql,,Hepatitis B virus surface Ab [Presence] in Serum,,HBV surface Ab Ql (S)
57735-3,Protein,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Kidney; Nephrology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urn,Prot Ur Ql Strip.auto,,Protein [Presence] in Urine by Automated test strip,,Protein Auto test strip Ql (U)
57734-6,Ketones,UA,Acetest; Acetoacetate; Acetoacetates; Acetone bodies; Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Ketone; Ketone bodies; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Ketones Ur Ql Strip.auto,,Ketones [Presence] in Urine by Automated test strip,,Ketones Auto test strip Ql (U)
33220-5,Transitional cells,UA,#/area; Artificial Intelligence; Automated detection; Cell; Cellularity; Comp Assist; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Trans Cells; UA; UR; URINALYSIS; Urn,Trans Cells #/area Ur Comp Assist,/HPF,Transitional cells [#/area] in Urine by Computer assisted method,/[HPF],Transitional cells Computer assisted (U) [#/Area]
3182-3,Cardiolipin Ab.IgM,COAG,ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Arbitrary concentration; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,Cardiolipin IgM Ser IA-aCnc,MPL U,Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay,[MPL'U],Cardiolipin IgM IA Qn (S)
42810-2,Hemoglobin,HEM/BC,CHr; Entitic mass; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Reticulocyte hemoglobin content,Hgb Retic Qn,pg,Hemoglobin [Entitic mass] in Reticulocytes,pg,Hemoglobin (Reticulocytes) [Entitic mass]
13658-0,Urobilinogen,CHEM,Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UBG; UR; Urn; Urobili; Urobilngn,Urobilinogen Ur Ql,,Urobilinogen [Presence] in Urine,,Urobilinogen Ql (U)
16251-1,Morphine,DRUG/TOX,Addiction; c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Morphine sulfate; MS; MSO4; OMPH; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,Morphine Ur Cfm-mCnc,ng/mL,Morphine [Mass/volume] in Urine by Confirmatory method,ng/mL,Morphine Confirm (U) [Mass/Vol]
1007-4,Direct antiglobulin test.polyspecific reagent,BLDBK,Antiglob; BLOOD BANK; DAGT; DAT; DAT Poly-Sp Reag; DCT; Dir; Direct antiglobulin test.non specific reagent; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Ordinal; Point in time; poly specific; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; UniversalLabOrders,DAT Poly-Sp Reag RBC Ql,,Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells,,Direct antiglobulin test.polyspecific reagent Ql (RBC)
41010-0,Parainfluenza virus 4 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HPIV4 RNA Spec Ql NAA+probe,,Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection,,Parainfluenza virus 4 RNA NAA+probe Ql (Specimen)
14725-6,Observation,SPEC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Nominal; Point in time; Random; SPEC; Typ",Body fld type,,[Type] of Body fluid,,Observation Nom (Body fld)
2889-4,Protein,CHEM,1 day; 24 hours; 24HR; Chemistry; Kidney; Mass Rate; mRate; Nephrology; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; UA; UniversalLabOrders; UR; Urn,Prot 24h Ur-mRate,g/24 H,Protein [Mass/time] in 24 hour Urine,g/(24.h),Protein (24H U) [Mass/Time]
5000-5,Cytomegalovirus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified,CMV DNA Spec Ql NAA+probe,,Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection,,CMV DNA NAA+probe Ql (Specimen)
3415-7,Buprenorphine,DRUG/TOX,Addiction; BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; Illicit; Level; Mass concentration; Norspan; Point in time; PotentialForAbuse; Prefin; QNT; Quan; Quant; Quantitative; Random; Suboxone; Subutex; Temgesic; UA; UR; Urn,Buprenorphine Ur-mCnc,ng/mL,Buprenorphine [Mass/volume] in Urine,ng/mL,Buprenorphine (U) [Mass/Vol]
12454-5,Urate crystals.amorphous,UA,AM; Amorph; Amorph Cry; Amorph Urate Cry; Amorphic; Crys; Cryst; Crystal; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; Urates; Uric acid; URINALYSIS; Urine sediment; Urn; UrnS,Amorph Urate Cry UrnS Ql Micro,,Urate crystals amorphous [Presence] in Urine sediment by Light microscopy,,Urate crystals amorphous LM Ql (Urine sed)
23826-1,Bordetella pertussis DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Whooping cough,B pert DNA Spec Ql NAA+probe,,Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection,,B. pertussis DNA NAA+probe Ql (Specimen)
19762-4,General categories,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Gen Categ; Genital tract; Genital vaginal; Gyn; Gynecology; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; OB; ObGyn; Obstetrics; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn; Vag fld; Vag fluid; Vagina; Vaginal fluid,Gen Categ Cvx/Vag Cyto-Imp,,General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain,,General categories Cyto stain (Cvx/Vag) [Interp]
31112-6,Reticulocytes/Erythrocytes,HEM/BC,Blood; Discocytes; Erthrocyte; Erythrocyte; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Manl; Number fraction; Percent; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Retic; Retics; Reticulocyte; WB; Whole blood,Retics/RBC NFr Manual,%,Reticulocytes/Erythrocytes in Blood by Manual,%,Reticulocytes/Erythrocytes Manual (Bld)
2078-4,Chloride,CHEM,Chemistry; Cl; Cl-; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UniversalLabOrders; UR; Urn,Chloride Ur-sCnc,mmol/L,Chloride [Moles/volume] in Urine,mmol/L,Chloride (U) [Moles/Vol]
30079-8,Renal tubular casts,UA,#/area; Cast; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Renal Tub Casts; UA; UR; URINALYSIS; Urn,Renal Tub Casts #/area Ur Micro,/LPF,Renal tubular casts [#/area] in Urine by Light microscopy,/[LPF],Renal tubular casts LM (U) [#/Area]
1952-1,Beta-2-Microglobulin,CHEM,B; B2 Microglob; b2-M; Chemistry; Hematology; Heme; II; Level; Mass concentration; Microglob; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,B2 Microglob SerPl-mCnc,mg/L;mcg/mL; ng/mL,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma,mg/L;ug/mL,Beta-2-Microglobulin [Mass/Vol]
46986-6,Cholesterol.in VLDL 3,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; III; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Very low density lipoprotein cholesterols; VLDL3c; VLDLc,VLDL3c SerPl-mCnc,mg/dL,Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma,mg/dL,Cholesterol in VLDL 3 [Mass/Vol]
13941-0,Lymphocytes/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Lymphocytes NFr Fld Manual,%,Lymphocytes/Leukocytes in Body fluid by Manual count,%,Lymphocytes/Leukocytes Manual cnt (Body fld)
48344-6,Activated clotting time.kaolin induced,COAG,ACT; ACT Kaolin Ind; Activ; Activated coagulation time; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation assay; Coagulation time; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; Tilt tube; UniversalLabOrders,ACT Kaolin Ind PPP,s,Activated clotting time.kaolin induced of Platelet poor plasma,s,Activated clotting time.kaolin induced Coag (PPP)
34645-2,Chlamydophila pneumoniae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Twar agent; Unspecified,C pneum DNA Spec Ql NAA+probe,,Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection,,C. pneumoniae DNA NAA+probe Ql (Specimen)
1823-4,Alpha tocopherol,CHEM,Alfa; A-Tocopherol Vit E; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tocopherols; UniversalLabOrders; Vit E; Vitamin E,A-Tocopherol Vit E SerPl-mCnc,mcg/mL; mg/dL,Alpha tocopherol [Mass/volume] in Serum or Plasma,mg/L;mg/dL,Alpha tocopherol [Mass/Vol]
32019-2,Hepatitis B virus surface Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBsAg; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); HBs; HBsAB; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; HepB; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Surf; Titer; Titered; Titre; Ttr,HBV surface Ab Titr Ser,titer,Hepatitis B virus surface Ab [Titer] in Serum,{titer},HBV surface Ab (S) [Titer]
24027-5,Streptococcus pneumoniae Ag,MICRO,Antigen; Antigens; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; Screen; Spn; Strep; Strept; UA; UniversalLabOrders; UR; Urn,S pneum Ag Ur Ql,,Streptococcus pneumoniae Ag [Presence] in Urine,,S. pneumoniae Ag Ql (U)
19429-0,Propoxyphene,DRUG/TOX,Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Napsalgesic; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn,Propoxyph Ur Ql Scn,,Propoxyphene [Presence] in Urine by Screen method,,Propoxyphene Screen Ql (U)
47000-5,Candida sp rRNA,MICRO,Cand; Candidiasis; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; Monilia; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; species; spp; Thrush; UniversalLabOrders; Vag fld; Vag fluid; Vagina; Vaginal fluid,Candida rRNA Vag Ql Probe,,Candida sp rRNA [Presence] in Vaginal fluid by Probe,,Candida sp rRNA Probe Ql (Vag fld)
16998-7,HYDROmorphone,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydromorphinone; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,HYDROmorphone Ur Cfm-mCnc,ug/mL,HYDROmorphone [Mass/volume] in Urine by Confirmatory method,ug/mL,HYDROmorphone Confirm (U) [Mass/Vol]
45194-8,Choriogonadotropin.intact+Beta subunit,CHEM,Arbitrary concentration; B; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; Chorionic gonadotropin.intact; HCG; HCG Intact; HCG Intact+B; Human chorionic gonadotropin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,HCG Intact+B SerPl-aCnc,mIU/mL,Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma,m[IU]/mL,HCG.intact+Beta subunit Qn
16137-2,Centromere Ab,SERO,ABS; Aby; ACA; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cen; CRST syndrome; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR,Centromere Ab Ser Ql,,Centromere Ab [Presence] in Serum,,Centromere Ab Ql (S)
55805-6,cycloSPORINE,DRUG/TOX,Blood; Ciclosporin; Ciclosporine; CsA; Cyclosporin a; Cyclosporins; DRUG/TOXICOLOGY; Drugs; Gengraf; Level; Mass concentration; Neoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Restasis; Sandimmune; SangCya; WB; Whole blood,cycloSPORINE Bld LC/MS/MS-mCnc,ug/L,cycloSPORINE [Mass/volume] in Blood by LC/MS/MS,ug/L,cycloSPORINE LC/MS/MS (Bld) [Mass/Vol]
49524-2,Influenza virus A H3 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H3; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,FLUAV H3 RNA Spec Ql NAA+probe,,Influenza virus A H3 RNA [Presence] in Specimen by NAA with probe detection,,FLUAV H3 RNA NAA+probe Ql (Specimen)
14869-2,Pathologist review,BLDBK,Blood; BLOOD BANK; cmmt; cmnt; Com; Comm; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Path; Path Cmnt; Path Rev; Point in time; Random; UniversalLabOrders; WB; Whole blood,Path Rev Bld -Imp,,Pathologist review of Blood tests,,Pathologist review (Bld) [Interp]
10385-3,Albumin concentration given,BLDBK,Alb; BLOOD BANK; Gvn; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Typ,Albumin Conc Gvn,,Albumin concentration given,%,Albumin concentration given [Type]
28153-5,Chronic pain,SURVEY.NURSE.HHCC,Clinical Care Classification; Finding; Findings; nursing; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NURSING.HHCC,,,Chronic pain [CCC],,
61425-5,Noroxycodone,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Noroxycodone Ur Cfm-mCnc,ng/mL,Noroxycodone [Mass/volume] in Urine by Confirmatory method,ng/mL,Noroxycodone Confirm (U) [Mass/Vol]
1761-6,Aldolase,CHEM,Catalytic Concentration; Chemistry; Fructose Aldolase; Fructose Biphosphate Aldolase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Aldolase SerPl-cCnc,mU/mL; units/L,Aldolase [Enzymatic activity/volume] in Serum or Plasma,U/L;mU/mL,Aldolase [Catalytic activity/Vol]
46128-5,Tissue transglutaminase Ab.IgA,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; EIA; ELFA; ELISA; Enzyme immunoassay; Fibrin stabilizing factor; Gastro; Gastroenterology; GI; IAA; Immune globulin A; Immunoglobulin A; MEIA; Point in time; Protein-glutamine gamma glutamyltransferase; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; TG2; tTG; UniversalLabOrders,tTG IgA Ser IA-aCnc,,Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,tTG IgA IA Qn (S)
63922-9,Are you considering quitting smoking during the next 6Mo,PHENX,Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Quit smoking consider; Random; Screen,Quit smoking consider PLCO,,Are you considering quitting smoking during the next 6 months [PLCO],,
26454-9,Erythrocytes,HEM/BC,#; ABS; absolute; absolutes; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid,RBC # CSF,10*3/uL,Erythrocytes [#/volume] in Cerebral spinal fluid,10*3/uL,RBC (CSF) [#/Vol]
6875-9,Cancer Ag 15-3,CHEM,Arbitrary concentration; CA; CA 153; CA 15-3; Cancer Ag15-3; Carbohydrate antigen; Chemistry; III; MUC-1 gene associated AG CA 15-3; Oncology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,Cancer Ag15-3 SerPl-aCnc,arb U/mL,Cancer Ag 15-3 [Units/volume] in Serum or Plasma,[arb'U];[arb'U]/mL,Cancer Ag 15-3 Qn
76078-5,Influenza virus A RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,FLUAV RNA Nph Ql NAA+probe,,Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection,,FLUAV RNA NAA+probe Ql (Nph)
55465-9,Influenza virus A H1 2009 pandemic RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUV; Fowl plague; H1N1; H1N1v; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; S-OIV; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,FLUAV H1 2009 pand RNA Spec Ql NAA+probe,,Influenza virus A H1 2009 pandemic RNA [Presence] in Specimen by NAA with probe detection,,FLUAV H1 2009 pand RNA NAA+probe Ql (Specimen)
19554-5,Methamphetamine,DRUG/TOX,Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Methamphet; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn,Methamphet Ur Ql Scn,,Methamphetamine [Presence] in Urine by Screen method,,Methamphetamine Screen Ql (U)
35384-7,Estradiol,CHEM,17-beta estradiol; Chemistry; E2; Gyn; Gynecology; HS; Level; Mass concentration; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Estradiol SerPl HS-mCnc,pg/mL,Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method,pg/mL,E2 High sensitivity method [Mass/Vol]
10701-1,Ova & parasites,MICRO,Bowel movement; Cnc; Conc; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; O&P; O+P; Ova and parasite; Ovum; Parasite; Point in time; Random; Stl; Stool = Fecal; UniversalLabOrders,O+P Stl Conc,,Ova and parasites identified in Stool by Concentration,,Ova and parasites identified Concentration Nom (Stl)
47419-7,Varicella zoster virus Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shingles; SR; SUDS; VZ; VZV; Zoster,VZV Ab Ser IA-aCnc,,Varicella zoster virus Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,VZV Ab IA Qn (S)
18948-0,Minocycline,ABXBACT,Aknemin; ANTIBIOTIC SUSCEPTIBILITIES; AST; c128; Dentomycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klinomysin; Lederderm; Mestacine; Mino-50; Minocin; Minomycin; Mynocine; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Minocycline Susc Islt,,Minocycline [Susceptibility],,Minocycline [Susc]
48797-5,Organic acids panel,PANEL.CHEM,Acd; Acid; Chemistry; Organic Acids Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; UA; UR; Urn,Organic Acids Pnl Ur,,Organic acids panel - Urine,,Organic acids panel (U)
8116-6,Cells.CD19,CELLMARK,#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; HD-37; Leu12; Leu-12; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,CD19 Cells # Bld,10*9/L,CD19 cells [#/volume] in Blood,/uL,CD19 cells (Bld) [#/Vol]
17395-5,oxyMORphone,DRUG/TOX,14-Hydroxydihydromorphinone; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Numorphan; Numorphone; Opana; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,oxyMORphone Ur Cfm-mCnc,ng/mL,oxyMORphone [Mass/volume] in Urine by Confirmatory method,ng/mL,oxyMORphone Confirm (U) [Mass/Vol]
5631-7,Copper,DRUG/TOX,Cu; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Copper SerPl-mCnc,mcg/dL; ng/mL,Copper [Mass/volume] in Serum or Plasma,ug/dL,Copper [Mass/Vol]
16249-5,oxyCODONE,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Lortab; Mass concentration; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn; Vicodin,oxyCODONE Ur Cfm-mCnc,ng/mL,oxyCODONE [Mass/volume] in Urine by Confirmatory method,ng/mL,oxyCODONE Confirm (U) [Mass/Vol]
3520-4,cycloSPORINE,DRUG/TOX,Blood; Ciclosporin; Ciclosporine; CsA; Cyclosporin a; Cyclosporins; DRUG/TOXICOLOGY; Drugs; Gengraf; Level; Mass concentration; Neoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Restasis; Sandimmune; SangCya; UniversalLabOrders; WB; Whole blood,cycloSPORINE Bld-mCnc,ug/L;ng/mL,cycloSPORINE [Mass/volume] in Blood,ng/mL,cycloSPORINE (Bld) [Mass/Vol]
70145-8,Cannabinoids,DRUG/TOX,Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Nasogastric; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;50 ng/mL; Scr; Screen; Scrn; THC; UA; UniversalLabOrders; UR; Urn,Cannabinoids Ur Ql Scn>50 ng/mL,,Cannabinoids [Presence] in Urine by Screen method >50 ng/mL,,Cannabinoids Screen method >50 ng/mL Ql (U)
49521-8,Influenza virus A H1 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,FLUAV H1 RNA Spec Ql NAA+probe,,Influenza virus A H1 RNA [Presence] in Specimen by NAA with probe detection,,FLUAV H1 RNA NAA+probe Ql (Specimen)
13317-3,Staphylococcus aureus.methicillin resistant isolate,MICRO,C&S; Celbenin; Cult; Cultures; Dimethoxypenicillin; ID; Infectious Disease; InfectiousDisease; Metacillin; Metin; Microbiology; Misc; Miscellaneous; MRSA; MRSA screen; o71; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; S aureus; Screen; Spec; Staficyn; Staph; Staphicillin; To be specified in another part of the message; UniversalLabOrders; Unspecified,MRSA Spec Ql Cult,,Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture,,MRSA isol Org specific cx Ql (Specimen)
1763-2,Aldosterone,CHEM,Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Aldost SerPl-mCnc,ng/dL,Aldosterone [Mass/volume] in Serum or Plasma,ng/dL,Aldosterone [Mass/Vol]
15192-8,Lymphocytes.variant,HEM/BC,Atypical lymphocytes; Auto; Automated detection; Blood; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reactive lymphocytes; Screen; Variant lymphocytes; Variant Lymphs; WB; Whole blood,Variant Lymphs Bld Ql Auto,,Variant lymphocytes [Presence] in Blood by Automated count,,Variant lymphocytes Auto Ql (Bld)
70151-6,Opiates,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; Nasogastric; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;300 ng/mL; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn,Opiates Ur Ql Scn>300 ng/mL,,Opiates [Presence] in Urine by Screen method >300 ng/mL,,Opiates Screen method >300 ng/mL Ql (U)
44-8,Aztreonam,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Azactam; Azaj; azthreonam; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Aztreonam Islt MIC,ug/mL,Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC),ug/mL,Aztreonam MIC [Susc]
58744-4,Multisection,RAD,Cardiac; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Hrt; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax,CT Hrt,,CT Heart,,
70141-7,Benzodiazepines,DRUG/TOX,Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Nasogastric; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;200 ng/mL; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn,Benzodiaz Ur Ql Scn>200 ng/mL,,Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL,,Benzodiazepines Screen method >200 ng/mL Ql (U)
6410-5,Gardnerella vaginalis rRNA,MICRO,DNA NUCLEIC ACID PROBE; DNA probe; G vaginalis; Gen; Genital tract; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; UniversalLabOrders; Urogenit; Urogenital,G vaginalis rRNA Genital Ql Probe,,Gardnerella vaginalis rRNA [Presence] in Genital specimen by Probe,,G. vaginalis rRNA Probe Ql (Genital specimen)
51838-1,Treponema pallidum Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; Syphilis; T pallidum; Treponemal,T pallidum IgG Ser IA-aCnc,,Treponema pallidum IgG Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,T. pallidum IgG IA Qn (S)
76184-1,Carbon dioxide,PULM,Art; Carbonic anhydride; Cardio; Cardiology; CO2; Heart Disease; Lung; PA; Partial pressure; PCO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory,pCO2 PA,mm Hg,Carbon dioxide [Partial pressure] in Pulmonary artery,mm[Hg],
50595-8,Pathologist interpretation,PATH,Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Misc; Miscellaneous; Nominal; Other; Path; Path Interp; PATHOLOGY; Point in time; Random; Spec; To be specified in another part of the message; Unspecified,Path Interp Spec-Imp,,Pathologist interpretation of Specimen tests,,Pathologist interpretation (Specimen) [Interp]
47383-5,Nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; UniversalLabOrders,ANA Ser Ql IA,,Nuclear Ab [Presence] in Serum by Immunoassay,,Nuclear Ab IA Ql (S)
49753-7,Norbuprenorphine,DRUG/TOX,Addiction; Buprenorphine metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; NBU; norBUP; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Norbuprenorphine Ur-mCnc,ng/mL,Norbuprenorphine [Mass/volume] in Urine,ng/mL,Norbuprenorphine (U) [Mass/Vol]
22592-0,Treponema pallidum Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Syphilis; T pallidum; Treponemal,T pallidum IgG Ser-aCnc,,Treponema pallidum IgG Ab [Units/volume] in Serum,[arb'U]/mL,T. pallidum IgG Qn (S)
30089-7,Transitional cells,UA,#/area; Cell; Cellularity; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Trans Cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Trans Cells #/area UrnS HPF,/HPF,Transitional cells [#/area] in Urine sediment by Microscopy high power field,/[HPF],Transitional cells LM.HPF (Urine sed) [#/Area]
6206-7,Arachis hypogaea Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f013; f13; Immune globulin E; Immunoglobulin E; Peanut; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Peanut IgE Qn,kIU/L; kU/L,Peanut IgE Ab [Units/volume] in Serum,k[IU]/L,Peanut IgE Qn (S)
3271-4,Heparin.low molecular weight,COAG,Anti-Xa; Arbitrary concentration; Chromogenic assay; Clexane; COAGULATION; Enoxaparin; ENZY; Enzymatic assay; Hematology; Heme; Hep; Hepar; Heparn; LMWH; Lovenox; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt,LMWH PPP Chro-aCnc,arb U/mL,LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic method,[arb'U]/mL,LMW Heparin Chromogenic method Qn (PPP)
44448-9,Beta 2 glycoprotein 1 Ab.IgG,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; APOH; Apolipoprotein H; Arbitrary concentration; Autoantibodies; Autoantibody; B; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; IAA; II; Immune globulin G; Immunoglobulin G; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,B2 Glycoprot1 IgG SerPl IA-aCnc,arb U/mL,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,[arb'U]/mL,Beta 2 glycoprotein 1 IgG IA Qn
29723-4,Bordetella parapertussis DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B parapert; B parapertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Whooping cough,B parapert DNA Spec Ql NAA+probe,,Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection,,B. parapertussis DNA NAA+probe Ql (Specimen)
20438-8,Glucose^1H post dose glucose,CHAL.ROUTINE,1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Glucose 1h p Glc SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose,mg/dL,Glucose 1 Hr post dose glucose [Mass/Vol]
38445-3,Calprotectin,CHEM,Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Inflammatory Bowel Disease; Mass content; MRP8/14; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheumatoid arthritis; S100A8/A9; Stl; Stool = Fecal; UniversalLabOrders,Calprotectin Stl-mCnt,ug/g,Calprotectin [Mass/mass] in Stool,ug/g,Calprotectin (Stl) [Mass/Mass]
3091-6,Urea,CHEM,Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Urea SerPl-mCnc,mg/dL,Urea [Mass/volume] in Serum or Plasma,mg/dL,Urea [Mass/Vol]
626-2,Bacteria,MICRO,Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Throat; UniversalLabOrders; Upper respiratory,Bacteria Throat Cult,,Bacteria identified in Throat by Culture,,Bacteria identified Cx Nom (Throat)
44449-7,Beta 2 glycoprotein 1 Ab.IgM,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; APOH; Apolipoprotein H; Arbitrary concentration; Autoantibodies; Autoantibody; B; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; IAA; II; Immune globulin M; Immunoglobulin M; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,B2 Glycoprot1 IgM SerPl IA-aCnc,arb U/mL,Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay,[arb'U]/mL,Beta 2 glycoprotein 1 IgM IA Qn
49300-7,Protein pattern,CHEM,Chemistry; Hematology; Heme; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Narrative; Nephrology; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Renal; Report; UA; UR; Urn,Prot Pattern Ur IFE-Imp,,Protein Fractions [Interpretation] in Urine by Immunofixation Narrative,,Protein Fractions Immunofixation Nar (U) [Interp]
2484-4,Insulin-like growth factor-I,CHEM,Chemistry; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; SR; Ultralente; UniversalLabOrders,IGF-I SerPl-mCnc,ug/L;ng/mL,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma,ng/mL,Insulin-like growth factor-I [Mass/Vol]
13964-2,Methylmalonate,CHEM,Chemistry; Level; Methylmalonic acid; Methylmalonic Acidemia; MMA; Pl; Plasma; Plsm; Point in time; Propionic acidemia; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Methylmalonate SerPl-sCnc,umol/L;mcmol/L; nmol/L,Methylmalonate [Moles/volume] in Serum or Plasma,nmol/L;umol/L,Methylmalonate [Moles/Vol]
17780-8,Helicobacter pylori Ag,MICRO,Antigen; Antigens; Bowel movement; C pylori; Campylobacter pylori; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; H pyl; H pylori; IAA; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS; UniversalLabOrders,H pylori Ag Stl Ql IA,,Helicobacter pylori Ag [Presence] in Stool by Immunoassay,,H. pylori Ag IA Ql (Stl)
17088-6,LORazepam,DRUG/TOX,Addiction; Ativan; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,LORazepam Ur Cfm-mCnc,ng/mL,LORazepam [Mass/volume] in Urine by Confirmatory method,ng/mL,LORazepam Confirm (U) [Mass/Vol]
69739-1,Drugs of abuse panel,PANEL.DRUG/TOX,DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn,Drugs of abuse Pnl Ur Scn,,Drugs of abuse panel - Urine by Screen method,,Drugs of abuse panel Screen (U)
3181-5,Cardiolipin Ab.IgG,COAG,ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Arbitrary concentration; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,Cardiolipin IgG Ser IA-aCnc,GPL U,Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay,[GPL'U],Cardiolipin IgG IA Qn (S)
102969-3,Allergen.miscellaneous Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alrgen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Misc Allergen; Misc allergen IgE; Point in time; PR; Radioallergosorbent test; Random; Serum; SmQn; SR,Misc Allergen IgE RAST,,Miscellaneous allergen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST),,Miscellaneous allergen IgE RAST (S) [Presence]
9269-2,Glasgow coma score.total,FUNCTION,FCN; Func; Funct; Function; GCS total; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl,GCS total,score,Glasgow coma score total,{score},
61422-2,Norhydrocodone,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydrocodone metabolite; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Norhydrocodone Ur Cfm-mCnc,ng/mL,Norhydrocodone [Mass/volume] in Urine by Confirmatory method,ng/mL,Norhydrocodone Confirm (U) [Mass/Vol]
16252-9,HYDROcodone,DRUG/TOX,Addiction; Anexsia; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vicodin,HYDROcodone Ur Cfm-mCnc,ug/mL,HYDROcodone [Mass/volume] in Urine by Confirmatory method,ug/mL,HYDROcodone Confirm (U) [Mass/Vol]
24339-4,Gas panel,PANEL.CHEM,BGas; Bld ven; Bld venous; Blood - venous; Blood gas; Blood gas ven; Blood gases; Blood ven; Blood venus; Chemistry; Gas Pnl; Gases; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous,Gas Pnl BldV,,Gas panel - Venous blood,,Gas panel (BldV)
5157-3,Epstein Barr virus capsid Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CAP; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders; VCA; Viral capsid,EBV VCA IgG Ser IA-aCnc,,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,EBV capsid IgG IA Qn (S)
601-5,Fungus,MICRO,Blood; C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders; WB; Whole blood,Fungus Bld Cult,,Fungus identified in Blood by Culture,,Fungus identified Cx Nom (Bld)
6303-2,Coagulation dilute Russell viper venom induced,COAG,Clot; Clottable; Coag; Coagulation assay; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube; UniversalLabOrders,Screen dRVVT,s,dRVVT (LA screen),s,dRVVT Coag (PPP) [Time]
5159-9,Epstein Barr virus capsid Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CAP; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders; VCA; Viral capsid,EBV VCA IgM Ser IA-aCnc,,Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay,{Index_val},EBV capsid IgM IA Qn (S)
46547-6,Surgical wound,SURVEY.OASIS,Finding; Findings; Ordinal; Outcome and assessment information set; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Survey; Survey.OASIS,,,Surgical wound [OASIS],,
2009-9,Cancer Ag 19-9,CHEM,CA; CA 19-9; Cancer Ag19-9; Cancer antigen 19-9; Carbohydrate antigen; Carbohydrate antigen 19-9; Chemistry; Oncology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker,Cancer Ag19-9 SerPl Ql,,Cancer Ag 19-9 [Presence] in Serum or Plasma,,Cancer Ag 19-9 Ql
19774-9,Cytology study comment,CYTO,AOEObservation; Cervix; cmmt; cmnt; Com; Comm; Comments; Commt; Cytology Cmnt; Cytology stain; Cytostain; Genital tract; Genital vaginal; Gyn; Gynecology; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; OB; ObGyn; Obstetrics; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; Remarks; Report; St; Stains; Stn; Study report; Vag fld; Vag fluid; Vagina; Vaginal fluid,Cytology Cmnt Cvx/Vag Cyto-Imp,,Cytology study comment Cervical or vaginal smear or scraping Cyto stain,,Cytology study comment Cyto stain Nar (Cvx/Vag) [Interp]
35275-7,Measles virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; MeV; Microbiology; Msls; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rubeola; Screen; Serum; SR; SUDS; UniversalLabOrders,MeV IgG Ser Ql IA,,Measles virus IgG Ab [Presence] in Serum by Immunoassay,,MeV IgG IA Ql (S)
3209-4,Coagulation factor VIII activity actual/Normal,COAG,Act/Nor; Activ; Actvty; AHF; AHG; Antihemophilic factor; Antihemophilic globulin; Circulating anticoagulant; Clot; Clottable; Coag; Coagulation assay; Control; F8; Fac; Fact; Fact VIII; Factor 8; Factor VIII clotting activity; FVIII; Hematology; Heme; Movements; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; RlTm; Thrombocyte cofactor A; Tilt tube; UniversalLabOrders; VIII:C,Fact VIII Act/Nor PPP,%,Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay,%,Coagulation factor VIII activity actual/normal Coag (PPP) [Relative time]
16250-3,Codeine,DRUG/TOX,Addiction; c260; C300; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Methylmorphine; Morphine methyl ether; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,Codeine Ur Cfm-mCnc,ng/mL,Codeine [Mass/volume] in Urine by Confirmatory method,ng/mL,Codeine Confirm (U) [Mass/Vol]
12951-0,Triglyceride,CHEM,Calc; Calculation; Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; Trig; Trigly; Triglycerides; Triglycrides,Trigl SerPl Calc-mCnc,mg/dL,Triglyceride [Mass/volume] in Serum or Plasma by calculation,mg/dL,Triglyceride Calc [Mass/Vol]
64234-8,Current smoker,H&P.HX,Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen,Current smoker,,Current smoker,,
50196-5,Occult blood panel,PANEL.CHEM,Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastrointestinal hemoglobin; OB Pnl; Occ; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Stl; Stool = Fecal,OB Pnl Stl,,Occult blood panel - Stool,,Occult blood panel (Stl)
32594-4,Tacrolimus,DRUGDOSE,Dose med or substance; DRUG DOSES; FK506; FK-506; Fujimycin; Hecoria; L04AD02; Point in time; Prograf; Protopic; QNT; Quan; Quant; Quantitative; Random,Tacrolimus Dose,mg,Tacrolimus [Mass] of Dose,mg,Tacrolimus (Dose) [Mass]
20433-9,Follitropin,CHEM,2nd International Reference Preparation; Arbitrary Concentration; Chemistry; Follicle stimulating hormone; FSH; IRP2; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,FSH SerPl IRP2-aCnc,mIU/mL,Follitropin [Units/volume] in Serum or Plasma by 2nd IRP,m[IU]/mL,Follitropin 2nd IRP Qn
33516-6,Reticulocytes.immature/Reticulocytes.total,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Imm; Imm Retics; Immat; IRF; Number fraction; Percent; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; Retic; Retics; Reticulocyte; Shift cells; Stress cells; Tot; Totl; WB; Whole blood,Imm Retics NFr,%,Immature reticulocytes/Reticulocytes.total in Blood,%,Immature reticulocytes/Total reticulocytes (Bld)
2821-7,Potassium,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; k; K+; Level; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance concentration",Potassium Fld-sCnc,mmol/L,Potassium [Moles/volume] in Body fluid,mmol/L,Potassium (Body fld) [Moles/Vol]
34543-9,Bilirubin direct & total panel,PANEL.CHEM,Bili; Bilirubin Direct+Tot Pnl; Bilirubins; Billirubin; Chemistry; Dir; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL; Tot; Totl; UniversalLabOrders,Bilirubin Direct+Tot Pnl SerPl-mCnc,,Bilirubin direct and total panel [Mass/volume] - Serum or Plasma,,Bilirubin direct and total panel [Mass/Vol]
5244-9,Measles virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; MeV; Microbiology; Msls; Point in time; QNT; Quan; Quant; Quantitative; Random; Rubeola; Serum; SR; SUDS; UniversalLabOrders,MeV IgG Ser IA-aCnc,EIA Index,Measles virus IgG Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL;{Index_val},MeV IgG IA Qn (S)
18261-8,Cholesterol.in LDL,CHEM,"Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPl.Ultracent; SerPlas; Serum; Serum or plasma; Serum or plasma, ultracentrifugate; SR",LDLc SerPl.Ultracent-mCnc,mg/dL,Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate,mg/dL,Cholesterol in LDL (S/P ultracentrifugate) [Mass/Vol]
19237-7,Base excess^^standard,CHEM,Base ex; BE; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; BSE; Calc; Calculation; Chemistry; EXS; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SBE; std; Substance Concentration; Venous,Base excess std BldV Calc-sCnc,mmol/L,Base excess standard in Venous blood by calculation,mmol/L,Base excess standard Calc (BldV) [Moles/Vol]
5706-7,Opiates,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Identity or presence; Illicit; Nominal; OP; Opi; Opiate; Point in time; PotentialForAbuse; Random; UA; UR; Urn,Opiates Ur,,Opiates [Identifier] in Urine,,Opiates Nom (U)
4091-5,Vancomycin^random,DRUG/TOX,c162; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Rand; Rando; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VANC; Vancocin; Vancor,Vancomycin Rand SerPl-mCnc,mg/L,Vancomycin [Mass/volume] in Serum or Plasma --random,mg/L,Vancomycin random [Mass/Vol]
6873-4,Beta hydroxybutyrate,CHEM,3-hydroxybutyrate; 3-hydroxybutyric acid; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; BOHB; B-OH-Butyr; Chemistry; Hydroxybutyric acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,B-OH-Butyr SerPl-sCnc,mmol/L,Beta hydroxybutyrate [Moles/volume] in Serum or Plasma,mmol/L,Beta hydroxybutyrate [Moles/Vol]
13532-7,Xanthochromia,SPEC,Cerebral spinal fluid; Cerebrospinal Fl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Xanthchromia; Xanthochromic,Xanthochromia CSF Ql,,Xanthochromia [Presence] of Cerebral spinal fluid Qualitative,,Xanthochromia Ql (CSF)
25700-6,Interpretation,CHEM,Chemistry; Hematology; Heme; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Interpretation SerPl IFE-Imp,,Immunofixation for Serum or Plasma,,Interpretation Immunofixation [Interp]
6743-9,Leukocytes,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",WBC # Fld Manual,10*6/L,Leukocytes [#/volume] in Body fluid by Manual count,/uL,WBC Manual cnt (Body fld) [#/Vol]
533-0,Mycobacterium sp,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Blood; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Myco; Mycobact; Nominal; Point in time; Random; Spec; species; spp; Tuberculosis; UniversalLabOrders; WB; Whole blood,Mycobacterium Bld Cult,,Mycobacterium sp identified in Blood by Organism specific culture,,Mycobacterium sp identified Org specific cx Nom (Bld)
2141-0,Corticotropin,CHEM,ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; Chemistry; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker; UniversalLabOrders,ACTH Plas-mCnc,pg/mL,Corticotropin [Mass/volume] in Plasma,pg/mL,Corticotropin (P) [Mass/Vol]
6741-3,Erythrocytes,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells",RBC # Fld Manual,10*6/L,Erythrocytes [#/volume] in Body fluid by Manual count,/uL,RBC Manual cnt (Body fld) [#/Vol]
31147-2,Reagin Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Charcoal flocculation; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neurosyphilis; Point in time; Random; Rapid plasma reagin; Serum; SmQn; SR; Syphilis; Titer; Titered; Titre; Treponema; Ttr; UniversalLabOrders,RPR Ser-Titr,titer,Reagin Ab [Titer] in Serum by RPR,{titer},Reagin Ab RPR (S) [Titer]
631-2,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Unknown substance; Usub,Bacteria Usub Aerobe Cult,,Bacteria identified in Unknown substance by Aerobe culture,,Bacteria identified Aer cx Nom (Unknown substance)
12238-2,Neutrophils/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Neutrophils NFr Fld Manual,%,Neutrophils/Leukocytes in Body fluid by Manual count,%,Neutrophils/Leukocytes Manual cnt (Body fld)
14836-1,Methotrexate,DRUG/TOX,Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,MTX SerPl-sCnc,umol/L;10-9 mol/L; mol/L,Methotrexate [Moles/volume] in Serum or Plasma,umol/L,Methotrexate [Moles/Vol]
75803-7,"During the past 4Ws, how would you rate your health in general",SURVEY.COOP,4 weeks; Last; Ordinal; Ql; Qual; Qualitative; Scale; Screen; Survey,,score,"During the past 4 weeks, how would you rate your health in general [COOP]",{score},
64496-3,Do you have high blood pressure,PHENX,BP; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep apnea high B/P,Sleep apnea high B/P PhenX,,Do you have high blood pressure [PhenX],,
65968-0,How many Hs do you normally sleep,PHENX,Hs normal sleep; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random,Hs normal sleep DI-PAD,hours,How many hours do you normally sleep [DI-PAD],h,
1825-9,Alpha 1 antitrypsin,CHEM,A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Chemistry; Genetics; Hepatology; Heredity; Heritable; i; Inherited; Level; Liver; Lung; Mass Concentration; Pl; Plasma; Plsm; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,A1AT SerPl-mCnc,mg/dL,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,mg/dL,Alpha 1 antitrypsin [Mass/Vol]
4552-6,Hemoglobin A2/Hemoglobin.total,HEM/BC,Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A2; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,Hgb A2 MFr Bld Elph,%,Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis,%,Hemoglobin A2 Elph (Bld) [Mass fraction]
60474-4,Reticulocytes,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number concentration; Number Concentration (count/vol); Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; Retic; Retics; Reticulocyte; WB; Whole blood,Retics # Auto,10*3/uL,Reticulocytes [#/volume] in Blood by Automated count,10*3/uL,Reticulocytes Auto (Bld) [#/Vol]
5358-7,Smooth muscle Ab,SERO,ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; ASMA; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Musc; Muscl; Point in time; Random; Serology; Serum; SM; SMA; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; UniversalLabOrders,Smooth muscle Ab Titr Ser IF,titer,Smooth muscle Ab [Titer] in Serum by Immunofluorescence,{titer},Smooth muscle Ab IF (S) [Titer]
20077-4,Pressure.positive end expiratory setting,PULM,Lung; PEEP; PEEP setting; Point in time; Pos; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory,PEEP setting Vent,cm H2O,Positive end expiratory pressure setting Ventilator,cm[H2O],
6412-1,Giardia lamblia Ag,MICRO,Antigen; Antigens; Beaver fever; Bowel movement; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; G duodenalis; G intestinalis; G lamblia; Giardiasis; IAA; ID; Infectious Disease; InfectiousDisease; Lamblia intestinalis; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS; UniversalLabOrders,G lamblia Ag Stl Ql IA,,Giardia lamblia Ag [Presence] in Stool by Immunoassay,,G. lamblia Ag IA Ql (Stl)
41659-4,ABT492,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,ABT492 Islt KB,,ABT492 [Susceptibility] by Disk diffusion (KB),,ABT492 Disk diffusion (KB) [Susc]
51774-8,Cefuroxime,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c308; C33; Ceftin; Cefuroxime Axetil; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zinacef,Cefuroxime Islt MIC,,Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC),,Cefuroxime MIC [Susc]
20458-6,Rubella virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Congenital rubella syndrome; German measles; ID; Immune globulin G; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Point in time; Random; RUBV; Serum; SR,RUBV IgG Ser-Imp,,Rubella virus IgG Ab [Interpretation] in Serum,,Rubella virus IgG (S) [Interp]
19593-3,6-Monoacetylmorphine,DRUG/TOX,6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin metabolite; Illicit; LC/MS/MS; Level; MAM; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,6MAM Ur Cfm-mCnc,ng/mL,6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method,ng/mL,6-Monoacetylmorphine (6-MAM) Confirm (U) [Mass/Vol]
16201-6,Oxazepam,DRUG/TOX,Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; UA; UniversalLabOrders; UR; Urn,Oxazepam Ur Cfm-mCnc,ng/mL,Oxazepam [Mass/volume] in Urine by Confirmatory method,ng/mL,Oxazepam Confirm (U) [Mass/Vol]
40651-2,Metamyelocytes,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Metamyelocytes Bld Ql,,Metamyelocytes [Presence] in Blood,,Metamyelocytes Ql (Bld)
5810-7,Observation,UA,Point in time; QNT; Quan; Quant; Quantitative; Random; Refract; Sp Gr; UA; UR; URINALYSIS; Urn,Sp Gr Ur Refractometry,,Specific gravity of Urine by Refractometry,{Spec grav},Specific gravity Refractometry (U)
35801-0,Ertapenem,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; InVanz; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Ertapenem Islt MIC,,Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC),,Ertapenem MIC [Susc]
10328-3,Lymphocytes/Leukocytes,HEM/BC,Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Neuro; Neurology; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells,Lymphocytes NFr CSF Manual,%,Lymphocytes/Leukocytes in Cerebral spinal fluid by Manual count,%,Lymphocytes/Leukocytes Manual cnt (CSF)
42637-9,Natriuretic peptide.B,CHEM,Beta Natriuretic Peptide; Blood; BNP; Brain Natriuretic Peptide; B-type natriuretic peptide; Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Natriutietic peptide.B; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,BNP Bld-mCnc,pg/mL,Natriuretic peptide B [Mass/volume] in Blood,pg/mL,Natriuretic peptide B (Bld) [Mass/Vol]
3432-2,carBAMazepine,DRUG/TOX,Carbamazapine; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; Level; Mass concentration; Neuro; Neurology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril; UniversalLabOrders,carBAMazepine SerPl-mCnc,ug/mL,carBAMazepine [Mass/volume] in Serum or Plasma,ug/mL,carBAMazepine [Mass/Vol]
2923-1,Retinol,CHEM,Axerol; Axerophthol; Biosterol; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vit A; Vit A alcohol; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A1,Vit A SerPl-mCnc,mcg/dL; mcg/mL,Retinol [Mass/volume] in Serum or Plasma,ug/mL,Retinol [Mass/Vol]
29950-3,Nuclear Ab.IgG,SERO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS,Nuclear IgG Ser Ql IA,,Nuclear IgG Ab [Presence] in Serum by Immunoassay,,Nuclear IgG IA Ql (S)
33255-1,Cell fractions,HEM/BC,Blood; Differential count; Frac; Fract; Fraction; Fractionated; Fractionation; HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood,Cell Fract Bld-Imp,,Cell Fractions/Differential [Interpretation] in Blood,,Cell Fractions/Differential (Bld) [Interp]
30963-3,Funds vaccine purchased with,VACCIN,Finding; Findings; Nominal; Point in time; Random,Funds vaccine purchased with VAERS,,Funds vaccine purchased with VAERS,,
40726-2,Hepatitis C virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HCV; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS,HCV IgG SerPl Ql IA,,Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay,,HCV IgG IA Ql
20475-0,Cytomegalovirus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Immune globulin G; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,CMV IgG SerPl-Imp,,Cytomegalovirus IgG Ab [Interpretation] in Serum or Plasma,,CMV IgG [Interp]
17851-7,Herpes simplex virus 2 Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,HSV2 IgG Ser Ql,,Herpes simplex virus 2 IgG Ab [Presence] in Serum,,HSV 2 IgG Ql (S)
2529-6,Lactate dehydrogenase,CHEM,"2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; Fl; Fld; FLU; Fluid; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker",LDH Fld-cCnc,arb U/L,Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid,U/L,LDH (Body fld) [Catalytic activity/Vol]
6096-2,Dermatophagoides pteronyssinus Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; D pteronyss; D pteronyssinus; d001; d1; European house dust mite; HDM; House dust mite; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,D pteronyss IgE Qn,kIU/L; kU/L,European house dust mite IgE Ab [Units/volume] in Serum,k[IU]/L,European house dust mite IgE Qn (S)
21299-3,Gestational age method,OB.US,AOEObservation; Fetal; GA; GA method; Gest; Gestation; Gyn; Gynecology; Identity or presence; Meth; Method of; Nominal; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; Prenatal; Random,GA method,,Gestational age method,,
11259-9,Hepatitis C virus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HCV; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders,HCV RNA SerPl Ql NAA+probe,,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,,HCV RNA NAA+probe Ql
18185-9,Gestational age,OB.US,Fetal; GA; Gest; Gestation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; Prenatal; QNT; Quan; Quant; Quantitative; Random,GA,wk,Gestational age,wk,
5124-3,Cytomegalovirus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; EIA; ELFA; ELISA; Enzyme immunoassay; HHV-5; Human Herpesvirus-5; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,CMV IgG SerPl IA-aCnc,EIA Index; units/mL,Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,[arb'U]/mL,CMV IgG IA Qn
6095-4,Dermatophagoides farinae Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American house dust mite; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; D farinae; d002; d2; Dermatophagoides farianae; HDM; House dust mite; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,D farinae IgE Qn,kIU/L; kU/L,American house dust mite IgE Ab [Units/volume] in Serum,k[IU]/L,American house dust mite IgE Qn (S)
21394-2,Monocytes+Macrophages/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Mono; Monocyte; Monos; Monos+Macros; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Monos+Macros NFr Fld Manual,%,Monocytes+Macrophages/Leukocytes in Body fluid by Manual count,%,Monocytes+Macrophages/Leukocytes Manual cnt (Body fld)
49765-1,Calcium,CHEM,Blood; Ca; Cal; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Calcium Bld-mCnc,mg/dL,Calcium [Mass/volume] in Blood,mg/dL,Calcium (Bld) [Mass/Vol]
49580-4,HIV 1+2 Ab,MICRO,ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 & 2; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; UniversalLabOrders; Unspecified,HIV1+2 Ab Spec Ql IA.rapid,,HIV 1+2 Ab [Presence] in Specimen by Rapid immunoassay,,HIV 1+2 Ab IA.rapid Ql (Specimen)
9813-7,Cortisol^AM peak specimen,CHEM,17-Hydroxycorticosterone; 8 AM; 8AM; AM diurnal peak; Chemistry; circadian high; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Morning; Pl; Plasma; Plsm; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; UniversalLabOrders,Cortis AM peak SerPl-mCnc,ug/dL,Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen,ug/dL,Cortisol AM peak specimen [Mass/Vol]
1990-1,Cholecalciferol,CHEM,C27H43OH; Calciol; Chemistry; Colecalciferol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vit D3; Vitamin D3,Vitamin D3 SerPl-mCnc,ng/mL,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,ng/mL,Vitamin D3 [Mass/Vol]
16348-5,Alpha hydroxyalprazolam,DRUG/TOX,Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy alprazolam; Hydroxyalpraz; LC/MS/MS; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,A-OH Alpraz Ur Cfm-mCnc,ng/mL,Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method,ng/mL,Alpha hydroxyalprazolam Confirm (U) [Mass/Vol]
383-0,Oxacillin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Bactocill; c116; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Prostaphlin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Oxacillin Islt MIC,,Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC),,Oxacillin MIC [Susc]
6098-8,Dog dander Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Canine; Dog hair; e005; e5; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Dog Dander IgE Qn,kIU/L; kU/L,Dog dander IgE Ab [Units/volume] in Serum,k[IU]/L,Dog dander IgE Qn (S)
29541-0,HIV 1 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders; Viral load,HIV1 RNA SerPl NAA+probe-Log#,log copies/mL,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,{log_copies}/mL,HIV 1 RNA NAA+probe [Log #/Vol]
5876-8,Respiratory syncytial virus Ag,MICRO,Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; HRSV; IAA; ID; Infectious Disease; InfectiousDisease; Lung; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RSV; Screen; Spec; SUDS; To be specified in another part of the message; UniversalLabOrders; Unspecified,RSV Ag Spec Ql IA,,Respiratory syncytial virus Ag [Presence] in Specimen by Immunoassay,,RSV Ag IA Ql (Specimen)
17858-2,Gamma glutamyl transferase,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Fl; Fld; FLU; Fluid; Gamma glutamyl transpeptidase; Gamma-GTP; GGT; GGTP; GT; Hepatology; Liver; Point in time; QNT; Quan; Quant; Quantitative; Random",GGT Fld-cCnc,arb U/L,Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid,U/L,Gamma glutamyl transferase (Body fld) [Catalytic activity/Vol]
6833-8,Cat dander Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cat epithelium; Cat hair; e1; Feline; Felis domesticus; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Cat Dander IgE Qn,kIU/L,Cat dander IgE Ab [Units/volume] in Serum,k[IU]/L,Cat dander IgE Qn (S)
30471-7,levETIRAcetam,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Keppra; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,levETIRAcetam SerPl-mCnc,ug/mL,levETIRAcetam [Mass/volume] in Serum or Plasma,ug/mL,levETIRAcetam [Mass/Vol]
55305-7,Fungus,MICRO,Fung; Fungal; Fungi; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified,Fungus Spec Ql KOH Prep,,Fungus [Presence] in Specimen by KOH preparation,,Fungus KOH prep Ql (Specimen)
8633-0,QRS duration,EKG.MEAS,Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Point in time; QNT; Quan; Quant; Quantitative; Random,QRS dur,MS,QRS duration,ms,
33358-3,Protein.monoclonal,CHEM,Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Level; M Protein; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR,M Protein SerPl Elph-mCnc,g/L;g/dL,Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis,g/dL,Protein.monoclonal Elph [Mass/Vol]
59465-5,Pathologist review,PATH,Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Path; Path Rev; PATHOLOGY; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified,Path Rev,,Pathologist review of results,,Pathologist review [Interp]
59615-5,ALPRAZolam,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Xanax,Alpraz Ur Cfm-mCnc,ng/mL,ALPRAZolam [Mass/volume] in Urine by Confirmatory method,ng/mL,ALPRAZolam Confirm (U) [Mass/Vol]
233-7,Erythromycin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c212; EES; Erygel; Erythromycn; ID; Ilosone; Ilotycin; Iltycin; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Erythromycin Islt MIC,,Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC),,Erythromycin MIC [Susc]
48705-8,Leukocytes+Platelets,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Morphology; Nominal; Platelet; Platelt; Plt; Point in time; Random; Thrb; Thrombocyte; Thrombocytes; WB; WBC; WBC+Platelets; WBCs; White blood cell; White blood cells; Whole blood,WBC+Platelets Bld,,Leukocytes+Platelets [Morphology] in Blood,,WBC+Platelets Nom (Bld)
5185-4,Hepatitis B virus core Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBc; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HBc; HBV; HBV core; Hep; Hep B; Hepatis; Hepatit; Hepatitis Bc; HepB; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HBV core IgM SerPl IA-aCnc,U/ml; PEIU/ml,Hepatitis B virus core IgM Ab [Units/volume] in Serum or Plasma by Immunoassay,{Index_val},HBV core IgM IA Qn
2469-5,IgG subclass 4,CHEM,Chemistry; IgG 4; IgG4; Immune globulin G; Immunoglobulin G; Immunoglobulin G subclass 4; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Subclasses,IgG4 Ser-mCnc,g/L;mg/dL,IgG subclass 4 [Mass/volume] in Serum,mg/dL,IgG subclass 4 (S) [Mass/Vol]
17862-4,Calcium,CHEM,Ca; Cal; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,Calcium Ur-mCnc,mg/dL,Calcium [Mass/volume] in Urine,mg/dL,Calcium (U) [Mass/Vol]
36813-4,Multisection^W contrast IV,RAD,Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC,CT Abd+Pelvis W contr IV,,CT Abdomen and Pelvis W contrast IV,,
94565-9,SARS coronavirus 2 RNA,MICRO,2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus,SARS-CoV-2 RNA Nph Ql NAA+non-probe,,SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection,,SARS-CoV-2 (COVID-19) RNA NAA+non-probe Ql (Nph)
32585-2,Epstein Barr virus DNA,MICRO,#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified; Viral load,EBV DNA # Spec NAA+probe,copies/mL,Epstein Barr virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection,{copies}/mL,EBV DNA NAA+probe (Specimen) [#/Vol]
53306-7,Calcium oxalate crystals,UA,#/area; Artificial Intelligence; Automated detection; Ca; CaC2O4; Cal; CaOx; CaOx Cry; Comp Assist; Crys; Cryst; Crystal; Ethanedioate; Ethanedioic acid; Number areic; Oxal; Oxalic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn,CaOx Cry #/area Ur Comp Assist,,Calcium oxalate crystals [#/area] in Urine by Computer assisted method,/[HPF],Calcium oxalate crystals Computer assisted (U) [#/Area]
193-3,Clindamycin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c306; Cleocin; CLIJ; Dalacin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sobelin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Topical,Clindamycin Islt MIC,ug/mL,Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC),ug/mL,Clindamycin MIC [Susc]
2915-7,Renin,CHEM,Active renin; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; Chemistry; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; QNT; Quan; Quant; Quantitative; Random; Renal; UniversalLabOrders,Renin Plas-cCnc,mU/L;ng/mL/90 min; ng/mL/HR,Renin [Enzymatic activity/volume] in Plasma,ng/mL/h,Renin (P) [Catalytic activity/Vol]
17842-6,Cancer Ag 27-29,CHEM,Arbitrary concentration; B27.9; CA; CA 27-29; CA27.29; Cancer Ag27-29; Carbohydrate antigen; Carbohydrate antigen 27-29; Chemistry; MUC-1 gene associated AG CA 27-29; Oncology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,Cancer Ag27-29 SerPl-aCnc,arb U/mL,Cancer Ag 27-29 [Units/volume] in Serum or Plasma,[arb'U];[arb'U]/mL,Cancer Ag 27-29 Qn
14724-9,Ferritin,CHEM,Blood; Chemistry; Ferr; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood,Ferritin Bld-Imp,,Ferritin [Interpretation] in Blood,,Ferritin (Bld) [Interp]
10333-3,Observation,SPEC,Appearance; Cerebral spinal fluid; Cerebrospinal Fl; Nominal; Point in time; Random; SPEC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid,Appearance CSF,,Appearance of Cerebral spinal fluid,,Appearance (CSF)
20559-1,Temazepam,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; UA; UR; Urn,Temazepam Ur Cfm-mCnc,ng/mL,Temazepam [Mass/volume] in Urine by Confirmatory method,ng/mL,Temazepam Confirm (U) [Mass/Vol]
6106-9,Egg white Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f001; f1; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Egg White IgE Qn,kIU/L; kU/L,Egg white IgE Ab [Units/volume] in Serum,k[IU]/L,Egg white IgE Qn (S)
26752-6,Creatinine renal clearance,CHEM,120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; CR; Crea; Creat; Flow; Kidney; Nephrology; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UCr; UR; Ur+SerPl; Urn; Volume rate; vRate,Creat Cl 2h Ur+SerPl-vRate,mL/min,Creatinine renal clearance in 2 hour Urine and Serum or Plasma,mL/min,Creatinine renal clearance (2H U+S/P) [Vol/Time]
51776-3,7-Aminoclonazepam,DRUG/TOX,7-amino clonazepam; 7Aminoclonazepam; Addiction; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,7Aminoclonazepam Ur Cfm-mCnc,ng/mL,7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method,ng/mL,7-Aminoclonazepam Confirm (U) [Mass/Vol]
11287-0,Alcoholic drinks per drinking D,H&P.HX,1 day; 24 hours; 24H; 24HR; Alcoholic drinks/drinking D; Count/time; Dextro; H+P; H+P.HX; nRate; Number rate; Number Rate = Count/Time; P prime; QNT; Quan; Quant; Quantitative,Alcoholic drinks/drinking D Reported,/d,Alcoholic drinks per drinking day - Reported,/d,
20-8,Amoxicillin+Clavulanate,ABXBACT,Amox; Amoxicillin+clavulanic acid; Amoxicilloyl; Amoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Augmentin; Bristamox; c204; c305; c6; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Larotid; Minimum inhibitory concentration; Moxalin; Moxicillin+clavulanic acid; Point in time; Polymox; Random; Sumox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trimox; Wymox,Amoxicillin+Clav Islt MIC,,Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC),,Amoxicillin+Clavulanate MIC [Susc]
26881-3,Interleukin 6,CHEM,B-Cell Differentiation Factor-2; B-Cell Stimulatory Factor-2; BSF-2; Chemistry; Hepatocyte-Stimulating Factor; Hybridoma Growth Factor; IFN-beta 2; IL; IL6; IL-6; Level; Mass concentration; MGI-2; Myeloid Differentiation-Inducing Protein; Pl; Plasma; Plasmacytoma Growth Factor; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Il6 SerPl-mCnc,pg/mL,Interleukin 6 [Mass/volume] in Serum or Plasma,pg/mL,Interleukin 6 [Mass/Vol]
46099-8,Calcium^^corrected for albumin,CHEM,Alb; Album cor; Ca; Cal; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Calcium Album cor SerPl-mCnc,mg/dL,Calcium [Mass/volume] corrected for albumin in Serum or Plasma,mg/dL,Calcium corrected for albumin [Mass/Vol]
725-2,Hemoglobin,HEM/BC,Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn,Hgb Ur Ql,,Hemoglobin [Presence] in Urine,,Hemoglobin Ql (U)
49220-7,Prolactin,CHEM,3IS; 3rd International Standard; 3rdIS; Chemistry; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Prolactin SerPl 3rd IS-mCnc,ng/mL,Prolactin [Mass/volume] in Serum or Plasma by 3rd IS,ng/mL,Prolactin 3rd IS [Mass/Vol]
35788-9,DAPTOmycin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Cubicin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,DAPTOmycin Islt MIC,,DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC),,DAPTOmycin MIC [Susc]
26524-9,Promyelocytes/Leukocytes,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Promyelocytes NFr Bld,%,Promyelocytes/Leukocytes in Blood,%,Promyelocytes/Leukocytes (Bld)
26465-5,Leukocytes,HEM/BC,#; ABS; absolute; absolutes; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Neuro; Neurology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells,WBC # CSF,10*6/L,Leukocytes [#/volume] in Cerebral spinal fluid,/uL,WBC (CSF) [#/Vol]
6424-6,Heterophile Ab,MICRO,ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Epstein-Barr virus; Hetero; Heteroph; Hetr; ID; Infectious Disease; InfectiousDisease; Microbiology; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr,Heteroph Ab Titr Ser Aggl,titer,Heterophile Ab [Titer] in Serum by Agglutination,{titer},Heterophile Ab Aggl (S) [Titer]
27045-4,Microscopic exam,CYTO,Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Micro; Nominal; Point in time; Random; UA; UR; Urn,Microscopic Ur-Imp,,Microscopic exam [Interpretation] of Urine by Cytology,,Microscopic exam Cytology (U) [Interp]
8358-4,Cuff size,DEVICES,BP; BP cuff; BP device; Length; Point in time; Random,BP device Cuff size,cm,Blood pressure device Cuff size,cm,
6025-1,Aspergillus fumigatus Ab.IgE,ALLERGY,A fumigatus; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Fum; Immune globulin E; Immunoglobulin E; m003; m3; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,A fumigatus IgE Qn,kIU/L; kU/L,Aspergillus fumigatus IgE Ab [Units/volume] in Serum,k[IU]/L,A. fumigatus IgE Qn (S)
802-9,Spherocytes,HEM/BC,Blood; Hematology; HEMATOLOGY/CELL COUNTS; Heme; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sphero; Spherocyte; WB; Whole blood,Spherocytes Bld Ql Smear,,Spherocytes [Presence] in Blood by Light microscopy,,Spherocytes LM Ql (Bld)
58381-5,fentaNYL,DRUG/TOX,Actiq; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sublimaze; UA; UR; Urn,fentaNYL Ur Cfm-mCnc,ng/mL,fentaNYL [Mass/volume] in Urine by Confirmatory method,ng/mL,fentaNYL Confirm (U) [Mass/Vol]
3243-3,Coagulation thrombin induced,COAG,Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; TCT; Throm; Thrombin clotting time; Thrombin time; Tilt tube; TT; UniversalLabOrders,Thrombin time,s,Thrombin time,s,Thrombin time Coag (PPP) [Time]
20399-2,Nuclear Ab pattern.nucleolar,SERO,ANA; ANA nucleolar; ANA Pat; ANF; Antinuclear antibody; Dilution factor; Dilution Factor (Titer); NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr,ANA nucleolar Titr Ser,titer,Nucleolar nuclear Ab pattern [Titer] in Serum,{titer},Nucleolar nuclear Ab pattern (S) [Titer]
16228-9,Nordiazepam,DRUG/TOX,Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; UA; UniversalLabOrders; UR; Urn; Vegesan,Nordiazepam Ur Cfm-mCnc,ng/mL,Nordiazepam [Mass/volume] in Urine by Confirmatory method,ng/mL,Nordiazepam Confirm (U) [Mass/Vol]
72494-8,Cytomegalovirus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load,CMV DNA SerPl NAA+probe-Log IU,log IU/mL,Cytomegalovirus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,{Log_IU}/mL,CMV DNA NAA+probe [Log units/Vol]
5403-1,Varicella zoster virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shingles; SR; SUDS; UniversalLabOrders; VZ; VZV; Zoster,VZV IgG Ser IA-aCnc,ACU/mL; EIA Index,Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,VZV IgG IA Qn (S)
26523-1,Promyelocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number concentration; Number Concentration (count/vol); Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Promyelocytes # Bld,10*3/mm3,Promyelocytes [#/volume] in Blood,10*3/uL,Promyelocytes (Bld) [#/Vol]
32356-8,Yeast,UA,ID; Infectious Disease; InfectiousDisease; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Yeast UrnS Ql Micro,,Yeast [Presence] in Urine sediment by Light microscopy,,Yeast LM Ql (Urine sed)
44877-9,Insulin dependent diabetes mellitus,MISC,DM; HUM; Humulin; IDDM; IH7; Insul; Lente; MISC; NPH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Semilente; Sliding; Ultralente,IDDM Patient Ql,,Insulin dependent diabetes mellitus [Presence],,Insulin dependent diabetes mellitus Ql
58383-1,Norfentanyl,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Norfentanyl Ur Cfm-mCnc,ng/mL,Norfentanyl [Mass/volume] in Urine by Confirmatory method,ng/mL,Norfentanyl Confirm (U) [Mass/Vol]
11778-8,Delivery date,OB.US,AOEObservation; Clin est; Date of confinement; Deliv date; Due date; EDC; EDD; Est; estimation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random,Deliv date Clin est,MMDDYY,Delivery date Estimated,,
31418-7,Heterophile Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Epstein-Barr virus; Hetero; Heteroph; Hetr; ID; Infectious Disease; InfectiousDisease; Microbiology; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,Heteroph Ab Ser Ql,,Heterophile Ab [Presence] in Serum,,Heterophile Ab Ql (S)
2112-1,Choriogonadotropin.beta subunit,CHEM,B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Gyn; Gynecology; HCG; Human chorionic gonadotropin; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tumor marker; UA; UniversalLabOrders; UR; Urn,B-HCG Ur Ql,,Choriogonadotropin.beta subunit [Presence] in Urine,,HCG.beta subunit Ql (U)
6558-1,Streptococcus pyogenes Ag,MICRO,Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; GAS; Group A Strep; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; S pyogenes; Screen; Spec; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; SUDS; To be specified in another part of the message; Unspecified,S pyo Ag Spec Ql IA,,Streptococcus pyogenes Ag [Presence] in Specimen by Immunoassay,,S. pyogenes Ag IA Ql (Specimen)
2742-5,Angiotensin converting enzyme,CHEM,ACE; AGT; Angio convert enzy; Angiotensin I converting enzyme; Carboxycathepsin; Catalytic Concentration; Chemistry; Dipeptidylcarboxypeptidase; Enz; Enzymes; Kininase II; Lung; PDPA; Peptidase P; Peptidyl dipeptidase A; Pl; Plasma; Plsm; Point in time; Proangiotensin; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,ACE SerPl-cCnc,arb U/L,Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma,U/L,Angiotensin converting enzyme [Catalytic activity/Vol]
4993-2,Chlamydia trachomatis rRNA,MICRO,C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Spec; To be specified in another part of the message; Trachoma; UniversalLabOrders; Unspecified,C trach rRNA Spec Ql Probe,,Chlamydia trachomatis rRNA [Presence] in Specimen by Probe,,C. trachomatis rRNA Probe Ql (Specimen)
12189-7,Creatine kinase.MB/Creatine kinase.total,CHEM,Calc; Calculation; Cardio; Cardiology; Catalytic Fraction; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Heart Disease; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl,CK MB CFr SerPl Calc,%,Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation,%,CK.MB Calc [Catalytic fraction]
6969-0,Myeloperoxidase Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; MPO; MPO - ANCA; Myeloperoxidase ANCA; p-ANCA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; UniversalLabOrders; Vasculitis,Myeloperoxidase Ab Ser-aCnc,arb U/mL,Myeloperoxidase Ab [Units/volume] in Serum,[arb'U]/mL,Myeloperoxidase Ab Qn (S)
6020-2,Alternaria alternata Ab.IgE,ALLERGY,A alternata; A tenuis; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alternaria tenuis; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; m006; m6; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,A alternata IgE Qn,kIU/L; kU/L,Alternaria alternata IgE Ab [Units/volume] in Serum,k[IU]/L,A. alternata IgE Qn (S)
50225-2,Epithelial cells.non-squamous,UA,Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; Epi; Epi Cells; Epith; Epithelia; Non-sq Epi Cells; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Round epithelial cells; Screen; Small epithelial cells; Sq; UA; UR; URINALYSIS; Urn,Non-sq Epi Cells Ur Ql Auto,,Epithelial cells.non-squamous [Presence] in Urine by Automated,,Epithelial cells.non-squamous Auto Ql (U)
61404-0,Staphylococcus aureus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; Screen; SDA; Spec; Staph; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,S aureus DNA Spec Ql NAA+probe,,Staphylococcus aureus DNA [Presence] in Specimen by NAA with probe detection,,S. aureus DNA NAA+probe Ql (Specimen)
33341-9,Granular casts,UA,#/area; Artificial Intelligence; Automated detection; Cast; Comp Assist; Gran Casts; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn,Gran Casts #/area Ur Comp Assist,/HPF,Granular casts [#/area] in Urine by Computer assisted method,/[HPF],Granular casts Computer assisted (U) [#/Area]
19075-1,Cells counted.total,HEM/BC,Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Non-aggregate; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Total cells; Total Cells Counted; Totl,Total Cells Counted CSF,#,Cells Counted Total [#] in Cerebral spinal fluid,{#},Cells Counted Total (CSF) [#]
44751-6,Nuclear Ab,SERO,ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF,ANA Ser Ql IF Rat Kidney,,Nuclear Ab [Presence] in Serum by Immunofluorescence (IF) rat kidney,,Nuclear Ab IF rat kidney Ql (S)
19157-7,Tube number,SPEC,Cerebral spinal fluid; Cerebrospinal Fl; Ident; Identifier; No; Nominal; Num; Point in time; Random; SPEC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tube #,Tube # CSF,,Tube number of Cerebral spinal fluid,,Tube number Nom (CSF) [ID]
12210-1,Eosinophils/Leukocytes,UA,Eos; Eosin; Eosino; Eosinophil; Eosins; Kidney; Leuc; Leuk; Leukocyte; Lkcs; Manl; Nephrology; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UniversalLabOrders; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBCs; White blood cell; White blood cells,Eosinophil NFr UrnS Manual,%,Eosinophils/Leukocytes in Urine sediment by Manual count,%,Eosinophils/Leukocytes Manual cnt (Urine sed)
46999-9,Bacterial vaginosis & vaginitis rRNA panel,PANEL.MICRO,Bact; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; ribosomal RNA; Vag fld; Vag fluid; Vagina; Vaginal fluid; Vaginal pathogens; Vaginosis/itis rRNA Pnl,Vaginosis/itis rRNA Pnl Vag Probe,,Bacterial vaginosis and vaginitis rRNA panel - Vaginal fluid by Probe,,Bacterial vaginosis and vaginitis rRNA panel Probe (Vag fld)
60489-2,Streptococcus pyogenes DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; Screen; SDA; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; Throat; TMA; Transcription mediated amplification; Upper respiratory,S pyo DNA Throat Ql NAA+probe,,Streptococcus pyogenes DNA [Presence] in Throat by NAA with probe detection,,S. pyogenes DNA NAA+probe Ql (Throat)
30211-7,Collection duration,SPEC,Coll; Collect; Collect duration; Collected; Durat; QNT; Quan; Quant; Quantitative; Spec,Collect duration Time Spec,H,Collection duration of Specimen,h,Collection duration (Unsp spec)
133-9,cefTAZidime,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj,cefTAZidime Islt MIC,,cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC),,cefTAZidime MIC [Susc]
17353-4,Neutrophil cytoplasmic Ab.classic,SERO,ACIF; ACNA; ACPA; ANCA; Anticomplement Immunofluorescence; cANCA; c-ANCA; Cytopl; Cytoplas; Cytoplasmic ANCA; FA; Fluorescent antibody; Fluoresent; Granulocyte ab; Granulocyte nucleus ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neut; Neutr; Neutrophils; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF; Vasculitis,c-ANCA Ser Ql IF,,Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence,,Neutrophil cytoplasmic Ab.classic IF Ql (S)
25418-5,Mumps virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; MuV; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,MuV IgG Ser IA-aCnc,,Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay,{index_val},MuV IgG IA Qn (S)
7789-1,Acanthocytes,HEM/BC,Acanthocyte; Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spur cells; WB; Whole blood,Acanthocytes Bld Ql Smear,,Acanthocytes [Presence] in Blood by Light microscopy,,Acanthocytes LM Ql (Bld)
3719-2,Lithium,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Eskalith; Level; Li; Lithane; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Lithium SerPl-mCnc,ug/mL,Lithium [Mass/volume] in Serum or Plasma,ug/mL,Lithium [Mass/Vol]
54089-8,Newborn screening panel,PANEL.CHEM,Asympt; Asymptomatic; Chemistry; NB Screen Pnl; NBS; New born; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; UniversalLabOrders,NB Screen Pnl Patient AHIC,,Newborn screening panel American Health Information Community (AHIC),,NBS panel AHIC
56536-6,Thyroglobulin Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Antithyroglob; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; Hashimoto's thyroiditis; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tg; TgAbs; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker,Thyroglob Ab SerPl IA-aCnc,,Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay,[arb'U]/mL,Thyroglobulin Ab IA Qn
69002-4,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HPV; HPV E6+E7; HPV E6+E7 mRNA; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HPV E6+E7 mRNA Cvx Ql NAA+probe,,Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection,,HPV E6+E7 mRNA NAA+probe Ql (Cvx)
17792-3,Sjogrens syndrome-A extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA SS-A; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; UniversalLabOrders,ENA SS-A Ab Ser-aCnc,Index; units/mL,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum,[arb'U]/mL,Sjogrens syndrome-A extractable nuclear Ab Qn (S)
44447-1,Beta 2 glycoprotein 1 Ab.IgA,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; APOH; Apolipoprotein H; Arbitrary concentration; Autoantibodies; Autoantibody; B; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; IAA; II; Immune globulin A; Immunoglobulin A; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,B2 Glycoprot1 IgA SerPl IA-aCnc,arb U/mL,Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay,[arb'U]/mL,Beta 2 glycoprotein 1 IgA IA Qn
19128-8,Bacteria,MICRO,Bact; C&S; Cath Tip; Catheter tip; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; UniversalLabOrders,Bacteria Cath Tip Cult,,Bacteria identified in Catheter tip by Culture,,Bacteria identified Cx Nom (Catheter tip)
47596-2,Calcium.ionized,CHEM,Blood; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood,Ca-I Bld ISE-sCnc,mmol/L,Calcium.ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE),mmol/L,Calcium.ionized ISE (Bld) [Moles/Vol]
20421-4,Barbiturates,DRUG/TOX,Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Barbiturates SerPl Ql Scn,,Barbiturates [Presence] in Serum or Plasma by Screen method,,Barbiturates Screen Ql
11279-7,Urine sediment comments,UA,Finding; Findings; Kidney; LM; Micro; Micros; Microscopic; Narrative; Nephrology; Point in time; Random; Renal; Report; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; UrnS Cmnt,UrnS Cmnt Micro,,Urine sediment comments by Light microscopy Narrative,,Urine sediment comments LM Nar (Urine sed)
56469-0,Cardiac heart disease risk,CHEM,CHD risk; Chemistry; Dis; Diseases; Dz; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,CHD risk SerPl-Rto,,Cardiac heart disease risk [Ratio] in Serum or Plasma,,Cardiac heart disease risk [Ratio]
6447-7,Legionella pneumophila Ag,MICRO,Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; MEIA; Microbiology; Ordinal; Pneu; pneum; Pneumophilia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; UA; UniversalLabOrders; UR; Urn,L pneumo Ag Ur Ql IA,,Legionella pneumophila Ag [Presence] in Urine by Immunoassay,,L. pneumophila Ag IA Ql (U)
2110-5,Choriogonadotropin.beta subunit,CHEM,B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Gyn; Gynecology; HCG; Human chorionic gonadotropin; OB; ObGyn; Obstetrics; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders,B-HCG SerPl Ql,,Choriogonadotropin.beta subunit [Presence] in Serum or Plasma,,HCG.beta subunit Ql
801-1,Sickle cells,HEM/BC,Blood; Cell; Cellularity; Drepanocyte; Drepanocytes; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Sickle Cells Bld Ql Smear,,Sickle cells [Presence] in Blood by Light microscopy,,Sickle cells LM Ql (Bld)
7258-7,Cow milk Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f002; f2; f43; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Cow Milk IgE Qn,kIU/L,Cow milk IgE Ab [Units/volume] in Serum,k[IU]/L,Cow milk IgE Qn (S)
22763-7,Ammonia,CHEM,Amm; Ammon; Amon; Chemistry; Hepatology; Kidney; Level; Liver; Mass Concentration; Nephrology; NH3; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UniversalLabOrders,Ammonia Plas-mCnc,ug/dL,Ammonia [Mass/volume] in Plasma,ug/dL,Ammonia (P) [Mass/Vol]
8638-9,T wave axis,EKG.MEAS,Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Point in time; QNT; Quan; Quant; Quantitative; Random; T prime,T wave axis,,T wave axis,,
59590-0,1-Hydroxymidazolam,DRUG/TOX,1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Cfm; Chlonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; i; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,1OH-midazolam Ur Cfm-mCnc,ng/mL,1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method,ng/mL,1-Hydroxymidazolam Confirm (U) [Mass/Vol]
25162-9,Hyaline casts,UA,Cast; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Hyaline Casts UrnS Ql Micro,,Hyaline casts [Presence] in Urine sediment by Light microscopy,,Hyaline casts LM Ql (Urine sed)
48309-9,BK virus DNA,MICRO,#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; BKV; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load,BKV DNA # Spec NAA+probe,copies/mL,BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection,{copies}/mL,BK virus DNA NAA+probe (Specimen) [#/Vol]
8634-8,QT interval,EKG.MEAS,Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Point in time; QNT; Q-T interval; Quan; Quant; Quantitative; Random,Q-T interval,s,Q-T interval,s,
45324-1,Ethyl glucuronide,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; Gluc; Glucouronide; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,Ethyl glucuronide Ur-mCnc,mg/L,Ethyl glucuronide [Mass/volume] in Urine,mg/L,Ethyl glucuronide (U) [Mass/Vol]
38180-6,Hepatitis C virus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HCV; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders; Viral load,HCV RNA SerPl NAA+probe-Log IU,log IU/mL,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,{Log_IU}/mL,HCV RNA NAA+probe [Log units/Vol]
8626-4,P wave axis,EKG.MEAS,Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random,P wave axis,deg,P wave axis,deg,
13824-8,Arsenic/Creatinine,DRUG/TOX,1 day; 24 hours; 24HR; AS; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn,Arsenic/Creat 24h Ur,ug/g creatinine,Arsenic/Creatinine [Mass Ratio] in 24 hour Urine,ug/g{creat},Arsenic/Creatinine (24H U) [Mass ratio]
739-3,Metamyelocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Manl; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Metamyelocytes # Bld Manual,10*9/L,Metamyelocytes [#/volume] in Blood by Manual count,10*3/uL,Metamyelocytes Manual cnt (Bld) [#/Vol]
20428-9,Phospholipid Ab.IgG,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; Antiphospholipid; aPA; APL; Autoantibodies; Autoantibody; COAGULATION; Hematology; Heme; Immune globulin G; Immunoglobulin G; Lipid; Ordinal; Phoslpd; Phospholipids; Pl; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR,Phospholipid IgG Ser Ql,,Phospholipid IgG Ab [Presence] in Serum,,Phospholipid IgG Ql (S)
20429-7,Phospholipid Ab.IgM,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; Antiphospholipid; aPA; APL; Autoantibodies; Autoantibody; COAGULATION; Hematology; Heme; Immune globulin M; Immunoglobulin M; Lipid; Ordinal; Phoslpd; Phospholipids; Pl; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR,Phospholipid IgM Ser Ql,,Phospholipid IgM Ab [Presence] in Serum,,Phospholipid IgM Ql (S)
30361-0,HIV 2 Ab,MICRO,ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV type 2; HIV type II; Human immunodeficiency virus; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HIV 2 Ab SerPl Ql IA,,HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay,,HIV 2 Ab IA Ql
34557-9,Cell count & Differential panel,PANEL.HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell Cnt + Diff Pnl; Diff; Diff Pnl; Differl; Differn; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders",Cell Cnt + Diff Pnl Fld,,Cell count and Differential panel - Body fluid,,Cell count and Differential panel (Body fld)
586-8,Streptococcus agalactiae,MICRO,C&S; Cult; Cultures; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; S agalactiae; Screen; Spec; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; To be specified in another part of the message; UniversalLabOrders; Unspecified,Gp B Strep Spec Ql Cult,,Streptococcus agalactiae [Presence] in Specimen by Organism specific culture,,S. agalactiae Org specific cx Ql (Specimen)
40667-8,Rubella virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Congenital rubella syndrome; EIA; ELFA; ELISA; Enzyme immunoassay; German measles; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; RUBV; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS,RUBV IgG SerPl Ql IA,,Rubella virus IgG Ab [Presence] in Serum or Plasma by Immunoassay,,Rubella virus IgG IA Ql
62487-4,Urobilinogen,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UBG; UR; URINALYSIS; Urn; Urobili; Urobilngn,Urobilinogen Ur Ql Strip.auto,,Urobilinogen [Presence] in Urine by Automated test strip,,Urobilinogen Auto test strip Ql (U)
32624-9,Race,CLIN,AOEObservation; CLIN; Ethnicity; Nominal; Point in time; Random; Typ,Race,,Race,,
1795-4,Amylase,CHEM,"Alpha amylase; Ams; Amyl; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Diastase; Fl; Fld; FLU; Fluid; Gastro; Gastroenterology; GI; k87; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders",Amylase Fld-cCnc,arb U/L,Amylase [Enzymatic activity/volume] in Body fluid,U/L,Amylase (Body fld) [Catalytic activity/Vol]
51633-6,Platelets.reticulated/Platelets,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Immature platelets; Number fraction; Percent; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RP; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood; Young platelets,Platelets.reticulated NFr Bld,%,Platelets reticulated/Platelets in Blood,%,Platelets reticulated/Platelets (Bld)
19057-9,ABO & Rh group,BLDBK,ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; NB; New born; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; UniversalLabOrders; WB; Whole blood,ABO + Rh Bld NB,,ABO and Rh group [Type] in Blood from Newborn,,ABO and Rh group (Bld newborn)
17791-5,Sjogrens syndrome-B extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA SS-B; HA; Ha AB; La AB; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; Sjogren; SR; SS; SSB; SS-B; UniversalLabOrders,ENA SS-B Ab Ser-aCnc,Index; units/mL,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum,[arb'U]/mL,Sjogrens syndrome-B extractable nuclear Ab Qn (S)
16226-3,Benzoylecgonine,DRUG/TOX,BEC; BEG; Benz; Benzoylec; BZE; Cfm; CNFR; CNFRM; Cocaine degradation production; Cocaine metabolite; Conf; Confirmation; Confirmatory; Crack metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,BZE Ur Cfm-mCnc,ng/mL,Benzoylecgonine [Mass/volume] in Urine by Confirmatory method,ng/mL,Benzoylecgonine Confirm (U) [Mass/Vol]
609-8,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; Eyeball; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; UniversalLabOrders; Vision; Visual,Bacteria Eye Aerobe Cult,,Bacteria identified in Eye by Aerobe culture,,Bacteria identified Aer cx Nom (Eye)
17850-9,Herpes simplex virus 1 Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type I; HSV; HSV1; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,HSV1 IgG Ser Ql,,Herpes simplex virus 1 IgG Ab [Presence] in Serum,,HSV 1 IgG Ql (S)
8219-8,Opiates,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Opiates SerPl Ql Scn,,Opiates [Presence] in Serum or Plasma by Screen method,,Opiates Screen Ql
16126-5,Helicobacter pylori Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C pylori; Campylobacter pylori; Gastro; Gastroenterology; GI; H pyl; H pylori; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,H pylori IgG Ser Ql,,Helicobacter pylori IgG Ab [Presence] in Serum,,H. pylori IgG Ql (S)
2095-8,Cholesterol.in HDL/Cholesterol.total,CHEM,Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Lipid; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TC; TCHHDL; Tot; Totl,HDLc SerPl,ratio,Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma,{ratio},Cholesterol in HDL/Total Cholesterol [Mass ratio]
19139-5,Pathologist name,CLIN,CLIN; Nominal; Path; Person name; Point in time; Random,Pathologist name,,Pathologist name,,
8172-9,Cannabinoids,DRUG/TOX,Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; THC,Cannabinoids SerPl Ql Scn,,Cannabinoids [Presence] in Serum or Plasma by Screen method,,Cannabinoids Screen Ql
20639-1,Aspartate,CHEM,Asp; Aspartic acid; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,Aspartate SerPl-sCnc,mcmol/dL; mcmol/L; umol/L,Aspartate [Moles/volume] in Serum or Plasma,umol/L,Aspartate [Moles/Vol]
33513-3,Observation,CHEM,Chemistry; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sp Gr; Spec; To be specified in another part of the message; Unspecified,Sp Gr Spec,,Specific gravity of Specimen,,Specific gravity (Specimen)
33863-2,Cystatin C,CHEM,Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Cystatin C SerPl-mCnc,mg/L,Cystatin C [Mass/volume] in Serum or Plasma,mg/L,Cystatin C [Mass/Vol]
19926-5,Volume expired during 1.0 s of forced expiration/Forced vital capacity,PULM,Breathing; End tidal volume; Exp; FEV; FEV1; FEV1%; FEV1/FVC; Forced expiratory volume in 1 second; FVC; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; S prime; VC; Vet; Vol; Vol exp; Volume ratio,FEV1/FVC,%,FEV1/FVC,%,
6948-4,lamoTRIgine,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Lamictal; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,lamoTRIgine SerPl-mCnc,ug/mL,lamoTRIgine [Mass/volume] in Serum or Plasma,ug/mL,lamoTRIgine [Mass/Vol]
9842-6,Casts,UA,#/area; Cast; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Casts #/area UrnS LPF,/LPF,Casts [#/area] in Urine sediment by Microscopy low power field,/[LPF],Casts LM.LPF (Urine sed) [#/Area]
17863-2,Calcium.ionized,CHEM,Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Ca-I SerPl-mCnc,mg/dL,Calcium.ionized [Mass/volume] in Serum or Plasma,mg/dL,Calcium.ionized [Mass/Vol]
3093-2,Urea nitrogen,CHEM,"B/F; BF; Blood urea nitrogen; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; N; N2; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; UN; UniversalLabOrders",Urea nit Fld-mCnc,mg/dL,Urea nitrogen [Mass/volume] in Body fluid,mg/dL,Urea nitrogen (Body fld) [Mass/Vol]
20394-3,Sample lipemic,SPEC,Milky; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR,Sample Lipemic SerPl Ql,,Sample lipemic [Presence] of Serum or Plasma Qualitative,,Sample lipemic Ql
58429-2,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine",DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; GCMS; i; II; III; Illicit; LC/MS/MS; Level; Mass concentration; Methadone metabolite; Methadone.long acting metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,EDDP Ur Cfm-mCnc,ng/mL,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method",ng/mL,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) Confirm (U) [Mass/Vol]"
703-9,Basophilic stippling,HEM/BC,Baso stipl; Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stip; Stipl; WB; Whole blood,Baso Stipl Bld Ql Smear,,Basophilic stippling [Presence] in Blood by Light microscopy,,Basophilic stippling LM Ql (Bld)
38256-4,Cells counted.total,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Non-aggregate; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Total cells; Total Cells Counted; Totl",Total Cells Counted Fld,#,Cells Counted Total [#] in Body fluid,{#},Cells Counted Total (Body fld) [#]
1974-5,Bilirubin,CHEM,"B/F; BF; Bili; Bilirubins; Billirubin; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TBIL; UniversalLabOrders",Bilirub Fld-mCnc,mg/dL,Bilirubin.total [Mass/volume] in Body fluid,mg/dL,Bilirubin (Body fld) [Mass/Vol]
2350-7,Glucose,CHEM,Chemistry; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,Glucose Ur-mCnc,mg/dL,Glucose [Mass/volume] in Urine,mg/dL,Glucose (U) [Mass/Vol]
16246-1,Methadone,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; METD; Methadose; MTD; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Methadone Ur Cfm-mCnc,ng/mL,Methadone [Mass/volume] in Urine by Confirmatory method,ng/mL,Methadone Confirm (U) [Mass/Vol]
25148-8,Calcium oxalate crystals,UA,#/area; Ca; CaC2O4; Cal; CaOx; CaOx Cry; Crys; Cryst; Crystal; Ethanedioate; Ethanedioic acid; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Oxal; Oxalic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,CaOx Cry #/area UrnS HPF,/HPF,Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field,/[HPF],Calcium oxalate crystals LM.HPF (Urine sed) [#/Area]
8191-9,Cocaine,DRUG/TOX,Addiction; Benzoylmethylecgonine; Coke; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; Snow; SR; UniversalLabOrders,Cocaine SerPl Ql Scn,,Cocaine [Presence] in Serum or Plasma by Screen method,,Cocaine Screen Ql
9795-6,Composition,PATH,Calc; Calculi; Compn; Gastro; Gastroenterology; GI; Kidney; Nephrology; Nominal; Pathology; Point in time; Random; Renal; Stn; Stone; Stones; Typ,Compn Stone,,Composition in Stone,,Composition Nom (Stone)
19448-0,Dihydrocodeine,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DF-118; DHC; DHCPlus; Drocode; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,DHC Ur Cfm-mCnc,ng/mL,Dihydrocodeine [Mass/volume] in Urine by Confirmatory method,ng/mL,Dihydrocodeine Confirm (U) [Mass/Vol]
15410-4,Varicella zoster virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Shingles; SR; SUDS; UniversalLabOrders; VZ; VZV; Zoster,VZV IgG Ser Ql IA,,Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay,,VZV IgG IA Ql (S)
6276-0,Triticum aestivum Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f004; f4; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Triticum sativum; UniversalLabOrders; Wheat,Wheat IgE Qn,kIU/L; kU/L,Wheat IgE Ab [Units/volume] in Serum,k[IU]/L,Wheat IgE Qn (S)
428-3,rifAMPin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,rifAMPin Islt MIC,,rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC),,rifAMPin MIC [Susc]
13068-2,Nuclear Ab pattern,SERO,ABS; Aby; ACIF; ANA; ANA Pat; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; NA; Nominal; Nuc; Point in time; Random; Serology; Serum; SR; Time Resolved Fluorescence; TRF,ANA Pat Ser IF-Imp,,Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence,,Nuclear Ab pattern IF (S) [Interp]
31625-7,Sjogrens syndrome-A extractable nuclear Ab.IgG,SERO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA SS-A; Immune globulin G; Immunoglobulin G; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Serum; Sjogren; SR; SS; SSA; SS-A,ENA SS-A IgG Ser Ql,,Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum,,Sjogrens syndrome-A extractable nuclear IgG Ql (S)
6248-9,Glycine max Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f014; f14; Gly; Immune globulin E; Immunoglobulin E; Largest; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Soja hispida; Soy bean; Soya bean; Soyabean; Soybean; SR; UniversalLabOrders,Soybean IgE Qn,kIU/L; kU/L,Soybean IgE Ab [Units/volume] in Serum,k[IU]/L,Soybean IgE Qn (S)
82202-3,Yersinia enterocolitica DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification; Y enterocol; Y enterocolitica,Y enterocol DNA Stl Ql NAA+non-probe,,Yersinia enterocolitica DNA [Presence] in Stool by NAA with non-probe detection,,Y. enterocolitica DNA NAA+non-probe Ql (Stl)
82211-4,Norovirus genogroup I+II RNA,MICRO,2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Norovirus 1; Norovirus G1; Norovirus GI; Norovirus GI + GII; Norovirus GI + GII RNA; Norovirus GI+II; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,Norovirus GI+II RNA Stl Ql NAA+non-probe,,Norovirus genogroup I+II RNA [Presence] in Stool by NAA with non-probe detection,,Norovirus genogroup I+II RNA NAA+non-probe Ql (Stl)
82212-2,Rotavirus A RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,RVA RNA Stl Ql NAA+non-probe,,Rotavirus A RNA [Presence] in Stool by NAA with non-probe detection,,Rotavirus A RNA NAA+non-probe Ql (Stl)
18929-0,Gentamicin.high potency,ABXBACT,Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c213; Garamycin; Genirr; Genj; Gent; Gentamicin synergy; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Synergistic,Gentamicin Synergy Susc Islt,,Gentamicin.high potency [Susceptibility],,Gentamicin.high potency [Susc]
34524-9,Neutrophils.band form,HEM/BC,Auto; Automated detection; Bands; Blood; bnd; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Neuts Band Bld Ql Auto,,Band form neutrophils [Presence] in Blood by Automated count,,Band form neutrophils Auto Ql (Bld)
51487-7,Leukocytes,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells,WBC # Ur Auto,/uL,Leukocytes [#/volume] in Urine by Automated count,/uL,WBC Auto (U) [#/Vol]
43867-1,Beta-2 transferrin,CHEM,B; B2 Transferrin; Chemistry; II; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Siderophilin; SR; t fraction; Tf; Trf; TRFRN,B2 Transferrin Ser Ql,,Beta-2 transferrin [Presence] in Serum,,Beta-2 transferrin Ql (S)
82196-7,Campylobacter coli+jejuni+upsaliensis DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C coli; C coli+jej+upsa; C coli+jejuni; Campy; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,C coli+jej+upsa DNA Stl Ql NAA+non-probe,,Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with non-probe detection,,C. coli+jejuni+upsaliensis DNA NAA+non-probe Ql (Stl)
82199-1,Salmonella enterica+bongori DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S ent+bong; S enterica; Sal; Salmonel; Salmonella choleraesuis; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,S ent+bong DNA Stl Ql NAA+non-probe,,Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection,,S. enterica+bongori DNA NAA+non-probe Ql (Stl)
2467-9,IgG subclass 2,CHEM,Chemistry; IgG 2; IgG2; II; Immune globulin G; Immunoglobulin G; Immunoglobulin G subclass 2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Subclasses,IgG2 Ser-mCnc,g/L;mg/dL,IgG subclass 2 [Mass/volume] in Serum,mg/dL,IgG subclass 2 (S) [Mass/Vol]
30083-0,Epstein Barr virus nuclear Ab.IgG,MICRO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EBNA; EBV; EBV NA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,EBV NA IgG Ser IA-aCnc,IU/mL,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay,[IU]/mL,EBV nuclear IgG IA Qn (S)
2468-7,IgG subclass 3,CHEM,Chemistry; IgG 3; IgG3; III; Immune globulin G; Immunoglobulin G; Immunoglobulin G subclass 3; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Subclasses,IgG3 Ser-mCnc,g/L;mg/dL,IgG subclass 3 [Mass/volume] in Serum,mg/dL,IgG subclass 3 (S) [Mass/Vol]
20522-9,chlordiazePOXIDE,DRUG/TOX,Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Librium; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Chlordiazep Ur Cfm-mCnc,ug/mL,chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method,ug/mL,chlordiazePOXIDE Confirm (U) [Mass/Vol]
12286-1,Drugs,DRUG/TOX,Drug; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn,Drugs Ur Scn Nom,,Drugs identified in Urine by Screen method Nominal,,Drugs identified Screen Nom (U)
57782-5,Complete blood count W Ordered Manual Differential panel,PANEL.HEM/BC,Blood; CBC W ordered manual diff; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,CBC W ordered manual diff Bld,,CBC W Ordered Manual Differential panel - Blood,,CBC W Ordered Manual Differential panel (Bld)
2466-1,IgG subclass 1,CHEM,Chemistry; i; IgG 1; IgG1; Immune globulin G; Immunoglobulin G; Immunoglobulin G subclass 1; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Subclasses,IgG1 Ser-mCnc,g/L;mg/dL,IgG subclass 1 [Mass/volume] in Serum,mg/dL,IgG subclass 1 (S) [Mass/Vol]
20392-7,Sample icteric,SPEC,Icterus; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR,Sample Icteric SerPl Ql,,Sample icteric [Presence] of Serum or Plasma Qualitative,,Sample icteric Ql
20513-8,Turbidity,SPEC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC",Turbidity Fld Ql,,Turbidity [Presence] of Body fluid Qualitative,,Turbidity Ql (Body fld)
16229-7,clonazePAM,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,clonazePAM Ur Cfm-mCnc,ug/mL,clonazePAM [Mass/volume] in Urine by Confirmatory method,ug/mL,clonazePAM Confirm (U) [Mass/Vol]
51484-4,Hyaline casts,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Cast; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Kidney; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn,Hyaline Casts # Ur Auto,/uL,Hyaline casts [#/volume] in Urine by Automated count,/uL,Hyaline casts Auto (U) [#/Vol]
5786-9,Epithelial casts,UA,#/area; Cast; Epi; Epith; Epith Casts; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Epith Casts #/area UrnS LPF,/LPF,Epithelial casts [#/area] in Urine sediment by Microscopy low power field,/[LPF],Epithelial casts LM.LPF (Urine sed) [#/Area]
5247-2,Mitochondria Ab,SERO,ABS; Aby; ACIF; AMA; Antby; Anti; Antibodies; Antibodies to Microtubule Associated Protein 2; Antibody; Anticomplement Immunofluorescence; Antimitochondrial antibodies; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; M2; MA; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial Ab; PBC; Point in time; Primary Biliary Cirrhosis; Random; S; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; UniversalLabOrders,Mitochondria Ab Titr Ser IF,titer,Mitochondria Ab [Titer] in Serum by Immunofluorescence,{titer},Mitochondria Ab IF (S) [Titer]
8625-6,PR interval,EKG.MEAS,Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Point in time; P-R interval; QNT; Quan; Quant; Quantitative; Random,P-R interval,s,P-R Interval,s,
14367-7,Trichomonas vaginalis,MICRO,Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Prep; QL; Qual; Qualitative; Random; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Vag fld; Vag fluid; Vagina; Vaginal fluid; Wet mount; Wet prep,T vaginalis Vag Ql Wet Prep,,Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation,,T. vaginalis Wet prep Ql (Vag fld)
24114-1,Epstein Barr virus capsid Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAP; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; UniversalLabOrders; VCA; Viral capsid,EBV VCA IgG Ser Ql IA,,Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay,,EBV capsid IgG IA Ql (S)
46976-7,Benzodiazepines,DRUG/TOX,Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Benzodiaz SerPl Ql Scn,,Benzodiazepines [Presence] in Serum or Plasma by Screen method,,Benzodiazepines Screen Ql
1747-5,Albumin,CHEM,"Alb; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Hepatology; Kidney; Level; Liver; Mass Concentration; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UniversalLabOrders",Albumin Fld-mCnc,g/L;g/dL,Albumin [Mass/volume] in Body fluid,g/dL,Albumin (Body fld) [Mass/Vol]
53029-5,Neutrophil cytoplasmic Ab.perinuclear.atypical,SERO,ACIF; ACNA; ACPA; ANCA; Anticomplement Immunofluorescence; Atyp; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; Granulocyte ab; Granulocyte nucleus ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neut; Neutr; Neutrophils; NSNA; Ordinal; pANCA; p-ANCA; p-ANCA atypical; pANCA DNAse sensitive; pANCA DNAse sensitivity; Perinuclear ANCA; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Reactive; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF; Vasculitis,p-ANCA atypical Ser Ql IF,,Neutrophil cytoplasmic Ab.perinuclear.atypical [Presence] in Serum by Immunofluorescence,,Neutrophil cytoplasmic Ab.perinuclear.atypical IF Ql (S)
5640-8,Ethanol,DRUG/TOX,Alc; Alcohol; Blood; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Ethanol Bld-mCnc,mg/dL,Ethanol [Mass/volume] in Blood,mg/dL,Ethanol (Bld) [Mass/Vol]
18998-5,Trimethoprim+Sulfamethoxazole,ABXBACT,Acetylsulfamethoxazole; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bactrim; c202; c203; c223; c242; C61; C62; Cotrim; Cotrimoxazole; Co-trimoxazole; Gantanol; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Polytrim; Primsol; Proloprim; Random; Septra; SMX; SMX-TMP; Sulfa; Sulfamethox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; SXT; TMP; TMP SMX; TMP-SMX; Trimeth; Trimpex,TMP SMX Susc Islt,,Trimethoprim+Sulfamethoxazole [Susceptibility],,Trimethoprim+Sulfamethoxazole [Susc]
34571-0,Coagulation surface induced.lupus sensitive,COAG,Activated partial thromboplastin time; aPTT; aPTT with Platelin LS; aPTT-LA; Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube,Screen aPTT,s,aPTT.lupus sensitive (LA screen),s,aPTT.lupus sensitive Coag (PPP) [Time]
24115-8,Epstein Barr virus capsid Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAP; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; UniversalLabOrders; VCA; Viral capsid,EBV VCA IgM Ser Ql IA,,Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay,,EBV capsid IgM IA Ql (S)
116-4,cefOXitin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mefj; Mefoxin; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,cefOXitin Islt MIC,,cefOXitin [Susceptibility] by Minimum inhibitory concentration (MIC),,cefOXitin MIC [Susc]
6864-3,Hemoglobin S,HEM/BC,Blood; Haemoglobin; Hb; HBs; HEMATOLOGY/CELL COUNTS; Hgb; Hgb S; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S prime; Screen; Sickle cell; Sickle cell screen; Sickle cells; Sickledex; Sicklequik; Soly; UniversalLabOrders; WB; Whole blood,Hgb S Bld Ql Soly,,Hemoglobin S [Presence] in Blood by Solubility test,,Hemoglobin S Solubility test Ql (Bld)
54067-4,Clostridioides difficile toxin genes,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C diff; C diff Tox; C diff Tox gens; C difficile; Clostridium difficile; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders,C diff Tox gens Stl Ql NAA+probe,,Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection,,C. difficile toxin genes NAA+probe Ql (Stl)
66441-7,Beta hydroxybutyrate,CHEM,3-hydroxybutyrate; 3-hydroxybutyric acid; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; Blood; BOHB; B-OH-Butyr; Chemistry; Dip stick; Dipstick; Hydroxybutyric acid; Level; Point in time; Random; SmQn; Substance Concentration; WB; Whole blood,B-OH-Butyr Bld Strip-sCnc,mmol/L,Beta hydroxybutyrate [Moles/volume] in Blood by Test strip,mmol/L,Beta hydroxybutyrate Test strip (Bld) [Moles/Vol]
6273-7,Juglans spp Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f256; Immune globulin E; Immunoglobulin E; Juglans sp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders; Walnut; Walnuts,Walnut IgE Qn,kIU/L; kU/L,Walnut IgE Ab [Units/volume] in Serum,k[IU]/L,Walnut IgE Qn (S)
47387-6,Neisseria gonorrhoeae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen; Genital tract; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders; Urogenit; Urogenital,N gonorrhoea DNA Genital Ql NAA+probe,,Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection,,N. gonorrhoeae DNA NAA+probe Ql (Genital specimen)
72607-5,Streptococcus agalactiae,MICRO,C&S; Cult; Cultures; GBS; Genital vaginal; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rectal; S agalactiae; Screen; Spec; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; Vag fld; Vag fluid; Vagina; Vaginal fluid,Gp B Strep Vag+Rectum Ql Cult,,Streptococcus agalactiae [Presence] in Vag+Rectum by Organism specific culture,,S. agalactiae Org specific cx Ql (Vag+Rectum)
16233-9,Midazolam,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Versed,Midazolam Ur Cfm-mCnc,ug/mL,Midazolam [Mass/volume] in Urine by Confirmatory method,ug/mL,Midazolam Confirm (U) [Mass/Vol]
21424-7,Nuclear Ab.IgG,SERO,ABS; Aby; ACIF; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF,Nuclear IgG Ser Ql IF,,Nuclear IgG Ab [Presence] in Serum by Immunofluorescence,,Nuclear IgG IF Ql (S)
80382-5,Influenza virus A Ag,MICRO,Antigen; Antigens; Avian influenza; Bird flu; Breathing; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Lungs; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RS; Screen; Spec; SUDS; Up; Upper resp,FLUAV Ag Upper resp Ql IA.rapid,,Influenza virus A Ag [Presence] in Upper respiratory specimen by Rapid immunoassay,,FLUAV Ag IA.rapid Ql (Upper resp)
21416-3,Neisseria gonorrhoeae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UniversalLabOrders; UR; Urn,N gonorrhoea DNA Ur Ql NAA+probe,,Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection,,N. gonorrhoeae DNA NAA+probe Ql (U)
80383-3,Influenza virus B Ag,MICRO,Antigen; Antigens; Breathing; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Lungs; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RS; Screen; Spec; SUDS; Up; Upper resp,FLUBV Ag Upper resp Ql IA.rapid,,Influenza virus B Ag [Presence] in Upper respiratory specimen by Rapid immunoassay,,FLUBV Ag IA.rapid Ql (Upper resp)
26011-7,Macroamylase/Amylase.total,CHEM,Alpha amylase; Ams; Amyl; Catalytic Fraction; Chemistry; Diastase; k87; Macro amylase; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl,Macroamylase CFr SerPl,%,Macroamylase/Amylase.total in Serum or Plasma,%,Macroamylase [Catalytic fraction]
51196-4,Hemoglobin A1/Hemoglobin.total,HEM/BC,Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A1; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,Hgb A1 MFr Bld Elph,%,Hemoglobin A1/Hemoglobin.total in Blood by Electrophoresis,%,Hemoglobin A1 Elph (Bld) [Mass fraction]
66744-4,Heparin/body weight,COAG,Bdy weight; Blood; bod; Bodies; BW; COAGULATION; Hematology; Heme; Hep; Hepar; Heparn; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Wt,Heparin/BW Bld-mCnt,mg/Kg,Heparin/Body weight [Mass/mass] in Blood,mg/kg,Heparin/Body weight (Bld) [Mass/Mass]
16241-2,PHENobarbital,DRUG/TOX,Barbiturate; c417; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Luminal; Mass concentration; Nirvonal; PHBR; Phenobarb; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Phenobarb Ur Cfm-mCnc,ng/mL,PHENobarbital [Mass/volume] in Urine by Confirmatory method,ng/mL,PHENobarbital Confirm (U) [Mass/Vol]
38459-4,Crystals,UA,#/area; Crys; Cryst; Crystal; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Crystals #/area UrnS HPF,/HPF,Crystals [#/area] in Urine sediment by Microscopy high power field,/[HPF],Crystals LM.HPF (Urine sed) [#/Area]
17857-4,Rheumatoid factor,SERO,Dilution factor; Dilution Factor (Titer); Fac; Fact; Point in time; Random; RF; Rheum; Rheumatology; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr,Rheumatoid fact Titr Ser,titer,Rheumatoid factor [Titer] in Serum,{titer},Rheumatoid factor (S) [Titer]
45143-5,Methylenedioxyethylamphetamine,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; MDEA; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,MDEA Ur Cfm-mCnc,ng/mL,Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method,ng/mL,Methylenedioxyethylamphetamine Confirm (U) [Mass/Vol]
26487-9,Monocytes/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Monocytes NFr Fld,%,Monocytes/Leukocytes in Body fluid,%,Monocytes/Leukocytes (Body fld)
33768-3,Leukocyte clumps,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Leuc; Leuk; Leukocytes; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn; WBC; WBC clumps; WBCs; White blood cell; White blood cells,WBC clumps # Ur Auto,/uL,Leukocyte clumps [#/volume] in Urine by Automated count,/uL,Leukocyte clumps Auto (U) [#/Vol]
20124-4,Ventilation mode,PULM,Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory; Typ,Ventilation mode Vent,,Ventilation mode Ventilator,,
31969-9,Streptococcus pneumoniae Ag,MICRO,Antigen; Antigens; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; Screen; Spec; Spn; Strep; Strept; To be specified in another part of the message; Unspecified,S pneum Ag Spec Ql,,Streptococcus pneumoniae Ag [Presence] in Specimen,,S. pneumoniae Ag Ql (Specimen)
16237-0,Butalbital,DRUG/TOX,Addiction; Allylbarbital; Allylbarbituric acid; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fiorinal; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Butalbital Ur Cfm-mCnc,ng/mL,Butalbital [Mass/volume] in Urine by Confirmatory method,ng/mL,Butalbital Confirm (U) [Mass/Vol]
80349-4,Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EAEC; EAEC pAA plas aggR+aatA genes; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,EAEC pAA plas aggR+aatA St NAA+non-prb,,Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes [Presence] in Stool by NAA with non-probe detection,,E. coli enteroaggregative pAA plasmid aggR+aatA genes NAA+non-probe Ql (Stl)
18323-6,Smith extractable nuclear Ab.IgG,SERO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA SM; Immune globulin G; Immunoglobulin G; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SM; SR,ENA SM IgG Ser-aCnc,,Smith extractable nuclear IgG Ab [Units/volume] in Serum,[arb'U]/mL,Smith extractable nuclear IgG Qn (S)
57020-0,Urinalysis dipstick W Reflex Microscopic panel,PANEL.UA,Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UA dipstick W Reflex Micro pnl; UniversalLabOrders; UR; Urn,UA dipstick W Reflex Micro pnl Ur,,Urinalysis dipstick W Reflex Microscopic panel - Urine,,Urinalysis dipstick W Reflex Microscopic panel (U)
59705-4,Methadone,DRUG/TOX,Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Methadone SerPl Ql Scn,,Methadone [Presence] in Serum or Plasma by Screen method,,Methadone Screen Ql
8117-4,Cells.CD19/Cells,CELLMARK,B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,CD19 Cells NFr Bld,%,CD19 cells/cells in Blood,%,CD19 cells/cells (Bld)
46736-5,Fatty acid oxidation defects,CHEM,Acd; Acids; Blood; Chemistry; DBS; Dried blood spot; FA Oxidation; FAO; FAODS; Filter paper; FOD; FP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood,FOD DBS-Imp,,Fatty acid oxidation defects newborn screen interpretation,,Fatty acid oxidation defects (DBS) [Interp]
46744-9,Organic acidemias,CHEM,Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; OA; Point in time; Random; WB; Whole blood,OA DBS-Imp,,Organic acidemias newborn screen interpretation,,Organic acidemias (DBS) [Interp]
10230-1,Ejection fraction,HEMODYN.MOLEC,Cardiac; Cardio; Cardiology; EF; Frac; Fract; Fractionation; Fractions; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; L; LT; LV; LVEF; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Ventricular; Volfr; Volume fraction,LV EF,%,Left ventricular Ejection fraction,%,
18358-2,Methylenedioxymethamphetamine,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; MDMA; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,MDMA Ur Cfm-mCnc,ng/mL,Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method,ng/mL,Methylenedioxymethamphetamine Confirm (U) [Mass/Vol]
3282-1,Coagulation surface induced.hexagonal phase phospholipid,COAG,Activated partial thromboplastin time; aPTT; aPTT Hex PL; Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Hex; HPP; Lipid; Little(A)PTT; Partial Thromboplastin Time; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; STAClot LA; Surf; Tilt tube; UniversalLabOrders,aPTT Hex PL PPP,s,aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay,s,aPTT W excess hexagonal phase phospholipid Coag (PPP) [Time]
18893-8,cefTAZidime,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj,cefTAZidime Susc Islt,,cefTAZidime [Susceptibility],,cefTAZidime [Susc]
547-0,Streptococcus.beta-hemolytic,MICRO,B; B-Hem Strep; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Strep; Strept; To be specified in another part of the message; UniversalLabOrders; Unspecified,B-Hem Strep Spec Ql Cult,,Streptococcus.beta-hemolytic [Presence] in Specimen by Organism specific culture,,Streptococcus.beta-hemolytic Org specific cx Ql (Specimen)
49891-5,Human papilloma virus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HPV DNA Spec Ql NAA+probe,,Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection,,HPV DNA NAA+probe Ql (Specimen)
6968-2,Proteinase 3 Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; III; Point in time; PR3; PR-3; PR3-ANCA; Proteinase3; PRTN3; QNT; Quan; Quant; Quantitative; Random; Serine protease 3; Serology; Serum; SR; UniversalLabOrders; Vasculitis,Proteinase3 Ab Ser-aCnc,arb U/mL,Proteinase 3 Ab [Units/volume] in Serum,[arb'U]/mL,Proteinase 3 Ab Qn (S)
6189-5,Quercus alba Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Oak; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t007; t7; UniversalLabOrders; White oak,White Oak IgE Qn,kIU/L; kU/L,White Oak IgE Ab [Units/volume] in Serum,k[IU]/L,White Oak IgE Qn (S)
20545-0,Methylenedioxyamphetamine,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; MDA; Methylenedioxymethamphetamine metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,MDA Ur Cfm-mCnc,ug/mL,Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method,ug/mL,Methylenedioxyamphetamine Confirm (U) [Mass/Vol]
1668-3,17-Hydroxyprogesterone,CHEM,"17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; Chemistry; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders",17OHP SerPl-mCnc,ng/dL,17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma,ng/dL,17-Hydroxyprogesterone [Mass/Vol]
38482-6,Creatine kinase.MB,CHEM,Cardio; Cardiology; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Heart Disease; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,CK MB SerPl Ql,,Creatine kinase.MB [Presence] in Serum or Plasma,,CK.MB Ql
14912-0,Smudge cells/Leukocytes,HEM/BC,Basket cells; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Smudge Cells NFr Bld Manual,%,Smudge cells/Leukocytes in Blood by Manual count,%,Smudge cells/Leukocytes Manual cnt (Bld)
5206-8,Herpes simplex virus 1 Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type I; HSV; HSV1; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,HSV1 IgG Ser IA-aCnc,EIA Index,Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL;{Index_val},HSV 1 IgG IA Qn (S)
1501-6,Glucose^1H post 100 g glucose PO,CHAL.ROUTINE,1 hour; 1.0Hr; 1h p 100 g Glc PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Glucose 1h p 100 g Glc PO SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO,mg/dL,Glucose 1 Hr post 100 g glucose PO [Mass/Vol]
6085-5,Ambrosia elatior Ab.IgE,ALLERGY,A artemisiifolia; A elatior; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Ambrosia artemisiifolia; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common ragweed; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Short ragweed; SR; UniversalLabOrders; w001; w1,Common Ragweed IgE Qn,kIU/L; kU/L,Common Ragweed IgE Ab [Units/volume] in Serum,k[IU]/L,Common Ragweed IgE Qn (S)
9843-4,Circumference.occipital-frontal,BDYCRC.MOLEC,BODY CIRCUMFERENCE.MOLEC; Brain; Circumf OFC; Cranial; Cranium; Girth; Intracranial; Length; Point in time; QNT; Quan; Quant; Quantitative; Random; Skull,Head Circumf OFC,cm,Head Occipital-frontal circumference,cm,
19224-5,Oxygen saturation,HEMODYN.MOLEC,Bld mixed venous; Blood - mixed venous; Hemodynamics; HEMODYNAMICS.MOLEC; Lung; Mass fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2,SaO2 % BldMV,%,Oxygen saturation in Mixed venous blood,%,
20150-9,Volume expired during 1.0 s of forced expiration,PULM,Breathing; End tidal volume; Exp; FEV; FEV1; Forced expiratory volume in 1 second; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; S prime; Vet; Vol; Vol exp; Volume,FEV1,,FEV1,L,
80350-2,Shigella species+EIEC invasion plasmid antigen H (ipaH) gene,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Ag; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; EIEC; enteroinvasive E coli; enteroinvasive Escherichia coli; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shigella; Shigella sp+EIEC; Shigella sp+EIEC ipaH; Shigellosis; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,Shigella sp+EIEC ipaH St NAA+non-probe,,Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with non-probe detection,,Shigella species+EIEC invasion plasmid antigen H ipaH gene NAA+non-probe Ql (Stl)
82213-0,Sapovirus genogroups I+II+IV+V RNA,MICRO,2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Sapo I+II+IV+V; Sapov I+II+IV; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,Sapo I+II+IV+V RNA Stl Ql NAA+non-probe,,Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with non-probe detection,,Sapovirus genogroups I+II+IV+V RNA NAA+non-probe Ql (Stl)
20561-7,traMADol,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tramal; UA; Ultram; UR; Urn,traMADol Ur Cfm-mCnc,ug/mL,traMADol [Mass/volume] in Urine by Confirmatory method,ug/mL,traMADol Confirm (U) [Mass/Vol]
82210-6,Astrovirus subtypes 1-8 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Astro typ 1-8; Astro virus; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; HAstV; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,Astro typ 1-8 RNA Stl Ql NAA+non-probe,,Astrovirus subtypes 1-8 RNA [Presence] in Stool by NAA with non-probe detection,,Astrovirus subtypes 1-8 RNA NAA+non-probe Ql (Stl)
82203-1,Escherichia coli Stx1+Stx2 toxin stx1+stx2 genes,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EC stx1 + stx2 genes; EC stx1+stx2 genes; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shiga-Like Toxins; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,EC stx1+stx2 genes Stl Ql NAA+non-probe,,Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with non-probe detection,,E. coli stx1+stx2 genes NAA+non-probe Ql (Stl)
10895-1,Clostridioides difficile toxin B,MICRO,Bowel movement; C diff; C diff Tox; C diff Tox B; C difficile; Clostridium difficile; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal,C diff Tox B Stl Ql,,Clostridioides difficile toxin B [Presence] in Stool,,C. difficile toxin B Ql (Stl)
82198-3,Plesiomonas shigelloides DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P shigelloides; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,P shigelloides DNA Stl Ql NAA+non-probe,,Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection,,P. shigelloides DNA NAA+non-probe Ql (Stl)
82201-5,Vibrio cholerae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification; V cholera; V cholerae,V cholerae DNA Stl Ql NAA+non-probe,,Vibrio cholerae DNA [Presence] in Stool by NAA with non-probe detection,,V. cholerae DNA NAA+non-probe Ql (Stl)
82206-4,Cyclospora cayetanensis DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C cayetanenis; C cayetanensis; C cyaetinesus; Cyclo; Cyclosporiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,C cayetanensis DNA Stl Ql NAA+non-probe,,Cyclospora cayetanensis DNA [Presence] in Stool by NAA with non-probe detection,,C. cayetanensis DNA NAA+non-probe Ql (Stl)
82209-8,Adenovirus 40+41 DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV 40+41; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enteric adenoviruses; Faecal; Faeces; Fecal; Feces; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,AdV 40+41 DNA Stl Ql NAA+non-probe,,Adenovirus 40+41 DNA [Presence] in Stool by NAA with non-probe detection,,Adenovirus 40+41 DNA NAA+non-probe Ql (Stl)
80351-0,Escherichia coli enterotoxigenic ltA+st1a+st1b genes,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; E coli; ETEC; ETEC ltA+st1a+st1b; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,ETEC ltA+st1a+st1b tox St NAA+non-probe,,Escherichia coli enterotoxigenic ltA+st1a+st1b genes [Presence] in Stool by NAA with non-probe detection,,E. coli enterotoxigenic ltA+st1a+st1b genes NAA+non-probe Ql (Stl)
82207-2,Entamoeba histolytica DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Ameba; Amebiasis; Amebic; Amoeba; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E histolyt; E histolytica; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,E histolyt DNA Stl Ql NAA+non-probe,,Entamoeba histolytica DNA [Presence] in Stool by NAA with non-probe detection,,E. histolytica DNA NAA+non-probe Ql (Stl)
82200-7,Vibrio cholerae+parahaemolyticus+vulnificus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification; V chol+para+vul; V cholera; V cholerae,V chol+para+vul DNA Stl Ql NAA+non-probe,,Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with non-probe detection,,V. cholerae+parahaemolyticus+vulnificus DNA NAA+non-probe Ql (Stl)
82205-6,Cryptosporidium sp DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Crypt; Crypto; Cryptosporidiosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,Cryptosp DNA Stl Ql NAA+non-probe,,Cryptosporidium sp DNA [Presence] in Stool by NAA with non-probe detection,,Cryptosporidium sp DNA NAA+non-probe Ql (Stl)
82208-0,Giardia lamblia DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Beaver fever; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; G duodenalis; G intestinalis; G lamblia; Giardiasis; ID; Infectious Disease; InfectiousDisease; Lamblia intestinalis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification,G lamblia DNA Stl Ql NAA+non-probe,,Giardia lamblia DNA [Presence] in Stool by NAA with non-probe detection,,G. lamblia DNA NAA+non-probe Ql (Stl)
55793-4,Nucleated cells,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random",Nuc cell # Fld,10*3/uL,Nucleated cells [#/volume] in Body fluid,10*3/uL,Nucleated cells (Body fld) [#/Vol]
11266-4,Streptococcus agalactiae Ag,MICRO,Antigen; Antigens; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; S agalactiae; Screen; Spec; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; To be specified in another part of the message; UniversalLabOrders; Unspecified,Gp B Strep Ag Spec Ql,,Streptococcus agalactiae Ag [Presence] in Specimen,,S. agalactiae Ag Ql (Specimen)
28642-7,Oxygen saturation,CHEM,Bld cord; Chemistry; Cord arterial blood; Cord BldA; Gyn; Gynecology; Mass fraction; O2; OB; ObGyn; Obstetrics; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SaO2; SAT; Satn; SO2; tO2,SaO2 % BldCoA,%,Oxygen saturation in Arterial cord blood,%,SaO2% (BldCoA) [Mass fraction]
22633-2,Path report.site of origin,TUMRRGT,Anatomy; Narrative; Oncology; Point in time; Random; Report; Spec; TUMOR REGISTRY(NAACCR),Path report.site of origin Spec,,Pathology report site of origin Narrative,,
58374-0,Meprobamate,DRUG/TOX,Addiction; Carisoprodol metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Meprobamate Ur Cfm-mCnc,ng/mL,Meprobamate [Mass/volume] in Urine by Confirmatory method,ng/mL,Meprobamate Confirm (U) [Mass/Vol]
29893-5,HIV 1 Ab,MICRO,ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HIV1 Ab SerPl Ql IA,,HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay,,HIV 1 Ab IA Ql
58427-6,Carisoprodol,DRUG/TOX,Carisoma; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flexartal; GCMS; Isopropylmeprobamate; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rela; Sanoma; Soma; Somadril; Somalgit; UA; UR; Urn,Carisoprodol Ur Cfm-mCnc,ng/mL,Carisoprodol [Mass/volume] in Urine by Confirmatory method,ng/mL,Carisoprodol Confirm (U) [Mass/Vol]
3695-4,Insulin,CHEM,Chemistry; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente,Insulin SerPl-mCnc,ug/L,Insulin [Mass/volume] in Serum or Plasma,ug/L,Insulin [Mass/Vol]
6212-5,Penicillium notatum Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; m001; m1; P chrysogenum; P notatum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,P notatum IgE Qn,kIU/L; kU/L,Penicillium notatum IgE Ab [Units/volume] in Serum,k[IU]/L,P. notatum IgE Qn (S)
69563-5,Candida glabrata DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid,C glabrata DNA Vag Ql NAA+probe,,Candida glabrata DNA [Presence] in Vaginal fluid by NAA with probe detection,,C. glabrata DNA NAA+probe Ql (Vag fld)
33512-5,Observation,SPEC,Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified,Color Spec,,Color of Specimen,,Color (Specimen)
16253-7,Meperidine,DRUG/TOX,Addiction; Algil; Alodan; Centralgine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Pethidine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Meperidine Ur Cfm-mCnc,ng/mL,Meperidine [Mass/volume] in Urine by Confirmatory method,ng/mL,Meperidine Confirm (U) [Mass/Vol]
28639-3,Base excess,CHEM,Base ex; BE; Bld cord; BSE; Calc; Calculation; Chemistry; Cord BldV; Cord venous blood; EXS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Base excess BldCoV Calc-sCnc,mmol/L,Base excess in Venous cord blood by calculation,mmol/L,Base excess Calc (BldCoV) [Moles/Vol]
51480-2,Bacteria,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Bact; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; ID; Infectious Disease; InfectiousDisease; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn,Bacteria # Ur Auto,/uL,Bacteria [#/volume] in Urine by Automated count,/uL,Bacteria Auto (U) [#/Vol]
6041-8,Cynodon dactylon Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bermuda grass; g002; g2; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Bermuda grass IgE Qn,kIU/L; kU/L,Bermuda grass IgE Ab [Units/volume] in Serum,k[IU]/L,Bermuda grass IgE Qn (S)
16238-8,Secobarbital,DRUG/TOX,Addiction; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Secobarb; Seconal; UA; UR; Urn,Secobarbital Ur Cfm-mCnc,ng/mL,Secobarbital [Mass/volume] in Urine by Confirmatory method,ng/mL,Secobarbital Confirm (U) [Mass/Vol]
61807-4,How often did your fatigue make it difficult to organize your thoughts when doing things at work (include work at home) in past 7D,SURVEY.PROMIS,Fatigue difficult to organize work thoughts past 7D; Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS,,,How often did your fatigue make it difficult to organize your thoughts when doing things at work (include work at home) in past 7 days [PROMIS],,
64701-6,Have your menstrual periods stopped permanently,PHENX,Finding; Findings; Menstrual period stop permanent; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen,Menstrual period stop permanent PhenX,,Have your menstrual periods stopped permanently [PhenX],,
77247-5,Readiness for change for improved exercise,SURVEY.HWS,Activity; Exchange; EXCZ; Exercise; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Scale; Screen; Survey; SURVEY.HWS,,,Readiness for change for improved exercise [Reported],,
46733-2,Amino acidemias,CHEM,AA; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Urea Cyle; WB; Whole blood,Amino acidemias DBS-Imp,,Amino acidemias newborn screen interpretation,,Amino acidemias (DBS) [Interp]
5908-9,Platelets.giant,HEM/BC,Blood; Giant Platelets; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Platelet; Platelet adequacy; Platelet estimate; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood,Giant Platelets Bld Ql Smear,,Giant platelets [Presence] in Blood by Light microscopy,,Giant platelets LM Ql (Bld)
18267-5,Cells.CD16+CD56+/Cells,CELLMARK,Blood; CD16 Cells; CD16+CD56+ Cells; Cell; CELL MARKERS; Cellularity; FCGR3A; Leu11; Leu-11; Leu11b; Leu-11B; Leu19; Leu-19; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,CD16+CD56+ Cells NFr Bld,%,CD16+CD56+ cells/cells in Blood,%,CD16+CD56+ cells/cells (Bld)
22580-5,Toxoplasma gondii Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; T gondii; Toxo; Toxoplasmosis,T gondii IgG Ser Ql,,Toxoplasma gondii IgG Ab [Presence] in Serum,,T. gondii IgG Ql (S)
35254-2,Ammonia,CHEM,Amm; Ammon; Amon; Chemistry; Hepatology; Kidney; Level; Liver; Nephrology; NH3; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal,Ammonia Plas-msCnc,,Ammonia [Mass or Moles/volume] in Plasma,,Ammonia (P) [Mass or moles/Vol]
18906-8,Ciprofloxacin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Ciprofloxacin Susc Islt,,Ciprofloxacin [Susceptibility],,Ciprofloxacin [Susc]
20402-4,Cells.CD16+CD56+,CELLMARK,#; ABS; absolute; absolutes; Blood; CD16 Cells; CD16+CD56+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; FCGR3A; Leu11; Leu-11; Leu11b; Leu-11B; Leu19; Leu-19; NCAM; Neural cell adhesion molecule; NKH1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,CD16+CD56+ Cells # Bld,/uL,CD16+CD56+ cells [#/volume] in Blood,/uL,CD16+CD56+ cells (Bld) [#/Vol]
71575-5,ECG,NEMSIS,National EMS Information Services; Nominal; Point in time; Random; Typ,ECG NEMSIS,,ECG NEMSIS,,
58389-8,Normeperidine,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Meperidine metabolite; Norpethidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Normeperidine Ur Cfm-mCnc,ng/mL,Normeperidine [Mass/volume] in Urine by Confirmatory method,ng/mL,Normeperidine Confirm (U) [Mass/Vol]
46216-8,Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Arbitrary concentration; Blood; Contrl; ID; IFN; IGRA; Infectious Disease; InfectiousDisease; Lung; M tb; M TB tuberc IFN-g; M tuberculosis; Microbiology; Mitogen IGNF; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Normal; Point in time; PPD; Pulmonary; Pulmonology; Purified protein derivative; QFT; QNT; Quan; Quant; Quantiferon; Quantitative; Random; Respiratory; TB; Tuberculosis; Tuberculosis antigen; WB; Whole blood,M TB tuberc IGNF/Mitogen IGNF Control,IU/mL,Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon [Units/volume] in Control Blood,[IU]/mL,M. tuberculosis tuberculin stim IFN-g/Mitogen stimulated gamma interferon Qn (Bld control)
13315-7,Bacteria,MICRO,1 day; 24 hours; 24HR; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; UA; UR; Urn,Bacteria 24h Ur Cult,,Bacteria identified in 24 hour Urine by Culture,,Bacteria identified Cx Nom (24H U)
34564-5,Cell count & Differential panel,PANEL.HEM/BC,Cell Cnt + Diff Pnl; Cerebral spinal fluid; Cerebrospinal Fl; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; UniversalLabOrders,Cell Cnt + Diff Pnl CSF,,Cell count and Differential panel - Cerebral spinal fluid,,Cell count and Differential panel (CSF)
32554-8,Thiamine,CHEM,Blood; c106; c238; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UniversalLabOrders; Vit B1; Vit B-1; Vitamin B1; Vitamin B-1; WB; Whole blood,Vit B1 Bld-sCnc,nmol/L,Thiamine [Moles/volume] in Blood,nmol/L,Thiamine (Bld) [Moles/Vol]
3948-7,PHENobarbital,DRUG/TOX,Barbiturate; c417; DRUG/TOXICOLOGY; Drugs; Level; Luminal; Mass concentration; Nirvonal; PHBR; Phenobarb; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Phenobarb SerPl-mCnc,ug/mL,PHENobarbital [Mass/volume] in Serum or Plasma,ug/mL,PHENobarbital [Mass/Vol]
12805-8,Alkaline phosphatase isoenzyme,CHEM,Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Iso; AP; Arbitrary concentration; Chemistry; Hepatology; ISO; Isoen; Isoenzymes; Liver; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,ALP Iso SerPl-aCnc,arb U/L,Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma,[arb'U]/L,ALP Iso Qn
3299-5,Acetaminophen,DRUG/TOX,ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hepatology; Hydroxyacetanilide; Illicit; Liver; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Tylenol; u209; UA; UniversalLabOrders; UR; Urn,APAP Ur Ql,,Acetaminophen [Presence] in Urine,,Acetaminophen Ql (U)
11546-9,Observation,MICRO,ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Other Stn; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified,Other Stn Spec,,Microscopic observation [Identifier] in Specimen by Other stain,,Microscopic observation Other stain Nom (Specimen)
50555-2,Glucose,UA,Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Glu; Gluc; Glucoseur; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Glucose Ur Ql Strip.auto,,Glucose [Presence] in Urine by Automated test strip,,Glucose Auto test strip Ql (U)
49701-6,pH^^adjusted to patient's actual temperature,CHEM,adj; Blood; Chemistry; Kidney; Log molar concentration; Lung; Nephrology; Point in time; Pulmonary; Pulmonology; Random; Renal; Respiratory; S prime; SmQn; Temp; temp adj; WB; Whole blood,pH temp adj Bld,pH,pH of Blood adjusted to patient's actual temperature,[pH],pH adjusted to patient's actual temperature (Bld)
49049-0,Collection time,SPEC,Coll; Collect; Collect Tme; Collected; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Time stamp; Timestamp,Collect Tme Spec,,Collection time of Specimen,{clock_time},Collection time (Specimen) [Date/time]
46126-9,Endomysium Ab.IgA,SERO,ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; EMA; Endomysial; FA; Fluorescent antibody; Fluoresent; Gastro; Gastroenterology; GI; IFA; Immune fluorescence; Immune globulin A; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin A; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; Transglutaminase; TRF,Endomysium IgA Ser Ql IF,,Endomysium IgA Ab [Presence] in Serum by Immunofluorescence,,Endomysium IgA IF Ql (S)
53318-2,Epithelial cells.squamous,UA,Auto; Automated detection; Cell; Cellularity; Elec; Elect; Electr; Epi; Epi Cells; Epith; Epithelia; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urn,Squamous Ur Ql Auto,,Epithelial cells.squamous [Presence] in Urine by Automated,,Epithelial cells.squamous Auto Ql (U)
3286-2,Phospholipid Ab.IgG,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; Antiphospholipid; aPA; APL; Arbitrary concentration; Autoantibodies; Autoantibody; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Immune globulin G; Immunoglobulin G; Lipid; MEIA; Phoslpd; Phospholipids; Pl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS,Phospholipid IgG Ser IA-aCnc,,Phospholipid IgG Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,Phospholipid IgG IA Qn (S)
3287-0,Phospholipid Ab.IgM,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; Antiphospholipid; aPA; APL; Arbitrary concentration; Autoantibodies; Autoantibody; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Immune globulin M; Immunoglobulin M; Lipid; MEIA; Phoslpd; Phospholipids; Pl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS,Phospholipid IgM Ser IA-aCnc,,Phospholipid IgM Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,Phospholipid IgM IA Qn (S)
9804-6,Weight,PATH,Calc; Calculi; Gastro; Gastroenterology; GI; Kidney; Nephrology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; Wt,Wt Stone,grams;gm; mg,Weight of Stone,g,Weight (Stone)
20629-2,levoFLOXacin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,levoFLOXacin Susc Islt,,levoFLOXacin [Susceptibility],,levoFLOXacin [Susc]
64125-8,Pregabalin,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Lyrica; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Pregabalin Ur Cfm-mCnc,ng/mL,Pregabalin [Mass/volume] in Urine by Confirmatory method,ng/mL,Pregabalin Confirm (U) [Mass/Vol]
58402-9,Tapentadol,DRUG/TOX,Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal; UA; UR; Urn,Tapentadol Ur Cfm-mCnc,ng/mL,Tapentadol [Mass/volume] in Urine by Confirmatory method,ng/mL,Tapentadol Confirm (U) [Mass/Vol]
46737-3,Galactosemias,CHEM,Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood,Galactosemias DBS-Imp,,Galactosemias newborn screen interpretation,,Galactosemias (DBS) [Interp]
48633-2,Trypsinogen I.free,CHEM,Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; FR; Immunoreactive trypsin; IRT; Level; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Trypsinogen I Free; WB; Whole blood,Trypsinogen I Free DBS-mCnc,ug/L,Trypsinogen I Free [Mass/volume] in DBS,ug/L,Trypsinogen I Free (DBS) [Mass/Vol]
38478-4,Biotinidase,CHEM,Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UniversalLabOrders; WB; Whole blood,Biotinidase DBS Ql,,Biotinidase [Presence] in DBS,,Biotinidase Ql (DBS)
33288-2,Galactose 1 phosphate uridyl transferase,CHEM,Blood; Cerebrose; Chemistry; DBS; Dried blood spot; Filter paper; FP; GAL-1-P; Gal1PO4; GAL-1-PO4; GAL1PTS; Gal1PUT; GAL-1-PUT; Galactose 1 Phosphate Uridyltransferase; Galactosemia; GALT; GPUT; Hexose-1-phosphate uridyltransferase; i; i Phos; Inorganic phosphate; Ordinal; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Gal1PUT DBS Ql,,Galactose 1 phosphate uridyl transferase [Presence] in DBS,,Galactose 1 phosphate uridyl transferase Ql (DBS)
29574-1,Thyrotropin,CHEM,Blood; Chemistry; DBS; Dried blood spot; Endocrine; Endocrinology; Filter paper; FP; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thyroid stimulating hormone; Thyrotropic hormone; TSH; UniversalLabOrders; WB; Whole blood,TSH DBS Ql,,Thyrotropin [Presence] in DBS,,TSH Ql (DBS)
32854-2,17-Hydroxyprogesterone,CHEM,"17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; Blood; Chemistry; DBS; Dried blood spot; Endocrine; Endocrinology; Filter paper; FP; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UniversalLabOrders; WB; Whole blood",17OHP DBS Ql,,17-Hydroxyprogesterone [Presence] in DBS,,17-Hydroxyprogesterone Ql (DBS)
3551-9,diazePAM,DRUG/TOX,Addiction; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; UA; UR; Urn; Valium,diazePAM Ur-mCnc,ng/mL,diazePAM [Mass/volume] in Urine,ng/mL,diazePAM (U) [Mass/Vol]
18928-2,Gentamicin,ABXBACT,Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c213; Garamycin; Genirr; Genj; Gent; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Gentamicin Susc Islt,,Gentamicin [Susceptibility],,Gentamicin [Susc]
72810-5,Gabapentin,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Horizant; LC/MS/MS; Level; Mass concentration; Neurontin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Gabapentin Ur Cfm-mCnc,ng/mL,Gabapentin [Mass/volume] in Urine by Confirmatory method,ng/mL,Gabapentin Confirm (U) [Mass/Vol]
13886-7,Lactate dehydrogenase 1/Lactate dehydrogenase.total,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Fraction; Chemistry; Dehydrog; Dehyrdogenase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; i; L.D.H; Lact; Lactate dehydrogenase.fraction 1; Lactic acid; Lactic acid dehydrogenase; LD; LD1; LD-1; LDH; LDH isoenzyme 1; LDH1; L-lactate; L-lactate dehydrogenase; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Tumor marker; UA; UR; Urn,LDH1 CFr Ur Elph,%,Lactate dehydrogenase 1/Lactate dehydrogenase.total in Urine by Electrophoresis,%,LDH 1 Elph (U) [Catalytic fraction]
16239-6,Amobarbital,DRUG/TOX,Addiction; Amobarb; Amylobarbitone; Amytal; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Amobarbital Ur Cfm-mCnc,ng/mL,Amobarbital [Mass/volume] in Urine by Confirmatory method,ng/mL,Amobarbital Confirm (U) [Mass/Vol]
17898-8,Bacteria,MICRO,Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Throat; UniversalLabOrders; Upper respiratory,Bacteria Throat Aerobe Cult,,Bacteria identified in Throat by Aerobe culture,,Bacteria identified Aer cx Nom (Throat)
72770-1,Zolpidem,DRUG/TOX,Addiction; Adormix; Ambien; Ambien CR; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; GCMS; Hypnogen; Illicit; Ivedal; LC/MS/MS; Level; Lioran; Mass concentration; Myslee; Nasen; Nytamel; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sanval; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist,Zolpidem Ur Cfm-mCnc,ng/mL,Zolpidem [Mass/volume] in Urine by Confirmatory method,ng/mL,Zolpidem Confirm (U) [Mass/Vol]
25372-4,Choriogonadotropin,CHEM,Arbitrary concentration; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn,HCG Ur-aCnc,IU/L,Choriogonadotropin [Units/volume] in Urine,[IU]/L,HCG Qn (U)
21582-2,Tryptase,CHEM,Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Tryptase SerPl-mCnc,ug/L;ng/mL,Tryptase [Mass/volume] in Serum or Plasma,ng/mL,Tryptase [Mass/Vol]
29254-0,Linezolid,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zyvox,Linezolid Islt MIC,,Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC),,Linezolid MIC [Susc]
20532-8,Hydroxyethylflurazepam,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; LC/MS/MS; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,OH-Ethylfluraz Ur Cfm-mCnc,ng/mL,Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method,ng/mL,Hydroxyethylflurazepam Confirm (U) [Mass/Vol]
13949-3,Cytomegalovirus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; EIA; ELFA; ELISA; Enzyme immunoassay; HHV-5; Human Herpesvirus-5; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS,CMV IgG SerPl Ql IA,,Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay,,CMV IgG IA Ql
49876-6,Alpha hydroxytriazolam,DRUG/TOX,1-hydroxytriazolam; Alfa; Alpha hydroxy triazolam; A-OH-triazolam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy triazolam; LC/MS/MS; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; UA; UR; Urn,A-OH-triazolam Ur Cfm-mCnc,ng/mL,Alpha hydroxytriazolam [Mass/volume] in Urine by Confirmatory method,ng/mL,Alpha hydroxytriazolam Confirm (U) [Mass/Vol]
9187-6,Fluid output.urine,IO_OUT.MOLEC,Fld; Fluid output urine; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume,Fluid output urine,cm3,Urine output,cm3,
23883-2,Inhibin A,CHEM,Chemistry; DIA; Dimeric inhibin A; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Inhibin A SerPl-mCnc,ng/L;pg/mL,Inhibin A [Mass/volume] in Serum or Plasma,pg/L,Inhibin A [Mass/Vol]
72790-9,Alpha-Phenyl-2-Piperidine acetate,DRUG/TOX,Acetic acid; Alfa; Alpha-phenyl-2-piperidine acetic acid; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; GCMS; II; LC/MS/MS; Level; Mass concentration; Methylphenidate metabolite; Phenylpiperidine acetate; Phenylpiperidine acetic acid; Point in time; PPAA; QNT; Quan; Quant; Quantitative; Random; Ritalinate; Ritalinic acid; UA; UR; Urn,PPAA Ur Cfm-mCnc,ng/mL,Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method,ng/mL,Alpha-Phenyl-2-Piperidine acetate Confirm (U) [Mass/Vol]
35076-9,Monocytes,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Mono; Monocyte; Monos; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random",Monocytes # Fld,10*3/uL,Monocytes [#/volume] in Body fluid,10*3/uL,Monocytes (Body fld) [#/Vol]
12234-1,Mesothelial cells/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Mesothl Cell NFr Fld Manual,%,Mesothelial cells/Leukocytes in Body fluid by Manual count,%,Mesothelial cells/Leukocytes Manual cnt (Body fld)
43201-3,BK virus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load,BKV DNA Spec NAA+probe-Log#,log copies/mL,BK virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection,{Log_copies}/mL,BK virus DNA NAA+probe (Specimen) [Log #/Vol]
82197-5,Clostridioides difficile toxin A+B tcdA+tcdB genes,MICRO,"3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Bowel movement; C dif tox tcdA+tcdB; C diff; C diff Tox; C diff Tox A; C diff Tox A+B; C difficile; Clostridium difficile; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification",C dif tox tcdA+tcdB Stl Ql NAA+non-probe,,Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with non-probe detection,,C. difficile toxin A+B tcdA+tcdB genes NAA+non-probe Ql (Stl)
30000-4,Albumin/Creatinine,CHEM,Alb; Chemistry; CR; Crea; Creat; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Micro albumin; Microalbumin; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Ratios; Renal; Rto; UA; UCr; UR; Urn,Microalbumin/Creat Ur-Rto,mg/mmol creatinine,Microalbumin/Creatinine [Ratio] in Urine,mg/mmol{creat},Albumin/Creatinine DL <= 20 mg/L (U) [Ratio]
20112-9,Tidal volume setting,PULM,Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; TV; Vol; Vol setting; Volume; VT; VT setting,VT setting Vent,mL,Tidal volume setting Ventilator,mL,
51777-1,7-Aminoflunitrazepam,DRUG/TOX,7-amino flunitrazepam; 7Aminoflunitrazepam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,7Aminoflunitrazepam Ur Cfm-mCnc,ng/mL,7-Aminoflunitrazepam [Mass/volume] in Urine by Confirmatory method,ng/mL,7-Aminoflunitrazepam Confirm (U) [Mass/Vol]
92904-2,N-nortramadol,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite; UA; UR; Urn,N-nortramadol Ur Cfm-mCnc,ng/mL,N-nortramadol [Mass/volume] in Urine by Confirmatory method,ng/mL,N-nortramadol Confirm (U) [Mass/Vol]
7919-4,HIV 2 Ab,MICRO,ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HIV type 2; HIV type II; Human immunodeficiency virus; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR,HIV 2 Ab Ser Ql,,HIV 2 Ab [Presence] in Serum,,HIV 2 Ab Ql (S)
6265-3,Phleum pratense Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; g006; g6; Immune globulin E; Immunoglobulin E; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Timothy; Timothy grass; UniversalLabOrders,Timothy IgE Qn,kIU/L; kU/L,Timothy IgE Ab [Units/volume] in Serum,k[IU]/L,Timothy IgE Qn (S)
24007-7,Epstein Barr virus early Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EA; EBV; EBV EA; Epstn; HHV-4; human herpesvirus 4; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,EBV EA IgG Ser-aCnc,arb U/mL,Epstein Barr virus early IgG Ab [Units/volume] in Serum,[arb'U]/mL,EBV early IgG Qn (S)
24346-9,Parathyrin.intact & Calcium panel,PANEL.CHEM,Ca; Cal; Chemistry; Intact Parathormone; intact parathyroid hormone; iPTH; Pan; PANEL.CHEMISTRY; Panl; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Pnl; Point in time; PTH; PTH-Intact; PTH-Intact + Ca Pnl; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker,PTH-Intact + Ca Pnl SerPl,,Parathyrin.intact and Calcium panel - Serum or Plasma,,Parathyrin.intact and Calcium panel
6109-3,Ulmus americana Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American elm; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Elm; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t008; t8; UniversalLabOrders; White elm,White Elm IgE Qn,kIU/L; kU/L,White Elm IgE Ab [Units/volume] in Serum,k[IU]/L,White Elm IgE Qn (S)
20393-5,Sample hemolyzed,SPEC,Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEC; SR,Sample Hemolyzed SerPl Ql,,Sample hemolyzed [Presence] of Serum or Plasma Qualitative,,Sample hemolyzed Ql
5213-4,Heterophile Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Epstein-Barr virus; Hetero; Heteroph; Hetr; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Microbiology; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,Heteroph Ab Ser Ql LA,,Heterophile Ab [Presence] in Serum by Latex agglutination,,Heterophile Ab LA Ql (S)
8670-2,History of family member diseases,H&P.HX,Fam Mem; Family member diseases Hx; H/O; H+P; H+P.HX; History; Hx; Nominal; P prime; Point in time; Random,Family member diseases Hx,,History of family member diseases,,
53978-3,Epithelial cells.non-squamous,UA,Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Non-sq Epi Cells; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Round epithelial cells; Screen; Small epithelial cells; Sq; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Non-sq Epi Cells UrnS Ql Micro,,Epithelial cells.non-squamous [Presence] in Urine sediment by Light microscopy,,Epithelial cells.non-squamous LM Ql (Urine sed)
24338-6,Gas panel,PANEL.CHEM,BGas; Blood; Blood gas; Blood gases; Chemistry; Gas Pnl; Gases; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Gas Pnl Bld,,Gas panel - Blood,,Gas panel (Bld)
906-8,Blood group antigens present,BLDBK,Ag; Blood; BLOOD BANK; Identity or presence; Nominal; Point in time; Random; WB; Whole blood,Antigens Present Bld,,Blood group antigens present [Identifier] in Blood,,Blood group antigens present Nom (Bld)
49779-2,Ketones,UA,Acetest; Acetoacetate; Acetoacetates; Acetone bodies; Ketone; Ketone bodies; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn,Ketones Ur-mCnc,mg/dL,Ketones [Mass/volume] in Urine,mg/dL,Ketones (U) [Mass/Vol]
2657-5,Nitrite,CHEM,Chemistry; Level; Mass concentration; NO2; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Nitrite Ur-mCnc,mg/mL,Nitrite [Mass/volume] in Urine,mg/mL,Nitrite (U) [Mass/Vol]
10380-4,Stomatocytes,HEM/BC,Blood; Fish mouth cell; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stomatocyte; WB; Whole blood,Stomatocytes Bld Ql Smear,,Stomatocytes [Presence] in Blood by Light microscopy,,Stomatocytes LM Ql (Bld)
50544-6,Everolimus,DRUG/TOX,Afinitor; Blood; Certican; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; RAD-001; Random; UniversalLabOrders; WB; Whole blood; Zortress,Everolimus Bld-mCnc,ng/mL,Everolimus [Mass/volume] in Blood,ng/mL,Everolimus (Bld) [Mass/Vol]
70122-7,Epithelial cells.squamous,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells",Squamous Fld Ql,,Epithelial cells.squamous [Presence] in Body fluid,,Epithelial cells.squamous Ql (Body fld)
34481-2,Blood group antibodies,BLDBK,BLOOD BANK; Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Blood group antibodies SerPl Warm,,Blood group antibodies identified in Serum or Plasma by Warm incubation,,Blood group antibodies identified Warm incubation Nom
58450-8,Bilirubin,UA,Bili; Bilirubins; Billirubin; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; GCMS; Ictotest; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TBIL; UA; UR; URINALYSIS; Urn,Bilirub Ur Ql Cfm,,Bilirubin [Presence] in Urine by Confirmatory method,,Bilirubin Confirm Ql (U)
3052-8,Triiodothyronine.reverse,CHEM,Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; REV; Reverse T3; rT3; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3; T-3; T3Reverse; thyroid hormone; Total T3; Triodothyrne; UniversalLabOrders,T3Reverse SerPl-mCnc,ng/mL; pg/mL,Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma,pg/mL,T3.reverse [Mass/Vol]
8636-3,QTC interval,EKG.MEAS,Cardiac; Cardio; Cardiology; EKG; EKG.MEASUREMENTS; Electrocardiogram; Heart Disease; Hrt; Point in time; QNT; Q-T interval corrected; Quan; Quant; Quantitative; Random,Q-T interval corrected,s,Q-T interval corrected,s,
27416-7,SCL-70 extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Arbitrary concentration; Autoantibodies; Autoantibody; DNA-Topoisomerase I; ENA; ENA Scl70; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Scleroderma ab; Serology; Serum; SR; Topo I; Topoisomerase I; UniversalLabOrders,ENA Scl70 Ab Ser-aCnc,arb U/mL,SCL-70 extractable nuclear Ab [Units/volume] in Serum,[arb'U]/mL,SCL-70 extractable nuclear Ab Qn (S)
772-4,Erythrocytes.nucleated,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Manl; Normoblasts; nRBC; nRBCs; Nuc; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,nRBC # Bld Manual,10*9/L,Nucleated erythrocytes [#/volume] in Blood by Manual count,10*3/uL,Nucleated RBC Manual cnt (Bld) [#/Vol]
32769-2,Alpha 1 antitrypsin phenotype,CHEM,A1; A1A; A1AT; A-1-AT; A1-AT; A1AT Phenotyp; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Chemistry; Hepatology; i; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Liver; Lung; Nominal; Pl; Plasma; Plsm; Point in time; Pulmonary; Pulmonology; Random; Respiratory; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,A1AT Phenotyp SerPl-Imp,,Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma,,Alpha 1 antitrypsin phenotype [Interp]
60568-3,Synoptic report,PATH,Document; Finding; Findings; Path; Pathology; Point in time; Random,Pathology synoptic report,,Pathology synoptic report,,Pathology synoptic report
29953-7,Nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; UniversalLabOrders,ANA Titr Ser,titer,Nuclear Ab [Titer] in Serum,{titer},Nuclear Ab (S) [Titer]
18864-9,Ampicillin,ABXBACT,Amcil; Amicil; Amp; Ampicilloyl; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c5; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Omnipen; Penbritin; Point in time; Polycillin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Ampicillin Susc Islt,,Ampicillin [Susceptibility],,Ampicillin [Susc]
32709-8,Neutrophils,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Neut; Neutr; Neutrophil; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random",Neutrophils # Fld,/uL,Neutrophils [#/volume] in Body fluid,10*3/uL,Neutrophils (Body fld) [#/Vol]
12293-7,Cotinine,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Nicotine metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Cotinine Ur Ql,,Cotinine [Presence] in Urine,,Cotinine Ql (U)
23904-6,Monocytes+Macrophages/Leukocytes,HEM/BC,Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Manl; Mono; Monocyte; Monos; Monos+Macros; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells,Monos+Macros NFr CSF Manual,%,Monocytes+Macrophages/Leukocytes in Cerebral spinal fluid by Manual count,%,Monocytes+Macrophages/Leukocytes Manual cnt (CSF)
31868-3,Legionella pneumophila 1 Ag,MICRO,Antigen; Antigens; i; ID; Infectious Disease; InfectiousDisease; L pneumo; L pneumo1; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 1; Microbiology; Ordinal; Philadelphia 1; Pneu; pneum; Pneumophilia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn,L pneumo1 Ag Ur Ql,,Legionella pneumophila 1 Ag [Presence] in Urine,,L. pneumophila 1 Ag Ql (U)
30567-2,Thyroid stimulating immunoglobulins,CHEM,Arbitrary concentration; Chemistry; Endocrine; Endocrinology; HTS; Human Thyroid Stimulator; LATS; Long-acting thyroid stimulator; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Thyroid stimulating antibody; TSAb; TSI,TSI Ser-aCnc,Index,Thyroid stimulating immunoglobulins [Units/volume] in Serum,{Index_val},Thyroid stimulating immunoglobulins Qn (S)
3969-3,Phenytoin.free,DRUG/TOX,DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; FR; Lehydan; Level; Mass concentration; Non-protein bound; Phenhydan; Phenytoin Free; PHYT; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; UniversalLabOrders; Zentropil,Phenytoin Free SerPl-mCnc,ug/mL,Phenytoin Free [Mass/volume] in Serum or Plasma,ug/mL,Phenytoin Free [Mass/Vol]
69565-0,Atopobium vaginae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; A vaginae; A vaginae DNA; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid,A vaginae DNA Vag Ql NAA+probe,,Atopobium vaginae DNA [Presence] in Vaginal fluid by NAA with probe detection,,A. vaginae DNA NAA+probe Ql (Vag fld)
53774-6,Epstein Barr virus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load,EBV DNA Spec NAA+probe-Log#,log copies/mL,Epstein Barr virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection,{Log_copies}/mL,EBV DNA NAA+probe (Specimen) [Log #/Vol]
80316-3,Pain scale,H&P.PX,H+P; H+P.PX; Nominal; P prime; Point in time; Random; Typ,Pain scale type,,Pain scale [Type],,
31111-8,Reticulocytes/Erythrocytes^^hematocrit adjusted,HEM/BC,adj; Blood; Discocytes; Erthrocyte; Erythrocyte; Hct; Hct adj; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number Fraction; PCV; Percent; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Retic; Retics; Reticulocyte; WB; Whole blood,Reticulocyte production index,%,Reticulocyte production index,%,Reticulocytes/Erythrocytes hematocrit adjusted (Bld)
47531-9,Wet mount panel,PANEL.MICRO,Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Vag fld; Vag fluid; Vagina; Vaginal fluid; Wet mount Pnl,Wet mount Pnl Vag,,Wet mount panel - Vaginal fluid,,Wet mount panel (Vag fld)
11274-8,Elliptocytes,HEM/BC,Blood; Elliptocyte; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Elliptocytes Bld Ql Smear,,Elliptocytes [Presence] in Blood by Light microscopy,,Elliptocytes LM Ql (Bld)
64217-3,"Do you now smoke cigarettes, as of 1Mo ago",PHENX,Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke cigarettes now,Smoke cigarettes now PhenX,,"Do you now smoke cigarettes, as of 1 month ago [PhenX]",,
2283-0,Folate,CHEM,Chemistry; Erythrocytes; Folat; Folic acid; Level; Mass concentration; Point in time; Pteroylglutamate; Pteroylglutamic acid; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; UniversalLabOrders; Vit M; Vitamin M,Folate RBC-mCnc,ng/mL,Folate [Mass/volume] in Red Blood Cells,ng/mL,Folate (RBC) [Mass/Vol]
1839-0,Ammonia,CHEM,Amm; Ammon; Amon; Blood; Chemistry; Hepatology; Kidney; Level; Liver; Nephrology; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration; WB; Whole blood,Ammonia Bld-sCnc,umol/L,Ammonia [Moles/volume] in Blood,umol/L,Ammonia (Bld) [Moles/Vol]
19087-6,Collection end time,SPEC,Coll; Collect; Collect End Tme; Collected; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Time stamp; Timestamp; UA; UR; Urn,Collect End Tme Ur,,Collection of urine specimen end time,{clock_time},Collection end time (U) [Date/time]
12646-6,Glucose^1H post XXX challenge,CHAL,1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Glucose 1h p chal SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge,mg/dL,Glucose 1 Hr post Unsp challenge [Mass/Vol]
19258-3,Oxygen^^adjusted to patient's actual temperature,CHEM,adj; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Lung; O2; O2 partial pressure; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; S prime; Temp; temp adj; tO2; Venous,pO2 temp adj BldV,mm Hg,Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood,mm[Hg],Oxygen adjusted to patient's actual temperature (BldV) [Partial pressure]
49036-7,Parathyrin.intact^post excision,CHAL,After; CHEMISTRY.CHALLENGE TESTING; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Mass concentration; p Excision; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; post surgery; PST; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker,PTH-Intact p Excision SerPl-mCnc,pg/mL,Parathyrin.intact [Mass/volume] in Serum or Plasma --post excision,pg/mL,Parathyrin.intact post excision [Mass/Vol]
5126-8,Cytomegalovirus Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; EIA; ELFA; ELISA; Enzyme immunoassay; HHV-5; Human Herpesvirus-5; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,CMV IgM SerPl IA-aCnc,,Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay,{Index_val},CMV IgM IA Qn
58805-3,Leukocytes,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Dip stick; Dipstick; Elec; Elect; Electr; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells,WBC # Ur Strip.auto,/uL,Leukocytes [#/volume] in Urine by Automated test strip,/uL,WBC Auto test strip (U) [#/Vol]
5156-5,Epstein Barr virus nuclear Ab.IgG,MICRO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; EBNA; EBV; EBV NA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; UniversalLabOrders,EBV NA IgG Ser Ql IA,,Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay,,EBV nuclear IgG IA Ql (S)
43895-2,Influenza virus B Ag,MICRO,Antigen; Antigens; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen,FLUBV Ag Nph Ql,,Influenza virus B Ag [Presence] in Nasopharynx,,FLUBV Ag Ql (Nph)
2963-7,Somatotropin,CHEM,Chemistry; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH; UniversalLabOrders,GH SerPl-mCnc,ug/L;mg/mL; ng/mL,Somatotropin [Mass/volume] in Serum or Plasma,ng/mL,Somatotropin [Mass/Vol]
5644-0,Ethanol,DRUG/TOX,Alc; Alcohol; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Ethanol Ur Ql,,Ethanol [Presence] in Urine,,Ethanol Ql (U)
5393-4,Treponema pallidum Ab,MICRO,ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluorescent treponemal antibody; Fluoresent; FTA-ABS; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Syphilis; T pallidum; Time Resolved Fluorescence; Treponemal; TRF; UniversalLabOrders,T pallidum Ab Ser Ql IF,,Treponema pallidum Ab [Presence] in Serum by Immunofluorescence,,T. pallidum Ab IF Ql (S)
43874-7,Influenza virus A Ag,MICRO,Antigen; Antigens; Avian influenza; Bird flu; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen,FLUAV Ag Nph Ql,,Influenza virus A Ag [Presence] in Nasopharynx,,FLUAV Ag Ql (Nph)
21667-1,F5 gene targeted mutation analysis,MOLPATH.MUT,"Activated protein C cofactor; APC; Blood; Coagulation Factor V - Leiden gene; coagulation factor V (proaccelerin, labile factor); FVL; Genetics; Heredity; Heritable; Identity or presence; Inherited; Labile factor; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCCF; PCR; Point in time; Proaccelerin gene; Random; RPRGL1; THPH2; Thrombophilia; Tissue; Tissue, unspecified; UniversalLabOrders; WB; Whole blood; Whole blood or Tissue",F5 gene Mut Anl Bld/T,,F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,,F5 gene targeted mutation analysis Molgen Nom (Bld/Tiss)
6879-1,Corticotropin,CHEM,ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; Chemistry; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; RADIOIMMUNOASSAY; Random; Rc206; Tumor marker,ACTH Plas RIA-mCnc,pg/mL,Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA),pg/mL,Corticotropin RIA (P) [Mass/Vol]
32766-8,Trichomonas vaginalis,MICRO,Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; OB; ObGyn; Obstetrics; Ordinal; Other; Point in time; PR; Prep; QL; Qual; Qualitative; Random; Screen; Spec; T vaginalis; To be specified in another part of the message; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Unspecified; Wet mount; Wet prep,T vaginalis Spec Ql Wet Prep,,Trichomonas vaginalis [Presence] in Specimen by Wet preparation,,T. vaginalis Wet prep Ql (Specimen)
32683-5,Hemoglobin S/Hemoglobin.total,HEM/BC,Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HBs; HEMATOLOGY/CELL COUNTS; Hgb; Hgb S; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sickle cell; Sickle cells; Tot; Totl; WB; Whole blood,Hgb S MFr Bld Elph,%,Hemoglobin S/Hemoglobin.total in Blood by Electrophoresis,%,Hemoglobin S Elph (Bld) [Mass fraction]
16503-5,C reactive protein,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; CRP; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Reac; React",CRP Fld-mCnc,ng/dL,C reactive protein [Mass/volume] in Body fluid,mg/dL,CRP (Body fld) [Mass/Vol]
2639-3,Myoglobin,CHEM,Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Mb; Myog; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Myoglobin SerPl-mCnc,ug/L;ng/mL,Myoglobin [Mass/volume] in Serum or Plasma,ng/mL,Myoglobin [Mass/Vol]
6771-0,Alpha 1 antitrypsin,CHEM,A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Chemistry; Hepatology; i; Level; Light scattering; Liver; Lung; Mass Concentration; Nephelom; Pl; Plasma; Plsm; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,A1AT SerPl Neph-mCnc,g/L,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry,g/L,Alpha 1 antitrypsin Nephelometry [Mass/Vol]
20512-0,Turbidity,SPEC,Cerebral spinal fluid; Cerebrospinal Fl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid,Turbidity CSF Ql,,Turbidity [Presence] of Cerebral spinal fluid Qualitative,,Turbidity Ql (CSF)
47251-4,BK virus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,BKV DNA Spec Ql NAA+probe,,BK virus DNA [Presence] in Specimen by NAA with probe detection,,BK virus DNA NAA+probe Ql (Specimen)
5209-2,Herpes simplex virus 2 Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,HSV2 IgG Ser IA-aCnc,EIA Index,Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay,{Index_val},HSV 2 IgG IA Qn (S)
14361-0,Observation,MICRO,Genital vaginal; Gram Stn; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; St; Stains; Stn; Vag fld; Vag fluid; Vagina; Vaginal fluid,Gram Stn Vag,,Microscopic observation [Identifier] in Vaginal fluid by Gram stain,,Microscopic observation Gram stain Nom (Vag fld)
18895-3,cefTRIAXone,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c9; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Rocephin; ROCJ; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,cefTRIAXone Susc Islt,,cefTRIAXone [Susceptibility],,cefTRIAXone [Susc]
5813-1,Trichomonas vaginalis,UA,Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,T vaginalis UrnS Ql Micro,,Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy,,T. vaginalis LM Ql (Urine sed)
2250-9,Estriol.unconjugated,CHEM,Chemistry; E3; Estriol free; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; u Estriol; uE3; Uncnj; Unconj; Unconjug; Unconjugat; UniversalLabOrders,u Estriol SerPl-mCnc,ng/mL,Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma,ng/mL,E3.unconjugated [Mass/Vol]
18878-9,ceFAZolin,ABXBACT,Ancef; ANTIBIOTIC SUSCEPTIBILITIES; AST; C32; Cefamezin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kefj; Kefzol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Totacef; Zolicef,ceFAZolin Susc Islt,,ceFAZolin [Susceptibility],,ceFAZolin [Susc]
47252-2,Hepatitis C virus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HCV; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders; Viral load,HCV RNA SerPl NAA+probe-Log#,log copies/mL,Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,{log_copies}/mL,HCV RNA NAA+probe [Log #/Vol]
51486-9,Epithelial cells.squamous,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Epi; Epi Cells; Epith; Epithelia; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urn,Squamous # Ur Auto,/uL,Epithelial cells.squamous [#/volume] in Urine by Automated count,/uL,Epithelial cells.squamous Auto (U) [#/Vol]
8333-7,Body temperature,BDYTMP.MOLEC,Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Ear; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature,Tymp memb temp,deg F; deg C,Tympanic membrane temperature,Cel;[degF],
18955-5,Nitrofurantoin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Furadantin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Macrobid; Macrodantin; Nitrofurant; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Nitrofurantoin Susc Islt,,Nitrofurantoin [Susceptibility],,Nitrofurantoin [Susc]
72170-4,Photographic image,DOC.ONTOLOGY,DOC.ONT; Document; Finding; Findings; Photo image; Point in time; Random,Photo image,,Photographic image,,
2748-2,pH,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Log molar concentration; Point in time; Random; SmQn; UniversalLabOrders",pH Fld,pH,pH of Body fluid,[pH],pH (Body fld)
46217-6,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells,MICRO,Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Arbitrary concentration; Blood; Cell; Cellularity; Helper T cells; ID; IFN; IGRA; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Lung; M tb; M TB IFN-g; M TB IFN-g CD4+ T-cells; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; T prime; T4; T-4; TB; Tuberculosis; W3/25; WB; Whole blood,M TB IFN-g CD4+ T-cells Bld-aCnc,IU/mL,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood,[IU]/mL,M. tuberculosis stim IFN-g by CD4+ T-cells Qn (Bld)
20569-0,Creatine kinase.MB/Creatine kinase.total,CHEM,Cardio; Cardiology; Catalytic Fraction; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Heart Disease; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl,CK MB CFr SerPl,%,Creatine kinase.MB/Creatine kinase.total in Serum or Plasma,%,CK.MB [Catalytic fraction]
7155-5,Acer negundo Ab.IgE,ALLERGY,A negundo; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Box elder; Boxelder; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t001; t1; UniversalLabOrders,Boxelder IgE Qn,kIU/L,Boxelder IgE Ab [Units/volume] in Serum,k[IU]/L,Boxelder IgE Qn (S)
29512-1,Beta hydroxybutyrate,CHEM,3-hydroxybutyrate; 3-hydroxybutyric acid; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; BOHB; B-OH-Butyr; Chemistry; Hydroxybutyric acid; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,B-OH-Butyr SerPl-mCnc,mcg/mL; mg/dL,Beta hydroxybutyrate [Mass/volume] in Serum or Plasma,mg/dL,Beta hydroxybutyrate [Mass/Vol]
6087-1,Zea mays Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Corn; f008; f141; f74; f8; Immune globulin E; Immunoglobulin E; Maize; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Corn IgE Qn,kIU/L; kU/L,Corn IgE Ab [Units/volume] in Serum,k[IU]/L,Corn IgE Qn (S)
9800-4,Number,PATH,Calc; Calculi; Cnt; Count; Gastro; Gastroenterology; GI; Kidney; Nephrology; No; Num; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones,Number Stone,#,Number of Stones,{#},Number (Stone) [#]
22415-4,Mumps virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; MuV; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,MuV IgG Ser Ql,,Mumps virus IgG Ab [Presence] in Serum,,MuV IgG Ql (S)
6874-2,Calcium,CHEM,1 day; 24 hours; 24HR; Ca; Cal; Chemistry; Kidney; Mass Rate; mRate; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn,Calcium 24h Ur-mRate,mg/24 H,Calcium [Mass/time] in 24 hour Urine,mg/(24.h),Calcium (24H U) [Mass/Time]
1928-1,Immunoglobulin light chains,CHEM,Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn,BJ Protein Ur Ql,,Immunoglobulin light chains [Presence] in Urine,,Immunoglobulin light chains Ql (U)
69562-7,Candida albicans DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C albicans; C albicans DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid,C albicans DNA Vag Ql NAA+probe,,Candida albicans DNA [Presence] in Vaginal fluid by NAA with probe detection,,C. albicans DNA NAA+probe Ql (Vag fld)
69566-8,Bacterial vaginosis associated bacterium 2 DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Assoc; Bact; BVAB2; BVAB2 DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid,BVAB2 DNA Vag Ql NAA+probe,,Bacterial vaginosis associated bacterium 2 DNA [Presence] in Vaginal fluid by NAA with probe detection,,Bacterial vaginosis associated bacterium 2 DNA NAA+probe Ql (Vag fld)
24124-0,Casts,UA,Cast; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Casts UrnS Ql Micro,,Casts [Presence] in Urine sediment by Light microscopy,,Casts LM Ql (Urine sed)
4532-8,Complement total hemolytic CH50,HEM/BC,Arbitrary concentration; Comp; Complement CH50; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Total Hem Comp; Totl; UniversalLabOrders,CH50 SerPl-aCnc,arb U/mL,Complement total hemolytic CH50 [Units/volume] in Serum or Plasma,[arb'U]/mL,Complement total hemolytic CH50 Qn
30352-9,Hemoglobin,HEM/BC,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Finger stick; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random,Hgb BldC-mCnc,g/dL,Hemoglobin [Mass/volume] in Capillary blood,g/dL,Hemoglobin (BldC) [Mass/Vol]
34531-4,Blood type & Crossmatch panel,PANEL.BLDBK,Blood; BLOOD BANK; Hematology; Heme; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Type + XM Pnl; WB; Whole blood,Type + XM Pnl Bld,,Blood type and Crossmatch panel - Blood,,Blood type and Crossmatch panel (Bld)
46383-6,Views for bone density,RAD,BMD; BON; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; Films; Imaging; MAric; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; View; Views for BMD; VWS,DXA Bone ArMass BMD,g/cm2,DXA Bone [Mass/Area] Bone density,g/cm2,
69567-6,Megasphaera sp type 1 DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mega1; Mega1 DNA; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid,Mega1 DNA Vag Ql NAA+probe,,Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection,,Megasphaera sp type 1 DNA NAA+probe Ql (Vag fld)
504-1,Ticarcillin+Clavulanate,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Betimol; Blocadren; c305; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Novo-timol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Ticar; Ticar Clav; Timentin; TIMJ,Ticarcillin+Clav Islt MIC,,Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC),,Ticarcillin+Clavulanate MIC [Susc]
58465-6,DNA double strand Ab.IgG,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Native DNA; N-DNA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stranded; Strnd; SUDS,dsDNA IgG Ser Ql IA,,DNA double strand IgG Ab [Presence] in Serum by Immunoassay,,DNA double strand IgG IA Ql (S)
26028-1,HLA-B27,HLA,"Blood; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; UniversalLabOrders; WB; Whole blood; Whole blood or Tissue",HLA-B27 Ql FC,,HLA-B27 [Presence] by Flow cytometry (FC),,HLA-B27 FC Ql (Bld/Tiss)
15283-5,Betula verrucosa Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common silver birch; IFR; Immune globulin E; Immunoglobulin E; Isoflavone reductase; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Silver Birch; SR; t3; UniversalLabOrders,Silver Birch IgE Qn,kIU/L,Silver Birch IgE Ab [Units/volume] in Serum,k[IU]/L,Silver Birch IgE Qn (S)
33930-9,Coagulation surface induced.hexagonal phase phospholipid,COAG,Activated partial thromboplastin time; aPTT; aPTT Hex PL; Coag; Hematology; Heme; Hex; HPP; Lipid; Little(A)PTT; Ordinal; Partial Thromboplastin Time; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PR; PTT; QL; Qual; Qualitative; Random; Screen; STAClot LA; Surf,Confirm aPTT StaClot,,aPTT W excess hexagonal phospholipid (StaClot LA confirm),,aPTT W excess hexagonal phase phospholipid Ql (PPP)
2998-3,Thiamine,CHEM,Blood; c106; c238; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; Vit B1; Vit B-1; Vitamin B1; Vitamin B-1; WB; Whole blood,Vit B1 Bld-mCnc,ug/dL,Thiamine [Mass/volume] in Blood,ug/dL,Thiamine (Bld) [Mass/Vol]
6246-3,Pandalus borealis Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f024; f24; Immune globulin E; Immunoglobulin E; Point in time; Prawns; QNT; Quan; Quant; Quantitative; Random; Serum; Shrimp; SR; UniversalLabOrders,Shrimp IgE Qn,kIU/L; kU/L,Shrimp IgE Ab [Units/volume] in Serum,k[IU]/L,Shrimp IgE Qn (S)
15061-5,Erythropoietin,CHEM,Arbitrary concentration; Chemistry; Endocrine; Endocrinology; EPO; Epoetin; Erthropoyetin; Erythropoetin; Hematology; Heme; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,EPO SerPl-aCnc,mIU/mL,Erythropoietin (EPO) [Units/volume] in Serum or Plasma,[IU]/L;m[IU]/mL,Erythropoietin (EPO) Qn
32998-7,Tissue transglutaminase Ab.IgG,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; Fibrin stabilizing factor; Gastro; Gastroenterology; GI; Immune globulin G; Immunoglobulin G; Point in time; Protein-glutamine gamma glutamyltransferase; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; TG2; tTG; UniversalLabOrders,tTG IgG Ser-aCnc,EIA units; units,Tissue transglutaminase IgG Ab [Units/volume] in Serum,[arb'U],tTG IgG Qn (S)
6718-1,Anacardium occidentale Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cashew; Cashew nut; f202; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Cashew nut IgE Qn,kIU/L,Cashew nut IgE Ab [Units/volume] in Serum,k[IU]/L,Cashew nut IgE Qn (S)
14618-3,Observation,SPEC,Appearance; Calc; Calculi; Gastro; Gastroenterology; GI; Kidney; Nephrology; Nominal; Point in time; Random; Renal; SPEC; Stn; Stone; Stones,Appearance Stone,,Appearance of Stone,,Appearance (Stone)
24326-1,Electrolytes 1998 panel,PANEL.CHEM,98; Chemistry; Elect; Electr; Electrolyte; Lytes; Lytes 1998 Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Lytes 1998 Pnl SerPl,,Electrolytes 1998 panel - Serum or Plasma,,Electrolytes 1998 panel
1034-8,Fetal cell screen,BLDBK,Blood; BLOOD BANK; Fetal Cell Scn; Fetal maternal hemorrhage screen; feto-maternal hemorrhage screening test; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Scn; Scr; Scrn; WB; Whole blood,Fetal Cell Scn Bld-Imp,,Fetal cell screen [Interpretation] in Blood,,Fetal cell screen (Bld) [Interp]
49047-4,Globulin,CHEM,Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Globulin Ur Elph-mCnc,mg/dL,Globulin [Mass/volume] in Urine by Electrophoresis,mg/dL,Globulin Elph (U) [Mass/Vol]
31201-7,HIV 1+2 Ab,MICRO,ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 & 2; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,HIV1+2 Ab SerPl Ql IA,,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,,HIV 1+2 Ab IA Ql
12254-9,Specimen volume,SPEC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Vol; Volume",Specimen vol Fld,liters;mL,Volume of Body fluid,L,Specimen volume (Body fld)
1530-5,Glucose^3H post 100 g glucose PO,CHAL.ROUTINE,3h p 100 g Glc PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Glucose 3h p 100 g Glc PO SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO,mg/dL,Glucose 3 Hr post 100 g glucose PO [Mass/Vol]
32774-2,Chlamydia sp DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chlam; Chlamid; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gen; Genital tract; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; Urogenit; Urogenital,Chlamydia DNA Genital Ql NAA+probe,,Chlamydia sp DNA [Presence] in Genital specimen by NAA with probe detection,,Chlamydia sp DNA NAA+probe Ql (Genital specimen)
19076-9,Cells counted.total,HEM/BC,Cell; Cellularity; Cnt; Count; HEMATOLOGY/CELL COUNTS; Misc; Miscellaneous; Non-aggregate; Number; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Tot; Total cells; Total Cells Counted; Totl; Unspecified,Total Cells Counted Spec,#,Cells Counted Total [#] in Specimen,{#},Cells Counted Total (Specimen) [#]
26476-2,Lymphocytes,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random",Lymphocytes # Fld,10*3/uL,Lymphocytes [#/volume] in Body fluid,10*3/uL,Lymphocytes (Body fld) [#/Vol]
5014-6,Herpes simplex virus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HSV DNA Spec Ql NAA+probe,,Herpes simplex virus DNA [Presence] in Specimen by NAA with probe detection,,HSV DNA NAA+probe Ql (Specimen)
32681-9,Hemoglobin C/Hemoglobin.total,HEM/BC,Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb C; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,Hgb C MFr Bld Elph,%,Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis,%,Hemoglobin C Elph (Bld) [Mass fraction]
18879-7,Cefepime,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefipime; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Maxipime; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Cefepime Susc Islt,,Cefepime [Susceptibility],,Cefepime [Susc]
18996-9,Tobramycin,ABXBACT,Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; NEBCIN; NEBDIN; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TOBJ; TOBRA,Tobramycin Susc Islt,,Tobramycin [Susceptibility],,Tobramycin [Susc]
61373-7,Human papilloma virus 18 DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV18; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HPV18 DNA Spec Ql NAA+probe,,Human papilloma virus 18 DNA [Presence] in Specimen by NAA with probe detection,,HPV 18 DNA NAA+probe Ql (Specimen)
18865-6,Ampicillin+Sulbactam,ABXBACT,Amcil; Amicil; Amp; Ampicilloyl; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c5; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Omnipen; Penbritin; Point in time; Polycillin; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Unasyn,Ampicillin+Sulbac Susc Islt,,Ampicillin+Sulbactam [Susceptibility],,Ampicillin+Sulbactam [Susc]
20125-1,Ventilator type,PULM,Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory; Typ; Vent type,Vent type,,Ventilator type,,
29261-5,Lymphocytes.abnormal/Leukocytes,HEM/BC,abn; abnorm; Atypical; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lymph Abn; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Lymph Abn NFr Bld Manual,%,Abnormal lymphocytes/Leukocytes in Blood by Manual count,%,Abnormal lymphocytes/Leukocytes Manual cnt (Bld)
17527-3,Retinol.free,CHEM,Axerol; Axerophthol; Biosterol; Chemistry; FR; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit A; Vit A alcohol; Vit A Free; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A1,Vit A Free SerPl-mCnc,ug/mL,Retinol Free [Mass/volume] in Serum or Plasma,ug/mL,Retinol Free [Mass/Vol]
32764-3,Clue cells,MICRO,Cell; Cellularity; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; OB; ObGyn; Obstetrics; Ordinal; Other; Point in time; PR; Prep; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Vaginosis; Wet mount; Wet prep,Clue Cells Spec Ql Wet Prep,,Clue cells [Presence] in Specimen by Wet preparation,,Clue cells Wet prep Ql (Specimen)
6075-6,Cladosporium herbarum Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C herbarum; Hormodendrum; Immune globulin E; Immunoglobulin E; m002; m2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,C herbarum IgE Qn,kIU/L; kU/L,Cladosporium herbarum IgE Ab [Units/volume] in Serum,k[IU]/L,C. herbarum IgE Qn (S)
5005-4,Epstein Barr virus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified,EBV DNA Spec Ql NAA+probe,,Epstein Barr virus DNA [Presence] in Specimen by NAA with probe detection,,EBV DNA NAA+probe Ql (Specimen)
57778-3,Immunoglobulin light chains.free panel,PANEL.CHEM,Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Immune globulin; Immuno; Immunoglob; Immunoglobin; Immunoglobulin LC free Pnl; Imunoglbon; Imunoglobn; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Immunoglobulin LC free Pnl Ser,,Immunoglobulin light chains.free panel - Serum,,Immunoglobulin light chains.free panel (S)
48346-1,HIV 1+O+2 Ab,MICRO,ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,HIV 1+O+2 Ab SerPl-aCnc,,HIV 1+O+2 Ab [Units/volume] in Serum or Plasma,[arb'U]/mL,HIV 1+O+2 Ab Qn
40574-6,Platelets,HEM/BC,"#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes",Platelet # Fld Auto,10*9/L,Platelets [#/volume] in Body fluid by Automated count,10*3/uL,Platelets Auto (Body fld) [#/Vol]
40549-8,Hemoglobin F,HEM/BC,Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Fetal hemoglobin; Haemoglobin; Hb; HbF; HEMATOLOGY/CELL COUNTS; Hgb; Hgb F; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Hgb F Bld Elph-mCnc,g/L;gm/L,Hemoglobin F [Mass/volume] in Blood by Electrophoresis,g/L,Hemoglobin F Elph (Bld) [Mass/Vol]
10368-9,Lead,DRUG/TOX,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Capillary Lead Screen; DRUG/TOXICOLOGY; Drugs; Finger stick; Lead Screen Filter Paper; Level; Mass concentration; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random,Lead BldC-mCnc,ug/dL,Lead [Mass/volume] in Capillary blood,ug/dL,Lead (BldC) [Mass/Vol]
11273-0,Erythrocytes,HEM/BC,Auto; Automated detection; Blood; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Morphology; Nominal; Point in time; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,RBC Bld Auto,,Erythrocytes [Morphology] in Blood by Automated count,,RBC Auto Nom (Bld)
19229-4,Bicarbonate,CHEM,BIC; bicar; Bicarb; Bld mixed venous; Blood - mixed venous; Chemistry; HCO3; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration,HCO3 BldMV-sCnc,mmol/L,Bicarbonate [Moles/volume] in Mixed venous blood,mmol/L,HCO3 (BldMV) [Moles/Vol]
20404-0,Fibronectin.fetal,CHEM,Chemistry; fFN; Fibronectin Fetal; Fn; Genital vaginal; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UniversalLabOrders; Vag fld; Vag fluid; Vagina; Vaginal fluid,Fibronectin Fetal Vag Ql,,Fibronectin.fetal [Presence] in Vaginal fluid,,Fibronectin.fetal Ql (Vag fld)
47528-5,Cytology report,CYTO,Cervix; Cytology stain; Cytostain; Document; Finding; Findings; Genital tract; Genital vaginal; Gyn; Gynecology; OB; ObGyn; Obstetrics; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn; UniversalLabOrders; Vag fld; Vag fluid; Vagina; Vaginal fluid,Cytology Cvx/Vag Doc Cyto,,Cytology report of Cervical or vaginal smear or scraping Cyto stain,,Cytology report Cyto stain Doc (Cvx/Vag)
1514-9,Glucose^2H post 100 g glucose PO,CHAL.ROUTINE,120 min; 120 minutes; 120min; 2 hours; 2h p 100 g Glc PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Glucose 2h p 100 g Glc PO SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO,mg/dL,Glucose 2 Hr post 100 g glucose PO [Mass/Vol]
61372-9,Human papilloma virus 16 DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV16; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HPV16 DNA Spec Ql NAA+probe,,Human papilloma virus 16 DNA [Presence] in Specimen by NAA with probe detection,,HPV 16 DNA NAA+probe Ql (Specimen)
5859-4,Herpes simplex virus,MICRO,C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,HSV Spec Cult,,Herpes simplex virus identified in Specimen by Organism specific culture,,HSV identified Org specific cx Nom (Specimen)
45847-1,Oxygen therapy,SURVEY.MDS,Finding; Findings; O2; O2 therapy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; tO2,,,Oxygen therapy [Minimum Data Set],,
25302-1,Alanine aminotransferase,CHEM,"Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Fl; Fld; FLU; Fluid; Glutamic-pyruvic transferase; Hepatology; L-alanine; Liver; Point in time; QNT; Quan; Quant; Quantitative; Random; SGPT",ALT Fld-cCnc,arb U/L,Alanine aminotransferase [Enzymatic activity/volume] in Body fluid,U/L,ALT (Body fld) [Catalytic activity/Vol]
13655-6,Leukocytes,HEM/BC,Bowel movement; Faecal; Faeces; Fecal; Feces; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; UniversalLabOrders; WBC; WBCs; White blood cell; White blood cells,WBC Stl Ql Micro,,Leukocytes [Presence] in Stool by Light microscopy,,WBC LM Ql (Stl)
28646-8,pH,CHEM,Bld cord; Chemistry; Cord arterial blood; Cord BldA; Log molar concentration; Point in time; Random; SmQn,pH BldCoA,pH,pH of Arterial cord blood,[pH],pH (BldCoA)
9799-8,Length,PATH,Calc; Calculi; Gastro; Gastroenterology; GI; Kidney; Len; Length; Nephrology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones,Length Stone,mm,Length of Stone,mm,Length (Stone) [Length]
20479-2,Measles virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MeV; Microbiology; Msls; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rubeola; Screen; Serum; SR; UniversalLabOrders,MeV IgG Ser Ql,,Measles virus IgG Ab [Presence] in Serum,,MeV IgG Ql (S)
7966-5,Mumps virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; MuV; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,MuV IgG Ser-aCnc,,Mumps virus IgG Ab [Units/volume] in Serum,{Index_val},MuV IgG Qn (S)
3193-0,Coagulation factor V activity actual/Normal,COAG,Act/Nor; Activ; Actvty; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Fact V; Factor 5; FV; Hematology; Heme; Movements; Plas; Platelet poor plasma; Point in time; Proaccelerin; Proaccelerin accelerator globulin; QNT; Quan; Quant; Quantitative; Random; RlTm; The labile factor; Tilt tube; UniversalLabOrders,Fact V Act/Nor PPP,%,Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay,%,Coagulation factor V activity actual/normal Coag (PPP) [Relative time]
1926-5,Base excess,CHEM,Base ex; BE; Blood - capillary; BSE; Calc; Calculation; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; EXS; Finger stick; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration,Base excess BldC Calc-sCnc,mmol/L,Base excess in Capillary blood by calculation,mmol/L,Base excess Calc (BldC) [Moles/Vol]
6568-0,Trichomonas vaginalis rRNA,MICRO,DNA NUCLEIC ACID PROBE; DNA probe; Gen; Genital tract; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; UniversalLabOrders; Urogenit; Urogenital,T vaginalis rRNA Genital Ql Probe,,Trichomonas vaginalis rRNA [Presence] in Genital specimen by Probe,,T. vaginalis rRNA Probe Ql (Genital specimen)
58714-7,Oxidants,UA,Adulterant; Ordinal; Oxidant; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Oxidants Ur Ql,,Oxidants [Presence] in Urine,,Oxidants Ql (U)
7793-3,Howell-Jolly bodies,HEM/BC,Blood; bod; Body; H J bodies; HEMATOLOGY/CELL COUNTS; HJBody; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood,Howell-Jolly Bod Bld Ql Smear,,Howell-Jolly bodies [Presence] in Blood by Light microscopy,,Howell-Jolly bodies LM Ql (Bld)
656-9,Observation,MICRO,Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified; ZN Stn,ZN Stn Spec,,Microscopic observation [Identifier] in Specimen by Acid fast stain.Ziehl-Neelsen,,Microscopic observation Acid fast stain.Ziehl-Neelsen Nom (Specimen)
58470-6,Nucleated cells,HEM/BC,#; ABS; absolute; absolutes; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid,Nuc cell # CSF,10*3/uL,Nucleated cells [#/volume] in Cerebral spinal fluid,10*3/uL,Nucleated cells (CSF) [#/Vol]
11878-6,Fetuses,OB.US,AOEObservation; Cnt; Count; Echography; Fetal; Gyn; Gynecology; Number; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound,# Fetuses US,#,Number of fetuses by US,{#},
11034-6,Acetylcholine receptor binding Ab,SERO,ABS; Aby; Acetylch; ACH; AChR; AChR Bind; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Level; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SR; Substance concentration; UniversalLabOrders,AChR Bind Ab Ser-sCnc,nmol/L,Acetylcholine receptor binding Ab [Moles/volume] in Serum,nmol/L,Acetylcholine receptor binding Ab (S) [Moles/Vol]
55432-9,Immature cells,HEM/BC,#; ABS; absolute; absolutes; Blood; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Imm; Immat; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Immature cells # Bld,10*3/uL,Immature cells [#/volume] in Blood,10*3/uL,Immature cells (Bld) [#/Vol]
35663-4,Protein,UA,?Tm; Kidney; Level; Mass concentration; Nephrology; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; UA; UniversalLabOrders; UR; URINALYSIS; Urn,Prot ?Tm Ur-mCnc,mg/dL,Protein [Mass/volume] in Urine collected for unspecified duration,mg/dL,Protein Unsp time (U) [Mass/Vol]
15197-7,Lymphocytes.clefted/Leukocytes,HEM/BC,Blood; Cleaved; Cleft Lymphs; fissured; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphocytes.fissured; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,Cleft Lymphs NFr Bld Manual,%,Lymphocytes clefted/Leukocytes in Blood by Manual count,%,Lymphocytes clefted/Leukocytes Manual cnt (Bld)
14310-7,Phencyclidine,DRUG/TOX,Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nasogastric; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;25 ng/mL; Scr; Screen; Scrn; Sernylan; UA; UniversalLabOrders; UR; Urn,PCP Ur Ql Scn>25 ng/mL,,Phencyclidine [Presence] in Urine by Screen method >25 ng/mL,,Phencyclidine Screen method >25 ng/mL Ql (U)
3273-0,Heparin.unfractionated,COAG,Arbitrary concentration; Clot; Clottable; COAGULATION; Coagulation assay; Hematology; Heme; Hep; Hepar; Heparn; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Tilt tube; UFH,UFH PPP clot-aCnc,arb U/mL,Heparin unfractionated [Units/volume] in Platelet poor plasma by Coagulation assay,[arb'U]/mL,Heparin unfractionated Coag Qn (PPP)
6019-4,Prunus dulcis Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Almond; Amygdalus communis; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f020; f20; Immune globulin E; Immunoglobulin E; Point in time; Prunus amygdalus; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Almond IgE Qn,kIU/L; kU/L,Almond IgE Ab [Units/volume] in Serum,k[IU]/L,Almond IgE Qn (S)
5814-9,Triple phosphate crystals,UA,Crys; Cryst; Crystal; i Phos; Inorganic phosphate; Kidney; LM; Magnesium ammonium phosphate; MAP; MgNH4PO4.6H2O; Micro; Micros; Microscopic; Nephrology; Ordinal; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Strive; Struvite; Tri; Trip; Tri-Phos; Tri-Phos Cry; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Tri-Phos Cry UrnS Ql Micro,,Triple phosphate crystals [Presence] in Urine sediment by Light microscopy,,Triple phosphate crystals LM Ql (Urine sed)
30246-3,Cytomegalovirus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders,CMV DNA SerPl Ql NAA+probe,,Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection,,CMV DNA NAA+probe Ql
48803-1,Neural tube defect risk,CHEM,Anencephaly; Chemistry; Fetal; Gyn; Gynecology; Neural tube def; Neural tube defct; NTD; OB; ObGyn; Obstetrics; ONTD; Open spina bifida; OSB; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk,Neural tube defect risk Fetus,%,Neural tube defect risk [Likelihood] in Fetus,%,Neural tube defect risk Qn (fetus)
6825-4,Crystals,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Crys; Cryst; Crystal; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Identity or presence; LM; Micro; Micros; Microscopic; Nominal; Point in time; Random; UniversalLabOrders",Crystals Fld Micro,,Crystals [type] in Body fluid by Light microscopy,,Crystals LM Nom (Body fld)
14251-3,Mitochondria M2 Ab.IgG,SERO,ABS; Aby; AMA-M2; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hepatology; Immune globulin G; Immunoglobulin G; Liver; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Point in time; Pyruvate dehydrogenase ab; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; UniversalLabOrders,Mitochondria M2 IgG Ser-aCnc,EIA units,Mitochondria M2 IgG Ab [Units/volume] in Serum,[arb'U],Mitochondria M2 IgG Qn (S)
4576-5,Hemoglobin F/Hemoglobin.total,HEM/BC,Blood; Fetal hemoglobin; Haemoglobin; Hb; HbF; HEMATOLOGY/CELL COUNTS; Hgb; Hgb F; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,Hgb F MFr Bld,%,Hemoglobin F/Hemoglobin.total in Blood,%,Hemoglobin F (Bld) [Mass fraction]
16136-4,Beta 2 glycoprotein 1 Ab.IgM,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; APOH; Apolipoprotein H; Arbitrary concentration; Autoantibodies; Autoantibody; B; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; II; Immune globulin M; Immunoglobulin M; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,B2 Glycoprot1 IgM Ser-aCnc,arb U/mL,Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum,[arb'U]/mL,Beta 2 glycoprotein 1 IgM Qn (S)
73836-9,Bacteria.fluoroquinolone resistant,MICRO,Anus; Bact; Bacteria.fluoroq resist; C&S; Cult; Cultures; FLQ; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Rectal specimen; Spec,Bacteria.fluoroq resist Anal Cult,,Bacteria.fluoroquinolone resistant identified in Anal by Organism specific culture,,Bacteria.fluoroquinolone resistant identified Org specific cx Nom (Anal)
43913-3,Bordetella pertussis DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough,B pert DNA Nph Ql NAA+probe,,Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection,,B. pertussis DNA NAA+probe Ql (Nph)
30437-8,Monocytes+Macrophages/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Mono; Monocyte; Monos; Monos+Macros; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Monos+Macros NFr Fld,%,Monocytes+Macrophages/Leukocytes in Body fluid,%,Monocytes+Macrophages/Leukocytes (Body fld)
6178-8,Juniperus sabinoides Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Juniper sabinoides; Juniperus ashei; Mountain cedar; Mountain juniper; Mt Juniper; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t006; t6; UniversalLabOrders,Mt Juniper IgE Qn,kIU/L,Mountain Juniper IgE Ab [Units/volume] in Serum,k[IU]/L,Mountain Juniper IgE Qn (S)
4546-8,Hemoglobin A/Hemoglobin.total,HEM/BC,Blood; Haemoglobin; Hb; HbA; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,Hgb A MFr Bld,%,Hemoglobin A/Hemoglobin.total in Blood,%,Hemoglobin A (Bld) [Mass fraction]
6078-0,Blatella germanica Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B germanica; Cockroach; German cockroach; i006; i6; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Roach; Serum; SR; UniversalLabOrders,Roach IgE Qn,kIU/L; kU/L,Cockroach IgE Ab [Units/volume] in Serum,k[IU]/L,Cockroach IgE Qn (S)
27811-9,Antithrombin actual/Normal,COAG,Act/Nor; Anti thrombin; Antithrm; Antithrombin III; Antithrombn; AT; AT III; ATIII; Chromogenic assay; COAGULATION; Control; ENZY; Enzymatic assay; Hematology; Heme; Heparin cofactor I; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; RlCCnc; Thrombin inhibitor I; UniversalLabOrders,AT III Act/Nor PPP Chro,%,Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,%,Antithrombin actual/normal Chromogenic method (PPP) [Rel catalytic activity/Vol]
32350-1,Basophils+Eosinophils+Monocytes/Leukocytes,HEM/BC,Baso; Baso+Eos+Monos; Basophil; Basos; Blood; Bph; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; MID; Middle cells; Mid-range cells; Mid-size region; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood; W-MCR,Baso+Eos+Monos NFr Bld,%,Basophils+Eosinophils+Monocytes/Leukocytes in Blood,%,Basophils+Eosinophils+Monocytes/Leukocytes (Bld)
5817-2,Urate crystals,UA,Crys; Cryst; Crystal; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; Urates; Uric acid; URINALYSIS; Urine sediment; Urn; UrnS,Urate Cry UrnS Ql Micro,,Urate crystals [Presence] in Urine sediment by Light microscopy,,Urate crystals LM Ql (Urine sed)
5292-8,Reagin Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Microscopic flocculation; Neurosyphilis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Syphilis; Treponema; UniversalLabOrders; Venereal Disease Research Laboratory,VDRL Ser Ql,,Reagin Ab [Presence] in Serum by VDRL,,Reagin Ab VDRL Ql (S)
29967-7,Neutrophil cytoplasmic Ab.IgG,SERO,ABS; Aby; ACIF; ACNA; ACPA; ANCA; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Granulocyte ab; Granulocyte nucleus ab; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neut; Neutr; Neutrophils; PMN; PNM; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Vasculitis,ANCA IgG Titr Ser IF,titer,Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence,{titer},Neutrophil cytoplasmic IgG IF (S) [Titer]
51775-5,Chromatin Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Chromatin Ab SerPl-aCnc,arb U/mL,Chromatin Ab [Units/volume] in Serum or Plasma,[arb'U]/mL,Chromatin Ab Qn
58952-3,Testosterone free & total panel,PANEL.CHEM,Chemistry; FR; Level; Mass concentration; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost; Testost Free; Testost free+total panel; Testosterone.unconjugated; Tot; Totl,Testost free+total panel SerPl-mCnc,,Testosterone free and total panel [Mass/volume] - Serum or Plasma,,Testosterone free and total panel [Mass/Vol]
6082-2,Gadus morhua Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cod; Codfish; f003; f3; Fish; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrod; Serum; SR; UniversalLabOrders,Codfish IgE Qn,kIU/L; kU/L,Codfish IgE Ab [Units/volume] in Serum,k[IU]/L,Codfish IgE Qn (S)
16135-6,Beta 2 glycoprotein 1 Ab.IgG,COAG,ABS; Aby; Antby; Anti; Antibodies; Antibody; APOH; Apolipoprotein H; Arbitrary concentration; Autoantibodies; Autoantibody; B; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; II; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,B2 Glycoprot1 IgG Ser-aCnc,arb U/mL,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum,[arb'U]/mL,Beta 2 glycoprotein 1 IgG Qn (S)
24119-0,Cytomegalovirus Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; EIA; ELFA; ELISA; Enzyme immunoassay; HHV-5; Human Herpesvirus-5; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,CMV IgM SerPl Ql IA,,Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay,,CMV IgM IA Ql
23811-3,Alpha-1-Fetoprotein^^adjusted,CHEM,A1; adj; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; Feto; i; MoM; Multiple of the median; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker,AFP adj MoM SerPl,M.o.M,Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma,{M.o.M},AFP adjusted [MoM]
20506-2,Specimen drawn from,SPEC,Nominal; Point in time; Random; Spec; Typ,Specimen drawn from Patient,,Specimen drawn from,,Specimen drawn from Nom
5198-7,Hepatitis C virus Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HCV; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,HCV Ab Ser IA-aCnc,,Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay,{index_val},HCV Ab IA Qn (S)
19296-3,Opiates tested for,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Heroin; Identity or presence; Nominal; OP; Opi; Opiate; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn,Opiates Tested Ur Scn,,Opiates tested for in Urine by Screen method Nominal,,Opiates tested Screen Nom (U)
1869-7,Apolipoprotein A-I,CHEM,APO; Apo A; Apo A-I; ApoA1; Apolipo; Apolipoprot; Apolipoprotein A1; Apolipoproteins; Cardio; Cardiology; Chemistry; Heart Disease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Apo A-I SerPl-mCnc,g/L;mg/dL,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,mg/dL;g/L,Apolipoprotein A-I [Mass/Vol]
59466-3,Hematologist review,HEM/BC,HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified,Hematologist review,,Hematologist review of results,,Hematologist review [Interp]
32155-4,Basophils+Eosinophils+Monocytes/Leukocytes,HEM/BC,Auto; Automated detection; Baso; Baso+Eos+Monos; Basophil; Basos; Blood; Bph; Elec; Elect; Electr; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; MID; Middle cells; Mid-range cells; Mid-size region; Mono; Monocyte; Monos; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood; W-MCR,Baso+Eos+Monos NFr Bld Auto,%,Basophils+Eosinophils+Monocytes/Leukocytes in Blood by Automated count,%,Basophils+Eosinophils+Monocytes/Leukocytes Auto (Bld)
35265-8,Path report.addendum,PATH,Finding; Findings; Narrative; Pathology; Point in time; Random; Report; Spec,Path Report.addendum Spec,,Pathology report addendum in Specimen Narrative,,Pathology report addendum Nar (Spec)
19287-2,Cannabinoids tested for,DRUG/TOX,Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Identity or presence; Marijuana; Nominal; Point in time; Random; Scn; Scr; Scrn; THC; UA; UR; Urn,Cannabinoids Tested Ur Scn,,Cannabinoids tested for in Urine by Screen method Nominal,,Cannabinoids tested Screen Nom (U)
59467-1,Hemoglobin,HEM/BC,Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles,MCHC RBC-EntSCnc,mmol/L,MCHC [Entitic Moles/volume] in Red Blood Cells,mmol/L,MCHC (RBC) [Entitic Moles/Vol]
7604-2,Amaranthus retroflexus Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cmn pigweed; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rough pigweed; Rough pigweed IgE Ab; Serum; SR; UniversalLabOrders,Cmn pigweed IgE Qn,kIU/L,Common pigweed IgE Ab [Units/volume] in Serum,k[IU]/L,Common Pigweed IgE Qn (S)
18970-4,Piperacillin+Tazobactam,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Pip+Tazo; Piper; PIPJ; Pipracil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazobac; Tazocilline; Tazocin; Zosyn,Pip+Tazo Susc Islt,,Piperacillin+Tazobactam [Susceptibility],,Piperacillin+Tazobactam [Susc]
4058-4,Tobramycin^random,DRUG/TOX,Aminoglycosides; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; NEBCIN; NEBDIN; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Rand; Rando; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TOBJ; TOBRA,Tobramycin Rand SerPl-mCnc,mg/L;mcg/mL,Tobramycin [Mass/volume] in Serum or Plasma --random,mg/L,Tobramycin random [Mass/Vol]
6136-6,Corylus avellana Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; f017; f17; Filbert; Hazel nut; Hazelnut; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Hazelnut IgE Qn,kIU/L; kU/L,Hazelnut IgE Ab [Units/volume] in Serum,k[IU]/L,Hazelnut IgE Qn (S)
12187-1,Creatine kinase.MB/Creatine kinase.total,CHEM,Cardio; Cardiology; Catalytic Fraction; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Heart Disease; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl,CK MB CFr SerPl Elph,%,Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis,%,CK.MB Elph [Catalytic fraction]
6090-5,Populus deltoides Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cottonwood; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t014; t14; UniversalLabOrders,Cottonwood IgE Qn,kIU/L; kU/L,Cottonwood IgE Ab [Units/volume] in Serum,k[IU]/L,Cottonwood IgE Qn (S)
51892-8,ABO group,BLDBK,Blood - (umbilical) cord; BLOOD BANK; Cord (umbilical) blood; Cord bld; Cord blood; Gyn; Gynecology; Hematology; Heme; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Typ,ABO Group BldCo,,ABO group [Type] in Cord blood,,ABO group (BldCo)
19930-7,Gas flow,PULM,Breathing; Dynamic; Flow; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate,Gas flow Airway,,Gas flow Respiratory system airway,L/min,
24360-0,Hemoglobin & Hematocrit panel,PANEL.HEM/BC,Blood; Haemoglobin; Hb; Hct; HEMATOLOGY/CELL COUNTS; Hgb; Hgb+Hct Pnl; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; PCV; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood,Hgb+Hct Pnl Bld,,Hemoglobin and Hematocrit panel - Blood,,Hemoglobin and Hematocrit panel (Bld)
29604-6,Cytomegalovirus DNA,MICRO,#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Blood; CMV; Cnt; Count; Count/volume; CT; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood,CMV DNA # Bld NAA+probe,copies/mL,Cytomegalovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection,{copies}/mL,CMV DNA NAA+probe (Bld) [#/Vol]
57698-3,Lipid panel with direct LDL,PANEL.CHEM,Chemistry; Dir; Lipid pnl with direct LDL; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Lipid pnl with direct LDL SerPl,,Lipid panel with direct LDL - Serum or Plasma,,Lipid panel with direct LDL
18993-6,Tetracycline,ABXBACT,Achromycin V; ANTIBIOTIC SUSCEPTIBILITIES; AST; C18; c211; C75; Chemiciclina; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Panmycin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tetrabioptal,Tetracycline Susc Islt,,Tetracycline [Susceptibility],,Tetracycline [Susc]
20761-3,Clostridioides difficile,MICRO,Agg; Agglut; Agglutination; Bowel movement; C diff; C difficile; Clostridium difficile; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; UniversalLabOrders,C diff Stl Ql Aggl,,Clostridioides difficile [Presence] in Stool by Agglutination,,C. difficile Aggl Ql (Stl)
82176-9,Respiratory syncytial virus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RSV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,RSV RNA Nph Ql NAA+non-probe,,Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection,,RSV RNA NAA+non-probe Ql (Nph)
5946-9,Coagulation surface induced.factor substitution^immediately after addition of normal plasma,COAG,Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube,aPTT imm NP PPP,s,aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma,s,aPTT.factor substitution immediately after addition of normal plasma Coag (PPP) [Time]
51988-4,Ureaplasma urealyticum DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; U urealyticum; Unspecified,U urealyticum DNA Spec Ql NAA+probe,,Ureaplasma urealyticum DNA [Presence] in Specimen by NAA with probe detection,,U. urealyticum DNA NAA+probe Ql (Specimen)
19996-8,Oxygen/Inspired gas^on ventilator,PULM,Breathing; FIO2; Gases; Lung; Lungs; O2; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; tO2; Volfr; Volume fraction,FIO2 on vent,%,Oxygen/Inspired gas Respiratory system --on ventilator,%,
73561-3,Insulin-like growth factor-I,CHEM,Chemistry; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; SR; Standard score; Ultralente; Z score; Z value; Z-score,IGF-I Z-score SerPl,Z-score,Insulin-like growth factor-I [Z-score] in Serum or Plasma,{Z-score},Insulin-like growth factor-I [Z-score]
2601-3,Magnesium,CHEM,Chemistry; Level; MAG; Magnes; Mg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Magnesium SerPl-sCnc,mmol/L,Magnesium [Moles/volume] in Serum or Plasma,mmol/L,Magnesium [Moles/Vol]
12209-3,Eosinophils/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Eos; Eosin; Eosino; Eosinophil; Eosins; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Eosinophil NFr Fld Manual,%,Eosinophils/Leukocytes in Body fluid by Manual count,%,Eosinophils/Leukocytes Manual cnt (Body fld)
6932-8,Penicillin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; PCN; Pen; Penicilloyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wycillin,Penicillin Islt MIC,ug/mL,Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC),ug/mL,Penicillin MIC [Susc]
62236-5,Pyridoxal phosphate,CHEM,C8H10NO6P; C8H9NO3; Chemistry; Codecarboxylase; i Phos; Inorganic phosphate; Level; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; PLP; Plsm; PO4; Point in time; Pyridoxal 5-Phosphate; Pyridoxaldehyde; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit B6; Vit B6 coenzyme; Vitamin B6; Vitamin B6 coenzyme; Vitamin B6 hydrochloride,Pyridoxal Phos SerPl-sCnc,nmol/L,Pyridoxal phosphate [Moles/volume] in Serum or Plasma,nmol/L,Pyridoxal phosphate [Moles/Vol]
38496-6,Retinyl palmitate,CHEM,C16:0; Chemistry; Hexadecanoate; Hexadecanoic acid; Level; Mass concentration; Palmitic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinol palmitate; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vitamin A palmitate,Retinyl Palmitate SerPl-mCnc,ug/mL,Retinyl palmitate [Mass/volume] in Serum or Plasma,ug/mL,Retinyl palmitate [Mass/Vol]
60432-2,Date of previous PAP smear,H&P.HX,H+P; H+P.HX; P prime; Point in time; Prev; QNT; Quan; Quant; Quantitative; Random; smears,Date of previous PAP,MMDDYY,Date of previous PAP smear,,
53019-6,Sjogrens syndrome-A extractable nuclear 60kD Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA SS-A; ENA SS-a 60kD; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Serum; Sjogren; SR; SS; SSA; SS-A,ENA SS-a 60kD Ab Ser-aCnc,arb U/mL,Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum,[arb'U]/mL,Sjogrens syndrome-A extractable nuclear 60kD Ab Qn (S)
2572-6,Lipoprotein lipase,CHEM,Catalytic Concentration; Chemistry; Diacylglycerol lipase; Hepatic lipase; Lip; Lipoprot; Lipoproteins; LP; LPL; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,LPL SerPl-cCnc,arb U/L,Lipoprotein lipase [Enzymatic activity/volume] in Serum or Plasma,U/L,Lipoprotein lipase [Catalytic activity/Vol]
29374-6,Ribonucleoprotein extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA RNP; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonuclear protein; RNP; Ro; Serology; Serum; SR; UniversalLabOrders,ENA RNP Ab Ser-aCnc,EUS,Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum,[arb'U],Ribonucleoprotein extractable nuclear Ab Qn (S)
43995-0,Fetal trisomy 21 risk,CHEM,Chemistry; Down syndrome; Downs; Down's syndrome; ds; Fetal; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Ts; Ts 21 risk,Ts 21 risk Fetus,Risk,Trisomy 21 risk [Likelihood] in Fetus,{risk},Trisomy 21 risk Qn (fetus)
43994-3,Fetal trisomy 18 risk,CHEM,Chemistry; Edward syndrome; Fetal; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; T18 risk; Ts; Ts 18 risk,Ts 18 risk Fetus,Risk,Trisomy 18 risk [Likelihood] in Fetus,{risk},Trisomy 18 risk Qn (fetus)
19244-3,Character,SPEC,Appearance; Nominal; Point in time; Random; SPEC; UA; UR; Urn,Character Ur,,Character of Urine,,Character (U)
32286-7,Hepatitis C virus genotype,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gentyp; HCV; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders,HCV Gentyp SerPl NAA+probe,,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,,HCV genotype NAA+probe
62460-1,Candida sp DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid,Candida DNA Vag Ql NAA+probe,,Candida sp DNA [Presence] in Vaginal fluid by NAA with probe detection,,Candida sp DNA NAA+probe Ql (Vag fld)
19212-0,Carbon dioxide,CHEM,Bld mixed venous; Blood - mixed venous; Carbonic anhydride; Chemistry; CO2; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random,pCO2 BldMV,mm Hg,Carbon dioxide [Partial pressure] in Mixed venous blood,mm[Hg],CO2 (BldMV) [Partial pressure]
6683-7,Coagulation reptilase induced,COAG,Atroxin time; Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Reptilase time; Tilt tube,Reptilase time,s,Reptilase time,s,Reptilase time Coag (PPP) [Time]
2164-2,Creatinine renal clearance,CHEM,1 day; 24 hours; 24HR; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; CR; Crea; Creat; Flow; Kidney; Nephrology; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UCr; UR; Ur+SerPl; Urn; Volume rate; vRate,Creat Cl 24h Ur+SerPl-vRate,mL/sec;mL/min,Creatinine renal clearance in 24 hour Urine and Serum or Plasma,mL/min,Creatinine renal clearance (24H U+S/P) [Vol/Time]
35063-7,Eosinophils,HEM/BC,"#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Eos; Eosin; Eosino; Eosinophil; Eosins; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random",Eosinophil # Fld,10*3/uL,Eosinophils [#/volume] in Body fluid,10*3/uL,Eosinophils (Body fld) [#/Vol]
6208-3,Carya illinoinensis nut Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Carya pecan; f201; Hickory; Immune globulin E; Immunoglobulin E; Nuts; Pecan; Pecan/Hick; Pecan/Hick Nut; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Pecan/Hick Nut IgE Qn,kIU/L; kU/L,Pecan or Hickory Nut IgE Ab [Units/volume] in Serum,k[IU]/L,Pecan or Hickory Nut IgE Qn (S)
20572-4,Hemoglobin A/Hemoglobin.total,HEM/BC,Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HbA; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,Hgb A MFr Bld Elph,%,Hemoglobin A/Hemoglobin.total in Blood by Electrophoresis,%,Hemoglobin A Elph (Bld) [Mass fraction]
71772-8,Mitogen stimulated gamma interferon,MICRO,Arbitrary concentration; Blood; ID; IFN; IGRA; Infectious Disease; InfectiousDisease; Lung; Microbiology; Mitogen IGNF; Point in time; Pulmonary; Pulmonology; QFT; QNT; Quan; Quant; Quantiferon; Quantitative; Random; Respiratory; WB; Whole blood,Mitogen IGNF Bld-aCnc,IU/mL,Mitogen stimulated gamma interferon [Units/volume] in Blood,[IU]/mL,Mitogen stimulated gamma interferon Qn (Bld)
1884-6,Apolipoprotein B,CHEM,APO; Apo B; ApoB; Apolipo; Apolipoprot; Apolipoproteins; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Apo B SerPl-mCnc,g/L;mg/dL,Apolipoprotein B [Mass/volume] in Serum or Plasma,mg/dL,Apolipoprotein B [Mass/Vol]
54372-8,Cholesterol.in HDL,CHEM,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Fl; Fld; FLU; Fluid; HDLc; HDL-C; High density lipoprotein cholesterols; Level; Lipid; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TCHHDL",HDLc Fld-mCnc,g/L,Cholesterol in HDL [Mass/volume] in Body fluid,g/L,Cholesterol in HDL (Body fld) [Mass/Vol]
8130-7,Cells.CD45/Cells,CELLMARK,B220; Blood; CD45 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; LCA; Leukocyte common antigen; Ly5; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; WB; Whole blood,CD45 Cells NFr Bld,%,CD45 (Lymphs) cells/cells in Blood,%,CD45 (Lymphs) cells/cells (Bld)
8456-6,Intravascular mean^sitting,BP.PSTN.MOLEC,Art sys; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.POSITION.MOLEC; BP; BP mean; Cardio; Cardiology; Heart Disease; Intravenous; IV; MBP; Point in time; Position; Pressure; QNT; Quan; Quant; Quantitative; Random,BP mean--sitting,mm Hg,Mean blood pressure--sitting,mm[Hg],
71431-1,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HPV; HPV H Risk 12 DNA; HPV HR 12; HPV31; HPV31+33; HPV31+33+35; Human papilloma virus; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Papilloma virus intermediate/high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders,HPV HR 12 DNA Cvx Ql NAA+probe,,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection,,HPV 31+33+35+39+45+51+52+56+58+59+66+68 DNA NAA+probe Ql (Cvx)
82170-2,Influenza virus B RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,FLUBV RNA Nph Ql NAA+non-probe,,Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection,,FLUBV RNA NAA+non-probe Ql (Nph)
82160-3,Adenovirus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HAdV DNA Nph Ql NAA+non-probe,,Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection,,Adenovirus DNA NAA+non-probe Ql (Nph)
82165-2,Human metapneumovirus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; hMPV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,hMPV RNA Nph Ql NAA+non-probe,,Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection,,hMPV RNA NAA+non-probe Ql (Nph)
82175-1,Rhinovirus+Enterovirus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; HRV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rhino virus; RHV; Ribonucleic acid; RV+EV; RV+EV RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,RV+EV RNA Nph Ql NAA+non-probe,,Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection,,Rhinovirus+Enterovirus RNA NAA+non-probe Ql (Nph)
82166-0,Influenza virus A RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,FLUAV RNA Nph Ql NAA+non-probe,,Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection,,FLUAV RNA NAA+non-probe Ql (Nph)
50387-0,Chlamydia trachomatis rRNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C tracho; C trachomatis; Cervix; Chlam; Chlam trac; Chlamid; CT; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gen-Probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification; UniversalLabOrders,C trach rRNA Cvx Ql NAA+probe,,Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection,,C. trachomatis rRNA NAA+probe Ql (Cvx)
5783-6,Crystals.unidentified,UA,Crys; Cryst; Crystal; Kidney; LM; Micro; Micros; Microscopic; Nephrology; NOS AB; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; Unident Crys; UR; URINALYSIS; Urine sediment; Urn; UrnS,Unident Crys UrnS Ql Micro,,Unidentified crystals [Presence] in Urine sediment by Light microscopy,,Unidentified crystals LM Ql (Urine sed)
804-5,Leukocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood,WBC # Bld Manual,10*9/L,Leukocytes [#/volume] in Blood by Manual count,10*3/uL,WBC Manual cnt (Bld) [#/Vol]
41499-5,Legionella pneumophila 1 Ag,MICRO,Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Infectious Disease; InfectiousDisease; L pneumo; L pneumo1; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 1; MEIA; Microbiology; Ordinal; Philadelphia 1; Pneu; pneum; Pneumophilia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; UA; UniversalLabOrders; UR; Urn,L pneumo1 Ag Ur Ql IA,,Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay,,L. pneumophila 1 Ag IA Ql (U)
67848-2,Leukocyte clumps,UA,Kidney; Leuc; Leuk; Leukocytes; Lkcs; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBC clumps; WBCs; White blood cell; White blood cells,WBC clumps UrnS Ql Micro,,Leukocyte clumps [Presence] in Urine sediment by Light microscopy,,Leukocyte clumps LM Ql (Urine sed)
82177-7,Mycoplasma pneumoniae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enzootic pneumonia; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,M pneumo DNA Nph Ql NAA+non-probe,,Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection,,M. pneumoniae DNA NAA+non-probe Ql (Nph)
5060-9,Borrelia burgdorferi Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS,B burgdor Ab Ser IA-aCnc,,Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,B. burgdorferi Ab IA Qn (S)
8065-5,Cardiolipin Ab.IgG,COAG,ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Arbitrary concentration; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; Hematology; Heme; Immune globulin G; Immunoglobulin G; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Cardiolipin IgG SerPl-aCnc,arb U/mL;GPL units,Cardiolipin IgG Ab [Units/volume] in Serum or Plasma,[arb'U]/mL,Cardiolipin IgG Qn
18983-7,Streptomycin.high potency,ABXBACT,Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c232; C295; Cidam est; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Novostrep; Point in time; Random; Solustrep; Streptocol; Strepto-fatol; Streptomyc; Streptomycin High Pot; Streptomycin synergy; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Synergistic,Streptomycin High Pot Susc Islt,,Streptomycin.high potency [Susceptibility],,Streptomycin.high potency [Susc]
5370-2,Streptolysin O Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; ASO; ASOT; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strep; Strept; UniversalLabOrders,ASO Ab SerPl-aCnc,IU/mL;Todd units; units/mL,Streptolysin O Ab [Units/volume] in Serum or Plasma,[IU]/mL,Streptolysin O Ab Qn
75513-2,DRVVT with 1:1 Pooled Normal Plasma,COAG,Clot; Clottable; COAGULATION; Coagulation assay; Control; Dil Russell Vip Ven; dRVVT w 1:1 PNP; Hematology; Heme; i; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Russell viper venom time; Tilt tube,Mixing dRVVT,s,dRVVT with 1:1 PNP (LA mix),s,dRVVT w 1:1 PNP Coag (PPP) [Time]
29965-1,Sjogrens syndrome-B extractable nuclear Ab.IgG,SERO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-B; Enzyme immunoassay; HA; Ha AB; IAA; Immune globulin G; Immunoglobulin G; La AB; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; Sjogren; SR; SS; SSB; SS-B; SUDS,ENA SS-B IgG Ser IA-aCnc,arb U/mL,Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,Sjogrens syndrome-B extractable nuclear IgG IA Qn (S)
225-3,Doxycycline,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c206; c216; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vibramycin,Doxycycline Islt MIC,,Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC),,Doxycycline MIC [Susc]
18263-4,Cholesterol.in HDL,CHEM,"Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPl.Ultracent; SerPlas; Serum; Serum or plasma; Serum or plasma, ultracentrifugate; SR; TCHHDL",HDLc SerPl.Ultracent-mCnc,mg/dL,Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate,mg/dL,Cholesterol in HDL (S/P ultracentrifugate) [Mass/Vol]
6516-9,Human papilloma virus rRNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; Gen-Probe; HPV; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HPV rRNA Spec Ql NAA+probe,,Human papilloma virus rRNA [Presence] in Specimen by NAA with probe detection,,HPV rRNA NAA+probe Ql (Specimen)
29891-9,Carbon dioxide^post dose urea,MICRO,After; Breath; Carbamide; Carbonic anhydride; cO2; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; Helicobacter pylori breath test; Microbiology; Ordinal; p dose; p urea; Point in time; PR; PST; QL; Qual; Qualitative; Random; Screen; UBT; UniversalLabOrders; Urea breath test,Urea Breath Test Ql,,Helicobacter pylori [Presence] in Stomach by urea breath test,,CO2 post dose urea Ql (Exhl gas)
82162-9,Human coronavirus NL63 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV NL63; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HCoV NL63 RNA Nph Ql NAA+non-probe,,Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,HCoV NL63 RNA NAA+non-probe Ql (Nph)
82161-1,Human coronavirus HKU1 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HCoV HKU1 RNA Nph Ql NAA+non-probe,,Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,HCoV HKU1 RNA NAA+non-probe Ql (Nph)
82163-7,Human coronavirus 229E RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HCoV 229E RNA Nph Ql NAA+non-probe,,Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection,,HCoV 229E RNA NAA+non-probe Ql (Nph)
82164-5,Human coronavirus OC43 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HCoV OC43 RNA Nph Ql NAA+non-probe,,Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,HCoV OC43 RNA NAA+non-probe Ql (Nph)
82171-0,Parainfluenza virus 1 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HPIV1 RNA Nph Ql NAA+non-probe,,Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,Parainfluenza virus 1 RNA NAA+non-probe Ql (Nph)
82172-8,Parainfluenza virus 2 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV2; Human rubulavirus 2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PCR; PI2; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HPIV2 RNA Nph Ql NAA+non-probe,,Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,Parainfluenza virus 2 RNA NAA+non-probe Ql (Nph)
82173-6,Parainfluenza virus 3 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HPIV3 RNA Nph Ql NAA+non-probe,,Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,Parainfluenza virus 3 RNA NAA+non-probe Ql (Nph)
82174-4,Parainfluenza virus 4 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,HPIV4 RNA Nph Ql NAA+non-probe,,Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,Parainfluenza virus 4 RNA NAA+non-probe Ql (Nph)
2483-6,Insulin-like growth factor binding protein 3,CHEM,Bind; Chemistry; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente; UniversalLabOrders,IGF BP3 SerPl-mCnc,mg/L;mcg/mL; ng/mL,Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma,ng/mL,Insulin-like growth factor binding protein 3 [Mass/Vol]
16130-7,Herpes simplex virus 1 DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HSV1 DNA Spec Ql NAA+probe,,Herpes simplex virus 1 DNA [Presence] in Specimen by NAA with probe detection,,HSV 1 DNA NAA+probe Ql (Specimen)
71690-2,Nucleated cells,HEM/BC,"#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random",Nuc cell # Fld Auto,10*3/uL,Nucleated cells [#/volume] in Body fluid by Automated count,10*3/uL,Nucleated cells Auto (Body fld) [#/Vol]
2709-4,Oxygen saturation,HEMODYN.MOLEC,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Finger stick; Hemodynamics; HEMODYNAMICS.MOLEC; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2,SaO2 % BldC,%,Oxygen saturation in Capillary blood,%,
55752-0,Clinical information,PUBLICHEALTH,AOEObservation; Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report,Clinical info,,Clinical information,,
11090-8,Smith extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA SM; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SM; SR; UniversalLabOrders,ENA SM Ab Ser-aCnc,arb U/mL,Smith extractable nuclear Ab [Units/volume] in Serum,[arb'U]/mL,Smith extractable nuclear Ab Qn (S)
82167-8,Influenza virus A H1 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,FLUAV H1 RNA Nph Ql NAA+non-probe,,Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,FLUAV H1 RNA NAA+non-probe Ql (Nph)
82168-6,Influenza virus A H1 2009 pandemic RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUV; Fowl plague; H1N1; H1N1v; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; S-OIV; Strand Displacement Amplification; TMA; Transcription mediated amplification,FLUAV H1 2009 pan RNA Nph NAA+non-probe,,Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection,,FLUAV H1 2009 pand RNA NAA+non-probe Ql (Nph)
82169-4,Influenza virus A H3 RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H3; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,FLUAV H3 RNA Nph Ql NAA+non-probe,,Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection,,FLUAV H3 RNA NAA+non-probe Ql (Nph)
19211-2,Oxygen,CHEM,Bld mixed venous; Blood - mixed venous; Chemistry; Lung; O2; O2 partial pressure; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2,pO2 BldMV,mm Hg,Oxygen [Partial pressure] in Mixed venous blood,mm[Hg],Oxygen (BldMV) [Partial pressure]
57838-5,Coagulation dilute Russell viper venom induced.excess phospholipid,COAG,Coag; Coagulation dilute Russell viper venom induced confirmatory test; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; dRVVT confirm; EXS; Hematology; Heme; Lipid; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant,Confirm dRVVT,s,dRVVT W excess phospholipid (LA confirm),s,dRVVT excess phospholipid (PPP) [Time]
30351-1,Hemoglobin,HEM/BC,Bld mixed venous; Blood - mixed venous; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random,Hgb BldMV-mCnc,g/dL,Hemoglobin [Mass/volume] in Mixed venous blood,g/dL,Hemoglobin (BldMV) [Mass/Vol]
52114-6,Direct antiglobulin test.IgG specific reagent,BLDBK,Antiglob; BLOOD BANK; DAGT; DAT; DAT IgG-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Gyn; Gynecology; Immune globulin G; Immunoglobulin G; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Screen; Spec,DAT IgG-Sp Reag RBCCo Ql,,Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells,,Direct antiglobulin test.IgG specific reagent Ql (Cord RBC)
14908-8,Rh,BLDBK,Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; NB; New born; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood,Rh Bld NB,,Rh [Type] in Blood from Newborn,,Rh Nom (Bld newborn)
2715-1,Oxyhemoglobin/Hemoglobin.total,CHEM,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; Mass Fraction; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SO2; Tot; Totl,OxyHgb MFr BldC,%,Fractional oxyhemoglobin in Capillary blood,%,Oxyhemoglobin (BldC) [Mass fraction]
19219-5,Oxygen content,CHEM,Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; ctO2; Finger stick; Level; Lung; O2; O2 Ct; O2CT; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; tO2,O2 Ct BldC-sCnc,mol/L,Oxygen content in Capillary blood,mol/L,Oxygen content (BldC) [Moles/Vol]
21070-8,Antibiotic XXX,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Other Antibiotic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Other Antibiotic Islt MIC,,Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC),,Other Antibiotic MIC [Susc]
28638-5,Base excess,CHEM,Base ex; BE; Bld cord; BSE; Calc; Calculation; Chemistry; Cord arterial blood; Cord BldA; EXS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,Base excess BldCoA Calc-sCnc,mmol/L,Base excess in Arterial cord blood by calculation,mmol/L,Base excess Calc (BldCoA) [Moles/Vol]
45142-7,Sjogrens syndrome-B extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-B; Enzyme immunoassay; HA; Ha AB; IAA; La AB; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; Sjogren; SR; SS; SSB; SS-B; SUDS; UniversalLabOrders,ENA SS-B Ab Ser IA-aCnc,,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,Sjogrens syndrome-B extractable nuclear Ab IA Qn (S)
82178-5,Chlamydophila pneumoniae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Twar agent,C pneum DNA Nph Ql NAA+non-probe,,Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection,,C. pneumoniae DNA NAA+non-probe Ql (Nph)
2323-4,Gamma glutamyl transferase,CHEM,Catalytic Concentration; Chemistry; Ejaculate; Gamma glutamyl transpeptidase; Gamma-GTP; Genitourinary; GGT; GGTP; GT; GU; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology,GGT Smn-cCnc,arb U/L,Gamma glutamyl transferase [Enzymatic activity/volume] in Semen,U/L,Gamma glutamyl transferase (Sem) [Catalytic activity/Vol]
50388-8,Neisseria gonorrhoeae rRNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; DNA NUCLEIC ACID PROBE; DNA probe; GC; Genital tract; Gen-Probe; Gono; Gonorrhea; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UniversalLabOrders,N gonorrhoea rRNA Cvx Ql NAA+probe,,Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection,,N. gonorrhoeae rRNA NAA+probe Ql (Cvx)
14628-2,Bile acid,CHEM,Acd; Acids; Bile acid.total; Bile salt; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Bile Ac SerPl-sCnc,umol/L,Bile acid [Moles/volume] in Serum or Plasma,umol/L,Bile acid [Moles/Vol]
18943-1,Meropenem,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Meronem; Merrem; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Meropenem Susc Islt,,Meropenem [Susceptibility],,Meropenem [Susc]
21484-1,Race,CLIN,CLIN; Ethnicity; Gyn; Gynecology; Mat; Maternal; Matnl; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Typ,Mother's race,,Mother's race,,
75882-1,Lupus anticoagulant three screening tests W Reflex,COAG,3; Anticoag; Anti-phospholipid antibody; Asympt; Asymptomatic; Clot; Clottable; COAGULATION; Coagulation assay; Coagulation inhibiting antibody; dRVVT; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LA; LA 3 screen W Reflex; LAC; Lupus inhibitor; Nominal; Plas; Platelet poor plasma; Point in time; Random; Scn; Tilt tube,LA 3 screen W Reflex-Imp,,Lupus anticoagulant three screening tests W Reflex [interpretation],,Lupus anticoagulant three screening tests W Reflex Coag (PPP) [Interp]
7613-3,Pistacia vera Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f203; Green almond; Immune globulin E; Immunoglobulin E; Pistachio; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Pistachio IgE Qn,kIU/L,Pistachio IgE Ab [Units/volume] in Serum,k[IU]/L,Pistachio IgE Qn (S)
781-5,Promyelocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Manl; Number concentration; Number Concentration (count/vol); Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Promyelocytes # Bld Manual,10*9/L,Promyelocytes [#/volume] in Blood by Manual count,10*3/uL,Promyelocytes Manual cnt (Bld) [#/Vol]
33898-8,Bilirubin.glucuronidated+Bilirubin.non-glucuronidated,CHEM,Bc; Bili; Bilirub Conj; Bilirub Conj+Unconj; Bilirub Indirect; Bilirubin conjugated; Bilirubin glucuronides; Bilirubin indirect; Bilirubin non-conjugated; Bilirubin primary; Bilirubin unconjugated; Bilirubins; Billirubin; Bu; Bu+Bc; BuBc; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; NBIL; Neonatal Bilirubin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL,Bilirub Conj+Unconj SerPl-mCnc,mg/dL,Bilirubin.conjugated+indirect [Mass/volume] in Serum or Plasma,mg/dL,Bilirubin.conjugated+indirect [Mass/Vol]
5176-3,Helicobacter pylori Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C pylori; Campylobacter pylori; EIA; ELFA; ELISA; Enzyme immunoassay; Gastro; Gastroenterology; GI; H pyl; H pylori; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,H pylori IgG Ser IA-aCnc,EIA Index,Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay,{Index_val},H. pylori IgG IA Qn (S)
68519-8,How many standard drinks containing alcohol do you have on a typical D,H&P.HX,Alc; alcoholic; Count/time; Dextro; Drinks on a typical D; H+P; H+P.HX; nRate; Number rate; Number Rate = Count/Time; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random,Drinks on a typical D nRate,#/day,How many standard drinks containing alcohol do you have on a typical day,{#}/d,
41274-2,Alpha-1-Fetoprotein interpretation,CHEM,A1; AFP; AFP Interp; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; Feto; i; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker,AFP Interp SerPl-Imp,,Alpha-1-Fetoprotein interpretation in Serum or Plasma,,AFP interpretation [Interp]
8262-8,Service comment 02,MISC,cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 02; Spec; To be specified in another part of the message; Unspecified,Service Cmnt 02-Imp,,Service comment 02,,Service comment 02 [Interp]
6281-0,Morus alba Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Mulberry; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t070; t70; UniversalLabOrders; White mulberry,White mulberry IgE Qn,kIU/L; kU/L,White mulberry IgE Ab [Units/volume] in Serum,k[IU]/L,White mulberry IgE Qn (S)
19568-5,Methylenedioxymethamphetamine,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn,MDMA Ur Ql Scn,,Methylenedioxymethamphetamine [Presence] in Urine by Screen method,,Methylenedioxymethamphetamine Screen Ql (U)
1904-2,Ascorbate,CHEM,Ascorbic acid; c702; Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Vit C; Vitamin C,Vit C Ur Ql,,Ascorbate [Presence] in Urine,,Ascorbate Ql (U)
34200-6,Erythrocytes.nucleated,HEM/BC,Auto; Automated detection; Blood; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Normoblasts; nRBC; nRBCs; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen; WB; Whole blood,nRBC Bld Ql Auto,,Nucleated erythrocytes [Presence] in Blood by Automated count,,Nucleated RBC Auto Ql (Bld)
5724-0,Selenium,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SE; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Selenium SerPl-mCnc,ng/mL,Selenium [Mass/volume] in Serum or Plasma,ng/mL,Selenium [Mass/Vol]
70163-1,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel,PANEL.MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Cervix; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Genital tract; Gen-Probe; Gono; Gonorrhea; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification,C trach+GC pnl Cvx NAA+probe,,Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Cervix by NAA with probe detection,,C. trachomatis and N. gonorrhoeae rRNA panel NAA+probe (Cvx)
32018-4,Hepatitis A virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HAV; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR,HAV IgG Ser Ql,,Hepatitis A virus IgG Ab [Presence] in Serum,,HAV IgG Ql (S)
13516-0,Neutrophils/Leukocytes,HEM/BC,Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neuro; Neurology; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells,Neutrophils NFr CSF Manual,%,Neutrophils/Leukocytes in Cerebral spinal fluid by Manual count,%,Neutrophils/Leukocytes Manual cnt (CSF)
39575-6,Fungus.microscopic observation,PATH,Acd; Acids; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Misc; Miscellaneous; Nominal; Other; PAS stain; PAS Stn; PATHOLOGY; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified,Fungus Spec PAS Stn,,Fungus.microscopic observation [Identifier] in Specimen by Periodic acid-Schiff stain,,Fungus.microscopic observation Periodic acid-Schiff stain Nom (Specimen)
6244-8,Rumex acetosella Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sheep Sorrel; SR; UniversalLabOrders; w018; w18,Sheep Sorrel IgE Qn,kIU/L; kU/L,Sheep Sorrel IgE Ab [Units/volume] in Serum,k[IU]/L,Sheep Sorrel IgE Qn (S)
708-8,Blasts,HEM/BC,#; ABS; absolute; absolutes; Blast; Blood; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Blasts # Bld Manual,10*9/L,Blasts [#/volume] in Blood by Manual count,10*3/uL,Blasts Manual cnt (Bld) [#/Vol]
4625-0,Hemoglobin S/Hemoglobin.total,HEM/BC,Blood; Haemoglobin; Hb; HBs; HEMATOLOGY/CELL COUNTS; Hgb; Hgb S; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sickle cell; Sickle cells; Tot; Totl; UniversalLabOrders; WB; Whole blood,Hgb S MFr Bld,%,Hemoglobin S/Hemoglobin.total in Blood,%,Hemoglobin S (Bld) [Mass fraction]
43408-4,Bacteria,MICRO,"Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Tissue; Tissue, unspecified",Bacteria Tiss Cult,,Bacteria identified in Tissue by Culture,,Bacteria identified Cx Nom (Tiss)
65758-5,T-cell helper (CD4) subset panel,PANEL.CELLMARK,Blood; CELL MARKERS; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; T cell; T prime; T4; T-4; T-cell CD4 subset pnl; UCHL-1; UniversalLabOrders; W3/25; WB; Whole blood,T-cell CD4 subset pnl Bld,,T-cell helper (CD4) subset panel - Blood,,T-cell helper (CD4) subset panel (Bld)
6476-6,Mumps virus Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; MuV; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; UniversalLabOrders,MuV IgG Ser Ql IA,,Mumps virus IgG Ab [Presence] in Serum by Immunoassay,,MuV IgG IA Ql (S)
21112-8,Birth date,MISC,Birthdate; Date and time; Date of birth; DOB; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp,Birth date,MMDDYY,Birth date,{mm/dd/yyyy},Birth date [Date/time]
49586-1,First & Second trimester integrated maternal screen,CHEM,2nd; Alpha-1-fetoprotein & Choriogonadotropin & Estriol.unconjugated & Inhibin A & Pregnancy associated plasma protein A & Nuchal translucency; Chemistry; Gestation; Gyn; Gynecology; Impression; Impression/interpretation of study; Impressions; Integrated scn; Interp; Interpretation; Nominal; OB; ObGyn; Obstetrics; Point in time; Prenatal; Random; Scn; Scr; Scrn,Integrated scn Patient-Imp,,First and Second trimester integrated maternal screen [Interpretation],,First and Second trimester integrated maternal screen [Interp]
34539-7,Protein fractions panel,PANEL.CHEM,Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; PEUR; Pnl; Point in time; PR; Prot; Prot Elph Pnl; QNT; Quan; Quant; Quantitative; Random; Serum electrophoresis; UA; UPEP; UR; Urn,Prot Elph Pnl Ur Elph,,Protein electrophoresis panel - Urine,,Protein electrophoresis panel Elph (U)
25836-8,HIV 1 RNA,MICRO,#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AIDS; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified; Viral load,HIV1 RNA # Spec NAA+probe,copies/mL,HIV 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection,{copies}/mL,HIV 1 RNA NAA+probe (Specimen) [#/Vol]
16131-5,Herpes simplex virus 2 DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified,HSV2 DNA Spec Ql NAA+probe,,Herpes simplex virus 2 DNA [Presence] in Specimen by NAA with probe detection,,HSV 2 DNA NAA+probe Ql (Specimen)
5076-5,Cardiolipin Ab.IgA,COAG,ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Arbitrary concentration; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Immune globulin A; Immunoglobulin A; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,Cardiolipin IgA Ser IA-aCnc,APL U,Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay,[APL'U],Cardiolipin IgA IA Qn (S)
33569-5,Sjogrens syndrome-A extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-A; Enzyme immunoassay; IAA; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; SUDS; UniversalLabOrders,ENA SS-A Ab Ser IA-aCnc,,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,Sjogrens syndrome-A extractable nuclear Ab IA Qn (S)
10365-5,Cotinine,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nicotine metabolite; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Cotinine SerPl-mCnc,ng/mL,Cotinine [Mass/volume] in Serum or Plasma,ng/mL,Cotinine [Mass/Vol]
19213-8,pH,CHEM,Bld mixed venous; Blood - mixed venous; Chemistry; Kidney; Log molar concentration; Lung; Nephrology; Point in time; Pulmonary; Pulmonology; Random; Renal; Respiratory; SmQn,pH BldMV,pH,pH of Mixed venous blood,[pH],pH (BldMV)
53331-5,Crystals.amorphous,UA,#; ABS; absolute; absolutes; AM; Amorph; Amorph Cry; Amorphic; Artificial Intelligence; Automated detection; Cnt; Comp Assist; Count; Count/volume; Crys; Cryst; Crystal; CT; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn,Amorph Cry # Ur Comp Assist,/uL,Crystals.amorphous [#/volume] in Urine by Computer assisted method,/uL,Crystals.amorphous Computer assisted (U) [#/Vol]
42327-7,Leukocytes,HEM/BC,Bowel movement; Faecal; Faeces; Fecal; Feces; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; MB Stn; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stl; Stn; Stool = Fecal; WBC; WBCs; White blood cell; White blood cells,WBC Stl Ql MB Stn,,Leukocytes [Presence] in Stool by Methylene blue stain,,WBC Methylene blue stain Ql (Stl)
3853-9,Nicotine,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Illicit; Level; Mass concentration; Nicoderm; Nictoine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Nicotine SerPl-mCnc,ng/mL,Nicotine [Mass/volume] in Serum or Plasma,ng/mL,Nicotine [Mass/Vol]
34366-5,Protein/Creatinine,CHEM,Chemistry; CR; Crea; Creat; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn,Prot/Creat Ur-Rto,g/mmol creatinine,Protein/Creatinine [Ratio] in Urine,g/mmol{creat},Protein/Creatinine (U) [Ratio]
8264-4,Service comment 03,MISC,cmmt; cmnt; Com; Comm; Comment; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Remarks; Service Cmnt; Service Cmnt 03; Spec; To be specified in another part of the message; Unspecified,Service Cmnt 03-Imp,,Service comment 03,,Service comment 03 [Interp]
5809-9,Reducing substances,UA,Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reduc; Reduc subs; Reducing substance; Screen; UA; UniversalLabOrders; UR; URINALYSIS; Urn,Reducing Subs Ur Ql,,Reducing substances [Presence] in Urine,,Reducing substances Ql (U)
6234-9,Salsola kali Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Russian thistle; Salosola kali; Salsola pestifer; Saltwort; Saltwort (prickly); Serum; SR; UniversalLabOrders; w011; w11,Saltwort IgE Qn,kIU/L; kU/L,Saltwort IgE Ab [Units/volume] in Serum,k[IU]/L,Saltwort IgE Qn (S)
14580-5,ABO group,BLDBK,Blood; BLOOD BANK; Hematology; Heme; NB; New born; Nominal; Point in time; Random; Typ; WB; Whole blood,ABO Group Bld NB,,ABO group [Type] in Blood from Newborn,,ABO group (Bld newborn)
35802-8,Ertapenem,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; InVanz; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Ertapenem Susc Islt,,Ertapenem [Susceptibility],,Ertapenem [Susc]
20407-3,Nitrite,UA,Dip stick; Dipstick; Level; Mass concentration; NO2; Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn,Nitrite Ur Strip-mCnc,mg/dL,Nitrite [Mass/volume] in Urine by Test strip,mg/dL,Nitrite Test strip (U) [Mass/Vol]
2027-1,Carbon dioxide,CHEM,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2; Venous,CO2 BldV-sCnc,mmol/L,"Carbon dioxide, total [Moles/volume] in Venous blood",mmol/L,CO2 (BldV) [Moles/Vol]
20450-3,Alpha-1-Fetoprotein,CHEM,A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; Feto; i; MoM; Multiple of the median; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker,AFP MoM SerPl,M.o.M,Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma,{M.o.M},AFP [MoM]
43409-2,Bacteria,MICRO,Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random,Bacteria Islt Cult,,Bacteria identified in Isolate by Culture,,Bacteria identified Cx Nom (Isol)
52816-6,Nucleated cells,HEM/BC,#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid,Nuc cell # CSF Auto,cells/uL,Nucleated cells [#/volume] in Cerebral spinal fluid by Automated count,10*3/uL,Nucleated cells Auto (CSF) [#/Vol]
2900-9,Pyridoxine,CHEM,C8H11NO3; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pyridoxol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vit B6; Vitamin B6,Vit B6 SerPl-mCnc,ng/mL,Pyridoxine [Mass/volume] in Serum or Plasma,ng/mL,Pyridoxine [Mass/Vol]
6115-0,Franseria acanthicarpa Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; False ragweed; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w004; w4,False ragweed IgE Qn,kIU/L,False ragweed IgE Ab [Units/volume] in Serum,k[IU]/L,False ragweed IgE Qn (S)
40703-1,Lactoferrin,CHEM,Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; IAA; Lf; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS; UniversalLabOrders,Lactoferrin Stl Ql IA,,Lactoferrin [Presence] in Stool by Immunoassay,,Lactoferrin IA Ql (Stl)
53291-1,Epithelial casts,UA,#/area; Artificial Intelligence; Automated detection; Cast; Comp Assist; Epi; Epith; Epith Casts; Epithelia; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn,Epith Casts #/area Ur Comp Assist,,Epithelial casts [#/area] in Urine by Computer assisted method,/[HPF],Epithelial casts Computer assisted (U) [#/Area]
71694-4,Hemoglobin,HEM/BC,Auto; Automated detection; CHr; Elec; Elect; Electr; Entitic mass; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Reticulocyte hemoglobin content,Hgb Retic Qn Auto,pg,Hemoglobin [Entitic mass] in Reticulocytes by Automated count,pg,Hemoglobin Auto (Reticulocytes) [Entitic mass]
3284-7,Lupus anticoagulant neutralization.platelet,COAG,Anticoag; Anti-phospholipid antibody; Clot; Clottable; COAGULATION; Coagulation assay; Coagulation inhibiting antibody; dRVVT; Hematology; Heme; LA; LA Nt Platelet; LAC; Lupus inhibitor; Neut; Neutr; Pl; Plas; Platelet neutralization procedure; Platelet poor plasma; Platelets; Platelt; Plt; PNP; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; Tilt tube; UniversalLabOrders,LA Nt Platelet PPP,s,Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay,s,Lupus anticoagulant neutralization platelet Coag (PPP) [Time]
32030-9,Nitrate,DRUG/TOX,DRUG/TOXICOLOGY; Drugs; NO3; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn,Nitrate Ur Ql,,Nitrate [Presence] in Urine,,Nitrate Ql (U)
46138-4,Urate crystals,UA,#/area; Crys; Cryst; Crystal; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urates; Uric acid; URINALYSIS; Urine sediment; Urn; UrnS,Urate Cry #/area UrnS HPF,/HPF,Urate crystals [#/area] in Urine sediment by Microscopy high power field,/[HPF],Urate crystals LM.HPF (Urine sed) [#/Area]
7885-7,Epstein Barr virus capsid Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CAP; EBV; EBV capsid Ab; EBV VCA; Epstn; HHV-4; human herpesvirus 4; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders; VCA; Viral capsid,EBV VCA IgG Ser-aCnc,arb U/mL,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum,[arb'U]/mL,EBV capsid IgG Qn (S)
49090-4,Fetal trisomy 21 risk,CHEM,Chemistry; Down syndrome; Downs; Down's syndrome; ds; Fetal; from Mat age; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Ts; Ts 21 risk,Fet Ts 21 risk from Mat age,Risk,Fetal Trisomy 21 risk [Likelihood] Based on maternal age,{risk},Trisomy 21 risk Based on maternal age Qn (fetus)
24313-9,Hepatitis 1996 panel,PANEL.MICRO,96; Hep; Hepatis; Hepatit; Hepatitis 1996 Pnl; Hepatology; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR,Hepatitis 1996 Pnl Ser,,Hepatitis 1996 panel - Serum,,Hepatitis 1996 panel (S)
3937-0,Phencyclidine,DRUG/TOX,Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; PCP; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sernylan; UA; UR; Urn,PCP Ur-mCnc,ug/L;ng/mL,Phencyclidine [Mass/volume] in Urine,ug/L,Phencyclidine (U) [Mass/Vol]
28640-1,Bicarbonate,CHEM,BIC; bicar; Bicarb; Bld cord; Chemistry; Cord arterial blood; Cord BldA; Gyn; Gynecology; HCO3; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration,HCO3 BldCoA-sCnc,mmol/L,Bicarbonate [Moles/volume] in Arterial cord blood,mmol/L,HCO3 (BldCoA) [Moles/Vol]
38476-8,Mullerian inhibiting substance,CHEM,AMH; Anti Mullerian hormone; Chemistry; Level; Mass concentration; MIF; MIH; MIS; Mullerian inhibiting factor; Mullerian inhibiting hormone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Subs; UniversalLabOrders,MIS SerPl-mCnc,ng/mL,Mullerian inhibiting substance [Mass/volume] in Serum or Plasma,ng/mL,Mullerian inhibiting substance [Mass/Vol]
27048-8,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA RNP; ENA SM; ENA SM+RNP; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonuclear protein; RNP; Ro; Serology; Serum; SM; SR; UniversalLabOrders,ENA SM+RNP Ab Ser-aCnc,,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum,[arb'U]/mL,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab Qn (S)
2111-3,Choriogonadotropin.beta subunit,CHEM,B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker; UniversalLabOrders,B-HCG SerPl-sCnc,mmol/L,Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma,mmol/L,HCG.beta subunit [Moles/Vol]
38204-4,Pain primary location,H&P.HX,Anatomy; H+P; H+P.HX; Nominal; P prime; Point in time; Random,Pain primary location Reported,,Pain primary location - Reported,,
82179-3,Bordetella pertussis.pertussis toxin promoter region,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pert.PT; B pert.PT Prmt; B pertussis; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough,B pert.PT Prmt Nph Ql NAA+non-probe,,Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection,,B. pertussis toxin promoter region NAA+non-probe Ql (Nph)
30372-7,Sucrase,CHEM,Catalytic Content; Chemistry; Disaccharidase; Point in time; QNT; Quan; Quant; Quantitative; Random; Sucrose alpha-d-glucohydrolase; Sucrose alpha-glucosidase; Tissue small intestine,Sucrase TSMI-cCnt,umol/min/g,Sucrase [Enzymatic activity/mass] in Small intestine Tissue,umol/min/g,Sucrase (Small intestine Tissue) [Catalytic activity/Mass]
30315-6,Acid alpha glucosidase,CHEM,"Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Catalytic Content; Chemistry; GAA; Glucoinvertase; Glucosidosucrase; Maltase; Maltase-glucoamylase; Point in time; Pompe disease; QNT; Quan; Quant; Quantitative; Random; Tissue small intestine",Acid A-Glucosidase TSMI-cCnt,umol/min/g,Acid alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue,umol/min/g,Acid alpha glucosidase (Small intestine Tissue) [Catalytic activity/Mass]
30319-8,Beta galactosidase,CHEM,B; B-Galactosidase; Catalytic Content; Chemistry; Disaccharidase; GM 1-gangliosidosis; Lactase; Morquio disease type B; MPS IV B; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue small intestine,B-Galactosidase TSMI-cCnt,umol/min/g,Beta galactosidase [Enzymatic activity/mass] in Small intestine Tissue,umol/min/g,Beta galactosidase (Small intestine Tissue) [Catalytic activity/Mass]
33825-1,Leukocyte casts,UA,Cast; Kidney; Leuc; Leuk; Leukocytes; Lkcs; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBC Casts; WBCs; White blood cell; White blood cells,WBC Casts UrnS Ql Micro,,WBC casts [Presence] in Urine sediment by Light microscopy,,WBC casts LM Ql (Urine sed)
8248-7,Spermatozoa,UA,Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Sperm; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Sperm UrnS Ql Micro,,Spermatozoa [Presence] in Urine sediment by Light microscopy,,Spermatozoa LM Ql (Urine sed)
69971-0,Gas flow at 25-75% of forced expiration,PULM,Breathing; Dynamic; Exp; FEF 25-75%; Flow; Forced expiratory flow rate; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate,FEF 25-75% Predicted,L/s,FEF 25-75% Predicted,L/s,
603-1,Bacteria,MICRO,Bact; Brn; Burn; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random,Bacteria Burn Cult,,Bacteria identified in Burn by Culture,,Bacteria identified Cx Nom (Burn)
17433-4,pH,CHEM,Chemistry; Log molar concentration; Misc; Miscellaneous; Other; Point in time; Random; SmQn; Spec; To be specified in another part of the message; Unspecified,pH Spec,pH,pH of Specimen,[pH],pH (Specimen)
17782-4,Lipoprotein.beta.subparticle,CHEM,B; Chemistry; Entitic length; LDL; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,LDL SerPl Qn,Angstrom,Lipoprotein.beta.subparticle [Entitic length] in Serum or Plasma,Ao;nm,Lipoprotein.beta.subparticle [Entitic length]
35071-0,Basophils,HEM/BC,"#; ABS; absolute; absolutes; B/F; Baso; Basophil; Basos; BF; bod; Bodies; Body fluid; Body fluid, unsp; Bph; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random",Basophils # Fld,10*3/uL,Basophils [#/volume] in Body fluid,10*3/uL,Basophils (Body fld) [#/Vol]
19151-0,Specimen drawn,SPEC,Date and time; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Time stamp; Timestamp,Specimen drawn SerPl,,Specimen drawn [Date and time] of Serum or Plasma,,Specimen drawn [Date/time]
77307-7,Lead,DRUG/TOX,Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous,Lead BldV-mCnc,ug/dL,Lead [Mass/volume] in Venous blood,ug/dL,Lead (BldV) [Mass/Vol]
2158-4,Creatine kinase.total/Creatine kinase.MB,CHEM,Cardio; Cardiology; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; CK; CK 2; CK MB; CK-2; CKMB; CK-MB; CPK; Creatine phosphokinase; Enzymatic activity ratio; Heart Disease; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl,CK/CK MB SerPl-cRto,U/U,Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma,U/U,CK.total/Creatine kinase.MB [Catalytic ratio]
22131-7,Borrelia burgdorferi Ab.IgG+IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders,B burgdor IgG+IgM Ser Ql,,Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum,,B. burgdorferi IgG+IgM Ql (S)
49700-8,Metanephrine.free,CHEM,Chemistry; FR; Level; Metaneph; Metaneph Free; Metanephrne; Metenephrine; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Unconjugated metanephrine,Metaneph Free SerPl-sCnc,nmol/L,Metanephrine Free [Moles/volume] in Serum or Plasma,nmol/L,Metanephrine Free [Moles/Vol]
49051-6,Gestational age in W,OB.US,Fetal; GA; GA (weeks); Gest; Gestation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; Prenatal; QNT; Quan; Quant; Quantitative; Random,GA (weeks),wk,Gestational age in weeks,wk,
13980-8,Albumin/Protein.total,CHEM,Alb; Albumin fraction; Albumin%; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP,Albumin MFr SerPl Elph,%,Albumin/Protein.total in Serum or Plasma by Electrophoresis,%,Albumin Elph [Mass fraction]
47322-3,SCL-70 extractable nuclear Ab.IgG,SERO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Arbitrary concentration; Autoantibodies; Autoantibody; DNA-Topoisomerase I; EIA; ELFA; ELISA; ENA; ENA Scl70; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Scleroderma ab; Serology; Serum; SR; SUDS; Topo I; Topoisomerase I,ENA Scl70 IgG Ser IA-aCnc,arb U/mL,SCL-70 extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,SCL-70 extractable nuclear IgG IA Qn (S)
63379-2,DNA double strand Ab.IgG,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Immune globulin G; Immunoglobulin G; Native DNA; N-DNA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stranded; Strnd,dsDNA IgG Ser Ql,,DNA double strand IgG Ab [Presence] in Serum,,DNA double strand IgG Ql (S)
13982-4,Beta globulin/Protein.total,CHEM,B; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP,B-Globulin MFr SerPl Elph,%,Beta globulin/Protein.total in Serum or Plasma by Electrophoresis,%,Beta globulin Elph [Mass fraction]
3289-6,Prothrombin.activity actual/Normal,COAG,Act/Nor; Activ; Actvty; Clot; Clottable; COAGULATION; Coagulation assay; Coagulation factor II; Control; Factor 2; Factor II; Factor II activity; FII; FII activity; Hematology; Heme; Movements; Plas; Platelet poor plasma; Point in time; Prothombin; Prothrm; Prothromb; QNT; Quan; Quant; Quantitative; Random; RlTm; Tilt tube; UniversalLabOrders,Prothrom Act/Nor PPP,%,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,%,Prothrombin activity actual/normal Coag (PPP) [Relative time]
13981-6,Alpha 2 globulin/Protein.total,CHEM,A2; Alfa; Alpha2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP,Alpha2 Glob MFr SerPl Elph,%,Alpha 2 globulin/Protein.total in Serum or Plasma by Electrophoresis,%,Alpha 2 globulin Elph [Mass fraction]
39466-8,Carbon dioxide,CHEM,Bld cord; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; Cord arterial blood; Cord BldA; ctCO2; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2,CO2 BldCoA-sCnc,mmol/L,"Carbon dioxide, total [Moles/volume] in Arterial cord blood",mmol/L,CO2 (BldCoA) [Moles/Vol]
4087-3,Valproate.free,DRUG/TOX,Depakene; Divalproex; DRUG/TOXICOLOGY; Drugs; FR; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VALP; Valproate Free; Valproic acid,Valproate Free SerPl-mCnc,ug/mL,Valproate Free [Mass/volume] in Serum or Plasma,ug/mL,Valproate Free [Mass/Vol]
13983-2,Gamma globulin/Protein.total,CHEM,Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP,Gamma glob MFr SerPl Elph,%,Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis,%,Gamma globulin Elph [Mass fraction]
10976-9,6-Monoacetylmorphine,DRUG/TOX,6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; MAM; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,6MAM Ur Ql,,6-Monoacetylmorphine (6-MAM) [Presence] in Urine,,6-Monoacetylmorphine (6-MAM) Ql (U)
46137-6,Triple phosphate crystals,UA,#/area; Crys; Cryst; Crystal; i Phos; Inorganic phosphate; Kidney; LM; Magnesium ammonium phosphate; MAP; MgNH4PO4.6H2O; Micro; Micros; Microscopic; Nephrology; Number areic; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Strive; Struvite; Tri; Trip; Tri-Phos; Tri-Phos Cry; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Tri-Phos Cry #/area UrnS HPF,/HPF,Triple phosphate crystals [#/area] in Urine sediment by Microscopy high power field,/[HPF],Triple phosphate crystals LM.HPF (Urine sed) [#/Area]
13978-2,Alpha 1 globulin/Protein.total,CHEM,A1; Alfa; Alpha1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP,Alpha1 Glob MFr SerPl Elph,%,Alpha 1 globulin/Protein.total in Serum or Plasma by Electrophoresis,%,Alpha 1 globulin Elph [Mass fraction]
31626-5,Sjogrens syndrome-B extractable nuclear Ab.IgG,SERO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA SS-B; HA; Ha AB; Immune globulin G; Immunoglobulin G; La AB; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; Sjogren; SR; SS; SSB; SS-B,ENA SS-B IgG Ser Ql,,Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum,,Sjogrens syndrome-B extractable nuclear IgG Ql (S)
20436-2,Glucose^2H post dose glucose,CHAL.ROUTINE,120 min; 120 minutes; 120min; 2 hours; 2h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Glucose 2h p Glc SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose,mg/dL,Glucose 2 Hr post dose glucose [Mass/Vol]
10587-4,Sexual abstinence duration,FERT,Durat; FERTILITY TESTING; Point in time; QNT; Quan; Quant; Quantitative; Random; Sex Abstin duration,Sex Abstin duration Time Patient,days,Sexual abstinence duration,d,Sexual abstinence duration [Time]
18862-3,Amoxicillin+Clavulanate,ABXBACT,Amox; Amoxicillin+clavulanic acid; Amoxicilloyl; Amoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Augmentin; Bristamox; c204; c305; c6; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Larotid; Moxalin; Moxicillin+clavulanic acid; Point in time; Polymox; Random; Sumox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trimox; Wymox,Amoxicillin+Clav Susc Islt,,Amoxicillin+Clavulanate [Susceptibility],,Amoxicillin+Clavulanate [Susc]
26452-3,Eosinophils/Leukocytes,HEM/BC,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Eos; Eosin; Eosino; Eosinophil; Eosins; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells",Eosinophil NFr Fld,%,Eosinophils/Leukocytes in Body fluid,%,Eosinophils/Leukocytes (Body fld)
30394-1,Granulocytes,HEM/BC,#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Gran; Grans; Granulocyte; Granulocytes; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,Granulocytes # Bld,/uL,Granulocytes [#/volume] in Blood,10*3/uL,Granulocytes (Bld) [#/Vol]
40851-8,Normetanephrine.free,CHEM,Chemistry; FR; Level; Non-protein bound; Normeta; Normetaneph; Normetaneph Free; Normetanephrn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Unconjugated normetanephrine,Normetaneph Free SerPl-sCnc,nmol/L,Normetanephrine Free [Moles/volume] in Serum or Plasma,nmol/L,Normetanephrine Free [Moles/Vol]
13992-3,Albumin/Protein.total,CHEM,Alb; Albumin fraction; Albumin%; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Kidney; Mass Fraction; Nephrology; Percent; PEUR; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn,Albumin MFr Ur Elph,%,Albumin/Protein.total in Urine by Electrophoresis,%,Albumin Elph (U) [Mass fraction]
15343-7,Blood group antibody,BLDBK,Ab; Bld gp Ab Scn; BLOOD BANK; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr,Bld gp Ab Scn Titr SerPl,titer,Blood group antibody screen [Titer] in Serum or Plasma,{titer},Blood group antibody screen [Titer]
43182-5,Smith extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SM; Enzyme immunoassay; IAA; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SM; SR; SUDS; UniversalLabOrders,ENA SM Ab Ser IA-aCnc,,Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,Smith extractable nuclear Ab IA Qn (S)
66126-4,Cholesterol.in VLDL,CHEM,Calc; Calculation; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Very low density lipoprotein cholesterols; VLDLc,VLDLc SerPl Calc-sCnc,mmol/L,Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation,mmol/L,Cholesterol in VLDL Calc [Moles/Vol]
82186-8,Streptococcus agalactiae DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S agalactiae; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification,Gp B Strep DNA CSF Ql NAA+non-probe,,Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection,,S. agalactiae DNA NAA+non-probe Ql (CSF)
3426-4,Tetrahydrocannabinol,DRUG/TOX,Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Marijuana; Nabilone; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; THC; UA; UniversalLabOrders; UR; Urn,THC Ur Ql,,Tetrahydrocannabinol [Presence] in Urine,,Tetrahydrocannabinol Ql (U)
27816-8,von Willebrand factor Ag actual/Normal,COAG,Act/Nor; Ag Act/Nor; Antigen; Antigens; COAGULATION; Control; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Hematology; Heme; IAA; MEIA; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative mass concentration; RLMCNC; SUDS; UniversalLabOrders; Von will; Vonwillebrand; vWf; vWF:Ag,vWF Ag Act/Nor PPP IA,%,von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay,%,vWf Ag actual/normal IA (PPP) [Relative mass conc]
14801-5,Iron saturation,CHEM,Chemistry; Fe; FE/TIBC; Iron Satn; Iron/Iron binding capacity.total; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SAT; Satn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Transferrin saturation,Iron Satn SFr SerPl,%,Iron saturation [Molar fraction] in Serum or Plasma,%,Iron saturation [Molar fraction]
33983-8,U1 small nuclear ribonucleoprotein Ab.IgG,SERO,ABS; Aby; ANA IgG; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonuclear protein; RNP; Serology; Serum; snRNP; SR; U1 RNP; U1 snRNP; U1RNP,U1 snRNP IgG Ser-aCnc,arb U/mL,U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum,[arb'U]/mL,U1 small nuclear ribonucleoprotein IgG Qn (S)
6892-4,Thyroxine.free,CHEM,Chemistry; Dialy; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4; UniversalLabOrders,T4 Free SerPl Dialy-mCnc,ng/dL,Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis,ng/dL,Free T4 Dialysis [Mass/Vol]
11565-9,Jo-1 extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA Jo1; Histidyl-tRNA synthease; i; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; UniversalLabOrders,ENA Jo1 Ab Ser-aCnc,arb U/mL,Jo-1 extractable nuclear Ab [Units/volume] in Serum,[arb'U]/mL,Jo-1 extractable nuclear Ab Qn (S)
20437-0,Glucose^3H post dose glucose,CHAL.ROUTINE,3h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Glucose 3h p Glc SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucose,mg/dL,Glucose 3 Hr post dose glucose [Mass/Vol]
42176-8,"1,3 beta glucan",MICRO,"1,3-Beta-D-Glucan; B; Beta glucan; i; ID; III; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders","1,3 beta glucan Ser-mCnc",ng/mL,"1,3 beta glucan [Mass/volume] in Serum",ng/mL,"1,3 beta glucan (S) [Mass/Vol]"
35741-8,Prostate specific Ag,CHEM,Antigen; Antigens; Chemistry; DL&lt;=0.01 ng/mL; Kallikrein 3; Level; Mass concentration; Nasogastric; P-30 antigen; Pl; Plasma; Plsm; Point in time; PS; PSA; QNT; Quan; Quant; Quantitative; Random; Seminin; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Tumor marker; Ultrasensitive; UniversalLabOrders,PSA SerPl DL<=0.01 ng/mL-mCnc,ug/L,Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL,ug/L,Prostate specific Ag DL <= 0.01 ng/mL [Mass/Vol]
20624-3,Creatinine,CHEM,1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UniversalLabOrders; UR; Urn,Creat 24h Ur-mCnc,g/L; mcg/mL; mg/dL; mg/mL,Creatinine [Mass/volume] in 24 hour Urine,mg/dL,Creatinine (24H U) [Mass/Vol]
39486-6,pH^^adjusted to patient's actual temperature,CHEM,adj; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Kidney; Log molar concentration; Lung; Nephrology; Point in time; Pulmonary; Pulmonology; Random; Renal; Respiratory; S prime; SmQn; Temp; temp adj; Venous,pH temp adj BldV,pH,pH of Venous blood adjusted to patient's actual temperature,[pH],pH adjusted to patient's actual temperature (BldV)
15082-1,Methemoglobin,CHEM,Blood; Chemistry; Hemiglobin; Hi; Level; Mass concentration; Methaemoglobin; MetHb; Methgb; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood,MetHgb Bld-mCnc,g/L;g/dL,Methemoglobin [Mass/volume] in Blood,g/L,Methemoglobin (Bld) [Mass/Vol]
3160-9,Specimen volume,FERT,Ejaculate; FERTILITY TESTING; Genitourinary; GU; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Spec; URO; Urology; Vol; Volume,Specimen vol Smn,cc; mL,Volume of Semen,mL,Specimen volume (Sem)
21262-1,Escherichia coli shiga-like toxin,MICRO,Bowel movement; E coli; E coli SLTEC; E coli SXT; EHEC; EIA; ELFA; ELISA; Enterohemorrhagic E coli; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; o002; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SLTEC; Stl; Stool = Fecal; SUDS; UniversalLabOrders,E coli SXT Stl Ql IA,,Escherichia coli shiga-like toxin [Presence] in Stool by Immunoassay,,E. coli shiga-like toxin IA Ql (Stl)
51435-6,Protein.monoclonal band 1,CHEM,Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; i; Level; M Protein; M Protein 1; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR,M Protein 1 SerPl Elph-mCnc,g/L,Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis,g/L,Protein.monoclonal band 1 Elph [Mass/Vol]
24363-4,Acute hepatitis 2000 panel,PANEL.MICRO,00; Acute Hep 2000 Pnl; Hep; Hepatis; Hepatit; Hepatology; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; UniversalLabOrders,Acute Hep 2000 Pnl Ser,,Acute hepatitis 2000 panel - Serum,,Acute hepatitis 2000 panel (S)
17719-6,traMADol,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tramal; UA; Ultram; UR; Urn,traMADol Ur-mCnc,ug/mL,traMADol [Mass/volume] in Urine,ug/mL,traMADol (U) [Mass/Vol]
19066-0,Blood bank comment,BLDBK,Blood Bank Cmnt; cmmt; cmnt; Com; Comm; Comments; Commt; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Remarks,Blood Bank Cmnt Patient-Imp,,Blood bank comment,,Blood bank comment [Interp]
57130-7,Newborn screening report - overall interpretation,CHEM,Asympt; Asymptomatic; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; NBS report - overall interp; New born; Nominal; Point in time; Random; Scn,NBS report - overall interp,,Newborn screening report - overall interpretation,,NBS report - overall interpretation [Interp]
40464-0,Drugs,DRUG/TOX,Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Drug; DRUG/TOXICOLOGY; Drugs; GCMS; Identity or presence; LC/MS/MS; Nominal; Point in time; Random; UA; UniversalLabOrders; UR; Urn,Drugs Ur Cfm,,Drugs identified in Urine by Confirmatory method,,Drugs identified Confirm Nom (U)
21025-2,Pathologist interpretation,PATH,"B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; Path; Path Interp; PATHOLOGY; Point in time; Random",Path Interp Fld-Imp,,Pathologist interpretation of Body fluid tests,,Pathologist interpretation (Body fld) [Interp]
40619-9,Carbon dioxide^^adjusted to patient's actual temperature,CHEM,adj; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Carbonic anhydride; Chemistry; CO2; Lung; Partial pressure; PCO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; S prime; Temp; temp adj; Venous,pCO2 temp adj BldV,mm Hg,Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous blood,mm[Hg],CO2 adjusted to patient's actual temperature (BldV) [Partial pressure]
32329-5,Magnesium,CHEM,Chemistry; Level; MAG; Magnes; Mg; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified,Magnesium Spec-sCnc,mmol/L,Magnesium [Moles/volume] in Specimen,mmol/L,Magnesium (Specimen) [Moles/Vol]
6278-6,Fraxinus americana Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t015; t15; UniversalLabOrders; White ash,White Ash IgE Qn,kIU/L; kU/L,White Ash IgE Ab [Units/volume] in Serum,k[IU]/L,White Ash IgE Qn (S)
32730-4,Beta 1 globulin,CHEM,B; B1 globulin; Beta1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Beta1 Glob SerPl Elph-mCnc,g/dL,Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,g/dL,Beta 1 globulin Elph [Mass/Vol]
19141-1,Propoxyphene,DRUG/TOX,Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Napsalgesic; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn,Propoxyph Ur Ql,,Propoxyphene [Presence] in Urine,,Propoxyphene Ql (U)
6800-7,Spermatozoa.motile/Spermatozoa,FERT,Ejaculate; FERTILITY TESTING; Genitourinary; GU; Mot; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Motile; URO; Urology,Sperm Motile NFr Smn,%,Spermatozoa Motile/Spermatozoa in Semen,%,Spermatozoa Motile/Spermatozoa (Sem)
13995-6,Gamma globulin/Protein.total,CHEM,Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Mass fraction; Percent; PEUR; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; UA; UPEP; UR; Urn,Gamma glob MFr Ur Elph,%,Gamma globulin/Protein.total in Urine by Electrophoresis,%,Gamma globulin Elph (U) [Mass fraction]
59274-1,Oxygen content,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Calc; Calculation; Chemistry; ctO2; Lung; O2; O2 Ct; O2CT; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Volfr; Volume fraction,O2 Ct VFr BldA Calc,ml/dl,Oxygen content in Arterial blood by calculation,mL/dL,Oxygen content Calc (BldA) [Volume fraction]
35333-4,Jo-1 extractable nuclear Ab,SERO,ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA Jo1; Enzyme immunoassay; Histidyl-tRNA synthease; i; IAA; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS,ENA Jo1 Ab Ser IA-aCnc,,Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay,[arb'U]/mL,Jo-1 extractable nuclear Ab IA Qn (S)
4459-4,Vancomycin,DRUGDOSE,c162; Dose med or substance; DRUG DOSES; Point in time; QNT; Quan; Quant; Quantitative; Random; VANC; Vancocin; Vancor,Vancomycin Dose,,Vancomycin [Mass] of Dose,mg,Vancomycin (Dose) [Mass]
13994-9,Beta globulin/Protein.total,CHEM,B; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Kidney; Mass Fraction; Nephrology; Percent; PEUR; Point in time; PR; Prot; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn,B-Globulin MFr Ur Elph,%,Beta globulin/Protein.total in Urine by Electrophoresis,%,Beta globulin Elph (U) [Mass fraction]
62904-8,PhenX - pain protocol 170401,PANEL.PHENX,Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random,Pain proto,,PhenX - pain protocol 170401,,
18338-4,Nortramadol,DRUG/TOX,Desmeth; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite; UA; UR; Urn,Nortramadol Ur-mCnc,ug/mL,Nortramadol [Mass/volume] in Urine,ug/mL,Nortramadol (U) [Mass/Vol]
49617-4,Bacterial carbapenem resistance blaKPC gene,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; Bact; Carbapenem resistance gene; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec,blaKPC Islt/Spm Ql,,Carbapenem resistance blaKPC gene [Presence] by Molecular method,,Carbapenem resistance blaKPC gene Molgen Ql (Islt/Spec)
18860-7,Amikacin,ABXBACT,Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Amikacin Susc Islt,,Amikacin [Susceptibility],,Amikacin [Susc]
62467-6,Galactomannan Ag,MICRO,Antigen; Antigens; Arbitrary concentration; Aspergillus galactomannan; EIA; ELFA; ELISA; Enzyme immunoassay; GM; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; SUDS; To be specified in another part of the message; Unspecified,Galactomannan Ag Spec IA-aCnc,numerical index,Galactomannan Ag [Units/volume] in Specimen by Immunoassay,{Index_val},Galactomannan Ag IA Qn (Specimen)
73830-2,Fall risk assessment,H&P.HX,H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen,Fall risk assessment,,Fall risk assessment,,
6107-7,Egg yolk Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f075; f75; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Egg Yolk IgE Qn,kIU/L; kU/L,Egg yolk IgE Ab [Units/volume] in Serum,k[IU]/L,Egg yolk IgE Qn (S)
48952-6,Histoplasma capsulatum Ag,MICRO,Antigen; Antigens; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,H capsul Ag Ur-mCnc,ng/mL,Histoplasma capsulatum Ag [Mass/volume] in Urine,ng/mL,H. capsulatum Ag (U) [Mass/Vol]
3530-3,Tetrahydrocannabinol,DRUG/TOX,Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Level; Marijuana; Mass concentration; Nabilone; Point in time; QNT; Quan; Quant; Quantitative; Random; THC; UA; UR; Urn,THC Ur-mCnc,ng/mL,Tetrahydrocannabinol [Mass/volume] in Urine,ng/mL,Tetrahydrocannabinol (U) [Mass/Vol]
15069-8,Fructosamine,CHEM,Chemistry; Glucosamine; Glycated serum protein; GSP; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UniversalLabOrders,Fructosamine SerPl-sCnc,mcmol/L; mmol/L,Fructosamine [Moles/volume] in Serum or Plasma,umol/L,Fructosamine [Moles/Vol]
42595-9,Hepatitis B virus DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HBV; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load,HBV DNA SerPl NAA+probe-aCnc,IU/mL,Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,[IU]/mL,HBV DNA NAA+probe Qn
12710-0,Hemoglobin pattern,HEM/BC,Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood,Hgb Fract Bld-Imp,,Hemoglobin pattern [Interpretation] in Blood,,Hemoglobin pattern (Bld) [Interp]
54434-6,Lipoprotein.beta.subparticle,CHEM,B; Chemistry; LDL; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,LDL SerPl-sCnc,nmol/L,Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma,nmol/L,Lipoprotein.beta.subparticle [Moles/Vol]
4547-6,Hemoglobin A1/Hemoglobin.total,HEM/BC,Blood; Endocrine; Endocrinology; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A1; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood,Hgb A1 MFr Bld,%,Hemoglobin A1/Hemoglobin.total in Blood,%,Hemoglobin A1 (Bld) [Mass fraction]
41171-0,Collagen crosslinked C-telopeptide,CHEM,Beta crosslaps; Carboxyterminal cross-linking telopeptide of bone collagen; Chemistry; Collagen CTx; CrossLaps; C-Telopeptide of Type I Collagen; CTx; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Collagen CTx SerPl-mCnc,pg/mL; ng/mL,Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma,pg/mL,Collagen crosslinked C-telopeptide [Mass/Vol]
49539-0,Cytomegalovirus Ab.IgM,MICRO,ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; FA; Fluorescent antibody; Fluoresent; HHV-5; Human Herpesvirus-5; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF; UniversalLabOrders,CMV IgM SerPl Ql IF,,Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence,,CMV IgM IF Ql
24013-5,HIV 1 RNA,MICRO,AIDS; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Point in time; Random; Ribonucleic acid; Serum; SR,HIV1 RNA Ser-Imp,,HIV 1 RNA [Interpretation] in Serum,,HIV 1 RNA (S) [Interp]
6110-1,Plantago lanceolata Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Buckhorn plantain; Engl plantain; English plantain; Immune globulin E; Immunoglobulin E; Plantain Buckhorn; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribwort; Serum; SR; UniversalLabOrders; w009; w9,Engl plantain IgE Qn,kIU/L; kU/L,English plantain IgE Ab [Units/volume] in Serum,k[IU]/L,English plantain IgE Qn (S)
3747-3,Meperidine,DRUG/TOX,Addiction; Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Pethidine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Meperidine Ur-mCnc,ng/mL,Meperidine [Mass/volume] in Urine,ng/mL,Meperidine (U) [Mass/Vol]
13993-1,Alpha 2 globulin/Protein.total,CHEM,A2; Alfa; Alpha2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Kidney; Mass Fraction; Nephrology; Percent; PEUR; Point in time; PR; Prot; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn,Alpha2 Glob MFr Ur Elph,%,Alpha 2 globulin/Protein.total in Urine by Electrophoresis,%,Alpha 2 globulin Elph (U) [Mass fraction]
6584-7,Virus,MICRO,C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified,Virus Spec Cult,,Virus identified in Specimen by Culture,,Virus identified Cx Nom (Specimen)
53903-1,Collection method,SPEC,Coll; Collect; Collected; Meth; Method of; Nominal; Point in time; Random; Spec; Typ,Collection method Spec,,Collection method - Specimen,,Collection method Nom (Spec)
41399-7,Herpes simplex virus 1+2 Ab.IgM,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV1; HSV1+2; i; IAA; ID; II; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders,HSV1+2 IgM Ser IA-aCnc,,Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay,{Index_val},HSV 1+2 IgM IA Qn (S)
33052-2,Leukocytes,UA,Leuc; Leuk; Leukocyte; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells,WBC Ur Ql,,Leukocytes [Presence] in Urine,,WBC Ql (U)
43727-7,Lipoprotein.beta.subparticle.small,CHEM,B; Chemistry; LDL; LDL particle concentration; LDL particle number; LDL Small; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,LDL Small SerPl-sCnc,nmol/L,Lipoprotein.beta.subparticle.small [Moles/volume] in Serum or Plasma,nmol/L,Lipoprotein.beta.subparticle.small [Moles/Vol]
14045-9,D-lactate,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Dextro; Lact; Lactic acid; Level; L-lactate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration,D-Lactate SerPl-sCnc,mmol/L,D-Lactate [Moles/volume] in Serum or Plasma,mmol/L,D-Lactate [Moles/Vol]
60431-4,Date of previous biopsy,H&P.HX,Bx; Date previous bx; H+P; H+P.HX; P prime; Point in time; Prev; QNT; Quan; Quant; Quantitative; Random,Date previous bx,MMDDYY,Date of previous biopsy,,
49535-8,Influenza virus B RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,FLUBV RNA Islt Ql NAA+probe,,Influenza virus B RNA [Presence] in Isolate by NAA with probe detection,,FLUBV RNA NAA+probe Ql (Isol)
32731-2,Beta 2 globulin,CHEM,B; B2 globulin; Beta2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,Beta2 Glob SerPl Elph-mCnc,g/dL,Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis,g/dL,Beta 2 globulin Elph [Mass/Vol]
58442-5,Other elements,UA,Identity or presence; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Nominal; Othr; Point in time; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Other elements UrnS Micro,,Other elements [Identifier] in Urine sediment by Light microscopy,,Other elements LM Nom (Urine sed)
8146-3,Amphetamines,DRUG/TOX,Addiction; Amph; Amphetam; Amphetamine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mec; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Speed; UniversalLabOrders,Amphetamines Mec Ql Scn,,Amphetamines [Presence] in Meconium by Screen method,,Amphetamines Screen Ql (Mec)
18886-2,Cefotaxime,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Cefotaxime Susc Islt,,Cefotaxime [Susceptibility],,Cefotaxime [Susc]
59826-8,Creatinine,CHEM,Blood; Chemistry; CR; Crea; Creat; Kidney; Level; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration; WB; Whole blood,Creat Bld-sCnc,umol/L,Creatinine [Moles/volume] in Blood,umol/L,Creatinine (Bld) [Moles/Vol]
3681-4,HYDROcodone,DRUG/TOX,Addiction; Anexsia; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vicodin,HYDROcodone Ur-mCnc,ug/mL,HYDROcodone [Mass/volume] in Urine,ug/mL,HYDROcodone (U) [Mass/Vol]
24601-7,Multisection,RAD,Brst; CorePlaybook; Document; Echography; Finding; Findings; Gyn; Gynecology; Imaging; OB; ObGyn; Obstetrics; Playbook; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound,US Brst,,US Breast,,
32515-9,Cells.CD3+CD4+,CELLMARK,#; ABS; absolute; absolutes; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Misc; Miscellaneous; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; T3; T4; T-4; T4 helper/inducer cells; To be specified in another part of the message; Unspecified; W3/25,CD3+CD4+ Cells # Spec,cells/uL,CD3+CD4+ (T4 helper) cells [#/volume] in Specimen,/uL,CD3+CD4+ (T4 helper) cells (Specimen) [#/Vol]
8897-1,QRS complex,HRTRATE.MOLEC,Cardiac; Cardio; Cardiology; Compx; Count/time; ECG; Electrocardiogram; Electrocardiograph; Heart Disease; Heart Rate; HEART RATE.MOLEC; Hrt; Hrt ventrs; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; Ventricular,QRS Complex nRate Hrt ventrs EKG,,QRS complex Ventricles by EKG,,
13440-3,Interpretation,CHEM,Chemistry; Hematology; Heme; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; Point in time; Random; UA; UniversalLabOrders; UR; Urn,Interpretation Ur IFE-Imp,,Immunofixation for Urine,,Interpretation Immunofixation (U) [Interp]
13358-7,Collection time,SPEC,Coll; Collect; Collect Tme; Collected; Date and time; Ejaculate; Genitourinary; GU; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; SPEC; Time stamp; Timestamp; URO; Urology,Collect Tme Smn,,Collection time of Semen,,Collection time (Sem) [Date/time]
8894-8,P wave,HRTRATE.MOLEC,Atrial; Cardiac; Cardio; Cardiology; Count/time; ECG; Electrocardiogram; Electrocardiograph; Heart Disease; Heart Rate; HEART RATE.MOLEC; Hrt; Hrt.atria; nRate; Number rate; Number Rate = Count/Time; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random,P wave Atrium by EKG,,P wave Atrium by EKG,,
11050-2,Immunoglobulin light chains.kappa,CHEM,Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Kappa LC SerPl-mCnc,g/L;mcg/mL; mg/dL,Kappa light chains [Mass/volume] in Serum or Plasma,mg/dL,Immunoglobulin light chains.kappa [Mass/Vol]
43009-0,HIV 1+2 Ab.IgG,MICRO,ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HIV 1 & 2; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR,HIV1+2 IgG Ser Ql,,HIV 1+2 IgG Ab [Presence] in Serum,,HIV 1+2 IgG Ql (S)
28644-3,Carbon dioxide,CHEM,Bld cord; Carbonic anhydride; Chemistry; CO2; Cord arterial blood; Cord BldA; Gyn; Gynecology; OB; ObGyn; Obstetrics; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random,pCO2 BldCoA,mm Hg,Carbon dioxide [Partial pressure] in Arterial cord blood,mm[Hg],CO2 (BldCoA) [Partial pressure]
9835-0,HYDROmorphone,DRUG/TOX,Addiction; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydromorphinone; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,HYDROmorphone Ur-mCnc,ng/mL,HYDROmorphone [Mass/volume] in Urine,ng/mL,HYDROmorphone (U) [Mass/Vol]
53319-0,Crystals,UA,Auto; Automated detection; Crys; Cryst; Crystal; Elec; Elect; Electr; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn,Crystals Ur Ql Auto,,Crystals [Presence] in Urine by Automated,,Crystals Auto Ql (U)
3508-9,Codeine,DRUG/TOX,Addiction; c260; C300; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Methylmorphine; Morphine methyl ether; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Codeine Ur-mCnc,ng/mL,Codeine [Mass/volume] in Urine,ng/mL,Codeine (U) [Mass/Vol]
2464-6,IgG,CHEM,Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; UniversalLabOrders,IgG CSF-mCnc,g/L;mg/dL,IgG [Mass/volume] in Cerebral spinal fluid,mg/dL,IgG (CSF) [Mass/Vol]
49531-7,Influenza virus A RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification,FLUAV RNA Islt Ql NAA+probe,,Influenza virus A RNA [Presence] in Isolate by NAA with probe detection,,FLUAV RNA NAA+probe Ql (Isol)
44099-0,Galactomannan Ag,MICRO,Antigen; Antigens; Aspergillus galactomannan; EIA; ELFA; ELISA; Enzyme immunoassay; GM; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders,Galactomannan Ag SerPl Ql IA,,Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay,,Galactomannan Ag IA Ql
44706-0,Actin.smooth muscle Ab.IgG,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; ASMA; Autoantibodies; Autoantibody; F-actin; Hepatology; Immune globulin G; Immunoglobulin G; Liver; Musc; Muscl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SM; SMA; SR,SMA IgG Ser-aCnc,arb U/mL,Actin smooth muscle IgG Ab [Units/volume] in Serum,[arb'U]/mL,Actin smooth muscle IgG Qn (S)
13990-7,Alpha 1 globulin/Protein.total,CHEM,A1; Alfa; Alpha1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Kidney; Mass Fraction; Nephrology; Percent; PEUR; Point in time; PR; Prot; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn,Alpha1 Glob MFr Ur Elph,%,Alpha 1 globulin/Protein.total in Urine by Electrophoresis,%,Alpha 1 globulin Elph (U) [Mass fraction]
14168-9,Palatinase,CHEM,"Catalytic Content; Chemistry; Congenital Sucrose Intolerance; CSID; Disaccharidase; Disaccharide Intolerance I; Point in time; QNT; Quan; Quant; Quantitative; Random; SI Deficiency; Sucrase-isomaltase; Sucrose intolerance; Tissue; Tissue, unspecified",Palatinase Tiss-cCnt,umol/min/g protein,Palatinase [Enzymatic activity/mass] in Tissue,umol/min/g{protein},Palatinase (Tiss) [Catalytic activity/Mass]
6039-2,Beef Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bos spp; f027; f27; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Beef IgE Qn,kIU/L; kU/L,Beef IgE Ab [Units/volume] in Serum,k[IU]/L,Beef IgE Qn (S)
50984-4,Horowitz index,CHEM,ABG; ART; Art bld; Art blood; Arterial; Arterial blood; BldA+IhG; Blood arterial; Chemistry; Gases; IhG; Inhaled Gas; Inspired; PaO2/FiO2; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto,Horowitz index BldA+IhG-Rto,mm Hg,Horowitz index in Arterial blood,mm[Hg],Horowitz index (BldA+Inhl gas) [Ratio]
49034-2,Microorganism,CYTO,Cervix; CYTOLOGY; Cytology stain; Cytostain; Genital tract; Genital vaginal; Identity or presence; Microorganisms; Nominal; Org; Organism; Organisms; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn; Vag fld; Vag fluid; Vagina; Vaginal fluid,Microorganism Cvx/Vag Cyto,,Microorganism identified in Cervical or vaginal smear or scraping by Cyto stain,,Microorganism identified Cyto stain Nom (Cvx/Vag)
10412-5,Platelets given,BLDBK,BLOOD BANK; Gvn; Nominal; Platelet; Platelt; Plt; Point in time; Random; Thrb; Thrombocyte; Thrombocytes; Typ,Platelet Gvn,,Platelets given [Type],,Platelets given [Type]
6190-3,Avena sativa Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f007; f7; Immune globulin E; Immunoglobulin E; Oat; Oats; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Oat IgE Qn,kIU/L; kU/L,Oat IgE Ab [Units/volume] in Serum,k[IU]/L,Oat IgE Qn (S)
18319-4,Neutrophils.vacuolated,HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Neut; Neutr; Neutrophil; Neuts Vac; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vaculated; WB; Whole blood,Neuts Vac Bld Ql Smear,,Neutrophils.vacuolated [Presence] in Blood by Light microscopy,,Neutrophils.vacuolated LM Ql (Bld)
29742-4,Date last dose,DRUGDOSE,Date and time; Dose med or substance; DRUG DOSES; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp,Date Last Dose,,Date last dose,,Date last dose (Dose)
19710-3,traMADol,DRUG/TOX,Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tramal; UA; Ultram; UniversalLabOrders; UR; Urn,traMADol Ur Ql Scn,,traMADol [Presence] in Urine by Screen method,,traMADol Screen Ql (U)
28647-6,pH,CHEM,Bld cord; Chemistry; Cord BldV; Cord venous blood; Log molar concentration; Point in time; Random; SmQn,pH BldCoV,pH,pH of Venous cord blood,[pH],pH (BldCoV)
888-8,Blood group antibodies,BLDBK,BLOOD BANK; Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Blood group antibodies SerPl,,Blood group antibodies identified in Serum or Plasma,,Blood group antibodies identified Nom
8332-9,Body temperature,BDYTMP.MOLEC,Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Rectal; Temp; Temperature,Rectal temp,deg F; deg C,Rectal temperature,Cel;[degF],
6050-9,Bertholletia excelsa Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brazil nut; f018; f18; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Brazil Nut IgE Qn,kIU/L; kU/L,Brazil Nut IgE Ab [Units/volume] in Serum,k[IU]/L,Brazil Nut IgE Qn (S)
51724-3,Cefuroxime,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; c308; C33; Ceftin; Cefuroxime Axetil; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zinacef,Cefuroxime Susc Islt,,Cefuroxime [Susceptibility],,Cefuroxime [Susc]
21233-2,Cryptosporidium sp Ag,MICRO,Antigen; Antigens; Bowel movement; Crypt; Crypto; Cryptosporidiosis; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Stl; Stool = Fecal,Cryptosp Ag Stl Ql,,Cryptosporidium sp Ag [Presence] in Stool,,Cryptosporidium sp Ag Ql (Stl)
50262-5,Reticulocytes panel,PANEL.HEM/BC,Blood; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; Retic; Retic Pnl; Retics; Reticulocyte; WB; Whole blood,Retic Pnl,,Reticulocytes panel - Blood,,Reticulocytes panel (Bld)
42338-4,Herpes simplex virus 2 glycoprotein G Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; gG; Glycoprot; Glycoproteins; GP; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; HSV2 gG; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR,HSV2 gG IgG Ser-aCnc,EIA Index,Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Serum,{Index_val},HSV 2 glycoprotein G IgG Qn (S)
13654-9,Epithelial cells.squamous,UA,#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; Epi; Epi Cells; Epith; Epithelia; Kidney; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Squamous # UrnS,/mL,Epithelial cells.squamous [#/volume] in Urine sediment,/mL,Epithelial cells.squamous (Urine sed) [#/Vol]
29637-6,Time last dose,DRUGDOSE,Date and time; Dose med or substance; DRUG DOSES; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp; Tme Last Dose,Tme Last Dose,h,Time last dose of Dose,h,Time last dose (Dose)
66756-8,Clot initiation^after addition of heparinase,COAG,add heparinase; Blood; COAGULATION; Hematology; Heme; P Hpase; Point in time; QNT; Quan; Quant; Quantitative; Random; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood,Clot init P Hpase Bld TEG,min,Clot initiation [Time] in Blood by Thromboelastography --after addition of heparinase,min,Clot initiation after addition of heparinase TEG (Bld) [Time]
18932-4,Imipenem,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Imipeneum; Imp; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Imipenem Susc Islt,,Imipenem [Susceptibility],,Imipenem [Susc]
1507-3,Glucose^1H post 75 g glucose PO,CHAL.ROUTINE,1 hour; 1.0Hr; 1h p 75 g Glc PO; 60 min; 60 minutes; 60M; 60min; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Glucose 1h p 75 g Glc PO SerPl-mCnc,mg/dL,Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO,mg/dL,Glucose 1 Hr post 75 g glucose PO [Mass/Vol]
20474-3,Bacteria,MICRO,"Bact; Bx; Bx Cult; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Tissue; Tissue, unspecified; UniversalLabOrders",Bacteria Tiss Bx Cult,,Bacteria identified in Tissue by Biopsy culture,,Bacteria identified Biopsy cx Nom (Tiss)
46083-2,Influenza virus B Ag,MICRO,Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; UniversalLabOrders,FLUBV Ag Nph Ql IA,,Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay,,FLUBV Ag IA Ql (Nph)
6357-8,Chlamydia trachomatis DNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification; UA; UniversalLabOrders; UR; Urn,C trach DNA Ur Ql NAA+probe,,Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection,,C. trachomatis DNA NAA+probe Ql (U)
46082-4,Influenza virus A Ag,MICRO,Antigen; Antigens; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS,FLUAV Ag Nph Ql IA,,Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay,,FLUAV Ag IA Ql (Nph)
13514-5,Hemoglobin pattern,HEM/BC,Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; WB; Whole blood,Hgb Fract Bld Elph-Imp,,Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative,,Hemoglobin pattern Elph Nar (Bld) [Interp]
30525-0,Age,MISC,AOEObservation; MISC; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random,Age,years,Age,a,Age
14937-7,Urea nitrogen,CHEM,Blood urea nitrogen; BUN; Chemistry; Kidney; Level; N; N2; Nephrology; Nit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UN,BUN SerPl-sCnc,mmol/L,Urea nitrogen [Moles/volume] in Serum or Plasma,mmol/L,Urea nitrogen [Moles/Vol]
85954-6,Streptococcus pneumoniae Danish serotype 1 Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 1,S pneum Da 1 IgG Ser-mCnc,ug/mL,Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum,ug/mL,S. pneumoniae Danish type 1 IgG (S) [Mass/Vol]
47526-9,Cytology report,CYTO,Cytology stain; Cytostain; Document; Finding; Findings; Misc; Miscellaneous; Other; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified,Cytology Spec Doc Cyto,,Cytology report of Specimen Cyto stain,,Cytology report Cyto stain Doc (Specimen)
49121-7,Erythrocyte inclusion bodies,HEM/BC,Blood; bod; Body; Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Identity or presence; Nominal; Point in time; Random; RBC; RBC inclusions; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood,RBC inclusions Bld,,Erythrocyte inclusion bodies [Identifier] in Blood,,RBC inclusion bodies Nom (Bld)
53132-7,Epithelial cells.non-squamous,UA,#/area; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Non-sq Epi Cells; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Round epithelial cells; Small epithelial cells; Sq; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS,Non-sq Epi Cells #/area UrnS LPF,/LPF,Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy low power field,/[LPF],Epithelial cells.non-squamous LM.LPF (Urine sed) [#/Area]
50210-4,Glomerular filtration rate,CHEM,"Blood; Chemistry; GFR; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood",GFR/BSA.pred SerPlBld Cys-based-ArV,mL/min; ml/min/1.73m2,"Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin C-based formula/1.73 sq M",mL/min/{1.73_m2},GFR Cystatin C-based formula/1.73 sq M (S/P/Bld) [Vol rate/Area]
6152-3,Sorghum halepense Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; g010; g10; Immune globulin E; Immunoglobulin E; Johnson grass; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,Johnson grass IgE Qn,kIU/L; kU/L,Johnson grass IgE Ab [Units/volume] in Serum,k[IU]/L,Johnson grass IgE Qn (S)
43156-9,Lot number,DEVICES,Ident; Identifier; Lot #; No; Nominal; Num; Point in time; Random,Reagent Lot #,,Reagent Lot number,,
20626-8,Reducing substances,UA,Arbitrary concentration; Dip stick; Dipstick; Point in time; Random; Reduc; Reduc subs; Reducing substance; SmQn; UA; UR; URINALYSIS; Urn,Reducing Subs Ur Strip-aCnc,,Reducing substances [Units/volume] in Urine by Test strip,[arb'U]/mL,Reducing substances Test strip SemiQn (U)
86122-9,Streptococcus pneumoniae Danish serotype 11A Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 11A; S pneum Da 11A Ab; S pneum Da 11A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 43,S pneum Da 11A IgG Ser-mCnc,ug/mL,Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum,ug/mL,S. pneumoniae Danish type 11A IgG (S) [Mass/Vol]
6242-2,Sesamum indicum Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f010; f10; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sesame Seed; Sesamum orientale; SR; UniversalLabOrders,Sesame Seed IgE Qn,kIU/L,Sesame Seed IgE Ab [Units/volume] in Serum,k[IU]/L,Sesame Seed IgE Qn (S)
16859-1,Fibrinogen,COAG,COAGULATION; Coagulation factor I; FGN; Hematology; Heme; Ordinal; Plas; Platelet poor plasma; Point in time; PR; QL; Qual; Qualitative; Random; Screen,Fibrinogen PPP Ql,,Fibrinogen [Presence] in Platelet poor plasma,,Fibrinogen Ql (PPP)
14865-0,Parathyrin,CHEM,Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,PTH SerPl-Imp,,Parathyrin [Interpretation] in Serum or Plasma,,Parathyrin [Interp]
86098-1,Streptococcus pneumoniae Danish serotype 10A Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 10A; S pneum Da 10A Ab; S pneum Da 10A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 34,S pneum Da 10A IgG Ser-mCnc,ug/mL,Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum,ug/mL,S. pneumoniae Danish type 10A IgG (S) [Mass/Vol]
58430-0,oxyCODONE+Oxymorphone,DRUG/TOX,14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Numorphan; Numorphone; Opana; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn; Vicodin,oxyCODONE+oxyMORphone Ur Ql Scn,,oxyCODONE+oxyMORphone [Presence] in Urine by Screen method,,oxyCODONE+oxyMORphone Screen Ql (U)
6219-0,Pork Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f026; f26; Immune globulin E; Immunoglobulin E; Pig; Point in time; Porcine; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sus spp; Swine; UniversalLabOrders,Pork IgE Qn,kIU/L; kU/L,Pork IgE Ab [Units/volume] in Serum,k[IU]/L,Pork IgE Qn (S)
49560-6,Payment procedure,CLIN,CLIN; Identity or presence; Nominal; Point in time; Random,Payment procedure,,Payment procedure,,
9811-1,Chromogranin A,CHEM,Cg; CgA; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,CgA SerPl-mCnc,ug/L;ng/mL,Chromogranin A [Mass/volume] in Serum or Plasma,ng/mL,Chromogranin A [Mass/Vol]
21518-6,SCL-70 extractable nuclear Ab.IgG,SERO,ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; DNA-Topoisomerase I; ENA; ENA Scl70; Immune globulin G; Immunoglobulin G; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scleroderma; Scleroderma ab; Screen; Serology; Serum; SR; Topo I; Topoisomerase I,ENA Scl70 IgG Ser Ql,,SCL-70 extractable nuclear IgG Ab [Presence] in Serum,,SCL-70 extractable nuclear IgG Ql (S)
29605-3,Observation,SPEC,Appearance; Joint aspirate; Joint fld; Joint flu; Joint fluid; Nominal; Point in time; Random; SF; SNV; SPEC; Syn; Syn fl; Synov; Synovial fluid,Appearance Snv,,Appearance of Synovial fluid,,Appearance (Syn fld)
28645-0,Carbon dioxide,CHEM,Bld cord; Carbonic anhydride; Chemistry; CO2; Cord BldV; Cord venous blood; Gyn; Gynecology; OB; ObGyn; Obstetrics; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random,pCO2 BldCoV,mm Hg,Carbon dioxide [Partial pressure] in Venous cord blood,mm[Hg],CO2 (BldCoV) [Partial pressure]
14604-3,Blood group antibodies,BLDBK,BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR,Blood group antibodies SerPl BPU,,Blood group antibodies identified in Serum or Plasma from Blood product unit,,Blood group antibodies identified Nom (S/P BPU)
83093-5,Digoxin,DRUG/TOX,Cardio; Cardiology; DGXN; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; Heart Disease; IAA; Lanoxin; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS,Digoxin SerPl IA-mCnc,ng/mL,Digoxin [Mass/volume] in Serum or Plasma by Immunoassay,ng/mL,Digoxin IA [Mass/Vol]
29591-5,Enterovirus RNA,MICRO,3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified,EV RNA Spec Ql NAA+probe,,Enterovirus RNA [Presence] in Specimen by NAA with probe detection,,Enterovirus RNA NAA+probe Ql (Specimen)
49549-9,Referral lab test method,MISC,Meth; Method of; MISC; Narrative; Point in time; Random; Ref Lab Test; Ref lab test method; Report; Test mthd; Typ,Ref lab test method,,Referral lab test method,,Referral lab test method
5297-7,Rheumatoid factor,SERO,Fac; Fact; LAT; Latex agglutination; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RF; Rheum; Rheumatology; Screen; Serology; Serum; SR; UniversalLabOrders,Rheumatoid fact Ser Ql LA,,Rheumatoid factor [Presence] in Serum by Latex agglutination,,Rheumatoid factor LA Ql (S)
6266-1,Lycopersicon lycopersicum Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f25; Immune globulin E; Immunoglobulin E; Lycopersicon esculatum; Lycopersicon lycopersicon; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tomato; UniversalLabOrders,Tomato IgE Qn,kIU/L; kU/L,Tomato IgE Ab [Units/volume] in Serum,k[IU]/L,Tomato IgE Qn (S)
3831-5,Morphine,DRUG/TOX,Addiction; c260; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Morphine sulfate; MS; MSO4; OMPH; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn,Morphine Ur-mCnc,ng/mL,Morphine [Mass/volume] in Urine,ng/mL,Morphine (U) [Mass/Vol]
14638-1,Calculus analysis,CHEM,Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Nephrology; Nominal; Point in time; Random; Renal; Stn; Stone; Stone Analysis; Stones,Stone Analysis-Imp,,Calculus analysis [Interpretation] in Stone,,Calculus analysis [Interp]
43404-3,Chlamydia trachomatis DNA,MICRO,Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Trachoma; Unspecified,C trach DNA Spec Ql Probe+sig amp,,Chlamydia trachomatis DNA [Presence] in Specimen by Probe with signal amplification,,C. trachomatis DNA Probe+sig amp Ql (Specimen)
79540-1,HEDIS 2016-2018 Value Set - PHQ-9 Total Score,PANEL.HEDIS,HEDIS 2016-18 PHQ-9 Total Score; Pan; Panel; PANEL.HEDIS; Panl; Patient Health Questionnaire; PHQ9; Pnl; Point in time; Random; Tot; Totl,HEDIS 2016-18 PHQ-9 Total Score,,HEDIS 2016-2018 Value Set - PHQ-9 Total Score,,HEDIS 2016-2018 Value Set - PHQ-9 Total Score
11038-7,Beta+gamma tocopherol,CHEM,B; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tocopherols; Vit E; Vitamin E,Beta+Gamma Tocopherol SerPl-mCnc,mcg/mL; mg/dL,Beta+gamma tocopherol [Mass/volume] in Serum or Plasma,mg/dL,Beta+gamma tocopherol [Mass/Vol]
28648-4,Oxygen,CHEM,Bld cord; Chemistry; Cord arterial blood; Cord BldA; O2; O2 partial pressure; Partial pressure; PO2; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2,pO2 BldCoA,mm Hg,Oxygen [Partial pressure] in Arterial cord blood,mm[Hg],Oxygen (BldCoA) [Partial pressure]
43413-4,Blood product units requested,BLDBK,BLOOD BANK; Blood product unit; Blood Product Unit (Pack); BPU Requested; Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random,Num BPU Requested,,Blood product units requested [#],{#};{# units},Blood product units requested (BPU) [#]
85977-7,Streptococcus pneumoniae Danish serotype 12F Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 12,S pneum Da 12F IgG Ser-mCnc,ug/mL,Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum,ug/mL,S. pneumoniae Danish type 12F IgG (S) [Mass/Vol]
52776-2,Clotting time.intrinsic coagulation system activated,COAG,Activ; Blood; Clot; Clottable; Coag; Coagulation time; CT.intrinsic; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; ROTEM; R-time; TEG; TEM; Thrombelastography; Thrombelastometry; Thromboelastometry; WB; Whole blood,CT.intrinsic Bld ROTEM,s,Clotting time.intrinsic coagulation system activated of Blood by Rotational TEG,s,Clotting time.intrinsic coagulation system activated ROTEM (Bld)
5388-4,Toxoplasma gondii Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; T gondii; Toxo; Toxoplasmosis; UniversalLabOrders,T gondii IgG SerPl IA-aCnc,EIA Index; REV; units/mL,Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,[arb'U]/mL,T. gondii IgG IA Qn
52773-9,Clotting time.extrinsic coagulation system activated,COAG,Activ; Blood; Clot; Clottable; Coag; Coagulation time; CT.extrinsic; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; ROTEM; R-time; TEG; TEM; Thrombelastography; Thrombelastometry; Thromboelastometry; WB; Whole blood,CT.extrinsic Bld ROTEM,s,Clotting time.extrinsic coagulation system activated of Blood by Rotational TEG,s,Clotting time.extrinsic coagulation system activated ROTEM (Bld)
52780-4,Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited,COAG,Activ; Blood; CF; Coag; Hematology; Heme; Length; MA; Maximum amplitude; MCF; MCF.extrinsic; MCF.platelet inhib; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; ROTEM; TEG; TEM; Thrb; Thrombelastography; Thrombelastometry; Thrombocyte; Thrombocytes; Thromboelastometry; WB; Whole blood,MCF.platelet inhib Bld ROTEM,mm,Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited [Length] in Blood by Rotational TEG,mm,Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited ROTEM (Bld) [Length]
27822-6,Protein S actual/Normal,COAG,Act/Nor; Clot; Clottable; COAGULATION; Coagulation assay; Control; Functional assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; PR; Prot; Prot S; PS; QNT; Quan; Quant; Quantitative; Random; RlTm; S prime; Tilt tube; UniversalLabOrders,Prot S Act/Nor PPP,%,Protein S actual/normal in Platelet poor plasma by Coagulation assay,%,Protein S actual/normal Coag (PPP) [Relative time]
14873-4,pH,CHEM,Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Log molar concentration; Point in time; Random; SmQn,pH BldCo,pH,pH of Cord blood,[pH],pH (BldCo)
19925-7,Volume expired during 1.0 s of forced expiration/Forced vital capacity,PULM,Breathing; End tidal volume; Exp; FEV; FEV1; FEV1%; FEV1/FVC; Forced expiratory volume in 1 second; FVC; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; S prime; VC; Vet; Vol; Vol exp; Volume ratio,FEV1/FVC Predicted,%,FEV1/FVC Predicted,%,
35670-9,Tobramycin,DRUG/TOX,Aminoglycosides; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; NEBCIN; NEBDIN; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TOBJ; TOBRA; UniversalLabOrders,Tobramycin SerPl-mCnc,mg/L,Tobramycin [Mass/volume] in Serum or Plasma,mg/L,Tobramycin [Mass/Vol]
19346-6,Amphetamine,DRUG/TOX,Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Speed; UA; UR; Urn,Amphet Ur-mCnc,ng/mL,Amphetamine [Mass/volume] in Urine,ng/mL,Amphetamine (U) [Mass/Vol]
20079-0,Pressure.support setting,PULM,Lung; Point in time; Pressure; Pressure support setting; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory,Pressure support setting Vent,cm H2O,Pressure support setting Ventilator,cm[H2O],
31037-5,Moxifloxacin,ABXBACT,ANTIBIOTIC SUSCEPTIBILITIES; AST; Avelox; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Moxifloxacin Islt MIC,,Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC),,Moxifloxacin MIC [Susc]
3665-7,Gentamicin^trough,DRUG/TOX,Aminoglycosides; c213; DRUG/TOXICOLOGY; Drugs; Garamycin; Genirr; Genj; Gent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders,Gentamicin Trough SerPl-mCnc,mg/L;mcg/mL,Gentamicin [Mass/volume] in Serum or Plasma --trough,mg/L,Gentamicin trough [Mass/Vol]
51478-6,Mucus,UA,#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Mucous; Mucous Threads; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn,Mucous Threads # Ur Auto,/uL,Mucus [#/volume] in Urine by Automated count,/uL,Mucus Auto (U) [#/Vol]
7415-3,Cladosporium sphaerospermum Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C sphaerospermum; H hordei; Hormodendrum; Hormodendrum hordei; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders,C sphaerospermum IgE Qn,kIU/L,Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum,k[IU]/L,Cladosporium sphaerospermum IgE Qn (S)
7691-9,Pecten spp Ab.IgE,ALLERGY,ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f053; f338; f53; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf338; Scallop; Serum; SR; UniversalLabOrders,Scallop IgE Qn,kIU/L,Scallop IgE Ab [Units/volume] in Serum,k[IU]/L,Scallop IgE Qn (S)
20465-1,Choriogonadotropin,CHEM,CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; MoM; Multiple of the median; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR,HCG MoM SerPl,M.o.M,Choriogonadotropin [Multiple of the median] in Serum or Plasma,{M.o.M},HCG [MoM]
22320-6,Hepatitis B virus little e Ab,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e; HB envelope; Hbe; HBEAB; HBV; HBV e; Hep; Hep B; Hep Be; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; Serum; SR,HBV e Ab Ser Ql,,Hepatitis B virus e Ab [Presence] in Serum,,HBV e Ab Ql (S)
52774-7,Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed,COAG,Activ; Blood; Clot; Clottable; Coag; Coagulation time; CT.extrinsic; CT.fibinolysis supp; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; ROTEM; R-time; TEG; TEM; Thrombelastography; Thrombelastometry; Thromboelastometry; WB; Whole blood,CT.fibinolysis supp Bld ROTEM,s,Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed of Blood by Rotational TEG,s,Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed ROTEM (Bld)
42200-6,DNA double strand Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Native DNA; N-DNA; Point in time; QNT; Quan; Quant; Quantitative; RADIOIMMUNOASSAY; Random; Serology; Serum; SR; Stranded; Strnd,dsDNA Ab Ser RIA-aCnc,IU/mL,DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA),[IU]/mL,DNA double strand Ab RIA Qn (S)
86064-3,Streptococcus pneumoniae Danish serotype 23F Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 23,S pneum Da 23F IgG Ser-mCnc,ug/mL,Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum,ug/mL,S. pneumoniae Danish type 23F IgG (S) [Mass/Vol]
85991-8,Streptococcus pneumoniae Danish serotype 14 Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 14,S pneum Da 14 IgG Ser-mCnc,ng/mL,Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum,ug/mL;ng/mL,S. pneumoniae Danish type 14 IgG (S) [Mass/Vol]
30241-4,Lactate,CHEM,2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Lact; Lactic acid; Level; L-lactate; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous,Lactate BldV-mCnc,mg/dL,Lactate [Mass/volume] in Venous blood,mg/dL,Lactate (BldV) [Mass/Vol]
22735-5,Bicarbonate,CHEM,BIC; bicar; Bicarb; Chemistry; HCO3; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified,HCO3 Spec-sCnc,mmol/L,Bicarbonate [Moles/volume] in Specimen,mmol/L,HCO3 (Specimen) [Moles/Vol]
75539-7,Body temperature,BDYTMP.MOLEC,Art; Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; forehead; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature,Bdy temp Temporal a,deg C; deg F,Body temperature - Temporal artery,Cel;[degF],
335-0,Minocycline,ABXBACT,Aknemin; ANTIBIOTIC SUSCEPTIBILITIES; AST; c128; Dentomycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klinomysin; Lederderm; Mestacine; Minimum inhibitory concentration; Mino-50; Minocin; Minomycin; Mynocine; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty,Minocycline Islt MIC,,Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC),,Minocycline MIC [Susc]
53982-5,Centromere protein B Ab,SERO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cen; CENP B; CENPB; CENP-B; Centromere B; CRST syndrome; Major centromere autoantigen B; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; UniversalLabOrders,Centromere B Ab Ser-aCnc,arb U/mL,Centromere protein B Ab [Units/volume] in Serum,[arb'U];[arb'U]/mL,Centromere protein B Ab Qn (S)
42337-6,Herpes simplex virus 1 glycoprotein G Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; gG; Glycoprot; Glycoproteins; GP; Herp splx; Herpes simplex virus type 1; HSV; HSV1; HSV1 gG; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR,HSV1 gG IgG Ser-aCnc,Index Value,Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Serum,{Index_val},HSV 1 glycoprotein G IgG Qn (S)
38253-1,Carbon dioxide,CHEM,Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; tCO2; To be specified in another part of the message; Unspecified,CO2 Spec-sCnc,mmol/L,"Carbon dioxide, total [Moles/volume] in Specimen",mmol/L,CO2 (Specimen) [Moles/Vol]
86024-7,Streptococcus pneumoniae Danish serotype 19F Ab.IgG,MICRO,ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 19,S pn Da sero 19F IgG Ser-mCnc,ug/mL,Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum,ug/mL,S. pneumoniae Danish type 19F IgG (S) [Mass/Vol]
